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1. INTRODUCTION 
1.1 MOLECULAR RECOGNITION OF ANIONS 
The recognition of anion plays a crucial role in a manifold of essential biological processes 
like enzyme-substrate interactions,1 protein folding,2 or DNA regulation.3 The overwhelming 
majority of enzyme substrates for instance is of anionic nature such as carboxylates in the 
citric acid cycle or nucleotides for DNA polymerization (see Figure 1).4 Hence, the 
importance of anion recognition processes in biological systems can hardly be overestimated. 
To gain a more detailed insight into these complex processes, which are up to this date not 
entirely understood in all their complexity, the development of synthetic model systems is 
worthwhile. 
 
Figure 1. X-ray crystal structure of a ternary complex between a DNA polymerase (green), a negatively charged 
double-stranded oligonucleotide helix (grey) and the anionic substrate thymidine triphosphate (red) (PDB 
access code: 3QEP5). 
In order to create artificial model systems, which are similarly selective and efficient as their 
natural archetypes, a detailled comprehension of the interactions between host and guest on 
the molecular level is indispensable. Such molecular recognition events are based on the 
combination of various attractive non-covalent interactions between receptor and substrate 
like electrostatic, dipole and dispersion interactions, π-stacking, and hydrogen bonding 
together with entropic contributions like for example the liberation of solvent molecules.6 
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While the selective recognition of cations by artificial receptor molecules was readily 
achieved by synthetic chemists, for example by binding alkaline metal ions with the crown 
ethers developed by Pederson as early as 1967,7 the molecular recognition of anions has 
proven to be a somewhat more demanding task. Due to additional electron-electron repulsion, 
anions are larger in size than their corresponding neutral species and even larger in 
comparison to respective cations. Therefore, anion receptor systems need to be comparably 
larger to allow for efficient interaction with their target atom or molecule, thus increasing 
their complexity. Furthermore, even simple inorganic anions occur in a multitude of 
geometries like spherical halides, tetrahedral phosphates, planar nitrates, linear azides or in 
even more complex forms (e.g. oligophosphates). The substrate´s geometry has to be matched 
by the artificial host system for efficient and selective binding. Furthermore, anions feature a 
higher free energy of solution in water.8 Consequently anion receptors have to compete more 
strongly with the surrounding aqueous medium for binding to their substrates and thereby 
replacing the tightly bound water molecules. Finally, organic and also some inorganic anions 
often only exist within a rather small pH window which necessitates the receptors to be in an 
appropriate protonation state at this pH range to allow for efficient molecular recognition. 
In natural systems the amino acid arginine is very often involved in binding events between 
anionic substrates and proteins.9 The energetic stabilization of carboxylates in the 
microenvironment of a protein by the guanidinium moiety in an arginine side chain for 
example outmatches the stabilization by the ammonium group of lysine by large because 
guanidinium is able to form a very stable bidentate hydrogen bonded salt bridge to the 
carboxylate.10 Furthermore, the basicity of the guanidine group ensures protonation over a 
broad range of pH values due to the delocalization of the positive charge over three nitrogen 
atoms, thus guaranteeing for charge-charge interactions and the capability to act as efficient 
hydrogen bond donor.11  
These valuable features are the reason why chemists have regularly and successfully 
designed guanidinium-based artificial host systems for anion recognition.12 Likewise in our 
working group, a guanidiniocarbonyl pyrrole (GCP) motif was developed for efficient binding 
of carboxylates, which can be equipped with a linear peptidic side chain for the formation of 
additional interactions with the substrate.13 Within the framework of the work presented in 
this thesis, novel receptors containing the GCP binding motif in one to three peptidic side 
chains will be developed for the recognition of biologically relevant targets like oligopeptides, 
nucleotides, or nucleic acids. In order to selectively and efficiently bind to these polar 
substrates without the help of metal ions in aqueous medium at physiological pH these new 
host molecules need to overcome the competing influence of the surrounding water molecules 
by means of multiple non-covalent interactions. From these model systems one may then 
deduce general information on the binding events and proceed by applying the so obtained 
knowledge. One potential application might for instance lie within the field of gene therapy.  
1.2 GENE THERAPY 
Gene therapy can be defined as the treatment of human diseases by the transfer of genetic 
material into specific cells of the patients.14 Advances in biotechnology paired with the 
decoding of the human genome lead to the identification of disease-causing genes.15 These 
findings set the road for treating inherited or acquired genetic defects by introducing the 
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missing genetic information, replacing corrupted ones, or by deleting deleterious genes. This 
way the limitations of small molecule therapies can be overcome and yet non-druggable 
diseases are rendered curable. Therefore, the genetic information has to be delivered into the 
desired cell and implemented into the cell´s own genetic code. Different from the majority of 
classical small molecule therapeutics,16 nucleic acids are not able to enter the cell on their 
own. They are repelled from the negatively charged cell surface due to the negative charge of 
their ribophosphate backbone. Furthermore, they are rapidly degraded in the human body by 
DNAses or RNases. To surmount these obstacles transport systems, so called vectors, are 
necessary. Nowadays the most frequently utilized gene carriers are recombinant viruses.17 The 
harmful parts of the virus´ RNA or DNA, e.g. their ability to replicate, are removed and 
replaced with the desired genetic information. Viruses are extremely efficient in delivering 
their genetic material into human cells, because this is the sole cause of their existence and 
ensures their survival. They were able to perfect this mechanism over millions of years. 
However, the gene transfer with designer viral vectors suffers from several severe drawbacks. 
First, the immune system recognizes the viral vectors as pathogens and reacts accordingly. 
This reaction is getting more severe with every treatment. Further, recombinant viruses are 
able to retrieve the removed harmful information by recombination with wild-type viruses and 
may thus become pathogenic again and spread. Another inconvenience is that the length of 
the therapeutic gene is limited to the size of the viral vector´s own genome. Acceptance in 
public is not very good. Finally, the scale-up for industrial production on large scale is very 
difficult to achieve for these biological systems. 
Due to these inconveniences alternatives are necessary. Chemical vectors are the most 
promising ones because they offer the potential to overcome most of the difficulties 
associated with viral gene carriers.18 These non-viral vectors are positively charged molecules 
which are able to condense the DNA into small, positively charged particles which are then 
able to cross the cell membrane. This way, the nucleic acid is also shielded from degrading 
enzymes and its half life in human serum is increased. Chemical vectors are not pathogenic 
and do not trigger an immune response. They can easily be produced in high quantities at low 
cost. However, there are still challenges which need to be addressed for efficient and safe 
delivery of genetic information by means of chemical vectors to enable application in gene 
therapy. Chemical vectors are not yet as efficient as viral vectors and due to their high 
positive charge they are often cytotoxic. Furthermore, they are not selective for a given cell 
type. Therefore, the development of novel chemical vectors with improved properties is 
necessary in order to overcome one of the major limitations of gene therapy – the transport of 
genetic material into the cell. Within this work novel polynucleotide-ligands containing the 
GCP oxoanion binding motif combined with peptidic side chains will be developed and tested 
for their ability to shuttle genetic information into human cells. The results of these 
experiments will improve our knowledge about the interactions between small molecules with 
nucleic acids and help to progress the highly active and still developing field of non-viral 
vectors for the delivery of genetic material. 
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2. BACKGROUND INFORMATION 
2.1 CARBOXYLATE- AND OLIGOPEPTIDE RECOGNITION  
2.1.1 The GCP-Oxoanion Binding Site 
The binding motif 1 depicted in Figure 1 nukleotid enzyme dna ternary komplex 
Figure 2 was introduced by Schmuck in 1999.19 It consists of a relatively rigid, planar 
guanidiniocarbonyl pyrrole moiety, which allows efficient binding of planar oxoanions, e.g. 
carboxylates (2), in aqueous medium. In addition to the salt bridge between the guanidinio 
group and the carboxylate the complex is stabilized by several well-defined hydrogen bonds. 
The guanidinium group is connected to the pyrrole core by an acetyl group, thus decreasing 
the pKA value of free guanidine from 13.5 to approximately 6-7.20 As a consequence the 
potency to act as a hydrogen donor increases dramatically. Furthermore, the intramolecular 
hydrogen bond between the carboxyl and guanidinium group preorganizes the binding motif 
in the correct conformation for oxoanion binding. Finally, by varying R´ the receptor can be 
fine tuned for a given substrate.  
 
Figure 2. Guanidiniocarbonyl pyrrole receptor 1 for the recognition of carboxylates (2).   
This way binding constants between K ≈ 103 and 104 M-1 could be obtained in 10 % 
DMSO/water for N-Ac-Ala-OH.21 This is a very good value when considering that water is an 
extremely competitive medium with regard to the recognition of polar substrates. Thus, by 
combining several weak, non-covalent interactions it was possible to devise artificial host 
systems for effective and selective binding of substrates in aqueous medium. 
  
1 
2 
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2.1.2 Recognition of Short Peptides with Linear Receptors 
Following Lehn´s description the term “receptor” will be used throughout this work as a 
chemical host which binds to a given guest.22 According to this definition, peptide receptors 
are synthetic organic molecules which selectively bind to a peptide sequence via multiple 
non-covalent interactions. The molecular recognition of short peptide sequences is a 
promising goal due to their importance in biochemical and medicinal processes.23 Artificial 
model systems may not only contribute to gain a more substantial understanding of the yet not 
fully understood molecular recognition process itself, they may also serve as new starting 
points for drug development24 or as sensors for diagnostics.25 A prerequisite for potential 
application is always a strong and selective complexation of the target peptide sequence.   
A well studied example for a short peptide sequence of biological importance is the amino 
acid sequence D-Ala-D-Ala-OH (3) and its depsipeptide analogue D-Ala-D-Lac-OH (4), which 
are both shown in Figure 3. The first one is crucial for the mode of action of the antibiotic 
Vancomycin (5) against Gram positive bacteria: Vancomycin binds to this sequence with high 
affinity (K = 2 × 105 M-1) thereby sterically blocking a transpeptidase enzyme from cross-
linking the peptide side chains of peptidoglycan strands, which act as precursors during 
bacterial cell wall biosynthesis. This leads to a decrease of mechanical cell wall stability and 
ultimately to lysis upon osmotic pressure changes. The depsipeptide 4 can be found in 
Vancomycin resistant bacteria: By exchanging an amide for an ester bond the complex 
stability is reduced by a factor of 1,000. This dramatic decrease is due to the loss of one 
hydrogen bond which is instead replaced by an electrostatic repulsion between the oxygen 
lone pairs of the ester and the corresponding carbonyl group in the antibiotic.26  
 
Figure 3. Comparison of interactions between Vancomycin (5) with normal (3) and mutated (4) bacterial cell 
wall-forming peptide sequence. An attractive hydrogen bond is replaced for a repulsive electrostatic interaction 
thus decreasing the affinity of the antibiotic by a factor of 1,000. 
With the help of the combinatorial library 6 shown in Figure 4 comprising 39,304 members 
(343 proteinogenic and non-natural amino acids) Ellman was able to identify receptors which 
bind to the depsipeptide sequence N,N´-Ac2-L-Lys-D-Ala-D-Lac-OH (7) in aqueous solution.27 
The design of Ellman´s receptor mimics that of Vancomycin: The right part corresponds to a 
simplified carboxylate binding pocket, which should be able to bind to both D-Ala-OH and 
5 
3 4 
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D-Lac-OH via three hydrogen bonds. The left side of the receptor on the other hand consists 
of a variable tripeptide, which is free to rotate and should therefore be able to avoid 
electrostatic repulsion between the antibiotic´s carbonyl group and the lactate oxygen. And 
indeed, an on-bead screening with fluorescent labeled substrate revealed binding constants 
five times as high as for Vancomycin. The best receptors mainly contained the amino acid 
sequence L-Tpi-L-His (29 %) and L-N-Me-Phe-L-Disc (20 %) in position AA1 and AA2 (L-
Disc 8 and L-Tpi 9 are shown in Figure 4). For AA3 no clear tendency could be observed. To 
determine the binding constants and to validate the results from the on-bead screening, the 
best performing sequences were synthesized and tested in solution for their binding affinity 
towards N,N´-Ac2-L-Lys-D-Ala-D-Lac-OH (7) with the help of microcalorimetry. The overall 
best receptor 10 with the sequence L-N-Me-Phe-L-Disc-L-Tyr has a binding constant of 3 × 
104 M-1 in water. For the recognition of peptides in aqueous solution this is a good result. 
However, the substrate is fully acetylated and therefore rather non-polar. This facilitates 
binding based on van-der-Waals interactions, but also is significantly different from the actual 
biological relevant substance. 
 
 
 
Figure 4. Schematic representation of receptor library 6 for the substrate N,N´-Ac2-L-Lys-D-Ala-D-Lac-OH (7) 
(left) and receptor of highest affinity 10 with the amino acid sequence L-N-Me-Phe-L-Disc-L-Tyr (right). 
As depicted in Figure 5 Schmuck was able to identify receptors for the dansyl-labeled polar, 
anionic peptide sequence N-Ac-D-Glu-L-Lys-D-Ala-D-Ala-OH (EKAA, 12) with binding 
constants of up to K ≈ 104 M-1 in buffered water at pH 6 by means of screening a 
combinatorial library with 512 peptide-based artificial receptors (11) containing GCP as 
headgroup.13 The best artificial receptor corresponds to the sequence R1 = R2 = lysine and R3 
= phenylalanine side chains (13). The C-terminus of the peptidic substrate 12 is bound by the 
GCP unit – this is the main driving force for the complex formation. Additionally, the 
attached linear tripeptide chain interacts with the substrate by forming a hydrogen bond 
mediated β-sheet with the peptidic substrate. An additional salt bridge is formed between 
glutamate and the lysine ammonium group. In order to verify the substrate selectivity the 
library was also screened against the inverse substrate sequence N-Ac-D-Ala-D-Ala-L-Lys-D-
Glu-OH (AAKE), which resulted in binding constants that were lower by approximately one 
order of magnitude.28 Thus, despite the fact that the complex stability is mainly based on 
undirected, long-range electrostatic interactions the binding constants are strongly dependent 
6 
7 10 
8 
9 
AA1-3 =  L/D:  Arg, Asn, His, Leu, N-Me-Leu, Lys, Phe, N-Me-Phe, Pro, Thr, Trp, Tyr, Tic 
 L: Aib, Chg, Atc, Dapa, Disc, Isn, Tpi, N-Me-Gly  
 34 × 34 × 34 = 39,304 receptors 
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on the amino acid sequence of the substrate. For binding of a polar substrate in water the so 
achieved binding constants are very good. 
 
 
 
Figure 5. General scheme of the tripeptide receptor library 11 and the dansyl-labeled substrate EKAA (12) (left) 
and calculated electrostatic surface potential (right), which shows the charge complementarity between receptor 
13 (GCP-KKF) and tetrapeptide 14 (EKAA). The molecular modeling images are reprinted with permission 
from Schmuck, C.; Heil, M. Chem. Eur. J. 2006, 12, 1339-1348. Copyright 2006 John Wiley and Sons.28 
In another set of experiments the best receptor for the EKAA sequence (CBS-KKF) was 
tested against a rather small combinatorial tetrapeptide library with 320 members.29 With only 
three amino acids present in the library (Ala, Lys and Glu) all substrates were closely related, 
only differing in the absolute configuration of one amino acid (D/L-Ala). Binding constants 
were determined via fluorescence in buffered water at pH 6.1 and ranged from K < 50 M-1 to 
3 × 104 M-1. More importantly, a sequence-dependent stereoselectivity of the receptor could 
be observed as depicted in Figure 6 when the D/L-Ala amino acid of the substrate was fixed by 
strong electrostatic interactions between host and guest at both sides. 
 
Figure 6. Screening of a tetrapeptide library revealed that stereoselectivity is observed at positions where 
receptor and substrate are locked by strong electrostatic interactions at both sides of the stereogenic center 
(right). When this is not the case no stereoselectivity can be witnessed (left). 
These experiments clearly demonstrate the potential of small but focused libraries, which 
allow determining the binding properties of all members. A large and random library would 
not have elucidated the subtle differences of the binding properties. By characterizing all 
possible interactions it was possible to gain a more detailed insight into the binding event as 
would have been the case for a large and random library, in which only a few selected hit 
structures are isolated and characterized. Of course, due to the limitations of small libraries 
with regard to their structural and functional diversity, the library has to be carefully designed 
to give the correct answer for the addressed problem.30   
11 
12 
14 
13 
AA1-3 =  Lys, Tyr, Ser, Glu, Phe, Val, Leu, Trp  
 8 × 8 × 8 = 512 receptors 
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2.1.3 Di- and Multivalent Receptors for Peptide Recognition 
Unlike linear receptors (vide supra) so called tweezer receptors contain two arms which are 
bridged via a template. Depending on the linker structure this kind of molecules are able to 
adopt a preorganized, yet flexible cavity where the substrate is held like between molecular 
tweezers.31 When correctly designed the second side chain is able to form additional attractive 
interactions to the substrate, thus increasing the complex stability and the substrate selectivity. 
The second arm may either be identical to the first one in symmetric tweezer receptors or 
completely different in non-symmetric tweezers. This scheme may of course be further 
expanded to receptors with three or more arms. In general the aim of such a multivalent 
approach is to strengthen the complex stability by means of simultaneous interactions 
between multiple complementary functionalities between host and guest. Optimally the 
binding affinity is then higher than the sum of the corresponding monovalent interactions. 
This approach is also widely made use of in nature, be it bacterium-cell-32, antibody-antigen-
interactions33 or the interplay of transcription factors with multiple sites of DNA.34 In the 
following, this chapter will be limited to di- and trivalent receptors which also corresponds to 
the overall focus of the dissertation.  
Pioneering in the early 90s Still designed a library comprising 10,000 (104) peptidosteroidal 
receptors for enkephalin-like peptides (15, Figure 7).35 The two arms are linked via a steroidal 
cheno-12-deoxycholic acid template and differ in their amino acid sequence. The non-
symmetric substitution was achieved by making use of the different chemical reactivity of the 
two hydroxyl groups at position C3 and C7. With the help of a two-colors-two-substrates-
assay receptors could be identified which were able to selectively bind to one of the two 
differently labeled substrates blue-dye-linker-L-Tyr-Gly-Gly-L-Phe-L-Leu-OH and red-dye-
linker-L-Tyr-D-Ala-Gly-L-Phe-L-Leu-OH in chloroform, which only differ by one amino acid. 
Thus, by selecting beads which are stained by merely one color only those receptors which 
are selective for one of the two substrates could be isolated. When utilizing a flexible instead 
of the rigid steroidal backbone a weakening of binding strength by a factor of five and the 
complete loss of selectivity could be observed. In order to molecularly recognize the 
pentapeptidic substrates used in this work highly flexible receptors seem to be 
disadvantageous, probably due to a loss of preorganization.  
   
Figure 7. The peptidosteroidal tweezer receptor library 15 with two differently substituted side chains was 
simultaneously screened for two substrates labeled with either a blue or a red dye. The image of the screening 
(right) is reprinted with permission from Boyce, R. Li, G. Nestler, H. P. Suenaga, T.; Still, W. C. J. Am. Chem. 
Soc. 1994, 116, 7955-7956. Copyright 1994 American Chemical Society.35 
HN
O
O
Gly
AA1
C3
C7
AA2
NHAc
Gly
AA3
AA4
NHAc
O
15 
AA1-4 =  Ala, Val, Leu, Phe, Pro,  
 Ser, Thr, Lys, Asp, Glu 
10 × 10 × 10 × 10 = 10,000 receptors 
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Wennemers synthesized five closely related, yet distinct tweezer receptors 19 which were 
labeled with a red dye as depicted in Figure 9. The two identical arms were linked via a rigid 
diamino diketopiperazine template.36 A screening for substrate selectivity in chloroform was 
carried out with the help of a substrate library comprising 293 = 24,389 tripeptides (18). 
Binding constants of up to 103 M-1 (chloroform) and high selectivity were observed: Only one 
out of 5,000 sequences is bound, e.g. the receptor with the amino acid sequence L-Tyr-L-
Asn(Trt)-L-Phe exclusively selects peptides containing D-His followed by two hydrophobic D-
amino acids. In order to verify whether a simplified receptor design is still able to achieve 
effective binding, corresponding host systems with only two amino acids per side chain and 
one-armed analogues were screened with the same substrate library. However, as a result of 
the truncation the host system completely lost its binding affinity.  
 
Figure 9. Schematic design of tweezer receptors 19 containing two identical tripeptidic arms labeled with a red 
dye (left) and alternative templates 20-24 (right).  
Under the conditions used for the experiments 19 seems to be the minimum structure which 
is necessary for the recognition of the tripeptides under investigation. In order to evaluate the 
role of the template on the binding properties similar receptors with the same side chains but 
different diamine templates 20-24 were synthesized as well.37 A screening against the same 
substrate library revealed that with only a few exceptions these analogues do not bind to the 
substrates at all. The U-shaped geometry of the original trans-trans-diketopiperazine template 
in 19 highly preorganizes the two arms in a fashion which is suitable for tripeptide binding. 
On the other hand side-chains which are connected via the cis-cis-diastereomer 24 adopt an 
almost linear geometry. Hence, a defined angle between template and side chains as well as a 
distance of approximately 8 Å in between (as is the case for the original diketopiperazine 
scaffold) seem to be superior to all other templates that were tested in this work. Accordingly, 
the template plays a decisive role concerning the affinity between receptor and substrate and 
has to be carefully chosen. However, with the help of these host systems only rather moderate 
affinities could be achieved. Although the selectivity is quite good, it has to be noted that the 
binding studies were only carried out in organic solvent and would probably suffer in more 
demanding aqueous surroundings. 
Further studies concerning the role of the template were conducted by Liskamp.38 As shown 
in Figure 10 tweezer receptors 25 consisting of two identical peptidosulfonamide side chains 
which were bridged by several templates 26-31, which differ in both their flexibility and the 
distance between the amine groups. A dye-label enables screening of a tripeptide library 
containing 293 = 24,389 members (18). The overall highest binding affinity in chloroform was 
19 20 
21 
22 
23 
24 
AA1-3 =  Gly, L/D: Ala, Val, 
 Leu, Phe, Pro, Ser, 
 Thr, Asp, Glu, Asn, 
 Gln, His, Lys, Arg 
29 × 29 × 29 = 24,389 
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found for the scaffold 26 with a binding constant for the peptide D-Ala-L-Asp-D-Ser of 4 × 
103 M-1. Since no binding affinity could be observed for a one-armed analogue it was 
concluded that the second arm is necessary for efficient tripeptide binding. The second best 
receptors with binding constants of up to 8 × 102 M-1 were those with template 27, which is 
more rigid and offers less space between the two arms. Third ranked are the two scaffolds 28 
and 29. The distance between side chains seems to become too large for stable complexation 
of the peptidic substrates. When implementing 30 as linker, the corresponding receptor 
showed high selectivity (> 95 %) for the amino acid sequence Glu-His-X. However, the 
binding affinity was rather poor – this was again probably due to the large distance between 
the two arms. No affinity at all could be observed for 31. The cause for this effect can 
probably be found in the repulsion between the free electron pairs of the sulfonamide oxygen 
groups, which would be in too close proximity in the depicted chair-chair-conformation of the 
template. Instead, it adopts a boat-chair-conformation which results in the loss of tweezer 
structure. A common feature of all examined host systems in this work is the high guest 
selectivity: the amino acid AA1 almost always is an acid; AA2 is a polar amino acid like 
asparagine or histidine. At position AA3, which is bound directly to the resin, no tendency 
could be observed. 
 
Figure 10. Schematic representation of tweezer receptors 25 and templates 26-31. 
The binding studies of library 25 were again conducted in organic solvents. For further 
studies in aqueous solution two more combinatorial tweezer libraries (32, Figure 11) 
consisting of 1,728 members each were synthesized based on the best scaffold 26.39 As before 
the two arms were identical but instead of sulfonamides they now consisted of tripeptides to 
facilitate the combinatorial approach. One of the two libraries contained the template without 
change, for the preparation of the other one the template was derivatized with a hydrocarbon 
chain as illustrated in Figure 11 to reduce its flexibility. Both libraries were then tested for 
their binding affinity towards dansyl-labeled biologically relevant substrates Gly-D-Ala-
D-Ala-OH (33) and Gly-D-Ala-D-Lac-OH (34) in aqueous phosphate buffer. Both substrates 
were linked to the fluorescent dansyl group via a glycine spacer. Characterization of hit 
structures revealed a highly consistent distribution of amino acids at position 3. For the 
dipeptide 33 lysine was reported with 40 % and proline and alanine each with 20 %. The 
results from the screening for the corresponding depsipeptide 34 show that position 3 was 
mainly occupied by proline (50 %), followed by lysine (25 %) and alanine (20 %). The 
conformity was less well pronounced for positions 1 and 2. However, in both cases mainly 
aromatic or aliphatic amino acids were present, which might be due to an interaction of the 
non-polar amino acid side chains with the dansyl label. The glycine linker is probably too 
25 
27 
26 28 
29 31 
30 AA1-3 =  Gly, L/D: Ala, Val, 
 Leu, Phe, Pro, Ser, 
 Thr, Asp, Glu, Asn, 
 Gln, His, Lys, Arg 
29 × 29 × 29 = 24,389 
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short to prevent this unwanted hydrophobic interaction with the fluorescence dye. With a 
binding constant of 5 × 102 M-1 the highest affinity for the depsipeptide in aqueous phosphate 
buffer was found for the amino acid sequence AA1-3 = L-Leu-L-Phe-L-Lys. In chloroform 
binding constants were significantly higher with values of up to 104 M-1. Due to the 
competitive influence of water the achieved binding constants are rather low. 
The comparison between both libraries reveals that the hydrocarbon chain has no significant 
influence on the complex stability. The addition of a third arm, which was indirectly attached 
to the scaffold via the hydrocarbon chain (35), did neither improve binding affinity nor 
selectivity.  
 
 
Figure 11. Schematic illustration of receptor library 32 with an additional hydrocarbon chain. Side chains 
consist of three variable amino acids AA1-3. The substrates D-Ala-D-Ala 33 and D-Ala-D-Lac 34 were labeled 
with a dansyl fluorescence marker. An additional arm attached to the hydrocarbon chain gave library 35. 
Kilburn prepared the combinatorial tweezer receptor library 36 depicted in Figure 12 with 
15,625 (56) members.40 The two non-symmetrical side chains consisted of varying tripeptide 
sequences. A guanidinium headgroup served as both, the scaffold and as a carboxylate 
binding site in order to increase the binding affinity to the C-terminus of the substrate via a 
hydrogen bond enforced salt bridge. The positive influence of the cationic headgroup was 
confirmed by comparing receptors that were bound to the solid support directly via the 
guanidine.41 These model systems lost all of their affinity to the substrate because the 
guanidine could not be protonated any more under these circumstances. An on-bead screening 
of 36 with the dye labeled peptide N-Ac-Lys(dye)-D-Ala-D-Ala-OH (37) in buffered water at 
pH 8.75 revealed that less than 2 % of the library members did bind to the substrate. The 
selected hit structure sequences were highly consistent as shown in Table 2. Additional on-
bead binding studies with the best receptor of the sequence AA1-6 = Gly-Val-Val-Met-His-Ser 
showed a binding constant of 103 M-1. The corresponding diastereomeric substrate N-Ac-
Lys(dye)-Ala-Ala-OH was bound less efficiently with a binding constant of 3 × 102 M-1. 
Binding studies in solution did not lead to an analyzable result. This indicates clearly that the 
resin influenced the binding event on solid support. It is therefore crucial to verify results 
from measurements that involve resin bound substances in solution.  
 
32 
X = NH 33 
X = O 34 
35 
AA1-3 =  Gly, Ala, Val, Leu, Ser, Pro, Asp, Tyr, His, Lys, Gln, Phe 
 12 × 12 × 12 = 1,728 receptors 
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Table 2. Occurrence of amino acids of selected hit structures at each of the six positions of the receptor. 
Position AA1 AA2 AA3 AA4 AA5 AA6 
Amino acid Gly (30 %) 
Ala (30 %) 
Val (40 %) 
Ala (40 %) 
Val (40 %) 
Ala (40 %) 
Met (50 %) 
 
Met (40 %) 
His (30 %) 
Ser (70 %) 
 
 
Figure 12. Non-symmetric tweezer receptor library 36 with a guanidinium template for carboxylate recognition 
and dye labeled substrate N-Ac-Lys(dye)-D-Ala-D-Ala-OH 37. 
In conclusion, multivalent receptors have proven to have the potential to increase both the 
selectivity and the affinity to a defined substrate in comparison to their one-armed analogues. 
By increasing the functional and structural diversity and summing up multiple non-covalent 
interactions the competing influence of the surrounding medium can be surmounted. This is 
of special importance when working in water, which is necessary when biological targets are 
involved. When designing such molecules several things have to be taken into account. First, 
the template that bridges the arms plays a decisive role for the complexation. Optimally it 
preorganizes the arms in a suitable fashion for substrate binding and is still flexible enough to 
allow for its accommodation. For peptide recognition by tweezer receptors the distance and 
angle between the side chains seems to be of utmost importance. Amongst the here presented 
scaffolds the aromatic template 26 has led to the best results. Concerning the side chains, 
building blocks, amino acids offer valuable resources especially when preparing 
combinatorial receptor libraries due to their diversity and the commercial availability. 
Regularly, the two arms are identical, because this way the synthesis is facilitated. Less well 
studied are host systems with two different arms, although this approach offers the possibility 
to add additional functionality. The introduction of a carboxylate binding site, like a 
guanidinium group, into the receptors has proven to be worthwhile for improving binding 
properties. Other things that should be kept in mind are that linkers and labels may also take 
part in the binding event as well as the solid support. Because of that it is advisable to always 
validate on-bead results with additional measurements in solution. 
Although the presented model systems have led to a better understanding on the molecular 
recognition of short peptide sequences and many receptors have promising binding properties 
in organic solvents like chloroform most of them struggle with binding polar peptide 
sequences in aqueous medium at physiological pH. In order to overcome the competitive 
influence of water the development of tweezer receptors with non-symmetric arms and a 
carboxylate binding site, like e.g. Schmuck´s binding motif 1, could be a promising approach. 
AA1-3 =  Gly, Ala, Val, Phe, Gln 
AA4-6 =  Gly, Ala, Ser, Met, His 
5 × 5 × 5 × 5 × 5 × 5 = 15,625 receptors 
36 37 
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2.2 NUCLEOTIDE RECOGNITION IN WATER 
Nucleotides are amongst the most targeted anionic species for artificial host systems, 
because they are ubiquitously present in biological systems where they exercise key roles in 
many cellular functions and thus offer interesting structural features for the benchmarking of 
designed host systems in supramolecular chemistry.42 Nucleotides are for example involved in 
DNA synthesis, energy and electron transfer events,43 cell signaling44 or membrane 
transport.45 These are complex events which require the molecular recognition of a specific 
nucleotide. In order to increase our insight into these processes the development of model 
systems for nucleotide recognition is desirable.  
Due to their structural features, nucleotides are quite interesting targets from a chemist´s 
point of view. As depicted in Figure 13 they consist of three main parts – nucleobase, 
phosphate hinge and sugar backbone. The sugar scaffold is a five-membered ribose for RNA 
and a 2´-deoxyribose ring for DNA building blocks. It connects the phosphate, which is 
attached to the 5´-hydroxy group with the nucleobase at position 1´, this way clearly defining 
the nucleotide´s geometry. The ribose ring itself is rather difficult to target. The hydroxy 
groups offer potential for hydrogen bonding. However, they are hard to differentiate from the 
surrounding water molecules. The hydrocarbon chain can be targeted by means of 
hydrophobic interactions. These are however, rather weak and unspecific. The best artificial 
carbohydrate receptors known today complex their targets with binding constants of merely 
5 × 103 M-1 (pH 7.4, buffered water).46 The phosphate hinge consisting of one to three 
phosphates is an easier target. Due to its multiple negative charges and the presence of several 
hydrogen bond acceptors it may be addressed via hydrogen bonds and salt bridges. In 
comparison to afore mentioned carboxylates, phosphate anions are of tetrahedral shape and 
therefore require a different kind of binding motif. The nucleobases are either purine- (A, G) 
or pyrimidine-based (C, U, T). Their aromatic nature allows for π-stacking while their 
heterocyclic nature and the exocyclic carbonyl and amine functions offer potential hydrogen 
bonding acceptor and donor sites. 
 
Figure 13. Uridine triphosphate 38, adenine (39), guanine (40), thymine (41) and cytosine (42). 
Due to the huge number of nucleotide receptors reported in literature this chapter will only 
focus on systems which have been used in aqueous medium. 
UTP (38) 
A (39) G (40) 
T (41) C (42) 
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2.2.1 Polyamine-Based Receptors 
In 1977 Nakai could show that the naturally occurring polyamines shown in Figure 14 (top) 
putrescine (43), spermidine (44), and spermine (45) are able to bind to nucleotides.47 Binding 
constants were determined by means of an anion-exchange resin method in buffered water at 
pH 7.5. While putrescine only forms a weak 1:1 complex with AMP (K = 82 M-1), spermidine 
is already able to form somewhat stronger 1:1 complexes with ADP (K = 103 M-1). Finally, 
spermine forms even stronger 1:1 complexes to ATP with a binding constant of 104 M-1. 
Obviously the complex formation is becoming stronger the more charge-charge interactions 
are established.  
 
Figure 14. Linear polyamines putrescine 43, spermidine 44 and spermine 45 (top) and exemplary macrocyclic 
polyamine receptors 46-48 (bottom).  
Not surprisingly, the first artificial nucleotide receptors developed by Kimura were 15- to 
18-members macrocyclic polyamines – some exemplary representatives are shown in Figure 
14 (46-48).48 By studying their binding properties towards phosphate, AMP, ADP and ATP 
via polarographic and NMR measurements in buffered water at neutral pH, binding constants 
of up to 4 × 106 M-1 could be observed. Again, ATP was bound strongest followed by ADP 
and AMP. Phosphate on its own was bound weaker than AMP by a factor 10-100, although 
their charge is the same. This effect was attributed to additional hydrogen bonds between the 
nucleobase and the receptor as indicated by NMR. By comparing spermine with its cyclic 
analogue 47 it could also be shown that the macrocycle bound stronger to nucleotides by 
approximately two orders of magnitude. Furthermore, only polyamines which are capable to 
incorporate at least three charges at neutral pH formed stable complexes. 
The next generation of receptors incorporated aromatic rings into the macrocycle. Lehn 
developed the nucleotide host 49 depicted in Figure 15, which is able to bind to nucleotides in 
buffered water at pH 6 with binding constants of up to 2 × 105 M-1 (ATP, NMR titration).49 
The lower charged AMP is bound more weakly by one order of magnitude. Interestingly the 
purine-derived nucleotides AMP and GMP are bound stronger than the smaller pyrimidine 
analogues CMP and UMP by a factor of 10. Lacking the phosphate hinge, the corresponding 
nucleosides are bound weaker by 2-3 orders of magnitude. Thus it can be concluded that both 
the stacking between nucleobase and aromatic scaffold as well as charge-charge interactions 
between the polyammonium chains and the phosphate part of the nucleotide are essential for 
efficient binding. 
43 44 45
47 46 48 
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Figure 15. Macrocyclic polyamine receptor 49 with two naphthalene bridges (left) and phenanthroline linked 
receptor 50 (right). 
Bencini developed the macrocyclic receptor 50 (Figure 15) with a phenanthroline unit inside 
the polyamine macrocycle.50 With the help of potentiometric measurements the highest 
affinity was found for ATP with an extremely high binding constant of 3 × 109 M-1. The 
corresponding nucleotides TTP, CTP and GTP were bound less well by 1-2 orders of 
magnitude. Furthermore, the artificial host could selectively sense ATP thanks to fluorescence 
quenching caused by a photoinduced electron transfer from an amine group of the receptor to 
the excited phenanthroline. Concerning the complex geometry it could be shown by means of 
NMR experiments, molecular modeling and a crystal structure of one of the complexes that 
the polyamine chain forms a cavity for the phosphate enforced by ion pairs and hydrogen 
bonds while the nucleobase stacks to the phenanthroline moiety. A macrocycle analogue with 
reduced ring size and one amine group less lost a huge part of its affinity, i.e. the binding 
constant to ATP was only 106 M-1 – lower by a factor of 3,000. These results demonstrate the 
importance of an appropriate mix of attractive interactions with the correct geometric 
prerequisites needed for efficient recognition of a given substrate molecule. 
 
Figure 16. Tweezer receptor 51 with two polyamine side chains linked via a phenanthroline template (left) and 
receptor 52 with two anthracene units bridged by a polyamine chain. 
Lin designed the tweezer receptor 51 (Figure 16) with two polyamine side chains linked via 
a phenanthroline scaffold; each arm incorporates a phenyl headgroup.51 The binding constant 
for ATP was measured via potentiometry to an excellent 7.9 × 1010 M-1. As expected, NMR 
and molecular modeling revealed charge-charge interactions between phosphate and 
polyammonium side chains and π-stacking between phenanthroline and phenyl groups with 
the nucleobase. These results prove that in order to achieve high binding affinity it is not 
necessary to make use of cyclic systems: Essentially more important for the molecular 
recognition event is the combination of several attractive non-covalent interactions in the 
correct molecular topology for binding. 
A similar system (52), also depicted in Figure 16 was developed by Garcia-España. Two 
anthracene moieties are linked by a polyamine chain.52 As determined by potentiometry the 
49 50 
51 52 
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binding constant for ATP was also similarly high with 109 M-1. ADP and ATP were bound 
consecutively worse by 2 and respectively 3 orders of magnitude. Furthermore, in this work 
also the effective binding constant for ATP at neutral pH was determined to approximately 
5 × 105 M-1. This value was confirmed with the help of a fluorescence titration. It is 
noteworthy that the effective binding constant is lower by more than three orders of 
magnitude compared to the maximal possible one reported by potentiometric measurements. 
 At this point it is important to state that great care has to be taken when comparing binding 
constants. Potentiometric measurements merely represent the binding constant of host and 
guest in a clearly defined protonation state. However, at a given pH there is always an 
equilibrium of many overlapping states. Consequently these K values only refer to single 
theoretical protonation states and are therefore not valid for the macroscopic ensemble but 
represent rather the maximum possible binding constant between two single species in the 
mixture. Without the calculation of an effective binding constant these data cannot be used to 
compare binding constants of different host systems. In above mentioned examples which 
made use of potentiometry the effective binding constant was never calculated with the 
exception of the work conducted by Garcia-España. This is also why many of the extremely 
high binding constants must be put into perspective – the effective binding constants are 
likely to be lower by several orders of magnitude. A more appropriate way to obtain 
comparable binding constants is to utilize methods like NMR, UV/Vis, fluorescence or ITC. 
Whatever the choice may be, it is always strongly advisable to use at least one alternative 
method to verify ones results. 
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2.2.2 Guanidinium-Based Receptors 
A statistical evaluation of 3,003 X-ray crystal structures of phosphate binding proteins 
revealed that two third of them do not make use of metal ions for phosphate binding.53 More 
than half of the metal-free proteins use lysine or arginine instead, especially those with 
phosphate binding sites located on their surface. Consequently, ammonium and guanidinium 
moieties seem to be well suited to bind to phosphate in natural systems, even when directly 
opposed to the competitive influence of the surrounding water molecules and counter ions. 
While most of the receptors reported in literature so far make use of ammonium groups in 
analogy to lysine, only very few host systems have been designed yet which utilize the 
corresponding arginine analogues – guanidinium moieties – for phosphate recognition. 
 
Figure 17. Tweezer receptor 53 for AMP with two tetramethylguanidinio groups (left) and ditopic receptor 54 
for TMP with two bicyclic, chiral guanidinium moieties (right). 
Wang reported the ditopic receptor 53 with two tetramethylguanidinio moieties linked via an 
aromatic scaffold (Figure 17).54 With the help of an NMR titration in D2O he could show that 
already this rather simple molecule is able to bind AMP with K = 7 × 104 M-1.  
In a similar approach Schmidtchen developed the tweezer 54 depicted in Figure 17.55 Two 
chiral, bicyclic guanidinium moieties were connected via an aromatic template. With the help 
of NMR titrations in water a very high binding constant of 106 M-1 to TMP could be observed, 
which was explained by a perfect preorganization of the two guanidine units perpendicular to 
each other. This way the geometry is perfectly matched to bind to the tetrahedral phosphate 
anion via two hydrogen bonded salt bridges. Once more, preorganization and structural 
complementarity proofed to be the key to high affinity. For phosphate binding especially 
ditopic receptors with two anion binding groups seem to be perfectly suitable. 
 
Figure 18. The amphiphilic receptor 55 combines a long hydrophobic chain with a positively charged 
guanidinium headgroup. At the air-water interface the positively charged guanidinium moieties point towards 
the aqueous phase while the hydrophobic part points towards the air. 
The most successful approach towards guanidinium-based nucleotide recognition so far was 
Kunitake´s receptor 55 shown in Figure 18.56 By attaching a long, lipophilic chain to a 
55 
53 54 
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positively charged guanidinium head group amphiphilic host systems were obtained, which 
were able to form micelles or bilayers in aqueous systems. The binding properties towards 
adenine-based nucleotides were characterized via ultrafiltration. With 2 × 107 M-1 the highest 
binding constant was observed at an air-water interface in buffered water at pH 7 for ATP; 
AMP was bound more weakly by one order of magnitude. The results of this approach stress 
the importance of the microenvironment on binding events. Kunitake´s system is actually a 
simple guanidinium moiety which is set into a defined microenvironment with the help of a 
long amphiphilic side chain, yet very good binding constants could be achieved this way. 
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2.2.3 Calixarene- and Cyclodextrin-Based Receptors 
The focus of most of above mentioned nucleotide receptors clearly lies within charge-charge 
interactions to their substrate, sometimes accompanied by stacking between nucleobase and 
one or more aromatic moieties of the host systems. While π-stacking is a powerful tool for 
molecular recognition, especially in aqueous medium, it is not the only possibility to make 
use of hydrophobic interactions in water. The following examples put more focus on this kind 
of interaction, which may contribute substantial amounts to the Gibbs free energy in water. 
Diederich for example made use of a bowl-shaped calixarene with a resorcin[4]arene 
scaffold and four phenylamidinium groups at the upper rim for his nucleotide receptor 56 
(Figure 19).57 Calixarenes form hydrophobic cavities in aqueous medium for the 
accommodation of non-polar guest molecules. NMR titrations in buffered D2O at pH 8.3 
revealed affinities corresponding to the nucleotide guest´s charge (ATP > ADP > AMP > 
cAMP) and binding constants for the 1:1 host-guest complexes of up to 7 × 105 M-1. AMP 
was slightly preferred over the G, C, T, and U derivatives by a factor of 2-3. As derived from 
NMR and molecular modeling the nucleobase is bound within the hydrophobic bowl and the 
phosphate interacts with two phenylamidinium groups via hydrogen bonded salt bridges. The 
preference for A-nucleotides can be ascribed to a superior stereoelectronic complementarity 
of this nucleobase with regard to the inclusion into the bowl-type cavity. 
   
Figure 19. Calixarene-based receptor 56 with four phenylamidinium groups (left) and calculated energy-
minimized structure of the complex with AMP (right). The hydrogen bonding pattern is marked a)-f). For 
simplification PEG-chains R were replaced by methyl groups. The modeling image is reprinted with permission 
from Sebo, L.; Diederich, F. Helv. Chim. Acta 2000, 93-113. Copyright 2000 John Wiley and Sons.57 
Another sort of cavity-forming molecules was used as scaffold by Schneider.58 By 
exchanging two or respectively all seven 6-hydroxy groups in β-cyclodextrin (CyD) for 
aminomethyl moieties the two nucleotide receptors 57 and 58 shown in Figure 20 were 
obtained. CyDs are highly water soluble, cyclic, 1,4-linked oligo-α-D-glucopyranoside units. 
Their topology is toroidal, with a bigger and a smaller opening which present their hydroxy 
groups to the solvent. Although the interior of the cavity is not hydrophobic, it is less 
hydrophilic than water. 58 forms strong nucleotide-complexes with binding constants of up to 
3 × 106 M-1 with ATP (effective binding constant obtained by potentiometry, verified via 
NMR titration). This is stronger by more than one order of magnitude compared to AMP. 
However, this host system is not able to differentiate between nucleobases or ribose and 
deoxyribose sugar moieties. 57 on the other hand forms weaker complexes (e.g. 105 M-1 for 
ATP) but is able to differentiate both between nucleobase and sugar.  
56 
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Figure 20. Cyclodextrin-based receptors 57 and 58 with two and respectively three methylammonium groups. 
With the help of knock-out analogues (e.g. ribose, phosphoribose, phosphate) the different 
contributions to the overall binding constant could be assigned. The main driving force stems 
from ionic interactions between phosphate and methylammonium groups. Surprisingly, the 
nucleobase does not contribute in an advantageous way to the binding. Instead, the second 
most important contribution to the binding strength stems from interactions with the sugar 
moiety. With the help of NMR and molecular modeling it could be shown that the ribose is 
inside the CyD cavity and interacts with it via hydrogen bonds. This is also why the 
deoxyribose is bound weaker than ribose although it is more hydrophobic. The nucleobase-
selectivity of 57 was explained by secondary, rather weak hydrogen bonds between 
nucleobase and upper rim hydroxyl groups. The higher charged 58 pulls the nucleotide deeper 
into the cavity and thus prevents these secondary interactions from forming. Again, these 
experiments are excellent examples for the difficult task to design receptors which have high 
selectivity as well as high affinity to a given substrate. All too often these two desirable 
properties are antipodal. Furthermore Schneider´s work is an instructive example on how 
model systems help to improve our understanding of anion recognition. 
 
Figure 21. Receptor 59 combines four cyclodextrin units with two guanidinium scaffolds. 
Marsura makes use of the same principle by bridging four β-cyclodextrin cavities via two 
guanidinium groups to receptor 59 as depicted in Figure 21.59 The cationic scaffolds allow for 
59 
57 58 
2. BACKGROUND INFORMATION   21 
 
hydrogen bonded ion pairing to nucleotide phosphates while the CyDs display pockets for 
hydrophobic inclusion. NMR experiments in D2O at pH 6.5 revealed that 1:2 host-guest 
complexes are formed to AMP, ADP and ATP with similar binding constants of 2 × 106 M-2. 
Two substrate molecules are bound with similar binding constants representing a non-
cooperative binding mode with two independent complexation steps. NMR also revealed that 
the phosphate hinge interacts with the guanidinium moieties via hydrogen bond enforced salt 
bridges. For ATP and ADP the nucleobase as well as the sugar moiety are inside the CyD 
cavity; for AMP on the other hand only the nucleobase is included. This is probably due to the 
distance between cavity and cationic template, which is becoming too large to be bridged by 
AMP´s monophosphate hinge when sugar and nucleobase are inside the CyD. 
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2.2.4 Peptide-Based Receptors 
As shown for carboxylate and oligopetide recognition (vide supra) peptides have proven to 
be excellent building blocks for the synthesis of artificial anion receptors. Furthermore, they 
are excellent model systems for proteins to investigate e.g. ATP binding sites, which are 
commonly present in many enzymes.  
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Figure 22. β-Hairpin receptor 60 with an Asn-Gly turn (green), a hydrophobic binding pocket composed of two 
Trp amino acids (blue) and two Lys moieties in close proximity for charge-charge interactions (red). 
Waters designed the 12 residue peptide-based receptor 60 depicted in Figure 22.60 It consists 
of the amino acid sequence N-Ac-Arg-Trp-Val-Lys-Val-Asn-Gly-Orn-Trp-Ile-Lys-Gln-NH2 
and adopts a β-hairpin secondary structure – the turn is composed of an Asn-Gly motif. This 
way the aromatic Trp side chains incorporated diagonally into opposing strands form a 
hydrophobic pocket for the nucleobase. Adjacent to both aromatic amino acids are placed two 
Lys moieties in order to help develop charge-charge interactions with the phosphate. A 
fluorescence titration with ATP revealed 1:1 complex formation and a binding constant of 6 × 
104 M-1 in buffered water at pH 5. ADP and AMP were bound significantly weaker by one 
order of magnitude. NMR experiments indicated that the nucleobase is stacked between both 
indole units and that the lysine ammonium groups interact with the phosphate chain. 
 
Figure 23. Receptor library 61 with 4913 members and fluorescence labeled hit structure 62 for ATP binding 
with amino acid sequence AA1-3 = Ser-Tyr-Ser. 
Anslyn used the combinatorial library 61 (R1, R2 = H) shown in Figure 23 with 4,913 
members (173) to obtain ATP selective receptors.61 Two combinatorial tripeptide side chains 
were linked by an aromatic scaffold which preorganizes adjacent groups alternately up and 
down with respect to the benzene ring. As a result, a cavity is formed for substrate 
60 
61: R1, R2 = H  62: R1 = 
AA1-3 =  Ala, Asp, Glu, Phe 69: R2 = 
 Gly, His, Ile,  Leu,    
 Met, Asn, Pro, Gln, AA1-3 = Ser-Tyr-Ser 
  Ser, Thr, Val, Trp, Tyr 
17 × 17 × 17 = 4,913 receptors 
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accommodation. Each arm was attached to the resin via a guanidinium group in order to act as 
phosphate binding site. The third arm was used as connection to the solid phase and features a 
lysine group. The library was screened in buffered water at pH 7.1 with fluorescence labeled 
ATP revealing that approximately 15 % of the library members bind to ATP. Several hit 
structures were re-synthesized and labeled with two different dyes, fluoresceine at the N-
termini of the two arms (R2) and coumarin in the third arm (R1, as internal standard). Binding 
studies in solution verified the binding properties in all but one example. This result again 
stresses the importance to confirm on-bead results in solution. The best receptor with the 
amino acid sequence AA1-3 = Ser-Tyr-Ser (62) binds to ATP with K = 3 × 103 M-1 (pH 7.1, 
buffered water). The competing analytes AMP and GTP were bound significantly less 
effective. The presence of Tyr and Ser in the best receptor hints at hydrogen bonding and π-
stacking between receptor and adenine and/or ribose. By attaching the fluorescence labeled 
receptors onto a solid support they could be used as selective sensors in arrays.62  
 
Figure 23. Combinatorial library of 6859 (193) ATP receptors 63 and hit structure 64. Rationally improved 
compound 65 and crosslinked ATP selective receptor 67 with phosphate (blue) and nucleobase (red) binding 
site. Cyclization was achieved by crosslinking the first and last Lys residue with dimethyl adipimidate (green). 
Matsui derived his ATP selective receptor 67 (Figure 24) in a three step procedure.63 First, 
the nonapeptide library 63 with three combinatorial amino acid positions comprising 6,859 
(193) members was screened with the help of fluorescence labeled ATP. The binding constant 
of the best receptor 64 with AA1-3 = Arg-Lys-Val was determined on-bead in buffered water 
at pH 7 to 6 × 103 M-1. Molecular modeling revealed that Arg and Lys bound to the phosphate 
hinge, while there is no interaction with the nucleobase. Furthermore, Val does not seem to 
take part in the recognition process. Thus Val was replaced by Gly-Gly-Glu-Lys-Tyr-Leu, a 
sequence derived from the adenine binding site of biotin carboxylase. The according receptor 
65 had an increased affinity to ATP (K = 104 M-1). In the last step the so derived peptide was 
crosslinked with dimethyl adipimidate (66) in the presence of ATP. The cyclic peptide 67 
now had a binding constant of 5 × 104 M-1 to ATP. Additionally, in contrary to its precursors 
67 was now able to distinguish between ATP and ADP, AMP, GDP, GTP which are all bound 
significantly weaker by one order of magnitude. When the cyclization was carried out without 
the presence of ATP the affinity of the corresponding receptors was decreased, which 
suggests the formation of alternative cyclization products. This effect was attributed to the 
preoccupation of the two middle Lys moieties with binding to the phosphate hinge. Only the 
AA1-3 =  Ala, Asp, Glu, Phe, Gly, His, Ile, 
Lys, Leu, Met, Asn, Pro, Gln, 
Arg, Ser, Thr, Val, Trp, Tyr 
19 × 19 × 19 = 6,859 receptors 
63 
64 65 67 66 
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
first and the last lysine side chains are then freely available for crosslinking. Unfortunately, 
the authors did not provide additional data in solution to support this hypothesis. However, 
they were able to proof the general concept of combining combinatorial chemistry with 
rational design and molecular imprinting in order to increase the affinity of a library-derived 
receptor – in this case by one order of magnitude.  
In conclusion, nucleotide recognition in water has received considerable attention. Many 
different artificial host systems have been developed and high binding constants of up to 
107 M-1 could be achieved in aqueous medium. The majority of nucleotide receptors are based 
on polyamines – either cyclic or linear ones. Another, less frequently used binding motif for 
ion pairing to the phosphate hinge is the guanidinium group. Very often aromatic moieties are 
implemented into the hosts in order to induce π-stacking. Following a similar approach 
calixarenes or cyclodextrins are used in order to present hydrophobic pockets for nucleobase 
and/or sugar. Another successful principle is the utilization of tweezer receptors which form a 
preorganized cavity for the accommodation of the substrate. Very often two anion binding 
motifs are incorporated – one into each arm. This way the receptors may adopt a geometry 
that matches the tetrahedral shape of the phosphate anion. Hydrogen bonding patterns play a 
crucial role for selective recognition of nucleotides. While strong binding is mainly achieved 
by increasing charge-charge interactions, introducing selectivity is more subtle, because 
purine and respectively pyrimidine nucleobases are quite similar in shape and hydrophobicity. 
Another kind of selectivity in all of the above mentioned systems is the preference – if there is 
any – for tri- over di- and monophosphates, which can easily be explained by additional ionic 
interactions. Peptide-based systems have also been used for the recognition of nucleotides. 
Although the results are not yet as good as for polycationic host systems, the utilization of 
amino acids as building blocks offers the intriguing potential to generate artificial receptors by 
means of rational approaches, combinatorial chemistry or combinations thereof. Therefore the 
development of peptide-based tweezer systems for nucleotide recognition making use of 
aromatic and cationic amino acids and the implementation of a powerful anion binding site, 
like e.g. 1, into each arm might present a promising new approach towards selective and 
efficient nucleotide recognition in water. 
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2.3 NUCLEIC ACIDS 
Selective binding to nucleic acids, i.e. the molecular recognition of double- (ds) and single 
stranded (ss) RNA and DNA, has received considerable attention during the last decades. 
Many functions of life, like storage, readout and transmission of genetic information or 
regulatory processes are linked to nucleic acids and their non-covalent interplay with other 
molecules.42 In order to gain more insight into these complex processes the development of 
small artificial molecules which are able to specifically interact with RNA or DNA is of great 
interest for the development of diagnostic probes and for the treatment of genetic or acquired 
diseases with the help of polynucleotide (PN) sensors,64 RNA and DNA targeted drug 
design,65,66 and delivery agents (see chapter 2.4). While nature has optimized complex protein 
structures which are able to bind to the desired sequence, chemists are trying to develop 
simpler, small artificial polynucleotide binding molecules which retain nature´s ability to 
molecularly recognize DNA and RNA with high affinity and selectivity.  
2.3.1 DNA/RNA Structure 
In order to develop such artificial host systems we have to understand the polynucleotide 
structure first. DNA consists of the nucleotides A, G, C and T depicted in Figure 13 (see 
chapter 2.2). Two such building blocks are linked via their 3´ and 5´ hydroxyl groups by a 
phosphate. RNA incorporates U instead of T. Consequently there are two ends of the strand, 
the 3´- and the 5´-terminus. Polymerases add new nucleotides to the hydroxyl group at 3´ – 
the chain grows into this direction. In the following, when describing polynucleotide 
sequences an annotation from 5´ to 3´ will be utilized. The sugar moiety is a five-membered 
ribose ring in RNA and a 2´-deoxyribose for DNA.  
 
Figure 25. Watson-Crick base pairing and schematic presentation of minor and major groove. The AT pair (left) 
forms two and the GC pair (right) three H-bonds, respectively. 
In 1953 Watson and Crick published their now famous paper about the “Molecular structure 
of nucleic acids: a structure for deoxyribose nucleic acid”,67 in which they could show for the 
first time that DNA forms a double helix. The nucleobases are paired as shown in Figure 25 in 
the center of the helix with adenine (39) pairing with thymine (41) and guanine (40) with 
cytosine (42), respectively. The rather hydrophobic base pairs (bps) are stacked above each 
39 41 40 42 
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other while the ribophosphate chain acts as backbone with the charged phosphate groups 
pointing outwards towards the surrounding water. The stability of the helix mainly stems from 
π-stacking between the base pairs and to a lower extent from the hydrogen bonds between the 
nucleobases. GC pairs contribute more to the thermal helix stability than AT pairs. Again, this 
is mainly due to superior stacking properties and only partly due to the additional hydrogen 
bond. The hydrogen bonding pattern between the nucleobases however is responsible for the 
molecular recognition between the Watson-Crick base pairs.68 The two strands of the double 
helix are antiparallel (the 5´-end of one strand opposes the 3´-end of the other) and 
complementary to each other. Since purine bases are always paired with pyrimidines the helix 
has a regular diameter. Depending on the sequence and the surrounding medium there are 
different kinds of DNA helices – the main representatives are depicted in Figure 26. 
 
Figure 26. From left to right: X-ray crystal structures of A-, Z- and B-DNA (PDB access code: 3QK4,69 2ELG,70 
and 436D71). In general, there are four possibilities to interact with DNA: binding in the minor or major groove, 
to the negatively charged phosphate backbone (red) or intercalation between two base pairs. 
B-DNA is the most commonly found form of DNA in cells. It adopts a right-handed helix 
with 2.0 nm diameter and 10 base pairs and a pitch of 3.4 nm per helical turn or in other 
words with each nucleotide the helix turns by 36° and is prolonged by 0.34 nm. The base 
pairs are tilted by 6° with regard to the helical axis. As a result of the regular helical winding 
the double strand features two openings where the nucleobases are directly exposed to the 
solvent, a narrow and deep minor groove and a wide and deep major groove. While proteins 
mainly bind to DNA via the major groove (e.g. transcription factors),72 most artificial DNA-
binders interact with the minor groove (vide infra). Other possibilities for the interaction with 
nucleic acids are intercalation between two base pairs or unspecific charge-mediated 
complexation to the phosphates.   
A-DNA does not normally occur under physiological conditions but rather under partially 
dehydrated conditions or in RNA-DNA hybrids and DNA-protein complexes.73 While 
B-DNA is usually formed at high humidity (> 85 %), A-DNA forms between 75 and 80 % 
humidity. At even lower values DNA becomes disordered (55-75 %). A-DNA is a right 
handed helix with 2.6 nm diameter and 11 base pairs and a pitch of 2.8 nm per helical turn. 
major groove 
major groove 
minor groove 
minor groove 
intercalation 
phosphate 
backbone 
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This translates to a twist of 33° and a prolongation of 0.26 nm per nucleotide. The base pairs 
are tilted by 20°. As a result the minor groove is wide and shallow while the major groove is 
narrow and deep.73 
Z-DNA is mainly found in GC-rich parts of the nucleic acid especially when cytidine is 
methylated.74 Its structure is very different from the other two types presented here. It is a left-
handed helix with 1.8 nm diameter, 12 base pairs and a pitch of 4.5 nm (twist of -30° and 
prolongation of 0.37 nm per nucleotide). The base pairs are tilted by 7°. In comparison to the 
B-form the guanosines are flipped upside down leading to a zigzag of the backbone. 
Consequently the minor groove is narrow and deep while the major groove in contrary is very 
broad and convex.73 
Hud and Plavec introduced the concept of A- and G-tracts to correlate the DNA-sequence 
with preferred metal-ion accommodation sites and helical structure.75 A-tracts are defined as 
sequences of at least four consecutive base pairs with only AA or AT steps (e.g. the synthetic 
homopolymer pdA × pdT). They adopt a peculiar B-type structure (B*) with an unusually 
narrow minor groove and a high propeller twist (angle between the planes of the two members 
of a base pair). Monovalent cations are predominantly bound in the minor groove, either deep 
inside or on top. Divalent cations are also bound in the minor groove bridging two opposing 
phosphate groups. The minor groove features the electronegative adenine N3 and thymine O2 
and no electropositive amino protons like in GC sequences. However, they do feature the 
electropositive adenine amino group near the center of the major groove, which is why cations 
are almost never found in the major groove in this kind of sequence. 
G-tracts on the other hand are defined by sequences which are rich in GG base steps and 
only contain GC base pairs (e.g. synthetic pdG × pdC). These sequences tend to undergo a 
transition from B- to A-DNA, especially with increasing cation association, which are 
preferentially bound in the major groove. The minor groove though is not very attractive for 
cations due to the electropositive protons of the N2 guanine amino group. 
Most sequences are neither A- nor G-tract and thus defined as generic DNA. Their sequence 
is a mixture of AT and GC base pairs and the consequent helix adopts a canonical B-form 
with cations binding to both minor (inside and on top, preferentially at AT bps) and major 
groove (near N7 of guanine).  
RNA differs from DNA by the 2´-OH group and the replacement of thymidine for uridine. 
Contrary to DNA it is not necessarily a double-strand but also exists in single-stranded forms. 
Therefore it may adopt a broader variety of structures: There exist for example hairpin, 
stemloop, loop and helical structures. As double-strand it either adopts an A or an A´-type 
Watson-Crick right-handed helix with two antiparallel and complementary strands. A´-helices 
are found at high salt concentrations. They accommodate 12 nucleotides per helix turn with a 
pitch of 3.0 nm and a base pair twist of 16-19° from the helical axis. Both structures form a 
very deep major and a rather shallow minor groove. 
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2.3.2 CD-Spectroscopy of Polynucleotides 
Circular Dichroism Spectroscopy 
Circular dichroism (CD) is a specific attribute of an optically active molecule: It interacts 
differently with right- (RCP) and left-circular polarized light (LCP).76 Electromagnetic 
radiation consists of an electric (E) and a magnetic field (B) which oscillate perpendicular to 
each other and to the propagation direction. As depicted in Figure 27 the electric field vector´s 
magnitude in linear polarized light only oscillates in one plane containing the propagation 
direction (k). In circular polarized light the electric field vector rotates around the propagation 
direction with constant magnitude. Per definition a counterclockwise rotation towards the 
observer is left-circular polarized light and the other way round. When passing through an 
optically active medium RCP and LCP are not absorbed equally – one enantiomer absorbs 
more strongly RCP and the other one LCP. CD is the difference in light absorbance. 
 
 
Figure 27. The electric field vector E of linear polarized light only oscillates in one plain containing the 
propagation direction k (left). In circular polarized light the electric field vector rotates around k (right). 
 
Figure 28. Scheme of a CD-spectrometer without (top) and with a CD active sample (bottom). White light from 
a high intensity light source is linear polarized and then converted to circular polarized light in a photoelastic 
modulator (PEM). Right- (RCP) and left-circular polarized (LCP) light are emitted alternately. The detector 
records a voltage signal which is converted to the CD signal. 
With the help of CD-based spectroscopic methods the structure of optically active molecules 
can be studied. Figure 28 depicts the scheme of a CD spectrometer. A strong light source 
emitting white light is needed because CD values are very low in comparison to for example 
simple absorption spectroscopy (10-4 to 10-1 extinction values). In order to achieve results 
above the detection limit and standard deviation, most commonly a strong high-pressure 
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Xenon lamp is used. For biological systems wavelengths between 160 and 400 nm are of 
interest. The white light is passed through a monochromator and linear polarizer to obtain 
linear polarized light of a specific wavelength. A photoelastic modulator (PEM) at an angle of 
45° converts the linear polarized light alternately to RCP and LCP (e.g. with a frequency of 
50 kHz). Without sample the detector records a constant voltage signal. An optically active 
sample on the other hand will absorb more strongly either RCP or LCP. The detector will now 
record a signal oscillating in the frequency generated by the PEM. By dividing the difference 
in absorption (ΔA) through the average signal (Sa) and taking into account an internal 
calibration factor the voltage signal can be converted into the CD signal. With the help of the 
monochromator this is done for a whole spectral range resulting in the CD spectrum of the 
optically active probe. 
Secondary Structure Determination 
The absorption of nucleic acids between 240 and 280 nm stems from π-π*-transitions of the 
aromatic purine and pyrimidine bases. These are planar and optically inactive and 
consequently do not have an inherent CD signal. When incorporated into nucleosides or 
nucleotides however, the adjacent ribose leads to a chiral perturbation of the absorption and to 
a CD signal. The more nucleotides are linked together, the stronger is the CD signal. The CD 
signal of oligonucleotides is even stronger than the sum of the single signals from the 
nucleotide monomers. This is due to the coupling of bases stacked above each other. Finally, 
double-stranded polynucleotides additionally adopt a chiral secondary structure further 
increasing the strength of the chiroptical signal. Each type of secondary structure leads to a 
different CD spectrum which can thus be used to determine the structure of a given nucleic 
acid. Figure 29 shows typical CD signatures of A-, B-, and Z-form helices: A B- to A-helix 
transition was induced by going from high to low relative humidity. The B- to Z-transition of 
the synthetic alternating polynucleotide p(dGdC)2 was triggered by increasing the ionic 
strength of the solvent.77 
  
Figure 29. Left: CD spectrum of A-form DNA at low relative humidity and B-form at high relative humidity. 
Right: B- to Z-transition of p(dGdC)2 occurs when going from low ([Na+] = 10 mM) to high ionic strength 
([Na+] = 3.9 M).77  
The B-form spectrum has a positive band centered at 275 nm, crosses zero around 260 nm to 
a negative band at 240 nm. This curvature is not due to exciton coupling but rather the sum of 
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all the couplings of transitions in all bases. At 220 nm the CD signal is either less negative 
than the band at 240 nm or slightly positive. A-helices show a strong positive band at 260 nm 
which is larger than the corresponding B-DNA band. Between 250 and 230 nm the curvature 
is rather flat, but not necessarily zero. Around 210 nm there is a big, negative band. The Z-
spectrum features a negative band at 290 nm and a positive one at 260 nm and near 200 nm 
again a negative band. 
Determination of Binding Mode 
CD spectroscopy is a useful tool for studying the binding mode of polynucleotide binders, 
also commonly referred to as polynucleotide ligands.78,79 Even when the ligand itself is not 
chiral and thus has no CD signal, upon binding to a nucleic acid it is brought into a chiral 
surrounding which gives rise to an induced CD (ICD) signal. The induced signal originates 
from coupling of electronic transition moments of the ligand and the DNA bases. Therefore 
the observation of an ICD is indicative of a polynucleotide-ligand interaction. The sign and 
intensity of the signal are dependent on the exact location and orientation of the nucleic acid-
binder and the oscillator strengths of the ligand transition.  
Intercalation between base pairs generally leads to small ICDs. When the transition moment 
of the intercalator is oriented along the short axis of the intercalation site (see Figure 30) the 
corresponding ICD is positive. Accordingly, it is weakly negative when oriented along the 
long axis. If the ligand is not placed in the middle of the intercalation site a more complicated 
signal is generated which depends on the lateral displacement and the surrounding base pairs.  
 
Figure 30. Schematic representation of an intercalation site between two planes defined by two base pairs. The 
plain itself has a long and a short axis. 
Stronger ICD signals are indicators for groove binding. These signals can be more intensive 
by up to two orders of magnitude compared to an intercalator signal. When the ligand is 
bound in the minor groove its transition moment is oriented alongside the groove with 
approximately 45° with respect to the helical axis. The resulting ICD signal is strong and 
positive. ICDs caused by major groove binding are more variable due to the larger amount of 
potential orientations in the broad groove. Two exemplary examples for titration experiments 
with the B-type helix forming calf thymus DNA (ctDNA) with the minor groove binder 
berenil 68 and respectively with the intercalator ethidium bromide 69 are depicted in Figure 
31. For the first one a strong positive ICD at approximately 380 nm is observed. The latter 
one gives rise to a weak, negative ICD band at 375 nm. 
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Generally, if only the intensity and not the shape of an ICD band changes during a titration 
experiment this is a strong indicator for a single binding mode. Alterations in the shape may 
be a hint for multiple binding modes, but might also originate from conformational changes of 
the polynucleotide or stem from ligand-ligand interactions. Ligand dimer formation or higher 
ordered complexes which bind to DNA often lead to a bisignate band shape with a positive 
and negative part localized on either side of the ligand´s absorption maximum. This kind of 
signal is due to exciton coupling caused by the close proximity of two identical transition 
moments of the same energy. Typically this is only the case for groove binders. 
 
 
 
 
Figure 31. A typical CD titration experiment of the minor groove binder berenil 68 with the B-helix forming 
ctDNA gives rise to a strong positive ICD signal (left). The CD titration with the intercalator ethidium bromide 
69 leads to a weak, negative ICD signal (right). The graphs of the CD experiments are reprinted with permission 
from Macmillan Publishers Ltd: Nature protocols, Garbett, N. C. Ragazzon, P. A.; Chaires, J. B. 2007, 3166-
3172. Copyright 2007.79  
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2.3.3 Thermal Melting Experiments 
The stability of secondary nucleic acid structures can be determined with the help of thermal 
melting experiments.80 When paired in a double helix the molar UV absorptivity of the 
nucleobases is lower than would be expected from the sum of all nucleobases. This 
hypochromicity is due to the coupling of transition dipoles between adjacent, stacked 
nucleobases and can be measured by heating a polynucleotide and observing the absorbance 
at 260 nm. Upon denaturation the UV absorption normally increases by 20-30 %.  
 
Figure 32. Thermal melting experiment of duplex RNA recorded at 260 nm (left) and calculation of the 1st 
derivative (right) allow the determination of the melting point Tm. 
Upon heating the helix starts unwinding in a cooperative process which leads to a sigmoidal 
UV curve (see Figure 32). The point of highest slope, i.e. the point where 50 % of the duplex 
is unwound, is called melting point Tm. It can be calculated by plotting the first derivative of 
the absorbance against the temperature. AT base pairs contribute less to the stability than GC 
base pairs. Consequently sequences with high GC content have higher melting temperatures. 
Homopolymers (e.g. pdA × pdT) generate steeper melting curves than mixed sequences (e.g. 
ctDNA). In mixed polynucleotides AT regions start melting first, followed by mixed and 
finally by GC-rich regions. Hence, the melting curve is broader. The melting temperature can 
also be utilized to estimate the affinity of a nucleic acid ligand.81 Generally high thermal 
stabilizations correlate with high binding constants. 
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2.3.4 Isothermal Titration Calorimetry 
Another method to characterize binding events between nucleic acids and their ligands is the 
isothermal titration calorimetry (ITC), which allows direct determination of the thermo-
dynamic parameters ΔH, K and n.82  
 
Figure 33. Scheme of an ITC: Reference and sample cell are isolated in an adiabatic jacket. Sample is injected 
via a rotating syringe (left). Heat vs. time is recorded during experiment, integrated and plotted against molar 
ratio. Binding enthalpy (ΔH), binding constant (K), and stoichiometry (n) are obtained by curve fitting (right). 
As shown in Figure 33 (left) a calorimeter consists of two cells built from thermal highly 
conductive material (e.g. gold) placed in an adiabatic jacket. One is a reference and the other a 
sample cell of known volume. The sample cell contains one binding partner (receptor or 
ligand), the reference cell pure solvent/buffer. The other binding partner (ligand or receptor) is 
injected by a high precision, computer-controlled rotating syringe in precisely known 
aliquots. The experiment is carried out at constant temperature which is constantly controlled 
by an external reference (ΔT2). Upon injection the association between receptor and substrate 
generates (exothermal) or consumes (endothermal) heat. The heat difference between sample 
and reference cell (ΔT1) is measured with the help of half-conducting thermopiles and kept 
constant. The amount of thermal power which has to be applied in order to compensate for the 
heat of reaction is applied or withdrawn and recorded. Thus the measurable quantity in an ITC 
experiment is the thermal power as a function of time. An exothermal experiment results in 
negative and an endothermal one correspondingly in positive heat spikes which are in the 
range of µcal. Figure 33 (right) depicts the results of a typical ITC experiment. During the 
first few injections there is a large excess of binding partner in the sample cell. Consequently, 
the entire amount of titrant is bound – a large heat signal is the outcome. At a certain point, 
the titrate in the sample cell starts to saturate and not all of the injected substance is bound - 
the heat becomes smaller. At the end of the experiment no binding occurs anymore and only 
the heat of dilution is measured. Each injection leads to a spike which is integrated over time 
and plotted against the molar ratio of receptor/substrate to give a sigmoidal curve. Fitting 
these data with a non-linear least squares method gives the reaction enthalpy (ΔH) as the 
difference between the baseline at the beginning of the binding event and after saturation. The 
binding constant (K) can be calculated from the slope and the stoichiometry (n) can be read 
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out at the point of highest slope. With the help of equation (1) the reaction´s Gibbs free 
energy (ΔG) and entropy (ΔS) can be calculated. R is the universal gas constant and T the 
temperature used for the experiment. 
ΔG  =  -RT ln(K)  =  ΔH – TΔS (1) 
A prerequisite for ITC measurements is that the binding event has a heat signature and that 
the resulting data points generate sufficient curvature of the integrated heat signals for fitting. 
The degree of curvature can be estimated by the C-value which should be between 10 and 100 
for an optimal binding experiment and can be calculated with equation (2). 
 C = n K [binding sites]  (2) 
The stoichiometry n multiplied with the binding constant K and the concentration of binding 
sites gives C. The number of binding sites can be approximated for nucleic acids as the 
concentration of phosphates. Too small values (< 1) lead to shallow, non-descriptive 
isotherms. With too big values (> 1,000) the transition region is devoid of data points. Neither 
extreme can be fitted unambiguously. Generally, for high binding constants relatively low 
concentrations must be used and vice versa. It has to be assured however that the heat of 
binding is higher than the detection limit of the instrument. Binding constants in the range 102 
- 109 M-1 are directly accessible, binding constants of up to 1012 M-1 with the help of 
competitive binding assays. ITC is a very sensitive method and great care has to be taken 
during sample preparation. All binding data have to be corrected for the heat of dilution of 
receptor and ligand which have to be determined in separate control experiments. If carried 
out correctly all important thermodynamic quantities of a binding event can be determined in 
just one experiment with the help of microcalorimetry. Concerning DNA-ligand interactions 
the energetic profile can give insight into the binding event. Several energetic barriers have to 
be overcome for binding, like conformational changes and the loss of translational and 
rotational freedom upon complexation. Advantageous contributions stem from liberation of 
bound water and counterions to the solvent and from molecular interactions between host and 
guest, like hydrogen bonds, ion pairing, and van-der-Waals forces. The exact knowledge of 
enthalpic and entropic contributions helps to elucidate which of these molecular interactions 
are involved in a given binding event.83 
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2.3.5 Specific DNA/RNA Recognition 
With the help of above mentioned methods together with NMR and X-ray crystal structure 
determination an impressive number of nucleic acid binding molecules have been 
characterized. In the following an excerpt of instructive examples of natural84 and synthetic 
systems85,86 will be presented. As already mentioned, in general four possibilities exist to 
interact with nucleic acids: unspecific interactions via charge interactions to the phosphates, 
intercalation between two base pairs or minor and major groove-binding. 
Ribophosphate-Binding and Counter Ion/Hydration Shell 
Double-stranded nucleic acid helices are linear polyanions. The pKA value for the hydroxy 
group of the bridging phosphates is < 1. Consequently, at physiological pH each of these 
phosphates carries one negative charge. In order to stabilize their structure in aqueous 
medium ds-polynucleotides accommodate metal cations for charge compensation. Manning 
described the metal ion binding to DNA as “counter ion condensation”.87 The metal ions are 
bound within a few angstrom of the surface keeping their primary hydration shell but are free 
to move along the helix thereby forming a hydrated counterion cloud around the negative 
charge density of the ribophosphate backbone. A typical B-type helix has 0.76-0.88 
monovalent counter ions per phosphate group. The associated metal ions strongly influence 
the physical nucleic acid properties. Binding events for example are strongly dependent on the 
salt concentration of the solvent. Furthermore a nucleic acid accommodates per average three 
molecules of water per phosphate. Extensive crystallographic studies with the Dickerson-
Drew dodecamer d(CGCGAATTCGCG)2 depicted in Figure 26 as typical B-type DNA 
representative revealed a complex hydration shell at low temperature.88 In the major groove 
there are two hydration layers. The first one is composed of 19 water molecules oriented 
around the N and O atoms of the nucleobases and on top of that is a second hydrate layer with 
36 water molecules. As shown in Figure 34 in the minor groove there is a highly ordered, 
zigzag patterned shell of water partially consisting of sodium cations, the so called “spine of 
hydration”.89 Around the first shell there is a second spine of hydration, again highly ordered. 
Therefore especially upon groove binding cations and water molecules are liberated to the 
solvent – an entropically favored process.90 
  
Figure 34. Crystal structure depicting the primary and secondary “spine of hydration” in the minor groove of 
B-DNA and schematic presentation thereof (left). The crystal structure is reprinted with permission from Shui, X. 
McFail-Isom, L. Hu, G. G.; Williams, L. D. Biochemistry 1998, 37, 8341-8355. Copyright 1998 American 
Chemical Society.89 Non-specific ribophosphate backbone binder spermidine 44 and spermine 45 (right). 
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Other molecules which compete with the metal counter ions for the unspecific electrostatic 
binding sites at the ribophosphate backbone are mainly polyamines like spermidine (44) and 
spermine (45). These are known to bind to phosphate (see chapter 2.2) and are present 
ubiquitously in eukaryotic cells, where they are thought to play multiple roles in the cell by 
interacting with nucleic acids, e.g. the modulation of protein-DNA interactions during cell 
proliferation.91 
Intercalators 
The concept of intercalation was first observed by Lerman in his studies concerning the 
interaction of aminoacridines like proflavine (70, Figure 35) with B-DNA.92 The polycyclic 
aromatic amine is inserted between two base pairs, their aromatic faces stacked above each 
other. This leads to an extension of the double helix by approximately the van-der-Waals 
thickness of a phenyl ring (3.4 Ǻ) and partial unwinding of the helix at the binding site. These 
physical changes have come to be known as the most important characteristics of DNA 
intercalation. The major driving forces for intercalation are π-stacking and electrostatics. All 
intercalators feature an aromatic polycyclic and electron deficient ring structure, which is in 
general positively charged at neutral pH and of more or less the same size as a base pair. 
Alternating pyrimidine-purine base-steps are preferred because they are easier to separate than 
their pyrimidine-pyrimidine and purine-purine analogues. Preferences apart from that are 
mainly due to additional interactions of non-intercalating parts in the grooves. From an 
energetic point of view there are many different interactions contributing to the overall 
binding energy. Hydrophobic transfer of the intercalator from the solvent to the binding site 
releases highly ordered water molecules and counterions – an entropically favored process. 
An enthalpic penalty has to be paid for the conformation change of nucleic acid. Enthalpy on 
the other hand is gained by π-stacking, van-der-Waals interactions, hydrogen bonding and the 
reduction of coulomb repulsion between phosphates in the unwound ribophosphate backbone.  
  
Figure 35. Intercalators proflavine 70, daunomycin 71, and adriamycin 72 (left). Crystal structure of 
daunomycin-d(CGTACG)2 complex (right) (PDB access code: 308D93). 
Many natural products bind to DNA via intercalation. The natural glycoside daunomycin 
(71) for instance intercalates into DNA as depicted in Figure 35. The antibiotic active 
compound is produced by S. peuceticus and S. coeruleorubidus and is used as cytostatic drug 
in cancer therapy.94 The crystal structure with the hexamer duplex d(CGTACG)2 shown in 
Figure 35 reveals that the amino carbohydrate lies within the minor groove while the methoxy 
containing ring is in the major groove. The stacking of the two adjacent rings perpendicular to 
70 
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the long axis of the base pairs separates them by 3.4 Ǻ but does not lead to unwinding at the 
intercalation site. The neighboring base pairs however are unwound by 8°. The tertiary 
hydroxy group donates hydrogen to the guanine N3 and at the same time acts as an acceptor 
for the amine group of respective guanine. The binding constant at neutral pH was determined 
as 6 × 106 M-1.95 The binding energy originates from large favorable enthalpy minus 
unfavorable entropic contributions. This energetic signature is typical for intercalators. 
However, alternative energy profiles exist, too. The structurally very similar adriamycin 72 
which only differs by one hydroxyl group intercalates stronger by a factor of 10. Here the 
entropy contributes a large favorable amount of energy to the binding event while enthalpy 
only contributes a little. Furthermore these two molecules are a good example that a similar 
structure does not automatically lead to a similar energetic profile. 
Due to their aromatic structure intercalators often absorb light in the visible range. As 
depicted in Figure 36 ethidium bromide (EB, 69) for instance is a red phenanthridine dye 
which intercalates into nucleic acids.96 Upon binding its fluorescence intensity at 600 nm 
increases by a factor of 50-100.97 This is why it is commonly used to stain nucleic acids, for 
example in gel electrophoresis experiments.98 Ethidium bromide´s binding constant for 
generic DNA was determined via fluorescence experiments in buffered water at pH 7.5 to K = 
3 × 106 M-1 with saturation taking place at 0.33 equivalents EB per base pair.99 Thus not all 
potential intercalation sites are occupied. It is true for all intercalators known so far that the 
maximum number of guest molecules which can be introduced into a double helix is 0.5 eq. 
Intercalators maximally bind to every second base pair. For more complex intercalators the 
maximum is 0.33 eq. This empiric observation is known as the “nearest neighbor principle”.73 
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Figure 36. Upon binding to nucleic acids the fluorescence intensity of the ethidium bromide (69) signal at 
600 nm increases by a factor of 50-100. 
Schmuck designed the bifunctional intercalator 73 depicted in Figure 37, which is able to 
differentiate between ds-DNA (B-helix) and ds-RNA (A-helix) at pH 5 in buffered water 
independently of the base pair sequence.100 At this pH the intercalator (0.3 eq) is able to 
thermally stabilize ctDNA by 7.3° while destabilizing the RNA pA × pU by 1.5°. Furthermore 
different spectroscopic answers are reported for RNA and DNA. At pH 7 neither stabilization 
nor spectroscopic differentiation could be observed. Determination of the complex stability 
revealed binding constants of up to 106 M-1 at pH 7 and of up to 6 × 106 M-1 at pH 5. The 
difference of binding mode and affinity can be attributed to the protonation of the GCP 
moiety at pH 5 (6 < pKA < 7). With the help of CD spectroscopy and molecular modeling 
defined binding modes could be determined at pH 5: 73 binds into the major groove of ds-
RNA by formation of a dimer with stacked pyrene moieties thus lacking intercalation. For 
ds-DNA however intercalation of the pyrene moiety was observed while the GCP interacted 
69 
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with the phosphate in the minor groove additionally forming five to six hydrogen bonds to the 
nucleobases. 
 
Figure 37. Bifunctional 73 combines an intercalating pyrene (blue) and an oxoanion binding motif (red). 
Schmuck also conducted an extensive structure-activity relationship study.101 Some 
exemplary potential bifunctional aryl-GCP intercalators (74-77) are depicted in Figure 38. It 
could be shown that the linker must be long enough to allow for simultaneous intercalation 
and minor groove binding. Ligand 77 only weakly interacted with nucleic acids because it 
was equipped with a too short linker. Acridine (74) seems to be the minimal size for 
intercalation – the according naphthalene derivatized ligand 75 did not intercalate into 
polynucleotides. The implementation of additional charges as in 76 further helped to improve 
the affinity, e.g. in comparison to the original ligand 73 the binding constant for ctDNA in 
buffered water at pH 7 was increased from 106 to 6 × 106 M-1. Lastly, it could also be shown 
in a cancer cell assay that high binding correlated with antiproliferative activity most likely 
due to more efficient intercalation of the pyrene chromophore. 
 
Figure 38. Bifunctional aryl-GCP ligands 74-77 were used for a structure-activity relationship study. 
Another principle derived from nature is bisintercalation, for instance by the naturally 
occurring antitumor antibiotic (-)-sandramycin 78 (Figure 39) as characterized by Boger.102 
The binding constant to ctDNA has been determined via fluorescence titration in buffered 
water at pH 7.4 to 3 × 107 M-1. The crystal structure of a complex with d(GCATGC)2 
illustrates some general principles for bisintercalation. Implementation of the two aromatic 
moieties most commonly takes place between next neighboring sites. In this case the 
depsipeptide linker rearranges its amide bonds to the more unfavorable cis configuration in 
order to span two instead of three base pairs. Next, the linker binds in the more accessible AT 
rich minor groove – also the biggest part of complex stability originates from non-covalent 
interactions of the depsipeptide with the groove. Finally, similar to mono intercalation, 
pyrimidine-purine sites are preferred for bisintercalation, too.  
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Figure 39. (-)-Sandramycin 78 and NMR structure of its complex with d(GCATGC)2. Reprinted from Tse, W.; 
Boger, D. Chem. Biol., 11, 1607-1617. Copyright 2004, with permission from Elsevier. 84 
The concept of bisintercalation was very successfully utilized by Chaires.103 By covalently 
linking two daunomycin molecules via an aromatic linker of 7 Ǻ lengths the bisintercalator 79 
depicted in Figure 40 was obtained. An extremely high binding constant of 3 × 1011 M-1 to 
herring sperm DNA could thus be achieved in buffered water. This affinity is four orders of 
magnitude higher than that of the monomer and almost in the region of specific protein-DNA 
interactions. The linker length corresponds exactly to the spacing between two daunomycin 
monomers as derived from the crystal structure depicted in Figure 35. By solving the crystal 
structure of artificial 79 with d(CDATCG)2 it could be shown that much of the original 
binding interactions stay intact for the bisintercalator.104 Intercalation takes place at CG steps 
and hydrogen bonding between the hydroxyl group and guanine is retained. The sugar 
moieties are still located in the minor groove but in contrast to the monomers they are lifted 
somewhat from the groove floor thereby forsaking the hydrogen bonding between the amines 
to the floor. The unwinding of DNA now is taking place more to the middle of the two 
intercalation sites and not at the neighboring base pairs. The energetic profile shows that 
binding affinity is dominated by a huge favorable enthalpy opposed by unfavorable entropy. 
The entropy penalty is higher than for the monomer which is probably due to the loss of 
rotational freedom of the linker upon binding. 
 
Figure 40. Two daunomycin moieties are linked via an aromatic spacer in the bisintercalator 79. 
Intercalation into base pairs is a very powerful method to achieve high binding constants to 
nucleic acids. Intercalators are polycyclic, often positively charged aromatic molecules which 
interact with the aromatic faces of their adjacent base pairs. Very high binding constants can 
be achieved by linking two of these molecules with an appropriate linker. There has been 
reasonable success in utilizing intercalators for the treatment of e.g. cancer or as antibiotics. 
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Unfortunately intercalation almost always comes at the cost of very high toxicity. Thus 
despite their usefulness the development of DNA-binders with alternative mode of interaction 
is desirable. 
Minor Groove Binders 
In contrary to proteins most natural and artificial groove-binding molecules bind to the 
minor groove due to its narrower, deeper structure which is better suited for interactions with 
small molecules, where they are able to interact with the deoxyribose groove walls and the 
groove floor which presents the edges of the base pairs as depicted in Figure 41.105 Free 
electron pairs are schematically displayed as circles with dots and amine groups as circles 
with an H. GC base pairs offer the free guanine N3 electron pair as hydrogen acceptor (Acc) 
and the guanine NH2 group as hydrogen donor (Do). With some spacing cytosine presents its 
O3 as acceptor. CG base pairs do possess the same Acc/Do/Acc pattern with reversed spacing. 
AT presents three hydrogen acceptor sites to the minor groove: the adenine N3 and in some 
distance the two free electron pairs of the thymine O3. For TA base pairs it is the other way 
round. 
         
Figure 41. Scheme of the hydrogen acceptor (circles with dots) and donor sites (circles with H) as they are 
presented on the floor of the minor groove.  
A very well studied group of minor groove binders is that of the naturally occurring antiviral 
antitumor antibiotics netropsin (80, from S. netropsis) and distamycin (81, from S. distallicus) 
shown in Figure 42. By binding to B-DNA they are able to interfere with both transcription 
and replication. Both molecules consist of repeated pyrrole (Py) subunits bridged by amide 
bonds and feature positively charged nitrogen-based headgroups at physiological pH. 
Netropsin incorporates a guanidine group at both ends and distamycin a charged amidine 
group at one end and an uncharged formyl moiety at the other one. This is a very typical 
design for minor groove binders. Very often simple aromatic rings like pyrrole, imidazole or 
benzene are linked via freely rotatable bonds. This way these molecules are able to adapt to 
the winding of the minor groove. Recognition of the groove mainly is a recognition of shape 
and curvature. This is also why in contrary to intercalators most minor groove binders prefer 
AT rich sites with narrower and deeper grooves where they can interact better with the groove 
walls via electrostatic and van-der-Waals contacts as well as hydrogen bonds. GC rich sites 
possess broader and shallower (due to the guanine amine) grooves and are less well suited for 
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accommodation of a ligand. Furthermore the negative electrostatic potential is greater in AT 
rich grooves making them better suited for positively charged ligands.106 Upon binding there 
is no distortion or unwinding of the nucleic acid as would be the case for intercalation. It is 
rather the ligand which has to change its conformation. The crystal structure of the 1:1 
complex of B-DNA with netropsin in Figure 42 was solved by Dickerson and clearly 
illustrates the shape-selective recognition in the narrow AT minor groove of the Dickerson-
Drew dodecamer.107 Netropsin spans approximately four AT base pairs with the carboxamide 
NH-groups pointing towards the minor groove floor where they form hydrogen bonds to the 
edges of AT and TA base pairs (adenine N3 and thymine O2). Upon binding several water 
molecules are displaced from the minor groove. Electrostatic contacts are formed between the 
guanidinium groups and the phosphates. Furthermore 80 forms van-der-Waals contacts with 
the ribophosphate groove walls. Thereby, the helical structure is only slightly altered. 
Netropsin does neither bind to ss-DNA nor to RNA or DNA/RNA hybrids. It actually 
promotes A to B and Z to B transformations, thus clearly underlining its propensity to bind to 
B-type DNA. While analogue 1:1 complexes are also known for distamycin Wemmer could 
show with the help of two dimensional NMR spectroscopy that 81 is also able to form 2:1 
complexes within the minor groove of sequences containing more than four consecutive AT 
bps.108 Two distamycin molecules are accommodated antiparallelly within the groove which 
consequently has to broaden. By accommodating two instead of one ligand the increased 
hydrophobic interactions overcompensate the enthalpic penalty which has to be paid for the 
changes of secondary DNA structure. Netropsin is probably prevented from forming a 2:1 
binding mode due to its charged headgroups at both ends.  
   
Figure 42. X-ray crystal structure of the 1:1 complex of netropsin (80) with the Dickerson-Drew dodecamer B-
DNA (left, PDB access code: 101D)109, scheme of a 2:1 complex of distamycin (81) and d(GTATATAC)2 and X-
ray crystal structure thereof (right, PDB access code: 378D).110 The hydrogen bonding pattern is schematically 
presented for both conjugates.  
More detailed calorimetric titration studies with the sequence d(GCCAAATTGGC)2 in 
buffered water at pH 7 revealed similar binding constants for the 1:1 complex of both 
molecules.111 Netropsin binds with K = 4 × 107 M-1 and distamycin with 3 × 107 M-1. Both 
processes are driven by favorable enthalpy. The enthalpic stabilization for distamycin is larger 
than that for netropsin (ΔH = -12.3 versus -7.5 kcal mol-1). This is probably due to the 
increased number of interactions of the additional pyrrole ring within the groove. Entropy on 
the other hand is only favorable for netropsin and not for distamycin (ΔS = 9.3 cal K-1 mol-1 
versus -8.0 cal K-1 mol-1) which was attributed to differences in the release of counter ions and 
water molecules from the groove. The second distamycin molecule binds more weakly than 
80 81 
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the first one by one order of magnitude with K = 3 × 106 M-1 despite a more favorable 
enthalpy (-18.8 kcal mol-1) originating from improved van-der-Waals contacts of the stacked 
monomers to each other and to the groove wall. The reason for that is that the formation of a 
2:1 complex leads to a huge entropic penalty (-34.0 K-1 mol-1) preventing higher affinity. 
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Figure 44. The fluorescence intensity of DAPI (82) increases upon binding to DNA minor groove. 
Another prominent minor groove binder is 4´,6-diamidino-2-phanylindole 82 (Figure 44), or 
short DAPI, which was synthesized by Dann in 1971. Although it was not, as usually 
planned, a successful drug against trypanosomiasis it is nowadays one of the most commonly 
used dyes for staining DNA. It is a minor groove binder with selectivity for AT rich 
sequences. Its blue fluorescence signal at 460 nm increases strongly upon binding to DNA. 
When binding to RNA the fluorescence intensity is not increased as strongly and the 
maximum shifts to 500 nm – it is thus able to discriminate between DNA and RNA. Since 
DAPI easily crosses cell membranes it is extensively used for staining cell nuclei or for the 
visualization of nucleic acids in both live and fixed cells.112 
In theory, sequence selectivity and the ability to span several base pairs make minor groove 
binders the ideal molecules for the sequence-specific recognition of nucleic acid sequences 
which are long enough to be unique in a cell. This would clear the road for very specific 
polynucleotide targeting drugs with little side effects or toxicity (cf. intercalators). While 
minor groove recognition itself is mainly driven by size complementarity, sequence 
selectivity was derived from selective recognition via hydrogen bonds of donor and acceptor 
sites presented at the minor groove floor by Dervan.113 His ligand design is similar to the 
naturally occurring distamycin. By replacing one pyrrole (Py) for an imidazole (Im) ring, the 
polyamide ImPyPy (83) depicted in Figure 46 was obtained. This compound forms 
antiparallel 2:1 complexes in the minor groove selectively to sequences of the type XGXCX 
(X = A or T). The stacked Im/Py pair selectively recognizes GC over CG base pairs and vice 
versa Py/Im prefers to bind to CG. Both combinations do not bind well to AT or TA base 
pairs. The imidazole interacts with the guanine N3 amine but unlike pyrrole is not able to form 
hydrogen bonds to cytosine, adenine or thymine. Additional complex stability stems from 
several hydrogen bonds between the polyamide NH groups with the edges of GC pairs. The 
Py/Py pair on the other hand is able to recognize AT/TA over GC/CG bps. In combination 
with the specific selectivity of Im/Py pairs this was the first step towards sequence selective 
minor groove binding. 2:1 complex forming ligands are able to recognize a given sequence 
with each monomer being responsible for one “side” of the base pairing system. This scheme 
can in theory be applied to many ds-nucleic acid sequences, but one can easily imagine 
sequences where two non-identical monomers would be necessary. This would then lead to 
the formation of two homodimers besides the desired heterodimer and thus to the loss of a 
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clearly defined complex structure. Consequently, such systems would lose their sequence 
specificity. 
   
Figure 46. Ligand 83 forms 2:1 complexes to DNA recognizing GC bps with its Im/Py pair (left). By linking two 
monomers via a covalent linker (84) high affinities without loss of selectivity can be achieved.105  
To circumvent this problem Dervan linked the ImPyPy monomer head to tail with a 
distamycin monomer via a γ-aminobutyric acid (GABA) resulting in the hairpin motif (84) 
depicted in Figure 46.114 It could be shown that very selective and strong DNA complexes 
were formed. The sequence TGTTA was bound with a binding constant of 8 × 107 M-1. 
Furthermore, it could be shown that selective binding by hairpin ligands is a generally 
applicable concept. A manifold of different sequences could be bound selectively with high 
binding constants with tailored ligands, the DNA binder ImPyPyPy-GABA-ImPyPyPy for 
example binds selectively to AGTACT with K = 4 × 1010 M-1.105 However, at this point it was 
only possible to design ligands which were able to differentiate between CG, GC and AT/TA, 
but not between TA and AT base pairs. 
  
Figure 47. The three building blocks for sequence selective double-stranded DNA recognition: Py (85), Im (86), 
and Hp (87) (left) and space-filling model of Hp/Py pair recognizing a TA base pair (right). From Kielkopf, C. 
L. White, S. Szewczyk, J. W. Turner, J. M. Baird, E. E. Dervan, P. B.; Rees, D. C. Science 1998, 282, 111-115. 
The calculated image is reprinted with permission from AAAS.115  
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In order to differentiate between AT and TA base pairs Dervan and Rees introduced 
hydroxypyrrole (87, Hp) as additional, rationally designed aromatic building block.115 A pair 
of Py/Hp is able to bind to AT but not to TA and the other way round. As shown in Figure 47 
the Hp ring forms hydrogen bonds to the thymine O7. Furthermore, the hydroxyl group 
perfectly fits into the cleft between A and T but sterically clashes with adenine in TA base 
pairs. With this finding the complete set for sequence selective minor groove binding ligands 
was complete.116 For each sequence a tailor-made minor groove binder can now be designed 
and applied. Table 3 describes the recognition code consisting of pairs of aromatic rings able 
to selectively bind to one of the four possible base pairs. 
Table 3. Code for sequence selective minor groove binding. Favored (+), disfavored (-). 
Pair GC CG TA AT 
Im/Py + - - - 
Py/Im - + - - 
Hp/Py - - + - 
Py/Hp - - - + 
 
A crystal structure solving the complex between ImImPyPy with the GGCC core sequence 
did not only verify that Im/Py forms three specific hydrogen bonds to a GC bp, it also 
revealed why it was not possible to target sequences longer than four to five base steps with 
this kind of molecules, although the rise per aromatic ring unit does perfectly match a base 
pair step.117 The problem was that the curvature of the ligands is too strong to match the 
winding of the minor groove. Dervan could show that the implementation of β-Ala as 
substitute for Py rings at certain positions allowed the ligand to adapt to the nucleic acid´s 
curvature while retaining the specificity for AT base pairs by an Ala/Ala pair. This way it was 
now possible to target 11-16 base pairs.118  
With sequence selective recognition motifs at hand Dervan then tested the possibility to 
interfere with regulatory mechanisms in the cell.119 The hairpin motif ImPyPyPy-GABA-
ImPyPyPy binds to AGTACT with a binding constant of 3 × 109 M-1. This sequence lies 
within the 50 bp recognition site of the gene-specific transcription factor TFIIIA, a zinc-finger 
protein. Binding affinity of the artificial groove binder is higher than for the protein which 
leads to a reduction of transcription of a specific gene encoded in the region. Thus it could be 
shown that the hairpin ligands are able to specifically interact with gene regulation in cell 
culture. 
In conclusion, minor groove binding has proven to be an excellent alternative to 
intercalation, in many cases surpassing their affinities. Very high binding constants, at times 
as high as protein-DNA interactions, have been reported. Recognition of the minor groove 
often takes place via shape complementarity between groove curvature and ligand. 
Furthermore, through a multitude of binding contacts to the nucleobase groove floor and the 
deoxyribose groove walls excellent specificity and selectivity could be achieved – a feature 
not present in intercalators. With these prerequisites fulfilled interference with cellular 
processes like gene regulation became possible. However, not all nucleic acid sequences are 
accessible that way due to the base pair dependent microstructuring of the helix and packing 
effects inside the nucleus. 
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Major Groove Binders 
Most sequence-selective DNA binding proteins in nature bind to the major groove where 
they fulfill their role in for example gene regulation.120 The broad major groove displays more 
hydrogen donor and acceptor sites than the minor groove and therefore offer more potential 
for selective binding. Due to their size proteins are able to make use of this multitude of 
interaction sites. Affinity is achieved by utilizing electrostatic interactions, van-der-Waals 
contacts or hydrogen bonding. Normally the secondary polynucleotide structure is not altered 
upon protein binding. It is rather the proteins that adapt to the helical structure by forming 
secondary and tertiary structures on their own, e.g. α-helices or antiparallel β-sheets, which 
are ideally formed for DNA binding. There is a broad variety of protein architectures, like 
helix-turn-helix, zinc-finger, basic region-helix-loop-helix, ribbon-helix-helix or basic region-
leucine zipper (bZIP) motifs. The latter one is exemplarily shown in Figure 48. The 
homodimeric protein consists of two monomers of approximately 60 residues which each 
form a continuous α-helix. Their C-termini are associated by forming a coiled-coil with an 
interface consisting of leucine residues. The N-termini are separated, each one binding to the 
major groove of B-DNA, but from opposing sides. Amazingly this highly ordered structure 
only forms upon binding to DNA. Apart from that the protein is unstructured. 
 
Figure 48. A basic region-leucine zipper protein (bZIP) is binding to the major groove of B-DNA from both 
sides via the N-terminus. The C-termini are linked by a leucine interface (PDB access code: 2E42). 
In terms of small molecule binding to the major groove only few examples have been 
reported so far. Although the major groove is attractive with respect to the sheer number of 
potential interaction sites, it is also very broad and often shallow and more exposed to the 
solvent. Small ligands would have to span the widths of the groove in order to bind 
efficiently to it. Apart from proteins, nature, too, only seldom makes use of major groove 
binders. One example is for instance the natural product azinomycin A (88) depicted in 
Figure 49, which indeed forms hydrogen bonds in the major groove. However, the main 
bZIP 
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driving force of DNA binding however stems from intercalation of the naphthalene 
moiety.84 Very often such natural products are alkylation agents for DNA adding most 
commonly to the nucleophilic guanine amine via an epoxide or aziridine. 
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Figure 49. Azinomycin B (88) is an intercalator which forms additional contacts to the major groove (left). 
Synthetic guanidinoneomycin B (89) binds to the major groove of RNA. 
The synthetic guanidinoneomycin B (89) synthesized by Butcher is shown in Figure 49.121 It 
was derived from a natural aminoglycoside antibiotic analogue by replacing all amine for 
guanidine groups. NMR studies revealed 1:1 binding to RNA major groove with binding 
constants of approximately 108 M-1. The rather large molecule spans the whole width of the 
major groove. At the edges of the groove the guanidinium groups interact with the phosphate 
backbone of the nucleic acid. 
 
Figure 50. Left: The dye methyl green (90) binds to the major groove of B-DNA. Right: In triple-stranded 
pdA × (pdT)2 one pdT strand binds to the B-type helix pdA × pdT via Hoogsteen base pairs in the major groove. 
Depending on the direction of the third arm either TAT (91) or AAT (92) base-triplets are formed.  
Nordén could show that the dye methyl green (90, Figure 50) binds to the major groove of 
B-DNA.122 Due to steric hindrances methyl green is not planar and therefore not fit for 
intercalation. Upon binding its CD signal clearly indicated groove binding. The triple helix 
pdA × (pdT)2 forms a B-type helix (corresponding to pdA × pdT) with the third strand (pdT) 
winding alongside the major groove forming Hoogsteen-type hydrogen bonds to the 
88 89 
90 
91 92 
2. BACKGROUND INFORMATION   47 
 
nucleobases. Methyl green binds to pdA × pdT but not to the triple-helix – unlike the minor 
groove binder DAPI which was tested as control. Thus it could be shown that methyl green 
binds to the major groove. 
  
Figure 51. The flexible anilinocalixarene dimer 93 (red) binds into the major groove of B-DNA (green, blue), 
the analogue 94 is too rigid for efficient binding.123 
Schrader reported the major groove binders shown in Figure 51.123 Two anilinocalixarene 
moieties were connected with a flexible (93) or a rigid linker (94) and tested for their binding 
ability towards B-DNA. Binding constants were as high as 6 × 107 M-1 for the ligand with 
flexible linker, the rigidly linked ligand bound less strongly by two orders of magnitude. 
Obviously this setup is not flexible enough to allow for adaption to the helix curvature. The 
rather large size of the dimer perfectly matches the DNA major groove – there is no 
conformational change of the nucleic acid needed. The ammonium groups form salt bridges to 
the phosphate backbone and hydrogen bonds to the nucleobases at the groove floor. 
In conclusion, major groove binding is a concept often used in nature by proteins for the 
sequence-selective recognition of DNA. However, it is rather difficult to achieve with small 
molecules. This is why there are only few reported examples of small molecule major groove 
binding by natural or synthetic ligands. 
Combinatorial Approaches 
Artificial DNA binding molecules are most commonly based on modified natural products 
or derived by rational design. With the help of combinatorial chemistry a much bigger 
quantity of compounds should be accessible within shorter time. 
Nielsen for instance was one of the first to utilize a combinatorial approach for the 
development of minor groove DNA binders.124 As shown in Figure 52 the one-bead-one-
compound library 95 comprising 5,832 (183) members was prepared by means of split and 
mix standard Boc solid phase peptide synthesis (SPPS). Two consecutive N-methylpyrroles 
(Py) were linked to three more adjacent Py units via a combinatorial tripeptide consisting of 
natural and unnatural amino acids (e.g. 96-104). The N-terminus was derivatized with 
γ-aminobutyric acid, thus bearing a positive charge at physiological conditions. Screening 
with the fluorescence labeled ds-DNA GCGTTTGCTTTCGC in neutral phosphate buffer and 
93 
94 
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consequent synthesis of the hit structure AA1-3 = Pip-β-Ala-Tyr and determination of the 
binding constant in solution revealed a moderate binding constant of 105 M-1 for the sequence 
TCTTTGCTTTGG. Not very surprisingly AT rich sequences were preferred due to the 
presence of at least seven Py units. 
 
Figure 52. Combinatorial minor groove ligand library 95. Boc-protected building blocks γ-Abu (96), Sar (97), 
β-Ala (98) , Py (99), pBenz (100), Ppa (101), pNic (102), mBenz (103), and Thex (104). 
As shown in Figure 53 Sasaki screened the large pentapeptide library 105 with 3,200,000 
(205) members for its binding affinity towards the target DNA duplex TTTTAAAG.125 The 
pentapeptide library was prepared on Merrifield resin with two 6-aminocaproic acid units as 
spacer with the help of standard Fmoc SPPS in a split and mix approach. 20 proteinogenic 
amino acids were used in the combinatorial positions AA1-5. The DNA was attached to 
magnetic beads and a mixture of library and nucleic acid was incubated in buffered water at 
pH 5. Beads with hit structures aggregated with the magnetic DNA beads and could be 
isolated with the help of a magnet and were then sequenced. The 71 hit structures were mainly 
built from hydrophobic amino acids (AA1 = Tyr, Ile, Leu; AA2 = Ile; AA3 = Tyr, Gly, Trp, 
Phe; AA4 = Glu; AA5 = Phe, Asn). Several consent sequences were re-synthesized and their 
binding affinity for several ds-DNA sequences was determined by an EB displacement 
titration. The best IC50 value was found for the amino acid sequence AA1-5 = Ile-Ile-Gly-Glu-
Phe to the 12mer duplex DNA CGTAGCGCTACG, corresponding to a binding constant of 
approximately 105-106 M-1. The affinity of the artificial peptide-based ligand to this sequence 
is higher than that of distamycin by one order of magnitude.  
AA1-3: Ala, Phe, Tyr, Val, Asn, Pro, γ-Abu, 
Gly, Sar, β-Ala, Trp, Gln, Py, pNic, 
pBenz, Ppa, mBenz, thex 
18 × 18 × 18 = 5,832 ligands 
95 
96 97 98 99 100 
102 101 103 104 
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Figure 53. Pentapeptide library 105 and target DNA sequence attached to a magnetic bead (106). 
Lokey designed the bisintercalator library 107 with 360 members depicted in Figure 54.126 
Two lysine-1,4,5,8-naphthalene tetracarboxylic diimide intercalator units were linked via a 
combinatorial tripeptide. The synthesis was carried out on solid phase by standard Fmoc 
SPPS preparing 12 mixtures with 30 different sequences. In position AA2 ten different amino 
acids were implemented; positions AA1 and AA3 either consisted of five different amino acids 
or were skipped. After cleavage from the resin the library was screened in buffered water at 
pH 7.5 with a 231 bp duplex DNA with the help of DNase I footprinting. The members of the 
most promising sublibrary were synthesized and individually tested for their binding ability. 
Two hit structures could be identified: AA1-3 = Gly-Gly-Gly and β-Ala-β-Ala-β-Ala. While 
the bisintercalator with shorter linker preferred GC rich sequences like for instance 
TGCCGGTACTGCCGG the second compound preferred non-GC rich sites like 
AGCTTATCATCGATAAGCT. For the latter combination the overall highest binding 
constant with K = 5 × 106 M-1 was observed. The different sequence specificity was explained 
by the different conformational flexibility of the linkers leading to differently oriented and 
spaced intercalator moieties. Furthermore NMR spectroscopic studies could show that the 
amino acids in the linkers form hydrogen bonds to the nucleobases in the groove. 
 
Figure 54. Bisintercalator library 107 and two of the building blocks: Pip (108) and mSer (109). 
Boger developed a total synthesis for distamycin (81, Figure 43) which allowed him to 
individually exchange the N-methylpyrrole units of the natural product for other amino 
acids.127 By implementing the building blocks 110-121 shown in Figure 55 two solution phase 
combinatorial libraries 122 and 123 were prepared, each one containing the same 1,320 (12 × 
105 
106 
AA1-3: Glu, Pro, Phe, Ser, Thr, 
Gly, Val, Met, Asn, Asp, 
Trp, Lys, Leu, Tyr, Cys, 
His, Glu, Ile, Ala 
20 × 20 × 20 × 20 × 20 
  = 3,200,000 ligands 
AA1,3: β-Ala, Gly-Gly, Pro, Pip, Gly 
AA2:  β-Ala, Asn, Gln, Gly, His, Pip, 
Leu, Pro, mSer, Tyr 
6 × 10 × 6 = 360 ligands 
107 
108 109 
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10 × 11) tripeptide members. The two sublibraries only differed in their N-terminus which 
was either Boc-protected or derivatized with a dimethylaminobutyric acid (DMABA). In 
contrast to the natural product distamycin, the positive charge was implemented at the N- and 
not at the C-terminus of the artificial ligands. Both libraries were screened for their binding 
affinity towards various nucleic acids with the help of a fluorescence-based high-throughput 
ethidium bromide displacement assay. After incubation of the polynucleotides with EB in 96-
well plates the combinatorial compounds were added to the fluorescent solution thus 
displacing the intercalator. The consequent decrease of fluorescence intensity is directly 
proportional to the binding affinity of the library members. This way qualitative data for all 
compounds were accessible. Individual hit structures were selected and quantitative EB 
displacement titrations were carried out to evaluate the binding constants. In general the Boc-
protected, uncharged library performed significantly worse than its positively charged 
DMABA analogue. The highest affinity for B-type DNA pdA × pdT was achieved for 
structures containing large subunits at AA2 (110-115) and a small subunits at AA3 (116-121). 
The overall highest binding affinity was found for compounds 124 and the distamycin 
analogue 125 with K = 6 × 106 M-1, which is as high as for the natural product. As expected, 
the affinity towards pdG × pdC was significantly lower compared to pdA × pdT for 124 and 
even lower for 125. To fully characterize its sequence specificity, the new binding motif 124 
was then screened against a library of 512 hairpin 21-mer oligonucleotides. It could be shown 
that purine-pyrimidine-pyrimidine sequences were preferentially bound. The distamycin 
analogue on the other hand prefers AT base pairs just like the natural product. Thus it could 
be demonstrated that with the help of solution phase combinatorial chemistry the sequence 
selectivity of a given nucleic acid ligand can be altered while retaining the high binding 
affinity of the corresponding natural product. 
 
Figure 55. The two libraries 122 and 123 each contain 1,320 members derived from the building blocks 110-121 
and only differ in their N-terminus. The best results were achieved with 124 and the distamycin analogue 125. 
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12 × 10 × 11 = 1,320 ligands 
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This approach was further exploited by Boger by screening a library of > 9,000 synthetic 
DNA binding molecules for their ability to inhibit the transcription factor lef-1.128 Figure 56 
shows the two most efficient sequences 126 and 127 which bound to the transcription factor´s 
target sequence CCTTTGATC with a binding constant of K = 9 × 106 M-1. The IC50 values for 
the inhibition of lef-1 were 6.2 and 0.15 µM, respectively. Hence, with the help of 
combinatorial chemistry it is possible to find sequence specific DNA ligands with the ability 
to efficiently down-regulate gene expression. 
 
Figure 56. The two lead compounds 126 and 127 were derived by a combinatorial library comprising > 9,000 
members. They are efficient inhibitors of the transcription factor lef-1. 
Combinatorial chemistry has only rarely been utilized for the development of DNA-binding 
molecules. The few examples reported in literature for library-derived intercalators or groove 
binders were only moderately successful in finding more advanced ligand systems. These 
libraries however, are mainly large and random – their screening only gives positive answers 
for hit structures but neglects the majority of library compounds. Therefore much of the 
information is lost. By generating a small but focused ligand library with biased building 
blocks which can then be screened in a fashion that gives quantitative or qualitative 
information about all possible compound-DNA binding affinities a more successful ligand 
optimization could be possible.30 
126 127 
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2.4 TRANSFECTION 
2.4.1 Gene Therapy 
The human genome is encoded in a long ds-DNA in the cell nucleus consisting of 
approximately 3 billion bps which are arranged in ca. 25,000 genes – the smallest functional 
units containing genetic information.42 The structure of a eukaryotic gene and the read-out 
mechanism of the genetic information (transcription) are depicted in Figure 57. The gene 
itself consists of regions which are transcribed to RNA and regulatory elements. The promoter 
region at the 5´-end of the gene in the DNA antisense strand marks the starting point for 
transcription and is recognized by a protein – the transcription factor. Enhancer and silencer 
regions either increase or decrease gene expression. These elements are found near the 
promoter region, but are not necessarily in the same strand. Regulatory elements far away in 
the strand may still come within close proximity of a given promoter due to supercoiling of 
the DNA helix. Once the starting point for the read-out is set, the DNA unwinds by ca. one 
winding and an RNA polymerase enzyme generates an RNA from 5´- to 3´-end, which is 
complementary to the antisense-strand. This premature messenger RNA (pre-mRNA) 
undergoes a maturation process upon which introns are cut off the strand and only extrons 
remain (splicing). During this processing a 5´-cap and a 3´-poly(A) tail are attached to the 
RNA for protection against RNases. The processed mRNA now consists of three parts: the 
open reading frame (ORF) contains the information for the translation of the nucleic acid into 
the corresponding protein at the ribosome. Three nucleobases form one codon – the code for a 
specific amino acid. The remaining parts of the mRNA, the 3´- and 5´-untranslated region 
(UTR), serve for the regulation of translation. 
 
Figure 57. Schematic illustration of the transcription process in the nucleus. 
Since the human genome was fully decoded in 2003 more and more functions of genes have 
come to be known.15 The DNA´s nucleobase sequence consists of parts which are conserved 
and others which can be different for different persons. Differing genes which are carried by 
> 5 % of the population are called polymorphisms, those carried by less than 5 % are 
mutations. There are different variations, e.g. single nucleotide exchange, duplications, 
insertions, translocations, inversions, deletions or different copy numbers, which may either 
be part of the heritable information or arise from environmental influences during life. 
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Mutations in extrons coding for proteins normally lead to a drastic decrease of gene activity. 
In introns or promoter regions it is the other way round. These changes may either be silent, 
advantageous or disadvantageous for the cell functionality. In the last case dysfunctional cells 
and diseases can be the result.  
While classical medicine introduces drugs from the outside into the cell, gene therapy strives 
to modify the genetic information inside the cell and thus to alter the biosynthesis as a drug 
from inside.129 There are different approaches to do so: replacement therapy exchanges or 
corrects defective / missing genes, e.g. in monogenic hereditary diseases like the severe 
combined immunodeficiency (SCID).130 Enhancement therapy amplifies or introduces genetic 
function (e.g. for cancer treatment) and suppression therapy turns off or prevents pathogen 
gene activities (like a vaccine).131 In principal it is possible to introduce a gene individually 
adjusted to a person and/or to a disease.132 However, this approach is nowadays limited to 
diseases which are based on a single gene defect. Unfortunately, most diseases are due to a 
combination of many polymorphisms and/or mutations. Up to this day it is not possible to 
treat multigene-derived diseases. Nevertheless, gene therapy is a powerful emerging field for 
the treatment of maladies which cannot be cured with classical small molecule drugs and thus 
opens a whole new field of medical treatment. One of the most important prerequisites for 
gene therapy is an effective gene transfer into the cell because it is difficult to introduce DNA 
directly into the cell due to its physical properties: The overall negative charge of the nucleic 
acid is repulsed by the negatively charged surface of the cell. Furthermore it rapidly degrades 
in biological surroundings due to the activity of RNases and DNases. Therefore appropriate 
transportation vehicles (= vectors) are necessary. These should be easy and cheap to produce 
in high quantities in a reproducible manner. They must enable uptake into the cell, ideally in a 
specific fashion. Inside the cell the genetic information has to be firmly integrated into the 
genome without interfering with the genetic information already inside. Last but not least 
vectors must be safe for application with regard to pathogenicity, cytotoxicity, adverse effects 
and immune responses. Nowadays, three main classes for the delivery of nucleic acids exist: 
physical, viral and chemical vectors. 
  
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
2.4.2 Viral Vectors 
First tries to shuttle genes into cells were carried out with the help of viruses in the 1970s.133 
Viruses are naturally very efficient in infecting cells and in implementing their genetic 
material into the host cell for the sake of self-replication. For the use as vectors their genome 
has to be modified:17 The desirable functions like cell recognition, packaging and delivery of 
genes into the host genome are kept. Troublesome parts of the virus´ genetic information like 
replication, pathogenicity, or expression of immunogenic viral antigens are deleted and 
replaced by the gene of interest together with the necessary transcriptional regulatory 
elements (= transgene). These recombinant viruses are now able to transduce (= delivery + 
expression of a gene) the cells they would normally infect. Most commonly adeno- and 
retroviruses are utilized as viral vectors nowadays, and are until now the only way to 
permanently heal monogenetic diseases. Because viruses practically evolved as gene-delivery 
vehicles, they are extremely efficient with a good cell type selectivity, which may even be 
altered by modifying their surface glycoproteins. Therefore they are broadly applied and are 
the most advanced vector system available. Unfortunately, viral vectors suffer from several 
severe inconveniences: the immune system is still able to recognize the viral surface and thus 
an immune response is triggered which becomes worse with every treatment. Further, 
although the dangerous parts of their genome are removed before usage there is potentially 
the threat of a recombination with a wild type virus leading to pathogenicity and mobilization 
of the genetically altered virus. The new information is now able to move to other cells or 
persons. Insertion of the delivered genes into the genome is not site-directed and may activate 
for example oncogenes. The overall length of the gene which is to be delivered into the cell is 
restricted by the original length of the viral genome. Acceptance for the treatment with viral 
vectors in public is generally low. Lastly, the up-scaling for mass production on an industrial 
scale is very difficult. 
2.4.3 Physical Vectors 
An alternative for viral gene delivery are physical vectors.134 Genes are directly delivered 
into the cells without the need for a vector. In order to cross the cell membrane several 
techniques have been applied. Electrophoresis and ultrasound for example use electrical or 
sonic pulses to increase the permeability of the cell membrane. Jet injection locally injects a 
DNA solution with high pressure so that the microdroplets penetrate the skin and the cell 
wall. Similarly, a gene gun shoots DNA coated heavy metal nanoparticles which directly 
penetrate through the cell membrane. A clear disadvantage of this method is the deposition of 
heavy metal in the body. Still, in general physical vectors are safer, not cytotoxic and allow 
for repeated administration. There is no limitation with regard to the length of DNA. 
Unfortunately there are several inconveniences greatly limiting these methods. They are not 
specific for cells and there is no inherent cell penetration mechanism. The expression level 
therefore is generally only low and the area of application is very limited. Only tissues at the 
surface like the skin are accessible without surgery. 
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2.4.4 Chemical Vectors 
The third alternative for gene delivery is the application of chemical vectors.135 Chemical 
delivery systems are positively charged molecules which form complexes with the negatively 
charged cargo thus neutralizing its charge and sterically shielding the ribophosphate backbone 
from degradation by nucleases. Unprotected plasmid for example is degraded within minutes 
by DNases, complexed with chemical vectors it is stable for hours. The now positively 
charged particles interact with the negatively charged cell surface. Unlike small molecules 
like amino acids or ions which can cross the cell membrane via integral protein pumps or 
channels the uptake of nucleic acid-chemical vector complexes usually takes place via 
endocytosis.136 During this process membrane bound vesicles form around the cargo by 
invagination and pinching off of pieces of the plasma membrane. These cell own vesicles 
(endosomes) are then released into the cytosol. There are various endosomal pathways which 
lead to the formation of vesicles with diameters between 60 and 120 nm thus restricting the 
maximum size of the cargo. The next step is the liberation of the nucleic acids from the 
endosomes to the cytosol. The endosomal escape is a major obstacle for chemical vectors. If it 
fails the polynucleotides are rapidly degraded by nucleases at low pH in the late 
endosomes/lysosomes.137 Once in the cytosol the gene has to be transported to the nucleus 
and integrated into the DNA. In general, chemical vectors are simple to prepare reproducibly 
in large quantities and offer improved safety compared to viral vectors. The main classes of 
chemical vectors are polyplexes, lipoplexes, and cell penetrating peptides. 
Polyplexes 
Cationic polymers have shown to form strong complexes to nucleic acids and hence to 
contract them to multimolecular aggregates called polyplexes. The overall size of these 
structures is then rather linked to the polymer size and not to that of DNA. All polyplexes 
form toroidal or spherical structures of similar diameter. The exact aggregation depends on 
the polymer structure.18 In general, polycations are potential gene transfer agents.138 
 
Figure 58. Poly(L-lysine) 128, PLL derivatized with L-histidine (129), and linear (130) or branched (131) 
polyethyleneimine (PEI). 
In 1975 Laemmli could demonstrate that poly(L-lysine) (128, PLL, see Figure 58) is able to 
strongly condense DNA.139 The size of the polyplexes correlates with molecular weight. 
Large polymers (224 kDa) form aggregates of 100-300 nm diameter and small PLLs lead to 
the formation of 20-30 nm sized condensates. Wu could show later on that PLL is able to 
transfect cells in vitro as well as in vivo.140 A minimum molecular weight of 3 kDa is 
necessary for transfection. However, most of the PLL-polyplexes are not able to escape the 
endosome after cellular uptake and are thus degraded in the lysosome. This is also why PLL 
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is a rather poor transfection agent and efficiencies are only high for cells undergoing mitosis. 
During the division process cells are in general more susceptible for transfection due to the 
general redistribution and partial breakdown of the nucleus wall. By partly replacing lysine 
groups for histidine (pKA = 6) the transfection efficiency could be increased.141 This 
difference can be explained by the proton sponge effect as shown in Figure 59. At 
physiological pH all primary lysine ε-amino groups but only very few histidine side chains 
are protonated. After endocytosis the pH within the endosomes is constantly reduced from 7.4 
to 4-5 when going from endosome to the lysosome by a specific ATPase.142 The weakly basic 
imidazole rings of the histidine amino acids are getting protonated at this pH and thus act as a 
buffer within the endosomes. Consequently more protons are pumped into the endosome 
accompanied by counterions and water. The increased osmotic pressure leads to vesicle 
swelling and finally to their rupture. The enclosed nucleic acid content is released into the 
cytosol before it can be degraded by nucleases in the lysosome. Another big disadvantage of 
PLL is its high cytotoxicity. This is a general problem of cationic species and especially of 
cationic polymers. They tend to aggregate and precipitate under the high salt concentrations 
(150 mM) found at physiological conditions. Furthermore cationic complexes bind to serum 
proteins like serum albumin, which hinders cellular uptake and further promotes aggregation. 
The higher the molecular weight and cationic charge, the higher is the toxicity. The 
cytotoxicity can be reduced by integrating polyethyleneglycol (PEG) chains into the 
polymer.143 However, due to their rather poor efficiency it is rather unlikely that PLL-derived 
vectors will be used for clinical applications in the future. 
 
Figure 59. Schematic illustration of the proton sponge effect. Protonation of the polyplex leads to increased 
influx of proton accompanied by counterions and water into the endocytic vesicles. Ultimately the vesicle bursts.  
Nowadays the most commonly used agent for cell transfection is polyethyleneimine (PEI) 
either as linear (130) or branched (131) polymer as shown in Figure 58. It was first utilized by 
Behr in 1995.144 It is very efficient due to its great buffer capacity. In branched PEI for 
example every third atom is a nitrogen atom. At physiological pH only approximately 20 % of 
the amine residues are protonated. In the endosome at pH 5 more than 50 % are protonated.145 
Hence, PEI is an excellent proton sponge and allows for efficient endosomal escape.146 
Amongst polymeric substances PEI is nowadays the gold standard for in vitro and in vivo cell 
transfection. Linear as well as branched PEI is commercially available. Linear PEI seems to 
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be less efficient in condensing DNA and affords less stable polyplexes. The efficacy of 
transfection also correlates with its molecular weight (MW). The higher the MW, the higher the 
percentage of transfected cells. Unfortunately, cytotoxicity similarly correlates with weight. 
The larger the polymers the more they adhere at the cell surface, which then leads to 
necrosis.147 Like PLL, highly cationic PEI easily aggregates under physiological salt 
concentrations and binds to serum proteins. Thus the optimal molecular weight for 
transfection experiments is a compromise between these two trends – a MW between 5 and 
25 kDa is regularly chosen for transfection experiments.  
In conclusion cationic polymers have shown to be capable of transfecting cells in vitro and 
in vivo. There are still several problems like e.g. cytotoxicity or the lack of inherent cell-
targeting that need to be solved. Further, polyplexes are still several orders of magnitude less 
efficient than viral vectors. Therefore there is still need to develop novel materials to 
overcome the intra- and extracellular obstacles which prevent higher efficiencies. 
Lipoplexes 
Another major class of gene carriers is that of cationic lipids, which are able to fuse with the 
cell membrane.148 In 1987 Felgner was the first to utilize cationic lipids for gene delivery.149 
In general cationic lipids consist of three structural domains: a cationic headgroup, a 
hydrophobic hydrocarbon and a linker in between.  
 
Figure 60. Scheme of cellular uptake mediated by cationic lipids. Reprinted with permission from Mintzer, M. 
A.; Simanek, E. E. Chem. Rev. 2009, 109, 259-302. Copyright 2009 American Chemical Society.18  
The first step of the lipofection mechanism is the association of the cationic headgroup with 
the ribophosphate backbone of the nucleic acid thus forming a supramolecular lammelarly 
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structured lipoplex.18 During this process the nucleic acid is condensed. As depicted in Figure 
60 the positively charged complexes recognize the negatively charged cell surface and 
cellular uptake then primarily takes place via endocytosis. Once inside the endosomes the 
positively charged lipoplexes interact with the negatively charged phospholipid-based vesicle 
wall, which is destabilized as a consequence. The result is a flip-flop like reorganization of the 
vesicle upon which the lipoplex is released into the cytoplasm. Since lipofection is very 
efficient there are several commercial compounds available for application in vitro and in 
vivo – some exemplary structures (132-135) are depicted in Figure 61. Especially 135, which 
is better known under its commercial name lipofactamineTM is today often referred to as the 
gold standard for transfection with chemical vectors. Lipid-based vectors are the most utilized 
and best studies chemical vectors and already were applied in many human gene-therapeutic 
clinical trials. 
Many studies concerning the structure-activity relationship have been undertaken.18,150 Two 
general trends could be observed: the nature and density of the cationic headgroup has a 
strong, predictable influence on the efficiency, but for a given headgroup the outcome of 
replacing the hydrocarbon chain is not predictable. For instance, by replacing the ammonium 
groups by more biocompatible groups like pyridinium groups, which are able to better 
delocalize the charge, the transfection and cytotoxic properties could be improved. 
Multivalent headgroups are more efficient if the charges are well spaced. Small distances 
between ammonium groups lead to lower efficiencies. This is probably due to a decrease of 
pKA for high charge density headgroups and thus an overall reduced charge. The better the 
charges are distributed in multivalent headgroups the better they are able to transfect cells. 
Generally the trend goes: the more charges, the higher the efficiency. Too many charges on 
the other hand may lead to stronger folding of the lipid conformation and a decrease of gene 
delivery. Variations of the hydrophobic group on the other hand did lead to different results 
for different head groups. Sometimes longer chains gave improved and sometimes poorer 
results. Finally, the replacement of the linkers for biodegradable moieties which are degraded 
after endosomal escape (e.g. carbamates) and hence facilitate the liberation of the nucleic acid 
from the lipoplex have demonstrated to improve gene delivery. 
 
Figure 61. Commercial cationic lipids DOGS (132), DOTMA (133), DOTAP (134), and DOSPA (135). 
Cationic lipids with two headgroups and two hydrophobic moieties which are bridged via a 
linker are called gemini surfactants. Engberts carbohydrate-based gemini surfactant 136 
(Figure 62) for example is more efficient than lipofectamine.151 At low pH these molecules 
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undergo a morphological change from lamellar to an inverted hexagonal structure. This 
change leads to endosomal fusion and very efficient liberation of the nucleic acid into the 
cytosol.152 
   
Figure 62. Gemini-surfactants like the sugar-derived 136 undergo a morphological change from lamellar to 
hexagonal structure at low pH thus triggering endosomal escape. The modeled image is reprinted with 
permission from Bell, P. C. Bergsma, M. Dolbnya, I. P. Bras, W. Stuart, M. C. A. Rowan, A. E. Feiters, M. C.; 
Engberts, J. B. F. N. J. Am. Chem. Soc. 2003, 125, 1551-1558. Copyright 2003 American Chemical Society.152 
Cationic lipids have shown to be very efficient delivery agents for the transfection of cells 
with genetic material. Even though they are not as effective as recombinant viral vectors they 
are the best known chemical vectors to this day. Together with the polyplex-forming PEI the 
cationic lipid lipofectamine is nowadays the most utilized chemical vector for in vitro and in 
vivo application. However, there are still some problems connected to cationic lipids. First, 
the reproducible fabrication of the liposomes and of the lipoplexes is not without trouble and 
strongly depends on the method of preparation and the order of preparation-steps as well as 
the surrounding medium. Further, the stability of the colloidal mixture is not unproblematic. 
Finally, cationic lipids are often cytotoxic due to their cationic nature.153 Still, they offer a 
very good platform for the development of safe and efficient chemical vectors and further 
development of their features is desirable.  
Cell Penetrating Peptides 
A more recently developed class of non-viral vectors is that of cell penetrating peptides 
(CPPs).154 These protein transduction domains are short (10-30 residues), basic amino acid-
rich sequences originally derived from proteins which are able to cross the cell membrane. In 
1988 Frankel and Pabo found that the transcription-transactivating (Tat) protein of HIV-1 is 
able to enter cells and translocate to the nucleus (Figure 63, bottom left),155 and in 1991 
Prochiantz could demonstrate that the Drosophila antennapedia homeobox peptide 
internalizes into neuronal cell (Figure 63, top left).156 A few years later, in 1994 the same 
group utilized the 16mer peptide penetratin (137) derived from the third helix of the 
antennapedia peptide (residues 86-102: Arg-Gln-Ile-Lys-Ile-Tyr-Phe-Gln-Asn-Arg-Arg-Met-
Lys-Trp-Lys-Lys) as first cell penetrating peptide.157 In 1998 Lebleu could show that the 
minimal Tat-derived peptide sequence for cellular uptake is the 11mer 138 (residues 47-57: 
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg).158 When attached covalently to a nucleic 
acid these CPPs were able to efficiently transfect cells. These findings led to an exploding 
search for other CPPs by protein screenings and rational design. Today, a broad variety of 
naturally derived and synthetic cell penetrating peptides is known.160 In 1997 the first non-
covalent CPP for the delivery of polynucleotides was introduced by Divita.161 This chimeric 
peptide of 27 amino acids length contains a hydrophilic, lysine-rich C-terminal domain 
derived from the nuclear localization sequence of the SV40 large T-antigen (Pro-Lys-Ser-Lys-
136 
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Arg-Lys-Val). Via a tripeptide linker a variable, N-terminal hydrophobic group derived from 
the fusion sequence of the HIV protein gp41 (Gly-Ala-Leu-Phe-Leu-Gly-Phe-Leu-Gly-Ala-
Ala-Gly-Ser-Thr-Met-Gly-Ala) is attached. The peptide forms strong complexes with 
polynucleotides via electrostatic interactions between its positively charged domain and the 
phosphates. Similar to poly- and lipoplexes the DNA is compacted. As a result of this general 
feature of non-covalent CPPs the stability of the nucleic acid against nucleolytic degradation 
is increased. The first contact to the cell is formed upon electrostatic interaction with the 
negatively charged proteoglycans at the cell surface. Although the exact mechanism of the 
cellular uptake is somewhat controversial it follows an endocytotic pathway in most cases. 
Transfection efficiencies are usually high, similar to lipoplexes. A big advantage is the lack of 
cytotoxicity of these rather small, naturally derived gene carriers. 
  
 
Figure 63. NMR structure of the cell-penetrating homeobox protein from Drosophila antennapedia and the 
minimum sequence for cell penetration 137 (top; PDB access code: 1HOM).159 NMR structure of the HIV-1 Tat 
protein and the corresponding minimum sequence for cell penetration 138 (bottom; PDB access code: 1TBC). 
A prominent example for artificial CPPs are oligoarginine compounds like Arg8 (139, Figure 
64) developed by Futaki.162 Efficient internalization proceeds via endocytosis, but only if a 
minimum of six arginine residues is present. The transfection efficiency peaks between six 
and eight residues to decrease again for longer oligoarginines. The structure of the gene 
carrier has no influence on the efficiency: both linear and branched oligoarginines have the 
same efficacy. Uptake takes place via endocytosis and endosomal escape is the limiting factor 
for more successful efficiencies. The guanidinium group seems to play a special role prior to 
cellular uptake by recognizing the phosphate in the cell membrane via a bidentate hydrogen 
bonded salt bridge.  
137 
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Figure 64. Cell penetrating peptide Arg8 (139) and octameric cis- γ -aminoproline 140. 
A general problem of CPPs is the rather low stability for in vivo applications. Under 
physiological conditions they are rapidly degraded by proteases due to their peptidic nature. 
By implementing non-natural amino acids their proteolytic stability was increased while their 
ability to transduce cells was retained. Albericio and Royo for instance devised oligo-cis-
γ-amino-proline CPPs like 140 as depicted in Figure 64.163 Although these compounds are 
slightly cytotoxic they proved to be capable of cell transfection and were not degraded in 
human serum.  
In conclusion cell penetrating peptides are a new and innovative class of gene carriers which 
offer great potential for efficient delivery of nucleic acids into cells. Hence, they have been 
frequently utilized for in vitro and in vivo applications with several ongoing clinical trials. 
CPPs are 10 to 30 residues long, naturally derived or rationally planned and rich in lysine 
and/or arginine amino acids and can be easily prepared by standard SPPS. So far, a minimum 
of six charges is necessary for efficient gene delivery. The major limitation is endosomal 
escape. In general, they are less toxic than cationic lipids or polymers. However, when not 
derivatized with non-natural moieties they are metabolically instable. Due to their peptidic 
nature a combinatorial approach for the development of even more efficient vectors should 
also be feasible.164-166 
.   
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3. PROJECT AND OBJECTIVES 
The focus of this dissertation lies within the field of molecular recognition of biologically 
relevant targets. The scope of the work ranges from the development of new methods and the 
design of novel model systems for studying supramolecular binding events to application in 
cell biology. 
Method Development: Raman Spectroscopy 
The first project is based on previous results of our working group concerning the molecular 
recognition between the artificial receptor GCP-KKF (13) and tetrapeptides (141) as shown in 
Figure 65. This host-guest system forms stable complexes in aqueous medium and is an ideal 
model system for the development of new Raman spectroscopy-based techniques for studying 
the interactions at the molecular level. This vibration-based method is in theory able to 
determine binding constants and to analyze at the same time which parts of the molecules 
interact with each other, but the method suffers from the weak intensity of the Raman signals. 
To circumvent these problems new approaches will be developed together with our 
cooperation partner, the working group of Prof. S. Schlücker at the Institute for Physics at the 
University of Osnabrück. In the first approach we will test whether it is possible to utilize 
Resonance Raman spectroscopy for the determination of binding constants. Therefore, the 
interaction between 13 and several anionic tetrapeptides will be studied. In previous work it 
could already be shown that Resonance Raman is able to give qualitative information for this 
binding event.167 Furthermore, the binding constants are already known thus rendering this 
host-guest pair the ideal model system.29  
 
Figure 65. Resonance Raman studies will be applied for the determination of the binding constant between 
receptor 13 and tetrapeptidic stubstrates 141. 
The second Raman project, which will be attended to together with our cooperation partner, 
will follow an entirely different approach. In previous work it could be shown that the above 
mentioned receptor 13 can be visualized on bead with the help of surface enhanced Raman 
spectroscopy by incubating the resin with silver nanoparticles.168 We will now try to develop 
a more sophisticated solid-support with integrated noble metal nanoparticles which would 
allow for direct and rapid detection of solid-bound substances on bead – a task which is to this 
day extremely difficult to achieve.  
13 141 
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Model Receptors for Oligopeptides and Nucleotides 
The second project of this thesis is based on the results of my diploma thesis, in which 
several divalent model receptors could be synthesized either with identical or with different 
arms.195 During this doctoral work the design of these systems will be optimized in order to 
improve their physicochemical properties for substrate binding – especially their pKA values, 
which were too low for efficient binding in water at physiological pH. The non-symmetric 
tweezer receptors 142 shown in Figure 66 will consist of two differently substituted peptidic 
side chains. One of these arms will carry a guanidiniocarbonyl pyrrole (red) unit as oxoanion 
binding motif. These model systems will then be tested for their binding properties towards 
the tripeptide 143, which plays a decisive role in the biosynthesis of bacterial cell wall. The 
GCP unit is responsible for the recognition of the C-terminus of the peptide and the amino 
acids (AA1-AA4) in the two side chains allow for additional interactions with the substrate.  
 
Figure 66. Symmetric (143) and non-symmetric tweezer receptors (144) for the molecular recognition of 
oligopeptides (143) and nucleotides (145) in aqueous medium at physiological pH. 
The symmetric tweezer receptor 144 will correspondingly carry two identical amino acids 
AA1 and AA2, as well as two oxoanion binding motifs. In comparison to the non-symmetric 
receptor, the additional GCP unit should allow for the recognition of anions apart from planar 
ones, like for instance tetrahedral phosphates (145). Therefore the binding characteristics 
towards nucleotides will be studied for this host system. 
Nucleic Acid Binding and Cell Transfection 
In the next step the molecular recognition of more complex biological systems, namely 
nucleic acids, will be studied. Therefore the symmetric tweezer system 144 will be tested for 
its ability to interact with various artificial and generic polynucleotides. Additionally the 
trivalent ligand 146 depicted in Figure 67 of similar design will be developed and compared 
142 
144 145 
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to its two-armed analogue. It will feature three side chains with GCP headgroups of the same 
amino acid composition as 144. 
 
Figure 67. Trivalent polynucleotide-ligand 146 with three identical side-chains and three GCP units. 
The affinity and selectivity of these systems will be studied as well as the structure of the 
complex. Finally, together with our cooperation partner, the working group of Prof. S. Knauer 
at the Institute for Biology at the Universtiy of Duisburg-Essen we will test the ability of these 
systems to transfect human cells with genetic information. Such experiments should give new 
insight into the interactions between small molecular ligands with nucleic acids and hence 
advance the applicability of non-viral vectors as an essential prerequisite for gene therapy. 
Combinatorial DNA-Ligand Library 
The combinatorial DNA-ligand library 147 shown in Figure 68 will be prepared next in 
order to improve the binding affinity of the symmetric two-armed ligands towards 
polynucleotides. The peptidic side chains will consist of either three, two, one or no amino 
acids per arm (AA1-AA3). This way the influence of the amino acid composition on the 
nucleic acid recognition event can be studied as well as the influence of the size of the 
ligands. Finally, the most promising DNA-binders will be tested for their transfection 
efficiency by our cooperation partner to study whether there is a correlation between strong 
binding and the ability to shuttle genetic material into human cells. 
 
Figure 68. Combinatorial DNA-binder library 147 for studying the influence of the amino acid composition and 
size of the ligands on the affinity towards nucleic acids. 
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Amphiphilic DNA-Ligands for Cell Transfection 
In the last part of this thesis the optimized lead-structures for high affinity DNA binding 
identified by means of the combinatorial library 147 will be derivatized with lipophilic 
octadecyl chains as depicted in Figure 69. These lipoplex-like structures (148) should then 
ensure very efficient gene transport. This hypothesis will also be tested by our cooperation 
partner. 
 
Figure 69. Combining high affinity DNA-ligands derived from the combinatorial library 147 with lipophilic 
hydrocarbon chains generates lipoplexes (148) which should be highly efficient gene carriers. 
By synthesizing the artificial host and ligand systems described above novel insights into the 
complex recognition events in natural systems should be revealed. Furthermore the goal of 
this work is to directly utilize the so obtained knowledge for the generation of efficient 
transfecting agents which can be directly applied in cell biology. 
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4. RESULTS AND DISCUSSION 
4.1 RAMAN SPECTROSCOPY AND MOLECULAR RECOGNITION 
The most common methods for studying supramolecular interactions between host and guest 
systems are NMR-,169 calorimetry- (see chapter 2.3.4), or spectroscopy-based methods like 
UV/Vis and fluorescence spectroscopy.170 A less well deployed but forthcoming 
spectroscopic method for the label-free studying of non-covalent receptor-ligand interactions 
is Raman spectroscopy which is named after the Indian physicist C. V. Raman who was 
awarded the 1930 Nobel Prize for the experimental discovery of Raman scattering in 1928.171 
This method does not only allow for the determination of the strength of a non-covalent 
complex, it also enables the elucidation of the dynamics and structure of the complex.172,173 
The Raman signals are characteristic features of a given molecule and are defined by its 
functional groups. By monitoring changes of these signals upon a binding event one may 
therefore deduce which functional groups are involved in the complexation process event – 
and to which extent.  
A limiting factor for a more widespread usage of this method however, is the low intensity 
of the Raman signals. Hence, for the measurement of Raman spectra high concentrations, 
efficient detectors and a strong energy source (e.g. lasers) are necessary. However, the 
increase of concentration is not always feasible, and a strong energy source may lead to 
overheating of the sample. Therefore two methods, which are able to increase the signal 
strength by several orders of magnitude and thus render Raman spectroscopy an excellent tool 
for the studying of host-guest interactions will be presented in the following: Resonance 
Raman (RR) and surface enhanced Raman spectroscopy (SERS). 
4.1.1 Resonance Raman Spectroscopy 
When irradiating a molecule at a wavelength close to or at an electronic transition, the 
intensity of the total symmetric vibrations involved in the electronic transition are magnified 
by a factor of 102 to 106.174,175 . An additional advantage of this method is that different parts 
of the molecule can be selected by tuning the wavelength to a specific absorption which 
corresponds to a defined moiety of the molecule. By doing so, the resulting Raman spectrum 
can be simplified tremendously.  
With the help of RR Schlücker and Schmuck could already qualitatively study the complex 
formation between the receptor GCP-KKF (13) and a tetrapeptidic substrate by preparing 
solutions of different mixing ratios of host and guest and recording the corresponding Raman 
spectra at a very low concentration for Raman spectroscopy (0.5 mM).167 In order to test the 
general feasibility for such a RR approach and to also quantitatively determine the binding 
constant of the host-guest system, RR titration studies were conducted within this work. 
Therefore, the receptor and several ligands had to be synthesized, first. 
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Synthesis of the Guanidinocarbonyl Pyrrole (GCP) Oxoanion Binding Motif 
The synthetic work started with the preparation of the guanidiniocarbonyl pyrrole (GCP).176 
The oxoanion binding motif originally prepared by Schmuck will be implemented into all 
receptor molecules presented within this work. Since the synthesis has already been reported 
in literature and is frequently used in our working group, it will only be explained briefly in a 
short overview. As depicted in Figure 70 the synthesis started with pyrrole (149) which was 
derivatized in an electrophilic aromatic substitution reaction with trichloroacetyl chloride 
(150) to trichloroacetyl pyrrole (151). This compound was then converted to the 
corresponding benzyl ester 152 via a haloform reaction. By means of a Vilsmeier-Haak 
formylation an aldehyde group was introduced at position 5 (153), which was then oxidized to 
the free carboxylic acid with potassium permanganate. In the next step N-Boc-guanidine (155) 
was attached to the acid 156 with PyBOP as coupling agent to give 157. Finally, the benzyl 
ester was selectively hydrogenated palladium-catalyzed with H2 in the presence of 
triethylamine to give the Boc-protected guanidinocarbonyl pyrrole 158, which in this form 
can be attached to N-termini of peptide sequences via solid phase synthesis. 
 
Figure 70. Synthesis of the guanidinocarbonyl pyrrole oxoanion binding motif 158. 
Solid Phase Peptide Synthesis of Receptor and Substrates 
The preparation of receptor 13 has already been described by Schmuck and Heil.177 Its 
synthesis was carried out with the help of standard Fmoc solid phase peptide synthesis 
(SPPS).178,179 The advantage of this method is, that peptide sequences can easily be prepared 
on solid support with high yields and purities. The amino acid building blocks are protected 
with a base-labile Fmoc protecting group at their N-termini and attached to the free 
N-terminus of the growing peptide chain via activation of their C-terminus with a coupling 
agent. To prevent cross-reactions, all amino acid side chains have to be protected as well – 
most commonly with tert-butoxycarbonyl (Boc) and tert-butyl (tBu) protecting groups.180 By 
carrying out the coupling steps with an excess of reactants with respect to the resin-bound 
155 154 
150 
156 157 158 
153 151 152 149 
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
functional groups, complete conversions can be ensured. No purification is necessary in 
between synthetic steps, because the reactants can easily be removed from the mixture by 
filtration and washing steps. Only after cleaving the resin-bound compound under acidic 
conditions and thereby simultaneously removing all protecting groups, the product has to be 
purified. This is why SPPS provides a convenient method for the preparation of oligopeptides 
with high yields and purities. 
 
Figure 71. Solid phase peptide synthesis of the receptor 13 on Fmoc-Rink-Amide resin. 
The synthesis of 13 was carried out as depicted in Figure 71 on Fmoc-Rink-Amide resin 
(loading: 0.94 mmol/g). After swelling the solid support in dimethylformamide (DMF) to 
increase the accessibility of the functional Fmoc-amine groups inside the resin, the Fmoc 
protecting group was removed by treating the polymer with 20 % piperidine/DMF (2 × 
20 min). Successful liberation of the amine functionalities on the resin was confirmed with 
the help of the Kaiser test.181 This color test gives a positive answer, when free amines are 
present on the solid-support and is negative when all amines have been converted to amides. 
Between all synthetic steps the resin was thoroughly washed with DMF. The first amino acid 
Fmoc-Phe-OH (3 eq) was activated with the coupling agent benzotriazol-1-yloxytri-
pyrrolidinophoshonium hexafluorophosphate (PyBOP, 3 eq) in 3 % N-methylmorpholine 
(NMM)/DMF under argon atmosphere and attached to the resin by shaking it for 8-12 h. 
Since the first step of a solid phase synthesis is regularly rather difficult, the coupling step 
was repeated to ensure complete conversion of the resin´s amine groups. In order to cap 
eventually still remaining free amines, the resin was then treated with acetic anhydride in 3 % 
NMM/DMF. A negative Kaiser test indicated complete conversion. After another Fmoc 
deprotection the next two amino acids, two times Fmoc-Lys(Boc)-OH and finally the Boc 
protected GCP group were attached accordingly. If necessary, coupling steps were repeated as 
indicated by the Kaiser tests. After completion of the SPPS, the resin was extensively washed 
with DMF, dichloromethane (DCM) and methanol (MeOH) and dried in vacuum. To cleave 
the resin-bound product 160 from the solid support and to simultaneously remove all 
protecting groups, the polymeric support was treated with a mixture of 50 % trifluoroacetic 
acid (TFA) in DCM containing 5 % triisopropylsilane (TIS) for 4 h.182 The latter was 
necessary as nucleophilic scavenger to intercept reactive cation species which are formed 
158 
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under these harsh acidic conditions, e.g. t-butyl cations from the Boc deprotection.183 These 
cationic species could else irreversibly add to the liberated product thus reducing the yield and 
complicating the purification. After precipitation from diethyl ether the crude product was 
purified with the help of reversed phase (RP) MPLC (RP18, H2O → MeOH, 0.1 % TFA) to 
obtain the product with 40 % yield. Finally, the trifluoroacetate counterions were exchanged 
for chlorides by dissolving the product several times in aqueous HCl (0.1 N) and consequent 
lyophilization to obtain 13 as the hydrochloride salt. 
The synthesis of the tetrapeptidic substrates N-Ac-Ala-(D-Glu)3-OH (161), N-Ac-Ala-D-Ala-
(D-Glu)2-OH (162), N-Ac-(D-Glu)3-D-Ala-OH (163), and N-Ac-(D-Glu)3-Ala-OH (164) (see 
Figure 72) was carried out via SPPS according to a procedure reported for 161 by Schmuck 
and Wich.29 Wang resin (1.63 mmol/g) was used as solid support – a polymer which features 
hydroxy instead of amine groups for the attachment of the first amino acid via its C-terminus. 
After cleavage from the resin, the products are consequently liberated as carboxylic acids 
instead of amides. To account for the reduced reactivity of the hydroxy group, the first 
coupling step was conducted with N,N´-diisopropylcarbodiimide (DIC, 2 eq) and 1-hydroxy-
benzotriazole (HOBt, 2 eq) plus catalytic 4-dimethylaminopyridine (DMAP) in a mixture of 
DCM/DMF (7/3) under argon atmosphere (8-12 h) and repeated four times. The following 
coupling and deprotection steps were carried out as described for 13 (vide supra) with PyBOP 
as coupling agent and the building blocks Fmoc-D/L-Ala-OH and Fmoc-D-Glu(OtBu)-OH. 
After removal of the last N-terminal Fmoc group, the resin was treated with acetic anhydride 
as persistent N-cap. After MPLC purification the substrates 161-164 were obtained with good 
to excellent yield (161: 90 %; 162: 83 %; 163: 53 %; and 164: 76 %). 
 
Figure 72. The four tetrapeptides 161-164 were synthesized by SPPS on Wang resin. 
In order to ensure the high purity needed for RR studies, the substrates were further 
subjected to purification via preparative HPLC. After identifying the ideal isocratic conditions 
on analytical HPLC (acetonitrile/water + 0.5 % TFA) the pure products were isolated via 
preparative HPLC on multimilligram scale. An exemplary purification of the substrate 161 is 
depicted in Figure 73. 
161 162 
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Figure 73. Purification conditions for 161 were optimized via analytical HPLC to isocratic elution at 3 % aceto-
nitrile/water (0.05 % TFA) as monitored by the UV/Vis absorption at 220 nm (left) and successfully transferred 
to purify the compound via preparative HPLC (right).  
Determination of the Binding Constants 
The so obtained substances were now ready for Raman measurements, which were 
conducted by Stephan Niebling in the framework of his Ph.D. thesis in the working group of 
Professor Sebastian Schlücker at the Institute of Physics at the University of Osnabrück.184 
With the experience of the qualitative binding studies at hand, the pyrrole moiety of the 
receptor was excited at 275 nm, which is 25 nm away from its absorption maximum at 
300 nm, to prevent fluorescence which would otherwise overlay the Raman signals.167 The 
observable signals are then exclusively due to the GCP unit. In order to acquire quantitative 
binding information, eleven solutions were prepared at a receptor concentration of 1 mM 
containing increasing amounts of substrate (0 to 10 eq). The resulting RR spectra were 
recorded. A representative example of three mixtures of 13 with 161 is illustrated in Figure 74 
(top, left). The measurements were conducted at pH 6 without buffer. Therefore the pH was 
checked before and after the measurement to guarantee a constant value (ΔpH ≤ ±0.05). In 
general, the observed spectral changes upon addition of the substrates are only weak: There 
are minor intensity changes at 940, 955, and 1630 cm-1. The most pronounced change could 
be witnessed for the two bands at 1440 and 1470 cm-1 (red). For the latter one also a shift to 
higher wavenumber could be observed upon addition of the substrate. Both bands can be 
ascribed to bending modes of the guanidinio part of the GCP group.  
The next step was to analyze the data in more detail for the calculation of the binding 
constant. Therefore, the experimental spectra were subjected to a non-negative matrix 
factorization.185 A matrix containing the experimental spectrum was factorized into matrices 
containing the spectra of the individual components and into matrices containing the 
contributions of the components to each experimental spectrum. In this case, the experimental 
spectrum only contains two components due to the lack of substrate RR signals: the spectrum 
of the free and of the substrate-bound receptor. While the first one corresponds to the known 
experimental spectrum for the receptor, the latter one can be approximated by the spectrum 
obtained with 10 eq of substrate. Thus, the degree of complexation can be extracted from each 
spectrum and plotted against the amount of ligand (Figure 74, right). With the already known 
1:1 host-guest stoichiometry,29 a multivariate non-linear least square fitting procedure was 
utilized to determine the binding constant.  
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Figure 74. Top: Resonance Raman spectra upon irradiation at 275 nm of GCP-KKF 13 (1 mM) and mixtures 
thereof with 161. The degree of complexation was determined by non-negative matrix factorization and fitted 
with a non-linear regression for a 1:1 complex stoichiometry. Bottom: FT-IR spectra of 13 and mixtures with 
161 and data processing thereof similar to the RR study (from: Niebling Ph.D.).184 
Table 1. Comparison of binding constants K [M-1] obtained by various methods. 
Substrate 
On-bead 
fluorescence29 
UV29 RR IR 
161 8500 n.d. 1910 2210 
162 2600 n.d. 1260 420 
163 2100 4500 n.d. n.d. 
164 200 1400 n.d. n.d. 
 
Table 1 lists the so obtained values and compares them to the data from the on-bead 
fluorescence screening and solution phase UV/Vis titrations. Additionally, FT-IR binding 
studies were conducted by Niebling and analyzed by the same procedure (Figure 74, bottom). 
In contrast to RR, the IR spectra contain signals from all functional groups of the receptor and 
not just from the GCP moiety, and additionally substrate-derived bands. The non-negative 
matrix factorization was thus conducted with three components instead of two. The resulting 
degrees of complexation were again plotted against the amount of substrate and a non-linear 
least square fit gave the binding constant. The data listed in Table 1 was still work in progress 
at the time this dissertation was written. However, it was possible to reproduce the order of 
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affinity 161 > 162 with this RR approach and hence this work can be regarded as proof-of-
principle that quantitative binding affinity studies are accessible with the help of Resonance 
Raman spectroscopy. Especially when taking into account that the original data stems from 
on-bead assays and was carried out with completely different conditions (concentration, 
buffer vs. no buffer) the results are in very good agreement. In future experiments also the 
binding affinities of 163 and 164 will have to be analyzed.  
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4.1.2 Surface Enhanced Raman Spectroscopy 
Another excellent method for the amplification of Raman signals is the surface enhanced 
Raman spectroscopy (SERS).186 In close proximity to metal surfaces Raman signals are 
amplified even stronger than it is the case for Resonance Raman by a factor of 106 to 108. The 
effect was first observed by Fleischmann in 1974 for pyridine molecules which were adsorbed 
at the surface of a silver electrode.187 In the best case SERS amplification by 14 orders of 
magnitude is possible. Most commonly noble metal nano-structures derived from gold or 
silver are utilized.188 The reasons for the massive increase of signal strength are high local 
electromagnetic fields (due to surface plasmon Resonances at the metal surface) and a 
dynamic charge-transfer electronic transition between metal and molecule. The SERS effect is 
extremely dependent on the distance between analyte and surface: It decreases with r–10. 
Schmuck and Schlücker utilized this SERS effect for the direct and label-free 
characterization of solid phase bound GCP-KKF (13).168 Due to the low loading of 
approximately 100 pmol per bead it is normally very difficult to analyze solid phase bound 
substances. The complexation properties of bound compounds are regularly screened with the 
help of UV/Vis or fluorescence tagged substrates. By doing so it is however not possible to 
gather structural information. It is not even possible to determine whether the expected 
compound is indeed present on the beads under inspection. This last point is especially 
troubling when working with huge, random libraries. To an extent mass spectrometry is able 
to characterize potential solid-bound hit structures in hindsight, but only if the compound is 
cleavable from the solid-support.189 Therefore chemical tags have been developed which 
allow for identification of the compound after screening.190 This approach however, increases 
the complexity of the synthesis and may potentially lead to unwanted interactions with the 
receptor or the substrate during the screening process and thus limit its application.40 Solid-
state NMR and even UV/Vis and fluorescence spectroscopy are not sensible enough to detect 
molecules that dilute in the presence of a high excess of solid support. Vibration-based 
spectroscopic techniques like IR and Raman neither allow for differentiation between actual 
compound and the matrix background of the bead. These inconveniences were circumvented 
by Schmuck and Schlücker by first preparing the receptor on TentaGel resin and subsequently 
adsorbing silver nanoparticles (NPs) onto the surface of the solid support. Consequently, the 
Raman signal could be increased by a factor of 106 to 107. Due to the distance-dependency of 
the SERS amplification (r–10), the receptor could unambiguously be distinguished from the 
resin despite the low resin loading and the huge excess of polystyrene matrix. However, for 
general application of this method two inconveniences remain: The first is potential 
interactions between the silver colloids and the resin-bound substances which may alter its 
original electronic, vibrational and conformational properties. Second, the strong interaction 
between metal and solid phase bound compound is often not reversible. Therefore, this 
approach restricts the further usage of the resin-bound substances. For instance, the control of 
a synthetic procedure at the intermediate state by Raman spectroscopy followed by 
continuation of the synthesis will be rather difficult to achieve, because the NPs are very 
difficult to remove from the surface of the resin. This is why in the following a new approach 
will be presented. As shown in Figure 75 beads for solid phase synthesis and silica-protected 
plasmonic nanoparticles for SERS analysis will be integrated into a bifunctional unit. Gold 
nanoparticles will be adsorbed onto the resin in a way that they almost completely cover its 
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surface (a, b) and will then be further derivatized with e.g. amine groups to allow for SPPS 
(c). The following work was carried out together with Magdalena Gellner from the working 
group of Professor Sebastian Schlücker at the Institute of Physics at the University of 
Osnabrück.191 
 
Figure 75. Design of the plasmonic microspheres. a) Self-organized, silica-encapsulated, 80 nm sized Au 
nanoparticles on a 130 µm TentaGel bead; b) Zoom onto the NP-loaded surface; c) Derivatization of the silica-
encapsulation with amino silane results in terminal amine groups ready for SPPS (from: Gellner Ph.D.).191 
Preparation of SPPS-Beads Modified with Silica-Encapsulated Au Nanoparticles  
Commercially available monodisperse gold nanoparticles of 80 nm size were encapsulated 
by Gellner with an ultrathin layer (2-3 nm) of silica by treating the nanoparticles with a dilute 
Na2Si3O7 solution according to a procedure described in literature.192 The glass-encapsulation 
prevents adsorption of unwanted molecules onto the gold surface and improves the 
mechanical stability of the Au NPs.193 Due to its thinness it still allows for plasmonic 
coupling and efficient SERS amplification.  
 
Figure 76. Left: SEM image of a TentaGel bead, which is completely covered with silica-encapsulated Au NPs 
(top) and zoom onto the surface (bottom). Middle: HR-TEM image of a gold NP with 2-3 nm glass-shell (top) 
and higher resolution image thereof (bottom). Right: Earlier try to silica-encapsulate the bead after adsorption 
of the Au NPs onto the resin surface lead to the formation of a wool-like structuring (top). At high resolution the 
single Au NPs are not visible (bottom). All pictures from Gellner Ph.D. 191 
a) b) c) 
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In the next step the solid support TentaGel-NH2 (130 µm) was incubated with an excess of 
Au colloid, which was adsorbed onto its surface via electrostatics. The large excess of NPs 
ensured a maximal coverage of the surface with nanoparticles almost side by side, which is a 
prerequisite for efficient SERS amplification.194 This could be proved with the help of 
scanning electron microscopy (SEM) as shown in Figure 76 (left, bottom). The successful 
ultrathin silica-encapsulation of the entire surface of the gold NPs could also be demonstrated 
via high resolution transmission electron microscopy (HR-TEM, Figure 76 middle). It is 
crucial to encapsulate the Au NPs prior to adsorption onto the TentaGel surface. Earlier tries 
to create the ultrathin glass layer after adsorption of the NPs led to complete capsulation of 
the bead with a thick silica-layer (see Figure 76, right). As a consequence no Raman signals 
could be observed after attaching substrates to these beads caused by the increased distance 
between Au surface and the compounds. 
SPPS of Amino Acids and a Dipeptide on the Modified Beads 
The further derivatization of the so obtained Au NP modified beads was carried out in our 
laboratory. Due to the complete coverage of the TentaGel surface with gold nanoparticles, it 
was not accessible anymore for SPPS. Therefore, an amine functionality was introduced onto 
the silica-surface by treating the beads with a solution of 0.5 % 3-amino-N-propyltrimethoxy-
silane (APTMS) in ethanol (EtOH) (50 µL) and 25 % aqueous ammonia (50 µL) in ethanol 
(1 mL) for 30 min. The trimethoxysilane part of this reactant adsorbs onto the glass surface 
and thus a free amine function is generated, which could be used for the attachment of various 
amino acids or oligopeptide substrates. The so obtained beads were washed with DMF and 
then subjected to SPPS. Approximately 20-30 beads were treated with a 30 mM solution of 
PyBOP and either Fmoc-Gly-OH, Fmoc-Phe-OH or Fmoc-Ser(OtBu)-OH in 3 % NMM/DMF 
(1 ml) for 8-12 h under argon atmosphere to attach the three different compounds to the 
surface-bound amine. The coupling step was repeated. Then the Fmoc groups were removed 
with 20 % piperidine/DMF (2 × 20 min). Fmoc-Phe-OH was then attached to a fraction (10-
15 beads) of the glycine derivatized beads and its Fmoc group removed according to the same 
procedure. Finally, all beads were treated with 33 % TFA/DCM for 4 h to remove the serine 
tBu protecting group and to generate the TFA salts from the free amine N-termini of all four 
substrates for means of better comparability of the resulting spectra. Finally, the beads were 
washed with MeOH and water.  
  
Figure 77. The UV/Vis absorption spectrum of the Fmoc-piperidine adduct 165 (left) and the corresponding 
linear fit of the concentration dependent absorption at 300 nm (right). 
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In order to determine the loading of the modified beads, the piperidine/DMF solutions and 
the following washing solutions were collected, combined and their UV/Vis spectrum was 
measured between 250 and 350 nm. As shown in Figure 77 the concentration of the Fmoc-
piperidine adduct (165) can be determined with the help of its UV absorption at 300 nm and a 
concentration dependent calibration curve as reported in my diploma thesis.195 By counting 
the number of beads with the help of a microscope, the loading per bead was then calculated 
as 17.14 (Gly), 22.55 (Phe), 31.69 (Ser) and 12.53 nm/bead (Gly-Phe). This loading is in the 
range of commercially available resin loadings (0.25-3 mmol/g). 
  
Figure 78. SEM images of the surface of the microspheres after one (a) and respectively two SPPS steps (b) and 
treatment with 33 % TFA/DCM for 4 h demonstrating that the surface is still completely covered with silica-
encapsulated gold nanoparticles (from Gellner Ph.D.).191 
Finally, for the use in surface enhanced Raman spectroscopy, it had to be ensured, that the 
packing density of the Au NPs on the TentaGel surface is still intact after the synthesis. As 
shown in Figure 78 SEM images were recorded by Gellner after glycine (a) or the dipeptide 
Gly-Phe (b) were attached to the beads via SPPS. The images clearly demonstrate that the 
packing of the Au NPs was unharmed even after two couplings, two basic deprotection steps, 
treatment with organic solvents like DMF or MeOH, and 4 h under very harsh acidic 
conditions. Thus the TentaGel-Au NP assembly has proven to be extremely stable under the 
conditions which are necessary for standard Fmoc SPPS. 
SERS of the Derivatized Beads 
In the next step, the so derivatized beads were analyzed via SERS measurements by Gellner. 
They were irradiated at an excitation wavelength of 785 nm emitted by a diode laser. Figure 
79 shows the spectra obtained from differently derivatized beads: Serine (magenta, 166), 
glycine (red, 167), phenylalanine (green, 168) and from beads after (cyan, 169) and prior to 
derivatization with APTMS (black, 170). Every set of spectra contains information about the 
mean value (colored line) and the standard deviation (upper and lower limit). 
It is clearly visible that the derivatization leads to the formation of additional bands and to 
changes of band intensities which are different from the spectra of the untreated beads (169, 
170) and therefore characteristic for the amino acids. Furthermore, serine and glycine could 
be differentiated from each other by the ratio of the intensity of the Raman signals at 1570 and 
1602 cm-1. The quotient is 0.63 ± 0.35 for Gly and 1.37 ± 0.32 for Ser. Phenylalanine could 
be discriminated from the other two amino acids by its overall lower Raman intensity in this 
region of the spectrum. Comparison of these spectra with those obtained from beads prior to 
a) after Gly b) after Phe-Gly
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and after APTMS functionalization revealed that all spectra are dominated by vibrational 
contributions of the polystyrene matrix and the silica network. The phenylalanine signals of 
the aromatic ring and the CH2 group are overlaid by PS phenyl ring modes and APTMS CH2 
deformation modes. Therefore, it was rather difficult to detect Phe. 
          
Figure 79. SERS spectra of serine (magenta, 166), glycine (red, 167) and phenylalanine (green, 168) as 
obtained from the Au-NP modified TentaGel as well as SERS spectra of beads after (cyan, 169) and prior to 
APTMS treatment (black, 170). Spectra from Gellner Ph.D.191 
  
Figure 80. Left: SERS spectrum of the dipeptide Gly-Phe (171) as obtained from the Au-NP modified TentaGel. 
Right: The calculated molecular model consisting of a small silica network, the C3 alkyl chain of the amino 
silane and Phe (green) and respectively Gly-Phe (blue). Spectrum and image from Gellner Ph.D.191 
To test whether the dipeptide Gly-Phe (171) can be discriminated from its parent amino 
acids Gly and Phe, the so derivatized beads were analyzed next. As illustrated in Figure 80 
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(left) an additional Raman band at 1144 cm-1 could be observed which was neither present in 
the glycine nor in the phenylalanine spectrum. To identify the origin of this new band, 
calculations of model systems comprised of a small silica network, the APTMS propyl chain 
and either the single amino acids Gly, Phe or the dipeptide Gly-Phe were carried out by 
Niebling. First a conformational analysis was carried out with the help of classical molecular 
mechanics. Then a DFT calculation for the conformer of lowest energy was performed. The 
results of these calculations indicated that Phe features several ring mode contributions with 
high Raman intensity at 1140 cm-1. Three normal modes which contribute to the Raman 
signal at this region are depicted in Figure 81. 
 
Figure 81. Eigenvectors of selected phenyl ring modes. A scale factor of 0.96 was utilized for the DFT-derived 
harmonic wavenumbers.196 The three normal modes stem from vibrational contributions in the region around 
1144 cm-1 (from Gellner Ph.D.).191 
As indicated in Figure 80 (right) a possible explanation of the lack of this band in the Phe 
spectrum is that in the dipeptide (blue) the phenyl ring is able to come within close proximity 
of the silica network due to its increased flexibility in comparison with the simple amino acid. 
The proximity to the silica surface also brings the phenyl ring within closer contact to the gold 
surface of the nanoparticles and thus leads to an increased amplification of the ring mode-
derived Raman signal. For the single amino acid Phe (green) this is not possible. 
In conclusion, in cooperation with the working group of Schlücker it was possible to develop 
a bifunctional system for the preparation of short peptides via SPPS and their direct 
observation via SERS. Therefore, commercial gold nanoparticles were encapsulated by an 
ultrathin silica layer, aggregated with commercial TentaGel resin and derivatized with an 
amine group. In the framework of these first proof-of-principle studies three amino acids 
(Gly, Phe, Ser) could be attached to the modified resin and discriminated from each other and 
also from an analogue dipeptide (Gly-Phe). The modified solid support is stable under harsh 
acidic and basic conditions as well as in various organic solvents and can be utilized with 
great ease for the preparation of short oligopeptide sequences via SPPS. In future studies, 
such integrated SERS/SPPS systems might find potential application for the studying of non-
covalent interactions, which can be directly observed via changes in their Raman signature. 
Hence, this bisignate system offers great potential in supramolecular chemistry, for instance 
as sensor for the rapid detection of guest molecules. 
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4.2 NON-SYMMETRIC TWEEZER RECEPTORS FOR PEPTIDE RECOGNITION  
Although many host systems have been proposed for the molecular recognition of short 
peptides sequences, the development of high affinity receptors for polar oligopeptides in 
water remains a demanding task due to the competitive influence of the medium. Within the 
framework of the continuation of the work I have conducted during my diploma thesis, non-
symmetric tweezer receptors, i.e. host systems with two different arms, which are linked via 
an aromatic template, will be prepared for the molecular recognition of the biologically 
relevant, polar tripeptide N-Ac-Lys-D-Ala-D-Ala-OH in water.195 
4.2.1 Synthesis of the Orthogonally Protected Template 
For the preparation of tweezer receptors with two different side chains on solid-support an 
orthogonally protected template is necessary. The synthesis of such a scaffold was already 
described in my diploma thesis and will therefore only be described in short, focusing on 
improvements of the original synthetic protocoll.195 As shown in Figure 82 commercial 3,5-
dimethylbenzoic acid (172) was converted with oxalyl chloride and catalytic amounts of DMF 
to the acyl chloride. In situ reaction in methanol gave the corresponding methyl ester 173.  
 
Figure 82. Synthesis of the orthogonally protected aromatic scaffold 181. 
A Wohl-Ziegler bromination with N-bromosuccinimide (NBS) and azobis(isobutyronitrile) 
(AIBN) afforded the dibromide 174. Instead of carbon tetrachloride as reported in the diploma 
thesis dichloromethane was utilized as solvent. By doing so, the yield could be increased from 
67 to 76 % thus facilitating the tedious isolation of the dibromide from various other 
brominated byproducts by column chromatography. Furthermore, this way the highly toxic 
and carcinogenic solvent CCl4 could be replaced by a less hazardous one. A classical 
substitution reaction generates the diazide 175 in quantitative yield. The following key-step of 
the reaction procedure, the mono Staudinger reduction to the azido-amido derivative 176, was 
carried out with triphenylphosphane in a two-phase system composed of an acidic aqueous 
phase and an organic phase as depicted in Figure 83. The iminophosphorane intermediate 177 
is formed in the organic phase. As soon as it is reduced to the corresponding amine 178 at the 
interphase it gets protonated by HCl and is transferred into the aqueous phase as ammonium 
172 173 174 175 
176 179 180 181 
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salt where it cannot be further reduced. By adding 25 % cyclohexane (CyHex) to the diethyl 
ether phase the yield could be improved from 61 %, as reported in the diploma thesis, to 
86 %. When adding 25 % ethyl acetate (EA) instead, the yield was reduced to 33 %. Thus it 
can be concluded that a decreased polarity of the organic phase favors the transfer of the 
protonated amine to the aqueous phase. The only side products were the diamine and 
hydrolyzed methyl ester derivatives with a free carboxylic acid. Hence, this kind of mono 
reduction in a biphasic system provides a facile and efficient approach for the generation of 
two differently derivatized amine functionalities of identical reactivity, which is otherwise 
often accompanied by low yields and tedious work-up procedures. In the next step the amine 
group was protected with a Boc group (179). Reduction of the second azide and saponi-
fication of the methyl ester afforded 180, which was Fmoc-protected in the last step to give 
the desired template 181. The yield of the last step could be improved from 71 to 80 % by 
recrystallizing the Fmoc-chloride from toluene/CyHex prior to use and by purifying the 
product via reversed phase (RP) MPLC with dioxane/water instead of normal phase (NP) with 
EA/MeOH. 
 
Figure 83. Selective mono reduction of the diazide 175 to the mono amine 176 in a two-phase system. 
The overall yield of the seven step synthetic procedure could be improved from 24 to 39 %. 
The reaction can be carried out in multigram quantities starting from commercially available 
compounds. The aromatic scaffold is now ready for the solid phase synthesis of tweezer 
receptors with two different side chains.  
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4.2.2 Microwave-Assisted Solid Phase Synthesis of Two Non-Symmetric Tweezer Receptors 
The so obtained orthogonally protected template has already proven to allow for the 
preparation of tweezer receptors with non-symmetric arms during the work which was 
conducted for my diploma thesis.195 For example, such a system with the amino acid sequence 
Ser-Tyr-Gly in the first and Asp-Phe-GCP in the second arm could be synthesized on MBHA 
resin with 45 % raw product yield. However, the purity of the raw product was rather poor 
(15 %) and tedious purification steps via RP MPLC were the consequence. In the following 
an improved receptor design will be presented which should allow for facilitated synthesis 
and improved binding properties to peptidic substrates (182 versus 183 in Figure 84).  
 
Figure 84. Former (182) and improved design (183) for the non-symmetric tweezer receptors. 
The general design of the receptors however will stay the same. Two arms with different 
amino acid sequence will be linked via the aromatic template, which has already proven to 
feature the correct spacing and the ability to preorganize the two arms in a fashion which is 
favorable for the binding of peptidic substrates. One arm will feature the GCP headgroup as 
carboxylate binding site for the substrate´s C-terminus. The receptor is supposed to be soluble 
in water at pH 7 and bind to a tripeptide substrate with good affinity. Several improvements 
will be introduced: First of all, the resin will be preloaded with glycine instead of directly 
attaching the aromatic template to the resin (Figure 84, blue). This spacer will be introduced 
because the first step of a solid phase synthesis is regularly the critical one. Very often the 
first attachment is difficult, resulting in incomplete conversions and thus in low yields and 
purities. The coupling of the aromatic scaffold 181 is not trivial due to steric constraints and a 
rather low reactivity of the aromatic carboxyl group. It is therefore not very practical to use it 
as first residue. Glycine on the other hand is a sterically undemanding amino acid with good 
reactivity and therefore convenient for the first coupling step. Furthermore, the first arm will 
be capped with an acetyl group (red) and the GCP unit will be attached to the second arm 
without an amine-containing linker (green). This way the overall charge of the receptor will 
be reduced by two positive charges. This should lead to a higher pKA value of the GCP unit, 
which is normally between 6 and 7 but was as low as 5-6 with the original design, which is 
inconvenient for binding studies at physiological pH. The higher the guanidine pKA value, the 
more it will be protonated at neutral pH and the higher should be the binding affinity to the 
carboxylate group of the substrate. Lastly, the TFA counterions will be exchanged for 
chlorides (red). This is necessary because the trifluoroacetate anions are able to interact with 
the GCP unit which is known to bind efficiently to carboxylates in aqueous medium.19 Hence, 
182 183 
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TFA would compete with the actual substrate for the carboxylate binding site thus reducing 
the affinity of the receptor. 
Additionally, the receptors will be synthesized with the help of microwave-assisted Fmoc-
SPPS, which has shown to be a viable tool for improving the yield and purity of difficult 
peptide sequences.197 With the help of a single-mode microwave reproducible results can be 
achieved under controlled conditions. Generally, irradiation of the reaction mixture by 
microwaves is a very efficient way to heat the solvent in a very homogenous fashion. This 
way all the reactants have the same energy and different reaction pathways caused by higher 
or lower energy are avoided. The heat is generated due to the excitation of rotational modes of 
polar molecules which are able to interact with the microwave irradiation via their dipoles. 
This way, the solvent molecules as well as the reactants are heated directly. In comparison, 
the standard heating method utilized in most chemical laboratories is the immersion of a flask 
into an oil bath which is heated on a heating plate. Thus, the heat is transferred from the oil 
bath to the outside of the flask and from there distributed by stirring the solvent with a stirring 
bar. This method leads to a very unbalanced distribution of heat. The consequence is spots of 
higher as well as lower temperature inside the reaction mixture. This may then lead to the 
formation of unwanted side products. Because standard SPPS is carried out at room 
temperature and microwave-assisted SPPS on the other hand at elevated temperature, another 
general advantage of the microwave is shorter reaction times for coupling and deprotection 
steps. 
Before synthesizing the non-symmetric tweezer receptors with the help of irradiation, the 
microwave reaction conditions had to be optimized: Time, temperature and microwave power 
can be altered for a given coupling step. Microwave-assisted coupling reactions have been 
reported to proceed without racemization at temperatures as high as 80° C.198 Therefore, a 
temperature of 60° C was chosen for the coupling steps during the synthesis of the tweezer 
receptor, which should ensure fast reaction without racemization. Test reactions were carried 
out by coupling Fmoc-Val-OH with the help of PyBOP (each 3 eq) in 5 % DIPEA/DMF. The 
Fmoc group was deprotected with 20 % piperidine/DMF and the resin thoroughly washed 
with DMF. The solutions were collected, joined, and a UV/Vis spectrum was recorded. The 
yield of each coupling step was determined by calculating the concentration of the Fmoc-
piperidine adduct as described in chapter 4.1.2. Variation of the Power (10-180 W) did not 
lead to significant differences of the coupling yield. Variation of the time (5-20 min) had a 
more pronounced effect. The best results were obtained for the longest coupling time. After 
20 min almost quantitative conversion could be observed. Hence, reaction conditions for the 
coupling steps with irradiation to a maximum temperature of 60° C for 20 min at 20 W were 
chosen.  
With these settings the first receptor was synthesized on MBHA resin according to standard 
Fmoc-procedure as shown in Figure 85.178 All coupling steps were conducted under argon 
atmosphere. The resin was at first swollen in DCM for one hour, because polystyrene-based 
polymers like the MBHA resin feature excellent swelling properties in this solvent. After 
washing with DMF a glycine spacer was attached to the solid phase as Fmoc-Gly-OH (3 eq) 
making use of the optimized microwave conditions with the help of PyBOP (3 eq) as coupling 
agent and 5 % diisopropylethyl amine (DIPEA) in DMF. To ensure complete conversion of 
all free amine groups on the resin, the first step was repeated. In order to cap eventually 
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remaining amine groups the resin was then treated with acetic anhydride in 5 % DIPEA/DMF. 
After each coupling step the resin was washed with DMF. Successful, quantitative coupling 
steps were verified by a negative Kaiser test.181 Fmoc deprotection was carried out by treating 
the resin twice with 20 % piperidine/DMF under microwave irradiation (1 + 5 min, max. 
60° C, 20 W). The liberation of free amine groups was verified by a positive Kaiser test. In 
the next step, the orthogonally protected scaffold 181 was coupled to the glycine spacer as 
described above. The next three amino acids, Fmoc-Ser(Bn)-OH, Fmoc-Tyr(Bn)-OH, and Ac-
Gly-OH were attached accordingly. If necessary, coupling steps resulting in a positive Kaiser 
test were repeated.  
Since the next step of the synthesis is the deprotection of the Boc group at the aromatic 
template, side chains in the first arm may not feature Boc or tBu groups. However, the 
according Cbz- or benzyl (Bn) protected amino acids, which are stable under the conditions 
necessary for Boc deprotection are also commercially available. The last amino acid can 
directly be coupled as the acetyl (Ac) derivative as persistent cap for the N-terminus of the 
first arm. The subsequent deprotection was then carried out with 50 % TFA/DCM without 
microwave irradiation. The resin was thoroughly washed with DCM and 5 % DIPEA/DMF to 
get rid of all TFA molecules, which could potentially react with the free amine group of the 
template under coupling conditions. The two following amino acids, Fmoc-Asp(OtBu)-OH 
and Fmoc-Phe-OH, as well as the GCP unit (158) were then again coupled under standard 
microwave conditions with the exception of the Fmoc deprotection step after the aspartic acid 
coupling, which was carried out with 5 % piperazine and 0.1 M HOBt instead of 20 % 
piperidine. This alteration was necessary to prevent aspartimide formation and consequent 
racemization during microwave-assisted Fmoc deprotection.198  
The cleavage of the resin-bound receptor was achieved by treating the solid support with 
8 % trifluoromethanesulfonic acid (TFMSA) in 80 % TFA for 4 h. Under these strongly 
acidic conditions the receptor is released from the resin and all side-chain protecting groups 
are cleaved. The deprotection mixture also contained 8 % thioanisole and 4 % 1,2-
ethanedithiol (EDT) as nucleophilic scavengers for cationic species which are generated under 
these conditions and could otherwise add irreversibly to nucleophilic groups of the product 
(e.g. unprotected hydroxy groups). After precipitation from the cleavage mixture with excess 
Et2O, the weight of the crude product was higher than expected (> 100 % yield). The analysis 
of the corresponding mass spectrum revealed compounds which still feature one or both 
benzyl protecting groups. Obviously these groups are not removed from the hydroxyl groups 
even under the harsh acidic cleavage conditions. Therefore the raw product was hydrogenated 
with H2 and 10 % Pd/C in acetone for 3 h and after purification via reversed phase MPLC 
(RP18, H2O → MeOH, 0.1 % TFA) the product was isolated with 53 % yield. Analytical 
HPLC however revealed a purity of only 24 %. MS analysis could show that the main 
byproduct was a methylated species, probably the methyl ester of the aspartic acid which was 
formed when distilling the acidic water/methanol mixture obtained from the liquid 
chromatography under reduced pressure and elevated temperature. After one more 
purification step via RP MPLC the desired product 187 could be obtained as TFA salt with 
99 % purity (see Appendix C.1, Figure C. 1). Still, when comparing the results of the 
microwave-assisted synthesis with those from the standard procedure it becomes clear that 
both the yield (45 → 53 %) and the purity (15 → 24 %) of the raw product could be 
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improved. Furthermore, instead of two weeks the synthesis can now be carried out in merely 
two days. 
 
Figure 85. The Fmoc SPPS for the non-symmetric tweezer receptor 187 was carried out with a microwave. 
Resin-attachment and coupling: 20 min, 20 W, max. 60° C. Fmoc deprotection: 1 + 5 min, 20 W, max. 60° C. 
According to this synthetic route a second non-symmetric tweezer receptor (188, Figure 86) 
was prepared with the amino acid sequence (from C- to N-terminus) Leu-Val-Ala in the first 
and Phe-Lys-GCP in the second arm. In this sequence no protecting groups are present in the 
first side chain. After a first MPLC (RP18, H2O → MeOH, 0.1 % TFA) the crude product 
could be isolated with 71 % yield and 52 % purity. After two more purification steps the 
desired product was 90 % pure according to analytical HPLC (see Figure C. 2). The so 
achieved yield and purity are excellent when considering the complexity of the receptor, and 
the implementation of a rather unreactive aromatic amino acid (181) and a non-peptidic 
building block (158). 
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Figure 86. The second non-symmetric tweezer receptor 188 was also prepared via microwave-assisted SPPS. 
Before carrying out the binding studies, the TFA counterions of the two receptors 187 and 
188 were exchanged for chlorides by dissolving the compounds several times in dilute hydro-
chloric acid with subsequent lyophyilization. The receptors were now ready for binding 
studies. 
  
188 
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4.2.3 Preliminary Binding Studies with N-Ac-Lys-D-Ala-D-Ala-OH 
After having successfully obtained two non-symmetric tweezer receptors their 
physicochemical properties were characterized first. In order to determine their pKA values 
the receptors were dissolved in water (0.1 mM) and half an equivalent of sodium hydroxide 
(0.1 N) was added and the pH value was determined. According to the Henderson-
Hasselbalch equation (1) under these conditions the concentration of the protonated (HA) and 
of the deprotonated species (A–) is equal and therefore pH = pKA is valid. 
 ݌ܪ ൌ ݌ܭ஺ െ log 
ሾு஺ሿ
ሾ஺షሿ
  (1) 
The second pKA value of each receptor was then determined by adding another equivalent of 
base and consequently measuring the resulting pH value. The results are listed in Table 4. 
Both receptors feature two different protonation sites. The carboxylic acid of the aspartic acid 
side chain in 187 has a pKA of 4.82 (pKAI), and the GCP unit´s pKA is 7.06 (pKAII). In 
comparison, the GCP moiety of 188 has a pKA of 6.73 (pKAI) and its lysine ammonium group 
9.82 (pKAII). The acidity of the guanidinio group in the receptors is increased tremendously in 
comparison to non-derivatized guanidinium (pKA = 13.71)199 due to the electron withdrawing 
carbonyl group, and to a lesser extent due to additional charges in the molecule. The hydrogen 
donor capability is thus greatly improved. However, a too low pKA value, like in the receptors 
developed during my diploma (pKA = 5-6), leads to the loss of the salt bridge. When 
comparing the pKA value of 187 with the analogue receptor of former design, it becomes 
immediately clear, that the changes indeed led to a decrease of the acidity of the guanidinio 
group by approximately one order of magnitude (pKAII: 5.98 → 7.06).195 The reduced acidity 
is mainly a result of the removal of positive charges in the receptor and should lead to 
improved binding properties towards carboxylate containing substrates. Hence, with the 
improved design of the receptors, the carboxylate binding site is now protonated to ca. 50 % 
at neutral pH instead of only ca. 10 %. At pH 6 already approx. 90 % of the guanidine groups 
are protonated.  
In order to minimize sources of errors caused by weighing in of the samples, concentrated 
stock solutions of all compounds were prepared. These can then be diluted with higher 
precision to the desired concentration during the experiments. For the preparation of these 
solutions it was necessary to test whether the substances are water soluble at 1 mM 
concentration. This was only the case for 187, but not for the less polar 188. Therefore, the 
stock solution for the latter receptor was prepared in DMSO. 
Table 4. Physicochemical characterization of receptor 187 and 188. 
Compound pKAI pKAII Water solubility 
at 1 mM 
ε [L/mol ˙ cm] 
   pH 5 pH 6 pH 7 
187 4.82 7.06 + 14920 15950 16440 
188 6.73 9.82 - 15440 16370 17700 
 
The determination of the binding constant was carried out with the help of a UV/Vis 
titration. Upon complexation, the intermolecular interactions between receptor and substrate 
lead to a redistribution of electron density which can be observed in the UV/Vis absorption of 
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the supramolecular system. The binding of carboxylates will take place via the GCP unit. 
Among other interactions a hydrogen bond will be formed between the pyrrole and the 
carboxylate.200 This leads to a decrease of absorption at the pyrrole band at 300 nm, which 
can then be used for the determination of the binding constant. In order to prevent any effects 
derived from changes in the pH value during the titration all experiments were carried out in 
buffered solution (bis-tris buffer, 20 mM) at constant pH. This precaution was necessary 
because slight pH changes already influence the outcome of the experiments very strongly. 
Therefore, the concentration of the buffer must at least be 100 times the concentration of 
substrate and receptor. The titration itself was carried out by titrating aliquots of substrate into 
a solution of receptor and subsequent measurement of the UV/Vis spectrum around 300 nm. 
A successful complexation is characterized by a change of absorption which differs from the 
reduction of signal due to dilution. In order to differentiate between these two effects, dilution 
series of all compounds were carried out and the extinction coefficient ε was calculated 
according to the Lambert-Beer law (2). Furthermore, this way it could be shown that the 
absorption is directly proportional to the concentration in the range under investigation and 
therefore follows equation (2). This is an essential requirement for the straightforward 
determination of binding constants by means of spectroscopic methods. 
 ܣ ൌ  ߝ · ܿ · ݀  (2) 
Since the pyrrole´s ε depends on pH, three different values were determined for the two 
compounds: for pH 5, 6, and 7 (Table 4). With increasing pH the molar absorption 
coefficients increase as well. Within the pH range from 5 to 7 this increase is linear. The 
degree of protonation of the adjacent guanidinio group, which acts as a buffer in this 
concentration range and is therefore steadily protonated, affects the electronic surroundings of 
the pyrrole ring and therefore also its absorption properties. At pH 7 187 and 188 absorb light 
at 300 nm more efficiently by approximately 10 %. The commercially available tripeptidic 
substrate N-Ac-Lys-D-Ala-D-Ala-OH (189, Figure 87), which plays a decisive role in the 
formation of the cell wall of Gram positive bacteria (see chapter 2.1.2), does not absorb at 
300 nm. 
  
Figure 87. Titration of aliquots of substrate 189 into a solution of 187 leads to a decrease of UV absorption 
(left). Comparison with the dilution shows that there is an additional effect: binding to the substrate (right).  
The titration was carried out in bis-tris buffer (0.02 M) with a receptor concentration of 5 × 
10-5 M in a microcuvette (750 µL) equipped with a stopper at 25° C. Substrate of the 
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concentration 2 × 10-3 M was titrated into the solution in aliquots of increasing volume (e.g. 4 
× 2.5, 4 × 5, 6 × 10, and 5 × 40 µL) up to ca. 15 equivalents. After one minute incubation time 
the resulting UV spectrum was recorded after each addition. All experiments were carried out 
in duplicate; the reported binding constants are average values. Figure 87 depicts a typical 
titration experiment (187 at pH 5) and the comparison of the excerpt at 300 nm with the 
calculated dilution. As expected, the UV absorption decreases during the experiment. The 
comparison between experimental titration curve (black) and calculated dilution curve (red) 
reveals that the decrease of absorption is non-linear and thus, that a binding event is taking 
place between 187 and the substrate involving the GCP unit. Assuming a 1:1 receptor-
substrate complex formation the binding constant can be calculated with the help of the 
following equation28 which can again be solved through a non-linear regression analysis for 
instance with the program Origin.201  
ܣ ൌ  ߳ோሾܴ଴ሿ ൅ ߳ௌሾܵ଴ሿ ൅
ሺ߳ோௌ െ ߳ோ െ ߳ௌሻ · ܭ · ሾܴ଴ሿ · ൜
ܭ · ሾܴ଴ሿ · ሾܵ଴ሿ
ሺ1 ൅ ܭ · ሾܵ଴ሿሻଶ ൅ ܭ · ሾܴ଴ሿ
ൠ
1 ൅ ܭ · ൜ ܭ ·
ሾܴ଴ሿ · ሾܵ଴ሿ
ሺ1 ൅ ܭ · ሾܵ଴ሿሻଶ ൅ ܭ · ሾܴ଴ሿ
ൠ
 
A = Absorption at 300 nm 
εR = Extinction coefficient of receptor 
εS = Extinction coefficient of substrate  
εRS  =  Extinction coefficient of receptor-substrate complex 
[R0]  = Starting concentration of receptor 
[S0]  = Starting concentration of substrate 
K = Binding constant 
All variables but two, the binding constant K and the extinction coefficient of the complex 
εRS, are known. Thus, the equation has to be solved iteratively in order to obtain the binding 
constant. Figure 88 shows the experimental data from the exemplary titration experiment by 
plotting the equivalents against the absorption at 300 nm (black) and the corresponding 
iteratively obtained least-squares fit (red).  
  
Figure 88. Non-linear least-squares fit for the titration of the tripeptidic substrate KAA with 169 at pH 5 (left). 
Graphic representation of the measured binding constants for 187 and 188 with KAA at three pH values (right). 
According to this procedure the complexation of receptors 187 and 188 with the substrate 
KAA (189) was measured at three different pH values (5, 6, and 7). The results of these 
measurements and the corresponding standard deviations are also depicted in Figure 88 
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(right). The red bars represent the binding constants for 187 (Ser-Tyr-Gly; Asp-Phe-GCP), the 
blue ones respectively for 188 (Leu-Val-Ala; Phe-Lys-GCP). A huge difference of the binding 
constant was observed at pH 7. While 188 only binds with 6.2 × 102 M-1, 187 binds 5 times as 
efficient to the substrate (K = 3.3 × 103 M-1). Only at pH 6 188 (K = 3.7 × 103 M-1) does also 
bind to the substrate with similar binding constant as 187 (K = 4.3 × 103 M-1), although the 
latter one is still somewhat more efficient. At pH 5, again 187 (K = 6 × 103 M-1) binds more 
efficiently than 188 (K = 5 × 103 M-1). Generally, the binding constant is higher at lower pH. 
This effect can be linked to the increased protonation of the guanidine unit. At pH 7 for 
instance only ca. 54 % of 187´s guanidine groups are protonated and even less for 188 (35 %). 
At pH 6 on the other hand, the majority of guanidine moieties is protonated (187: 92 % and 
188: 84 %). At pH 5 finally, almost all guanidines are in their protonated state (> 98 %). Since 
protonation is essential for the formation of the hydrogen bonded salt bridge to the C-terminus 
of the substrate, efficient binding only takes place when the majority of the GCP units are 
protonated. Another general trend is, that 187 has a higher affinity to KAA at all three pH 
values. In part, this can be explained by the differing pKA values (187: 7.05 and 188: 6.73). 
As shown above the consequence is, that 187 features on average a higher charge at its 
carboxylate binding site. This can however not entirely explain the huge difference at pH 7 
and the difference at pH 5, when practically all groups are protonated. A possible explanation 
is an additional salt bridge between the aspartic acid, which is negatively charged at this pH, 
and the ammonium group of the substrate´s lysine side chain. Furthermore, in contrast to 
receptor 188, the hydroxy groups in the serine and tyrosine side chains in the first arm of 187 
are potential hydrogen donor and acceptor sites and might thus slightly stabilize the complex 
via hydrogen bonding. The huge increase of affinity between pH 7 and pH 6 for 188 
demonstrates, that the binding strength of this system almost exclusively stems from the 
interaction between carboxylate and the GCP group, because there are no other groups in the 
molecule which can be protonated or deprotonated in this pH range. This is further evidence 
that there must form additional interactions between the substrate and 187.  
However, although these experiments concerning the interaction between the two non-
symmetric receptors and the tripeptide substrate are an illustrative example on how subtle 
changes may affect the molecular recognition of a given host-guest system, the overall 
binding constants are rather moderate. In comparison with the one-armed analogue GCP-KKF 
(13, Figure 5), which has a similar amino acid composition as 187 and is able to bind to the 
tetrapeptide sequence Glu-Lys-D-Ala-D-Ala (14) with a binding constant of ca. 104 M-1, these 
values are lower by a factor of 2-3.13 Hence, the addition of the second arm, at least with the 
amino acid sequences utilized in this approach, does not seem to be beneficial for the 
recognition of this biologically relevant target. Therefore, no advanced additional studies for 
the detailed analysis of molecular recognition events based on these non-symmetric tweezers 
have been carried out. The focus of this thesis will from here onward mainly be turned on the 
recognition of nucleotides and nucleic acids, as will be shown in the following chapters. 
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4.3 SYMMETRIC TWEEZER RECEPTOR FOR NUCLEOTIDE RECOGNITION 
The recognition of phosphate-based anions like nucleotides requires a different approach in 
comparison to carboxylate binding. Unlike carboxylates, phosphates are not planar, but of 
tetrahedral shape. Furthermore, depending on the pH alkylated phosphates can carry up to two 
negative charges instead of only one. Hence, an approach with only one oxoanion binding site 
will probably not yield the desired result. Rather, phosphate and nucleotide recognition should 
be feasible when implementing two such units into a receptor in a fashion which allows them 
to adopt a geometry which matches that of the phosphate anion. In principle, the 
implementation of two GCP units into tweezer receptors similar to the non-symmetric ones 
described above, but with two identical arms and thus two oxoanion binding sites should be 
ideally fit for phosphate binding.  
4.3.1 Synthesis of the Template 
For such symmetric receptors an adequate template is necessary. Instead of two different 
protecting groups, only one is necessary. Already in the course of my diploma such an 
aromatic template with two Fmoc protecting groups was synthesized. Therefore, the reaction 
scheme will only be described in short, focusing on improvements in the synthetic procedure, 
which follows the exact same route as described for the orthogonally protected template 181 
in chapter 4.2.1 up to the diazide 175. Instead of reducing only one azide group, both are now 
reduced with triphenylphosphane and water to give 190 as shown in Figure 89. Instead of 
removing the methyl ester via saponification to 191 and attaching the Fmoc protecting group 
as in the former synthetic scheme, now the Fmoc group is introduced first (192) and the 
methyl ester is then cleaved under acidic condition with hydrochloric acid at 100° C with very 
good yield to give the template 193, which is ready for the SPPS of symmetric tweezer 
receptors. 
 
 
Figure 89. Synthesis of the aromatic template 193 for the SPPS of symmetric tweezer receptors: a) according to 
the original; and b) according to the novel synthetic route . 
By switching the last two steps and replacing the basic with an acidic cleavage of the methyl 
ester, the yield over three steps could be improved from 49 to 62 %. The overall yield over six 
175 190 191 193 
175 190 192 193 
a) Original Synthetic Route 
b) Novel Synthetic Route 
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steps starting with 3,5-dimethylbenzoic acid is 42 %. Thus, the problematic Fmoc protection 
step of the polar diamine benzoic acid derivative 191 with non-polar Fmoc-Cl with its 
crucible dioxane/water solvent ratio is circumvented: Small changes did dramatically alter the 
result. As a consequence, this reaction only yielded max. 59 % and was not very reproducible: 
It often failed totally or only gave low yields. Another problem was the purification by 
column chromatography. 193 forms aggregates, which hardly dissolve and only elute slowly, 
even at 10 % MeOH/EA. 192 on the other hand is easier to purify and the methyl ester 190 is 
less polar than the free acid and therefore better compatible with the solubility of Fmoc-Cl. 
Consequently, the yield for the Fmoc protection was now reproducible and higher, facilitating 
the isolation of 193. It can be used for SPPS without chromatographic purification. The only 
side product is the starting material 192, which does not affect coupling to the resin. 
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4.3.2 Synthesis of the Symmetric Tweezer Receptor 
With the so obtained template it was now possible to prepare a tweezer receptor with two 
identical peptidic arms according to the optimized microwave-assisted SPPS strategy (see 
chapter 4.2.2). Since the receptor is supposed to bind to nucleotides in aqueous medium, it is 
important to choose appropriate amino acids to improve its binding properties. Therefore, 
lysine and phenylalanine were chosen for potential additional salt bridges between the lysine 
ammonium groups and the phosphate hinge of the nucleotides as well as π-stacking between 
the aromatic ring of phenylalanine and the nucleobases. Finally, two GCP headgroups were 
integrated into each arm for the recognition of a tetrahedral phosphate. As shown in Figure 90 
the synthesis starts again by attaching a glycine spacer to MBHA resin in the form of Fmoc-
Gly-OH (3 eq) with the help of PyBOP (3 eq) in 5 % DIPEA/DMF under microwave 
irradiation (max. 60° C, 20 min, 20 W) and argon atmosphere. In order to assure complete 
conversion of all amine groups of the resin, the first coupling was repeated twice and the solid 
support was afterwards treated with acetic anhydride to cap eventually leftover free amine 
groups. Fmoc deprotection was achieved by treating the resin with 20 % piperidine/DMF 
under microwave irradiation (max. 60° C, 1 + 5 min, 20 W). The attachment of the aromatic 
template 193 was carried out accordingly. After another Fmoc deprotection the next two 
amino acids Fmoc-Phe-OH and Fmoc-Lys(Boc)-OH, as well as the oxoanion binding site 158 
were coupled to the growing peptide chain. Instead of utilizing 3 eq of each reactant, now the 
double amount was necessary, because of the doubling of amine groups. If necessary, the 
coupling steps were repeated as indicated by the results of the Kaiser test.  
 
Figure 90. The Fmoc SPPS for the non-symmetric tweezer receptor 196 was carried out with a microwave. 
Attachment and coupling: 20 min, 20 W, max. 60° C. Fmoc deprotection: 1 + 5 min, 20 W, max. 60° C. 
193 
194 
158 
195 196 
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Finally, the resin bound receptor 195 was cleaved from the solid-support, at the same time 
removing all Boc protecting groups, by treating the resin with 80 % TFA and 8 % TFMSA 
together with the nucleophilic scavengers thioanisole (8 %) and EDT (4 %). After 
precipitation in Et2O the crude product was obtained after a first MPLC (RP18, H2O → 
MeOH, 0.1 % TFA) with 53 % yield and 74 % purity. After one more purification step via RP 
MPCL the desired symmetric tweezer receptor was obtained with 94 % purity (see Figure C. 
3). Finally the trifluoroacetate counterions were replaced for chlorides by dissolving the 
receptor several times in hydrochloric acid (0.1 N) and consequent lyophilization to obtain 
196 as the hydrochloride salt which can thus be used for binding studies. In comparison to the 
standard SPPS at ambient temperature without microwave irradiation, as carried out during 
my diploma thesis,195 both the yield (20 → 53 %) and the purity (60 → 74 %) could be 
increased. Furthermore, the reaction time could be reduced from one week to a single day. 
Hence, microwave-assisted SPPS has proven to be an excellent method for the rapid and 
convenient synthesis of oligopeptidic tweezer structures, especially if low reactive non-
proteinogenic amino acids like 193 or non-peptidic compounds (158) are to be implemented 
into the receptor. 
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4.3.3 Binding Studies 
Prior to the binding studies a physicochemical characterization of the compound was carried 
out. It revealed a good solubility up to 1 mM in water. The pKA values of the guanidinio and 
ammonium groups could be determined with the help of the half-equivalent point method to 
7.00 (pKAI) and 9.90 (pKAII), respectively. The values are average values for each group in 
both arms and were determined by dissolving 0.1 mM of the compound in water and adding 
one equivalent (not just a half) of sodium hydroxide (0.1 N) to the solution with subsequent 
determination of the pH. The second average pKA value was determined by adding another 
two equivalents of the base. Here again, the pKA value of the guanidinio group could be 
increased by more than one order of magnitude (5.52 → 7.00) in comparison to the analogue 
host system developed during my diploma studies, by removing charges from the receptor, 
thus ensuring an increased protonation at neutral pH. At pH 7 exactly 50 % of the guanidinio 
groups are protonated and 196 carries a total of three charges. 
 
Figure 91. Substrates for binding studies with the symmetric tweezer receptor 196: cAMP (197), AMP (198), 
ADP (199), ATP (200), CMP (201), UMP (202), GMP (203), phosphate (204), and diphosphate (205). 
Binding studies were carried out in buffered water (bis-tris buffer, 20 mM) at 25° C and 
neutral pH with the substrates cyclic adenosine monophosphate (cAMP), adenosine 
monophosphate (AMP), adenosine diphosphate (ADP), adenosine triphosphate (ATP), 
cytidine monophosphate (CMP), uridine monophosphate (UMP), guanosine monophosphate 
(GMP), phosphate (P), and diphosphate (PPi) depicted in Figure 91 (197-205).  
 
Figure 92. Mass spectrum obtained from a solution of 196 (100 µM) and cAMP (200 µM) in water by ESI-ToF 
in positive operation mode. Top: Complete spectrum; middle: Excerpt; bottom: Calculated Mass. 
197 198 199 200 
201 202 203 204 205 
M+H+ 
M+2H+ 
M+cAMP+H+ 
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As depicted in Figure 92, the 1:1 complex of 196 with cAMP in water could be observed by 
means of ESI-ToF measurements in positive operation mode ([196] = 100 µM, [cAMP] = 
200 µM). For AMP and UMP similar spectra could be obtained. These are clear indications, 
that complex formation between the symmetric tweezer receptor and nucleotides is possible. 
After these MS experiments and some preliminary UV/Vis titrations which showed that 196 
indeed binds to these substrates, it was necessary to determine the receptor-substrate 
stoichiometry first, before conducting more advanced measurements for the exact 
determination of the binding constants. The knowledge of the stoichiometry is crucial for the 
calculation of the binding constants and for the selection of appropriate conditions for the 
titrations. By making use of the method of continuous variation known as Job plot, the 
stoichiometry can be determined.202,203 Several solutions containing different molar fractions 
of receptor (R) and substrate (S) but with constant total concentration ([R] + [S]) had to be 
prepared. Complex formation should be maximal, when the ideal ratio of receptor and 
substrate is present in the solution, corresponding to the complex stoichiometry. By 
measuring an observable, which is directly proportional to the complex concentration a bell-
shaped curve is the result. The maximum of this curve corresponds to the stoichiometry of the 
complex which can thus be determined. A maximum at a molar ratio of 0.5 indicates a 1:1 
complex formation. A maximum at 0.33 or 0.66 corresponds to a 1:2 or respectively a 2:1 
complex. Such a Job plot can also be carried out with the help of UV/Vis spectroscopy if the 
absorption of the non-covalent complex differs from that of the two reaction partners. 
Equation (4) then allows for directly observing the complex formation with the help of the 
change in absorption.  
 ΔA = Aexp – AR – AS  (4) 
By subtracting the absorption of receptor (AR) and substrate (AS) of the concentration 
corresponding to the molar fraction from the experimentally observed absorption (Aexp), the 
difference of absorption (ΔA) is then directly proportional to the complex concentration. 
Generally, two common approaches exist to carry out Job plots: One may either prepare 
separate solutions with different molar fractions but of the same total concentration of R + S, 
and measure these separately, or one may extract the necessary data for the Job plot from the 
binding constant titrations. While the first approach is very substance-consuming, the latter 
one generates an inconvenient data point spreading. In a titration for the determination of 
binding constants, normally many data points are collected at low molar fractions and fewer at 
high ratios. For Job plots on the other hand, data points at the critical molar ratios (e.g. 0.5) or 
an even spreading of data points is desirable for the exact determination of the stoichiometry. 
Extracted data may therefore lead to inaccurate determination of the stoichiometry. This is 
why in this work a totally different approach was developed. First, a UV spectrum of pure 
receptor (60 µM) was recorded in bis-tris buffer (0.02 M) and the absorption at 300 nm was 
extracted. Then, a defined amount of the solution was removed, replaced by the same amount 
of substrate solution (60 µM), and the resulting absorption was measured. By repeating this 
procedure spectrums of varying molar fractions could be measured at constant total 
concentration. Finally, the spectrum of pure substrate (60 µM) was collected. This way, 
valuable amounts of receptor and substrate could be saved and a Job plot with the desired 
spacing of data points was derived. In Figure 93 the molar fractions of the substrates xS are 
plotted against ΔA = |Aexp – AR – AS| for all possible combinations with the symmetric tweezer 
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receptor 196. All experiments were carried out at least in duplicate. For all substrates the 
maximum of ΔA is at a molar fraction of 0.5 – the receptor forms 1:1 complexes to all 
substrates. 
 
Figure 93. Job plots for substrates 197-205 reveal 1:1 complex stoichiometry. Spectra were recorded at 300 nm 
in aqueous bis-tris buffer (20 mM) at pH 7 and a total concentration of [R] + [S] = 60 µM. 
With the knowledge of the complex stoichiometry, measurements concerning the binding 
affinity were conducted in bis-tris buffered water (20 mM) at neutral pH and 25° C. 
Experiments were carried out by adding aliquots of increasing volume (e.g. 8 × 10, 8 × 20, 
8 × 40 µL) of substrates to a solution of 196 in a microcuvette equipped with a stopper 
(800 µL, 2-5 × 10-5 M) and subsequent recording of the UV/Vis spectrum from 250 to 350 nm 
after 1 min incubation time. In addition, similar titrations were carried out with the help of 
fluorescence spectroscopy. When irradiating the GCP unit at a fixed wavelength at its 
absorption maximum at 300 nm, a fluorescence signal around 355 nm can be observed. This 
signal´s intensity is decreasing upon complex formation, similar to the absorption signal. 
Again, substrate was added in aliquots of increasing volume (e.g. 8 × 5, 8 × 10, 4 × 20 µL) to 
a solution of 196 in a florescence microcuvette equipped with a stopper (900 µL, 0.5-1 × 10-
5 M) and after 1 min incubation time the fluorescence emission was recorded from 335 to 
400 nm. Figure 94 depicts representative examples of such UV and fluorescence titrations 
with AMP as substrate (see Figure C. 14-Figure C. 28 for all other titrations). The UV/Vis 
titration features a shifting isosbestic point – a clear indication for the formation of a host-
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guest complex. All experiments were carried out at least two to three times. In the 
concentration range of the experiments both the fluorescence and the absorption decrease 
linearly with dilution and hence follow the Lambert-Beer law. 
   
   
Figure 94. Left: Absorption spectra of 196 upon incremental addition of AMP (2 mM) in aqueous bis-tris buffer 
(60 mM) at pH 7: UV/Vis ([196] = 5 × 10-5 M, top) and fluorescence spectrum ([196] = 10-5 M, bottom) (left). 
Middle: Comparison of dilution against excerpt of the experimental data at 300 nm. Right: Least-squares fit for 
the 1:1 complex formation as obtained by the program SpecFit. 
The plot comparing the theoretical dilution curve (red) of absorption or fluorescence versus 
the experimentally observed data (black) at 300 or 355 nm clearly indicates a complex 
formation. The data was fitted with the help of the program SpecFit developed by 
Zuberbühler.204,205 The program makes use of a least-squares fitting procedure over the entire 
spectral range (instead of a single wavelength). In general, multivariate approaches generate a 
more accurate data-fitting than procedures which concentrate on a single wavelength. 
However, for accurate spectral fitting several prerequisites have to be fulfilled. First, the level 
of complex formation should reach approximately 80 %. This was achieved by titrating 
varying amounts of substrate into the receptor solution (e.g. 10 eq for AMP and 45 eq for P). 
Further, the spectral range for the fitting procedure must neither contain regions where the 
detection limit is exceeded nor overlapping absorption signals and isosbestic points. This was 
assured by only taking the spectral range between 290 and 325 nm for UV/Vis and between 
345 and 370 nm for fluorescence titrations into account for the fitting procedure. As expected, 
fluorescence data was scattered stronger due to the increased sensitivity of the spectrometer. 
Still, excellent fitting curves could be obtained for all receptor-substrate combinations. The 
resulting binding constants are listed in Table 5 and visualized in Figure 95. The results 
obtained by the two independent methods are in excellent agreement – deviations are within 
the standard deviation. Generally, the standard deviation of the individual values lies within 
the error of the instrument, which is higher for fluorescence than for UV/Vis, as expected. 
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Table 5. Binding constants (K and log K) and standard deviations (σ) as calculated by SpecFit for the formation 
of 1:1 complexes of 196 in bis-tris-buffered water (20 mM) at neutral pH. 
Substrate 
 
K (UV) 
 [M-1] 
log K 
 
σ (UV) 
[M-1] 
K (Fluo) 
 [M-1] 
log K 
 
σ (Fluo) 
[M-1] 
AMP 76,400 4.88 6,200 73,000 4.86 14,000 
ADP 32,500 4.51 3,300 37,100 4.57 15,700 
ATP 8,300 3.92 1,400 11,400 4.06 2,700 
PPi 17,000 4.23 2,100 10,800 4.03 3,400 
P 13,400 4.13 2,400 17,900 4.25 3,400 
cAMP 64,400 4.81 5,300 52,300 4.72 9,400 
CMP 61,300 4.79 4,700 56,600 4.75 5,600 
UMP 93,500 4.97 4,000 112,300 5.05 27,000 
GMP 84,400 4.93 10,900 78,600 4.90 18,300 
 
 
Figure 95. The graphical representation of the binding constants as obtained by UV/Vis and fluorescence 
titration illustrates the excellent agreement between the two individual and independent methods. 
The general trend for binding affinity is UMP > GMP > AMP > cAMP ≈ CMP > ADP > 
ATP ≈ PPi ≈ P. Phosphate and diphosphate are both bound significantly weaker than 
nucleotides, with the exception of ATP. Therefore one can conclude, that 196 does not only 
interact via charge-charge interactions between the GCP guanidinio and/or lysine ammonium 
groups with the phosphate hinge, but that additional interactions are formed to the sugar 
and/or the nucleobases. The highest binding constant was found for UMP with K = 9 × 
104 M-1. However, there is no significant selectivity for any of the nucleobases. The weakest 
bound nucleotide CMP is still interacting with a binding constant of 6 × 104 M-1. According to 
that, the additional interactions are most likely non-directed π-π-interactions between the 
nucleobase and an aromatic moiety of the receptor. A more striking characteristic of the host 
196 is, that it prefers to bind to AMP (8 × 104 M-1) over ADP (3 × 104 M-1) and ATP (8 × 
103 M-1) – the monophosphate is bound stronger than the triphosphate by one order of 
magnitude. This binding behavior is unusual and so far unprecedented in literature. Normally 
the higher charged nucleotides are preferred due to the formation of additional charge-charge 
interactions between receptor and substrate (see chapter 2.2). To investigate in more detail the 
0
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binding mode of 196 towards the substrates and to elucidate the exceptional preference for 
monophosphates, NMR spectroscopic measurements and molecular modeling of the 
complexes were conducted. 
  
Figure 96. Left: Side view of the calculated energy-minimized structure of the complex between 196 and AMP as 
obtained from a Monte Carlo conformational search. Non-polar hydrogen atoms have been removed for clarity. 
Color code: substrate (yellow), GCP (orange), and receptor backbone (gray). Right: Side (top) and top view 
(bottom) of the complex. 196 is colored yellow, AMP green. Atoms are displayed as spheres with their 
corresponding Van-der-Waals radius. Reprinted with permission from Kuchelmeister, H. Y.; Schmuck, C. Chem. 
Eur. J. 2011, 17, 5311-5318. Copyright 2011 John Wiley and Sons.206 
The molecular modeling (MM) of the 1:1 complex between 196 and AMP was carried out 
with the program Macromodel v9.6 making use of the Amber* force field and a generalized 
Born/surface area (GBSA) water solvation.207 The energy-minimized structure of a Monte 
Carlo conformational search of 50,000 steps without conformational restraints was subjected 
to a molecular dynamics (MD) simulation at 300 K for 500 ps. The so obtained structure is 
depicted in Figure 96 (left): Two GCP units (orange) are oriented perpendicular to each other 
thus binding the tetrahedral phosphate (orange-red) of the substrate (yellow). This is in 
agreement with the hypochromism of the UV absorption at the pyrrole maximum at 300 nm. 
 Furthermore, 1H and 31P NMR spectra of a 1:1 mixture of AMP and 196 were recorded at a 
concentration of 10 mM in DMSO-d6 on a 500 MHz spectrometer.208 The most important 
results, which are listed in Table 6, are in good agreement with the calculated structure. 
Excerpts of the 1H spectra of the monomers as well as the 1:1 complex are depicted in Figure 
97. The 31P signal of the phosphate is shifted significantly upfield by 1.05 ppm with respect to 
pure substrate. On the side of the receptor, its guanidinium group (NH2)2+ is shifted the most 
(-0.29 ppm). The lysine NH (-0.04 ppm), pyrrole CH (-0.10 ppm), pyrrole NH (-0.02 ppm) 
and the guanidinium NH (-0.10 ppm) peaks all shift as well. Further, the calculation indicates 
that the lysine ammonium groups are also involved in phosphate binding. This finding is 
supported by the NMR measurements: the lysine ammonium group (-0.12 ppm) and the 
neighboring δ- (-0.02 ppm) and γ-CH2 groups (+0.01 ppm) all feature a complexation-induced 
3.38 Å
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chemical shift (CIS). Another important structural detail is the π-stacking between the 
nucleobase and the aromatic template of the receptor. The calculated distance between these 
two rings is 3.38 Å (Figure 96, green line) – which is in excellent agreement to the ideal π-
stacking distance of 3.4 to 4.5 Å as determined by a representative set of high resolution x-ray 
crystal structures.209 Again, the experimental data supports this result: all involved proton 
signals are shifted: the aromatic protons of the nucleobase A-H2 (+0.01 ppm) and A-H8 (-
0.18 ppm) as well as the template CHar signals (-0.02 and +0.03 ppm) undergo a CIS. Finally, 
as indicated in the space-filling representation of the calculated complex in Figure 96 (right), 
the receptor (yellow) forms a half-closed cavity for the accommodation of the substrate 
(green).  
 
Figure 97. Figure 981H NMR spectra of AMP (top), receptor 196 (bottom) and a 1:1 mixture thereof. Upon 
complexation, several proton signals shift. The spectra were recorded at 500 MHz in DMSO-d6. Reprinted with 
permission from Kuchelmeister, H. Y.; Schmuck, C. Chem. Eur. J. 2011, 17, 5311-5318. Copyright 2011 John 
Wiley and Sons.206 
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Table 6. Chemical shifts of selected 1H and 31P signals of 196 and AMP and the complexation-induced chemical 
shifts (CIS) of the corresponding 1:1 mixture. All measurements were carried out at a concentration of 10 mM in 
DMSO-d6 at 25° C and 500 MHz.  
Signal  
(196) 
δ [ppm] 
 
δ1:1 [ppm] 
 
CIS [ppm] 
 
Signal 
(AMP) 
δ [ppm] 
 
δ1:1 [ppm] 
 
CIS [ppm] 
 
1: Pyr-NH 12.49 12.47 –0.02 A-H8 8.51 8.33 –0.18 
2: Gua-NH 12.13 12.03 –0.10 A-H2 8.14 8.15 +0.01 
3: Gua-(NH2)2+ 8.72 8.43 –0.29 A-NH2 7.30 7.30 - 
4:Lys-NH 8.63 8.59 –0.04 H1´ 5.92 5.92 - 
5: Lys-NH3+ 7.91 7.79 –0.12 H2´ 4.68 4.59 –0.09 
6: 2 × CHar 7.66 7.64 –0.02 H3´ 4.28 4.18 –0.10 
7: Pyr-CH 7.58 7.48 –0.10 H4´ 4.06 4.07 +0.01 
8: CHar 7.47 7.50 +0.03 2 × H5´ 3.85 3.96 +0.11 
9: γ-Lys-CH 2.69 2.70 +0.01     
10: δ-Lys-CH 1.53 1.51 –0.02 PO42– a 1.23 0.18 –1.05 
a) 31P NMR spectroscopy. 
Due to the excellent agreement between experimental NMR data and MM/MD, additional 
calculations for the 1:1 complexes of 196 with ADP and ATP were carried out according to 
the procedure described for the calculation of the AMP complex (vide supra). In Figure 98 the 
solvent-accessible surfaces of receptor (yellow) and of the phosphate residues of the 
nucleotides (green) are displayed. From left to right: AMP, ADP, and ATP. It is clearly 
visible, that the solvent-accessible surface is getting larger within the series AMP < ADP < 
ATP. The strong charge-charge interactions between the positively charged groups of the 
receptor with the highest negatively charged α-phosphate of the nucleotide plus the 
hydrophobic interactions of the aromatic template of the receptor with the nucleobase tightly 
lock the complex geometry. The larger the phosphate hinge is now, the more it is located 
outside of the cavity, because the receptor is less well able to wrap around it. This way, the 
competitive influence of the surrounding water is getting stronger and consequently the 
binding strength is reduced. Hence, the explanation for the unique selectivity of 196, 
preferring the lower charged monophosphate over its higher charged analogues, can be 
explained through the formation of a distinct binding mode between host and guest and the 
competitive influence of the aqueous medium on the binding strength. 
 
Figure 98. Representation of the solvent-accessible surfaces of the calculated 1:1 complexes of receptor 196 
(yellow) and the phosphate residue of the nucleotides (green). From left to right: AMP, ADP, and ATP. 
Reprinted with permission from Kuchelmeister, H. Y.; Schmuck, C. Chem. Eur. J. 2011, 17, 5311-5318. 
Copyright 2011 John Wiley and Sons.206 
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In conclusion, with the help of UV/Vis, fluorescence and NMR experiments combined with 
molecular modeling and molecular dynamic calculations it could be shown that the symmetric 
tweezer receptor 196, with the sequence Phe-Lys (from C- to N-terminus) and a GCP 
headgroup in both arms, is able to form stable 1:1 complexes with nucleotides (max. K ≈ 
105 M-1) in buffered water at neutral pH. The host-guest relationship is based on non-covalent 
electrostatic and hydrophobic and/or π-π-stacking interactions. The latter one is responsible 
for the differentiation of the nucleotides from phosphates. The formation of a well-defined 
complex with specific interactions is the explanation of the unusual preference for AMP over 
its higher charged analogues ADP and ATP, which is yet unprecedented. All nucleotide hosts 
reported in literature so far form stronger complexes to the higher charged nucleotides due to 
unspecific charge-charge interactions. Hence, the complex formation between 196 and the 
phosphate-based substrates reported herewith stresses the importance to combine different 
types of non-covalent interactions with a defined structure in order to achieve selective 
molecular recognition of biologically relevant targets in aqueous solution.  
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4.4 TWO- AND THREE-ARMED LIGANDS FOR DNA/RNA-RECOGNITION 
After having successfully utilized the symmetric two-armed receptor 196 (side-chains: Phe-
Lys-GCP) for the molecular recognition of mononucleotides in buffered water at neutral pH, 
the next logical step was to study its ability to interact with nucleic acids. In the following, 
molecules which interact with DNA/RNA will be called ligand instead of receptor to do 
justice to the proportions of polynucleotide binder and the polynucleotide itself. Besides the 
ligand 196, two more ligands will be synthesized and tested for their capability to interact 
with nucleic acids: Another two-armed polynucleotide (PN)-binder with inverse amino acid 
sequence 206 (Lys-Phe-GCP) and a three-armed ligand of the original sequence 207 (Phe-
Lys-GCP). 
4.4.1 Synthesis of the Two-Armed Ligand with an Inverse Amino Acid Sequence 
The synthesis of 206 was carried out according to the microwave-assisted SPPS procedure 
on MBHA resin with the coupling agent PyBOP as described in chapter 4.3.2. Instead of the 
amino acid sequence Phe-Lys as in the original tweezer receptor 196, the novel one featured 
the inverse sequence Lys-Phe as depicted in Figure 98. The GCP unit was again implemented 
as headgroup. The product was isolated as TFA salt after two purification steps via MPLC 
(RP18, H2O → MeOH, 0.1 % TFA) with 22 % yield and a purity of 94 % as determined by 
analytical HPLC (see Figure C. 4). The trifluoroacetate counterions were then exchanged for 
chlorides by dissolving the TFA salt several times in dilute hydrochloric acid and consequent 
lyophilization to give 206 as hydrochloride salt. With the so obtained ligand the influence of 
the amino acid sequence on polynucleotide binding could now be studied by comparing the 
interaction of the two tweezer ligands 196 and 206 with nucleic acids. 
 
Figure 98. The symmetric tweezer ligand 206 (Lys-Phe-GCP) was obtained by microwave-assisted SPPS. 
  
206 
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4.4.2 Synthesis of the Three-Armed Ligand 
In order to study the influence of the valence of the nucleic acid-ligands, a three-armed 
analogue of the symmetric tweezer 196 with the side-chain sequence Phe-Lys-GCP was 
prepared. An aromatic triamino scaffold similar to the one for the divalent analogues was 
utilized in order to conserve the spacing and angle between the arms. However, this kind of 
template does not feature an additional functional group for the attachment to a solid-support. 
Hence, the three-armed ligand was synthesized following a convergent synthetic procedure in 
solution. First, the triamino template and the fully protected arms were synthesized 
independently and then coupled and deprotected to give the trivalent ligand 207. 
The first attempt to synthesize the template is depicted in Figure 99. The procedure was 
adapted from a known synthesis and started with commercial 1,3,5-tribromo benzene 208.210 
Conversion to the tricyano derivate 209 via nucleophilic aromatic substitution according to an 
SN2Ar mechanism and subsequent reduction with diisobutylaluminium hydride (DIBAL-H) 
at elevated temperature should afford the triamine scaffold 210. The first step was carried out 
with the help of copper (I) cyanide in N-methylpyrrolidone (NMP) at high temperature. 
However, no product formation could be observed. Probably this was due to the lack of an 
electron withdrawing substituent in ortho- or para-position which would stabilize the 
Meisenheimer complex analogue and/or because bromine was used instead of the better 
leaving group iodine as reported in literature. For a reaction mechanism via an arine 
intermediate the conditions were too mild. Furthermore, this reaction would have resulted in 
two regioisomers. A second attempt via a modified Heck reaction according to Herrmann and 
Beller was carried out at high temperature with the help of potassium cyanide, catalytic 
palladium(II) acetate and 1,5-bis(diphenylphosphino)pentane (dpppe) in N,N,N´,N´-tetra-
methylethylene diamine (TMEDA).211 The reaction proceeds via in situ formation of a Pd0 
species, oxidative addition to the aryl halogenide, ligand exchange (Br– → CN–), and 
reductive elimination of the aryl cyanide and regeneration of the Pd0 catalyst.212 The failure of 
this reaction might have been due to the bad solubility of the ligand213 or due to inactivation 
of the palladium component caused by a too high cyanide concentration via formation of 
polycyanides of differing oxidation states.214  
 
Figure 99. The first attempt to synthesize 210 starting from 1,3,5-tribromo benzene 208 failed. 
Due to the difficulties with the approaches starting from 208 a completely different synthetic 
route was tested next, starting from 1,3,5-trimethyl benzene 211 as shown in Figure 100. The 
first step of the synthesis is a benzylic bromination to 212 with NBS and AIBN as radical 
starter at elevated temperature in carbon tetrachloride in analogy to the synthesis of the 
symmetric tweezer receptors.215 The reaction only proceeded with moderate yield. Several 
differently brominated species could be isolated as byproducts. Purification was carried out 
208 209 210 
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with the help of flash column chromatography and was extremely tedious due to the similar 
retention factors of the brominated species. Replacing CCl4 for DCM did not improve the 
yield as was the case for the tweezer template. Instead, additional bromination at the ring 
could be observed. This was probably due to the reduced reaction temperature caused by the 
lower boiling point of DCM with regard to CCl4. Furthermore, 211 is more electron rich than 
the benzoic acid derivative 173 utilized for the synthesis of the template for the tweezer 
receptors (chapter 4.2.1). Therefore, bromination at the ring should be facilitated. The next 
two steps, a Gabriel synthesis according to Ing-Manske with potassium phthalimide (213) and 
subsequent hydrazinolysis afforded the triamine scaffold 210 in very good yield.216,217 No 
column chromatography is necessary in the last step, because the product is already highly 
pure after extraction from the reaction mixture. 
 
Figure 100. The synthesis of the triamine scaffold 210 was carried out in a three step procedure. 
With the linker at hand, the next step was to synthesize the side chains. This was done with 
the help of standard Fmoc SPPS on SASRIN resin.178 This solid-support is equipped with a 
linker that allows cleavage from the beads under very mild conditions thus leaving the Boc 
protecting groups of the amine functionalities intact. This is necessary to avoid unwanted 
coupling processes with the amino acid side chains. The synthesis was carried out manually at 
room temperature as depicted in Figure 101. Consequently, longer reaction times for the 
attachment to the resin and the coupling steps of at least 8 h were necessary. All coupling 
steps were conducted under argon atmosphere.  
 
Figure 101. Fmoc SPPS on SASRIN resin yielded the fully protected arm 216. 
After swelling of the resin in DMF/DCM (3/7), the first amino acid, Fmoc-Phe-OH was 
attached to the solid support with DIC and HOBt as coupling agents with catalytic DMAP in a 
mixture of DMF/DCM (3/7). The first step was repeated three times and still remaining free 
hydroxyl groups at the resin were capped with acetic anhydride in 3 % NMM/DMF. The 
following Fmoc deprotection was carried out by treating the resin with 20 % piperidine/DMF 
twice for 20 min. Conversion to the free amine as well as the following coupling steps were 
monitored with the help of the Kaiser test.181 The next amino acid Fmoc-Lys(Boc)-OH and 
210 211 212 213 
214 
215 216 
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the oxoanion binding site Boc-GCP were coupled with PyBOP (3 eq each) in 3 % 
NMM/DMF. If necessary, coupling steps were repeated according to the results of the Kaiser 
tests. Finally, the resin-bound product 215 was cleaved from the solid-support by treating the 
resin with 1 % TFA in DCM containing 2.5 % TIS and 2.5 % water as nucleophilic 
scavengers (5 × 1 h). After purification via MPLC (RP18, H2O → MeOH) 216 could be 
isolated with 28 % yield. For further improving the reaction yield in future approaches the 
deprotection time should be increased to five times 2 h and the cleavage mixture should 
immediately be neutralized with for example triethylamine to prevent partial deprotection of 
the Boc groups as was observed with the procedure described above. 
Before linking the two building blocks 210 and 216, a test reaction was conducted to find 
appropriate reaction conditions (Figure 102). In order to simulate the attachment of the fully 
protected arms, one equivalent of the triamine template was reacted with three equivalents 
Boc-Phe-OH with the coupling reagent HATU (3 eq) in 3 % DIPEA/DMF under argon 
atmosphere to give 217.218 Control via TLC indicated almost complete conversion of the 
starting materials. After removal of the solvent, the product could be identified via MS. It was 
concluded that these reaction conditions seem to be appropriate. They were thus utilized for 
the coupling of the scaffold 210 with the fully Boc-protected side chains 216. 
 
Figure 102. Test reaction for the coupling of 210 with 216. Boc-Phe-OH was utilized to simulate the fully 
protected side chain. The formation of the product 217 was verified by MS. 
As shown in Figure 103 the reaction of 210 with 216 was conducted accordingly. Since the 
triamine is not stable for long time, it was synthesized from the phthalimide precursor 213 in 
the amount necessary for the following reaction step and directly reacted. The resulting fully 
protected three-armed compound 218 was isolated via MPLC (NP, CyHex → EA), its 
formation verified with the help of MS, and the still crude product directly employed for the 
next step. Deprotection of all Boc protecting groups was achieved by treating the compound 
with 50 % TFA/DCM. The final product was purified via MPLC (RP18, H2O → MeOH, 
0.1 % TFA) and after exchange of the trifluoroacetate anion for chlorides the trivalent ligand 
207 was obtained with 26 % yield over two steps. When testing the purity via analytical 
HPLC three distinct peaks with identical UV/Vis spectra could be observed (see Figure 103). 
An MS analysis thereof revealed that all three peaks give the same m/z signals, corresponding 
to the desired product. Therefore, the separate signals may either stem from different 
diastereomers or from varying protonation states of the product (max. 6 positive charges). The 
potential formation of diastereomers would most probably have taken place during the 
coupling step of the fully protected 216 with the template as a result of racemization of the 
210 217 
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phenylalanine stereogenic center. This however, would have afforded four diastereomers 
(L-L-L, D-L-L, D-D-L, and D-D-D). Additional racemization of the lysine stereocenter during the 
SPPS would have afforded even more different diastereomers. The HPLC on the other hand 
only showed three peaks. Furthermore, as could be shown in the meantime in the work 
conducted by S. Junghänel during her master thesis,219 the number and retention time of the 
HPLC peaks are strongly depending on the TFA concentration during the HPLC run. 
Therefore, the three peaks were attributed to different protonation states and consequently, the 
purity was determined to 95 %. To further clarify in future work whether these three fractions 
are indeed different protonation states, the fractions should be isolated via preparative HPLC, 
treated with base, and be subjected to analysis via analytical HPLC. 
 
Figure 103. Coupling of the triamine scaffold 210 and the fully protected side chains 216 and subsequent 
deprotection of the Boc groups gave 207. The purity was determined via analytical HPLC. 
Thus, with the already available tweezer ligand 196 (Phe-Lys-GCP), the completion of the 
syntheses of the trivalent analogue 207 (Phe-Lys-GCP) and the novel tweezer 206 with 
inverse amino acid sequence (Lys-Phe-GCP), three compounds were now available for 
nucleic acid binding studies. In the following chapter their capability to bind to different 
polynucleotides will be elucidated.  
210 
218 
207 
216 
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4.4.3 Nucleic Acid Binding Studies 
Synthetic and Natural Polynucleotides for Binding Studies 
The three polynucleotide ligands 196, 206, and 207 were tested for their capability to 
interact with various synthetic and natural double-stranded nucleic acids consisting of both 
RNA and DNA. All ds-polynucleotides are commercially available and were used as obtained 
(except for ctDNA) from the commercial supplier (Sigma-Aldrich). Stock solutions were 
prepared in cacodylate buffer (0.05 M) at neutral pH and concentrations between 10-2 and 
10-3 M. ctDNA was ultrasonicated (8 × 4 sec) and filtered prior to use to break the long 
double stranded nucleic acid into smaller fragments. The exact concentrations of all nucleic 
acids described within this work are reported with respect to the number of the 
polynucleotide´s phosphate groups and were determined by means of UV measurements 
(three point titrations). Table 7 lists the literature-reported molar extinction coefficients ε at 
the maxima of the nucleic acids´ absorption bands λmax.220 
Table 7. Molar extinction coefficients ε at the maximum of UV absorption (λmax) of various nucleic acids.  
Nucleic acid pdA × pdT p(dAdT)2 pdG × pdC p(dGdC)2 pA × pU pG × pC ctDNA 
ε [L/mol · cm] 6000 6600 7400 8400 6000 7400 6600 
λmax [nm] 260 262 253 254 260 253 260 
 
The synthetic ds-PNs were either homopolymers (pdA × pdT, pA × pU, pdG × pdC, and 
pG × pC) or alternating heteropolymers (p(dAdT)2 and p(dGdC)2) of approximately 8,000-
9,000 base pairs length. The naturally occurring ctDNA features ca. 20,000 bps (untreated) 
according to the supplier. The ultrasound treatment of the ctDNA breaks it into fragments of 
varying lengths. Therefore, the exact compliance with the preparation procedure has to be 
assured for each sample for the sake of comparability. All measurements conducted with 
ctDNA within this work were carried out with the same stock solution. The molecular weight 
of the nucleic acids can be determined by assuming an average molecular weight of 650 Da 
per base pair.77 Thus the MW of synthetic polynucleotides ranges from 5,200 to 5,850 kDa and 
that of untreated ctDNA is ca. 13,000 kDa.  
 
Figure 104. Schematic representation of synthetic alternating (bottom) and homopolymeric (top) nucleic acids.  
p(dAdT)2 p(dGdC)2 
pdA × pdT pdG × pdC 
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Figure 104 schematically depicts some of the polynucleotides. Depending on their sequence 
they feature different secondary structures, which are summarized in Table 8.75 p(dAdT)2 for 
instance is a classical A-tract. It forms a B-helix with a well-defined, narrow groove, a deep, 
well-accessible minor groove, and a rather broad and shallow major groove. pdA × pdT 
adopts a B*-helix with larger propeller twist and forms the deepest and narrowest minor 
groove of all nucleic acids utilized within this work. The major groove is broad and shallow. 
Both AT sequences feature the electronegative thymine O2 and adenine N2 in the minor 
groove (see chapter 2.3.1 for numeration of atoms). Cations are normally bound inside or on 
top of the minor groove. The heteropolymer p(dGdC)2 also adopts a B-helix, but its minor 
groove features the electropositive guanine NH2, and is therefore less well suited for minor 
groove binding. pdG × pdC on the other hand adopts an A-type helix with a broad minor 
groove which also features the guanine NH2 and is therefore not very well suited for the 
accommodation of ligands at all. Its major groove is unusually narrow and could thus be an 
interesting target for small molecule binding. When cations are integrated into the major 
groove a B- to A-form transition can often be observed. ctDNA features approximately 40 % 
GC and 60 % AT base pairs and adopts a B-helix similar to that of p(dAdT)2 with an 
accessible but not that well-defined minor groove. The major groove is rather broad. The two 
RNA polymers pA × pU and pG × pC form typical A-helices with broad minor and narrow 
major groove. Therefore, these polynucleotides offer a broad spectrum of different secondary 
structures for the testing of the nucleic acid binding properties of the three artificial ligands. 
Table 8. Characteristic features of the studied polynucleotides´ helix type and their minor and major groove. 
PN Helix Minor Groove Major Groove 
ctDNA B rather narrow rather broad 
p(dAdT)2 B narrow, deep, electronegative thymine O2, adenine N2 broad, shallow 
pdA × pdT B* very deep, very narrow, electronegative thymine O2, adenine N2 broad, shallow 
p(dGdC)2 B shallow, electropositive guanine NH2 rather narrow 
pdG × pdC A broad, shallow, electropositive guanine NH2 narrow 
pA × pT A broad narrow 
pG × pC A broad narrow 
 
Physicochemical Characterization  
Before starting with the binding studies, the physicochemical properties of 196, 206, and 207 
(see Figure 105) were determined and the results are summarized inTable 9. All three 
compounds are well soluble in water at 1 mM – accordingly, stock solutions in sodium 
cacodylate buffered water (0.01 M) were prepared at this concentration. The pKA values were 
determined, again as described in chapter 4.2.3 by means of the half-equivalent method. For 
the two-armed ligands average values of the guanidinio groups (pKAI) and the lysine 
ammonium groups (pKAII) were obtained by adding 1 and 2 additional equivalents of sodium 
hydroxide and subsequent pH measurement after each titration. The respective average pKA 
values of the three-armed ligand were obtained by adding 1.5 and then another 3 equivalents. 
The molar extinction coefficients ε of the absorption maxima at 300 nm were determined with 
the help of four point titrations in cacodylate buffer (0.01 M) at pH 7. All systems follow the 
Lambert-Beer law in the concentration range used for the experiments. 
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Figure 105. Two-armed 196 and 206, and trivalent 207 were tested for their binding affinity to nucleic acids. 
Table 9. Physicochemical characterization of 196, 206, and 207 in sodium cacodylate buffered water (0.01 M). 
Compound pKAI 
 
pKAII
 
Water solubility 
at 1 mM 
ε 
[L/mol · cm]  
196 7.00 9.90 + 55,200 
206 7.20 9.94 + 53,450 
207 6.50 9.93 + 80,260 
 
Thermal Melting Experiments 
In thermal melting experiments defined amounts of ligand are heated to approx. 100° C 
together with the nucleic acid and the melting point (Tm) is determined by generating the first 
derivative of the resulting melting curve as explained in chapter 2.2.3.80 Before doing so, it 
has to be assured that the compounds in consideration are stable at high temperature and over 
time. Furthermore, it has to be tested whether the ligands´ UV/Vis absorption changes with 
temperature – such an effect would have to be taken into account when interpreting the 
thermal melting plots. Therefore, solutions of the compounds 196, 206, and 207 were 
prepared in cacodylate buffer at neutral pH (0.01 M) at a concentration of 2 × 10-5 M and the 
resulting UV spectra were recorded between 220 and 350 nm at 25° C and higher 
temperatures (40, 60, 70, 80, and 90° C). The illustrations in Figure 106 demonstrate that the 
changes of the absorption as a result of the rising temperature were negligible. Furthermore, 
after cooling down to 25° C the spectra were identical to the one recorded prior to heating 
within the error of the instrument. An additional spectrum recorded after 24 h did not feature 
any changes either. Therefore it was concluded that the ligands are stable over time and 
temperature and are thus suitable for the planned thermal melting experiments with 
polynucleotides. 
 
Figure 106. Temperature-dependent UV/Vis spectra of the three nucleic acid ligands 196, 206, and 207. 
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 The next step was to optimize the conditions for the melting experiments by varying the 
ionic strength and the pH of the solution. Melting experiments were carried out at an ionic 
strength of 0.05 M (buffer) at pH 7 and at a buffer concentration of 0.01 M at pH 5 and 7. 
ctDNA solutions were prepared at a concentration of approximately 1.5-2.0 × 10-5 M in 
microcuvettes which were equipped with stoppers (1 mL) resulting in absorption values 
around 0.15. By measuring the absorption at the polynucleotides´ maximum at 260 nm the 
exact concentration of the DNA was calculated with the help of the molar extinction 
coefficient (ε = 6600). Then 0.3 eq (0.05 M buffer) or 0.2 eq of 196 (0.01 M buffer) with 
respect to the DNA´s phosphate groups (r) were added. Furthermore, samples containing only 
ctDNA were prepared. All mixtures were then slowly heated by 0.5° C per minute to 99° C 
while measuring the absorption at 260 nm after 0.5 min incubation time at each 0.5° 
temperature step. The resulting thermal melting curves are shown in Figure 107. All 
measurements were carried out in duplicate. 
   
Figure 107. Thermal melting curves of ctDNA with 196 with 0.05 molar cacodylate buffer at pH 7 (left), and 
with 0.01 molar buffer at pH 5 (middle) and pH 7 (right) as determined by the UV absorption at 260 nm. 
At high ionic strength (0.05 M) the melting point of ctDNA was determined to an average of 
84.9° C. After addition of 0.3 eq 196 the melting point was reduced by -1.6° to 83.3° C. When 
taking into account the general error of the method (ΔTm = ± 1° C), this result signifies that 
the two-armed ligand is not able to stabilize the helix at this high buffer concentration – if at 
all, there is a slight destabilization. Obviously, the competitive influence of the surrounding 
medium is too strong for effective binding of 196 to the B-DNA helix. At lower buffer 
concentration (0.01 M) the influence of the solvent should be reduced. Furthermore, when 
carrying out the experiments at pH 5, all guanidinio groups of the ligand should be protonated 
and thus the complex formation should be favored due to increased charge-charge 
interactions. And indeed, at pH 5 the ctDNA helix is thermally stabilized by 4.6° from 
61.2° C (ctDNA) to 65.8° C (complex) already upon addition of only 0.2 eq of the ligand (the 
bulge around 30° C in the red line stems from bubbles in the cuvette, which are formed during 
the heating process). 196 is now able to bind to the ds-helix and stabilize it to a significant 
degree. Surprisingly, at the same ionic strength but at higher pH of 7 a similarly high 
stabilization of the ctDNA could be witnessed. The helix was stabilized by 4.4° from TM = 
70.6° C to 75° C. Consequently, the impact of full protonation of the guanidinio groups is 
only minor, while the influence of the ionic strength of the medium controls the efficiency of 
the stabilization of the double strand. Therefore, the more detailed additional measurements, 
which will be presented in the following, were conducted at a sodium cacodylate buffer 
concentration of 0.01 M at neutral pH. Denaturation experiments were carried out with 
different amounts of the three ligands (r = 0.1, 0.2, 0.3 eq) with the DNAs pdA × pdT, 
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p(dAdT)2, and ctDNA, as well as with the RNA pA × pU. The GC-based polynucleotides 
feature melting points, which are too high to be measured in water. The results of the 
denaturation experiments are listed in Table 10. All values are averaged from at least two 
measurements. A representative example of a thermal melting experiment with ctDNA and 
increasing amounts of 196 is depicted in Figure 108 (left), all other combinations can be 
found in appendix C.3 (Figure C. 29-Figure C. 33 Figure C. 39). Additionally, Figure 108 
(right) also depicts the 1st derivative of a ctDNA melting curve recorded with 0.2 eq of 196. 
Table 10. Stabilization of the polynucleotides (PN) upon addition of varying equivalents (r) of the three ligands 
(L) 196, 206, and 207 as determined by thermal denaturation in 0.01 M cacodylate buffer at pH 7. 
  Stabilization [°] 
 Ligand         r = [L] / [PN] ctDNAa p(dAdT)2b pdA × pdTc pA × pUd 
 0.1 eq 3.6 4.9 2.4 n.d. 
196 0.2 eq 4.4 6.0 3.7 0.9 
 0.3 eq 4.7 6.0 5.0 3.6 
 0.1 eq 2.3 4.5 2.3 n.d. 
206 0.2 eq * 6.9 3.3 0 
 0.3 eq * 5.4 8.4 (-2.6)* 
207 0.1 eq * 5.8 3.8 5.7 
a) Tm = 70.6° C; b) Tm = 42.7° C; c) Tm = 51.5° C; d) Tm = 42.6° C; *) precipitation. 
 
Figure 108. Melting curves of ctDNA were recorded at 260 nm with varying amounts of 196 in cacodylate buffer 
(0.01 M) at neutral pH (left) and the 1st derivative of a melting experiment with ctDNA and 0.2 eq of 196. 
In general, all three ligands are able to increase the thermal stability of the nucleic acids. 
That signifies that they prefer to bind to the double-stranded helical nucleic acids relative to 
their corresponding unfolded forms. The correlation between binding constant and increase of 
Tm is quite complex, because also the number of binding sites, potential cooperativity and the 
affinity for the unfolded polynucleotide have to be taken into account.80 However, at this 
point it may already be stated that the experiments proof that all ligands do interact with the 
tested nucleic acids. A general trend which was observed was that with increasing amount of 
PN-binder the stabilization increases until saturation is achieved, e.g. for the interaction 
between the two armed 196 and ctDNA (ΔTm = +4.4°) and the similarly shaped B-helical 
p(dAdT)2 (ΔTm = +6.0°) saturation occurs at 0.2 eq. For the inverse sequenced 206 this is also 
the case for p(dAdT)2 (ΔTm = +6.9°) – for ctDNA precipitation was observed at ratios higher 
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than r = 0.1 at increased temperature. The Tm of pdA × pdT on the other hand, which adopts a 
B-type helix with a narrower minor groove, is still increased by both ligands when going from 
0.2 to 0.3 eq (196: 3.7 → 5.0°; 206: 3.3 → 8.4°). Higher amounts of the divalent binders 
(0.5 eq) led to precipitation at higher temperature. Thus, the thermal stabilization properties of 
the two divalent ligands are rather similar for the different DNAs. For the RNA pA × pU on 
the other hand, only 196 is able to stabilize the A-helix, but not 206. Reasonable stabilization 
of RNA by 196 though is only achieved at r = 0.3 (ΔTm = +3.6°). However, for both 
molecules a broadening of the RNA melting transition can be observed as depicted in Figure 
109 (left). This phenomenon could previously be linked to ligand binding.221 Thus, it may be 
concluded that both two-armed ligands do interact with RNA, but only 196 thermally 
stabilizes it. 
For the three-armed 207, the addition of more than 0.1 eq led to precipitation at elevated 
temperature. At a ratio of r = 0.1 eq however, 207 affords the highest stabilizations of the 
three compounds for both DNA and RNA, e.g. it increases the melting temperature of 
p(dAdT)2 by 5.8° or that of pA × pU by 5.7°. For comparison, 196 and 206 stabilize p(dAdT)2 
for +4.9 and +4.5° at this ratio and pA × pU not at all. It has been shown, that larger ligands, 
which interact via the identical type of interactions with a nucleic acid, are less efficient in 
stabilizing a helix than corresponding smaller ligands.222 Therefore, one may conclude that 
the larger trivalent 207 binds with higher affinity to the nucleic acids than its dipodal 
analogues 196 and 206. Another interesting feature was observed for the interaction of 207 
with pdA × pdT, which features a second transition (+20.2°) after the first one (+3.8°) as 
shown in Figure 109 (right). This unusual, possibly biphasic melting curve was only noted for 
pdA × pdT. Because there are several possible reasons for such a melting curve other methods 
have to be taken into account before concluding on the origin of this effect.223 
 
Figure 109. Interaction of 206 with pA × pU does not lead to an increase of Tm, but to a broadening of the 
transition at r = 0.2. At higher ratio precipitation is observed at higher temperature (left). The interaction of 207 
with pdA × pdT leads to a biphasic transition with ΔTm values of +3.8° and +20.2° (right). 
In conclusion, the thermal melting experiments demonstrated that the three artificial ligands 
196, 206, and 207 are able to interact with both DNA and RNA and are further able to 
stabilize the helical form by up to 8.4° (pdA × pdT + 0.3 eq 206). Trivalent 207 seems to be 
especially apt to interact with nucleic acids, presumably with higher binding constants than its 
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two-armed analogues. To investigate in more detail these non-covalent interactions, 
experiments for the determination of the binding affinity were conducted in the following. 
Spectroscopic Measurements 
Similar to molecular recognition events between small host and guest systems (cf. chapter 
4.3.3), the binding affinity of small artificial ligands to macromolecules can be determined by 
means of titrations. Due to the large number of potential binding sites in nucleic acids, 
specially developed equations have to be utilized for the characterization of such binding 
events. Already in 1949 Scatchard proposed an equation for the fitting of protein-ligand 
titrations, which can also be utilized for polynucleotide-ligand binding events.224 This 
equation can be solved with the help of a statistical program (e.g. Statistica)225 by generating a 
non-linear regression for the spectroscopic data following the formalism of McGhee and von 
Hippel,226 which will give the binding constant and the stoichiometry as output. 
Thus, the first attempt to qualitatively determine the binding constants of the nucleic acid-
binders was conducted with the help of UV/Vis titrations. To a buffered aqueous solution 
(cacodylate buffer 0.01 M) of either ligand 196, 206, or 207 in a microcuvette equipped with a 
stopper (800 µL, c = 20 µM) a stock solution of ctDNA (0.75 mM) was titrated in aliquots 
(5 × 5, 5 × 10, 3 × 25, 3 × 50, 4 × 100 µL) to a maximum of 33 eq of nucleic acid at 25° C 
and neutral pH. After each addition and one minute incubation time the resulting UV/Vis 
spectrum was recorded from 250 to 350 nm. Figure 110 depicts excerpts of the absorption at 
300 nm, which are corrected for the dilution. At this wavelength DNA only absorbs negligibly 
and the absorption can thus be attributed to the pyrrole unit. Changes are almost proportional 
to the concentration of the DNA until a clear breakpoint at approximately 0.1 mM ctDNA 
concentration, which corresponds to ca. 5 equivalents of ctDNA or 0.2 equivalents of ligand 
with regard to ctDNA could be observed. This curvature did not allow accurate non-linear 
analysis by means of the Scatchard equation, which was developed for hyperbolic function 
fitting. Hence, at the micromolar concentrations used for the experiments the binding 
constants can only be estimated to a lower limit of K ≥ 106 M-1.  
 
Figure 110. The excerpts at 300 nm of the UV/Vis absorption during titrations of aliquots of ctDNA (c = 
0.75 mM) to 196, 206, and 207 (20 µM) in cacodylate buffer (0.01 M) were too steep for accurate fitting. 
The more sensitive fluorescence spectroscopy allows carrying out such titrations at lower 
concentration and therefore the determination of higher binding constants. Unfortunately, 
attempts to accomplish such binding studies with ctDNA and the three synthetic ligands failed 
due to overlapping excitation wavelengths of the pyrrole (270-330 nm) and the nucleobases 
(230-290 nm). Therefore ethidium bromide displacement assays were conducted. The 
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fluorescence of the intercalator EB (see chapter 2.3.5) increases by a factor of 10 to 100 upon 
intercalation between two base pairs of nucleic acids. The association process to generic DNA 
takes place with a binding constant of 3 × 106 M-1 at the experimental conditions used here 
(ionic strength = 0.01 M). Addition of aliquots of DNA-binding molecules leads to a 
displacement of ethidium bromide and consequently to reduction of the EB emission band 
around 600 nm. The amount of ligand which is necessary to displace EB (IC50) corresponds 
approximately to the affinity of the titrant.227 However, due to the approximative character of 
the affinities derived from the IC50 values, only differences of ca. one order of magnitude or 
greater may be regarded as significant. Furthermore, IC50 values are only comparable for the 
same polynucleotide due to differing binding constants of both EB and the artificial ligands to 
different nucleic acid sequences. Figure 111 depicts a typical displacement experiment of an 
EB/ctDNA complex with 207 and the corresponding excerpt of the fluorescence emission at 
600 nm, which is corrected for EB´s own emission. All other combinations can be found in 
appendix C.4 (Figure C. 34-Figure C. 47). First, a solution of ethidium bromide (0.75 µM, 
1 eq) in aqueous cacodylate buffer (0.01 M) was prepared in a microcuvette equipped with a 
stopper (900 µL) and the fluorescence spectrum resulting upon irradiation at 520 nm was 
recorded from 560 to 650 nm. Then, four equivalents of nucleic acid (3 µM) were added and 
after 5 min incubation time the fluorescence signal was measured again. Further, solutions of 
either 196, 206, or 207 (50 µM) were titrated in aliquots of increasing volume (e.g. 5 × 4, 4 × 
8, 16, 32 µL) and the emission was measured after each addition after 1 min incubation time. 
EB´s own emission was subtracted from the spectrum, the excerpt at 600 nm was plotted 
against the ratio EB/ligand, and the resulting data were then fitted with a first order 
exponential decay function. The amount of ligand which was necessary to result in 50 % of 
the original fluorescence emission, i.e. the point where half of the originally bound ethidium 
bromide is displaced, was determined (IC50). The resulting listed in Table 11 are average 
values from at least two measurements. All data were corrected for dilution and are average 
values obtained from at least two individual measurements. Finally, titrations with EB and the 
three ligands without polynucleotide were carried out. It could thus be shown that there is no 
interaction between the intercalator and the synthetic nucleic acid binders. Displacement of 
EB is only due to the affinity of 196, 206, or 207 towards the nucleic acid and not due to 
secondary interactions with EB. 
 
Figure 111. EB displacement experiment with ctDNA and 207 (left) and excerpt of the corrected fluorescence 
emission at 600 nm plotted against the ratio of EB/207 with the corresponding fit (right). 
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The IC50 values for pdG × pdC and pG × pC could not be determined (n.d.) this way because 
mixing of EB with the GC-RNA did not produce an increase of emission signal, and 
respectively because the interaction of EB with the homopolymeric GC-DNA did not result in 
reproducible fluorescence spectra. Obviously mixed binding modes are present at this low 
ionic strength of the medium hampering accurate determination of the IC50 values for these 
nucleic acids.  
From the results of the other experiments it is clearly visible that all three compounds are 
able to displace EB from all nucleic acids under investigation, thus underlining their ability to 
efficiently bind to both DNA and RNA. The obtained values are another clue that the binding 
constants range at least around K ≈ 106 M-1. The three armed receptor 207 is more efficient in 
displacing EB than its two-armed analogues 196 and 206 by up to one order of magnitude, 
which is in agreement with the thermal melting experiments. The IC50 values of the divalent 
ligands are identical within the error of the method – if anything, the IC50 values for 207 are 
slightly lower than for 196 in all cases, which would translate into slightly higher binding 
constants. To gain a more detailed insight into the binding events and to determine the exact 
binding constants, ITC measurements were carried out next. 
Table 11. IC50 values and standard deviations as obtained from EB displacement assays. 
Polynucleotide 196 206 207 
ctDNA 4.36 (± 0.31) 3.17 (± 0.30) 0.79 (± 0.11) 
p(dAdT)2 5.77 (± 0.26) 5.34 (± 0.23) 0.46 (± 0.08) 
pdA × pdT 1.25 (± 0.05) 1.01 (± 0.20) 0.35 (± 0.07) 
p(dGdC)2 5.90 (± 0.35) 4.96 (± 0.39) 0.72 (± 0.36) 
pdG × pdC n.d. n.d. n.d. 
pA × pU 3.03 (± 0.01) 2.96 (± 0.28) 0.69 (± 0.14) 
pG × pC n.d. n.d. n.d. 
 
Isothermal Titration Calorimetry 
Isothermal calorimetry allows the direct determination of the reaction enthalpy ΔH, the 
stoichiometry n, and the binding constant K of a given binding event with a single 
experiment.82 With these values at hand the reaction entropy ΔS can also be calculated. For 
successful data processing it is important to collect experimental data points with sufficient 
but not too steep curvature for accurate fitting. The correct experimental conditions can be 
estimated with the help of the C value, which is the product of binding constant K, 
stoichiometry n and the concentration c of the nucleic acid in the cell. C values between 1 and 
1000 lead to sigmoidal data, which can then be fitted with the help of the Origin software 
add-on provided by the manufacturer of the instrument (MicroCal). For the titration 
experiments with 196, 206, and 207 the concentration of polynucleotides was determined by 
setting the C value to 200. The binding constant was approximated with K ≈ 106 M-1 as 
derived from the UV/Vis titration and EB displacement data. The stoichiometry was estimated 
to n ≈ 0.2 as judged by the denaturation and UV/Vis experiments. Thus, the concentration of 
the nucleic acid in the cell was calculated to 0.1 mM (= 200 : 0.2 : 106). All measurements 
were carried out in cacodylate buffered water (0.01 M) at pH 7. The reference cell was filled 
with water. All solutions were degassed prior to usage by ultrasonication for at least one hour 
and subsequent vacuum treatment. The experiments were carried out at 25° C by titrating 
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aliquots of the ligand (25-35 × 5 µL) of a concentration of 0.3-0.6 mM to the polynucleotide 
(1.41 ml). This way 0.4 to 0.6 equivalents of the ligands had been added at the end of the 
titration, thus generating a data set with sufficient data points, sigmoidal curvature and clear 
starting and endpoints of the binding event. The delay between injections was set to 300 sec 
to allow for return of the signal to the baseline prior to the next injection.  
 
Figure 112. Left: Raw ITC data for the titration of 206 (0.6 mM) in aliquots of 5µL to p(dGdC)2 (0.1 mM). 
Right: Titration of 206 to pure buffer (aqueous sodium cacodylate, 0.01 M, pH 7) under identical conditions. 
    
Figure 113. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196, 206 (c = 0.6 mM), or 207 (c = 0.3 mM) to ctDNA (c = 0.1 mM). Bottom: the 
titrations were corrected for dilution and the first data point, and then fitted with a one-site model.  
A representative experiment is depicted in Figure 112. It shows the raw data of the titration 
as well as a dilution experiment of ligand into buffer. Titration of the ligands into buffer led to 
substantial endothermal heat signals, which were thence subtracted from the titration data. On 
the other hand when buffer was titrated into the nucleic acid only negligible heat changes 
were observed. The so obtained data for ctDNA was fitted according to a one-site model for 
all three ligands as shown in Figure 113. All other titrations can be found in appendix C.5 
(Figure C. 56-Figure C. 61). The results are listed in Table 12. Alternative curve fittings with 
two-site models were possible for all combinations and even necessary for fitting the titrations 
of p(dAdT)2 with the divalent ligands 196 and 206 (see Figure 114). However, the 
thermodynamic data obtained for the second process with these fits was very often physically 
unrealistic. This second process takes place at very low ligand ratios (< 0.1 eq) and thus the 
concentration range and the amount of added ligand during these titrations were probably not 
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appropriate to resolve the second process in the presence of the dominating primary binding 
mode. Therefore only the data for the main binding mode can be considered to be accurate. 
   
Figure 114. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196 or 206 (c = 0.6 mM) to p(dAdT)2 (c = 0.1 mM). Bottom: the titrations were 
corrected for dilution and fitted with a two-site model. The titration with 196 is corrected for the first data point.  
Table 12. Results from the ITC experiments with in aqueous cacodylate buffer (0.01 M) at neutral pH and 25° C. 
All experimental data was fitted according to a one-site model. 
PN L 
K 
[106 M-1] 
logK n ΔH 
[kcal/mol] 
TΔSa 
[kcal/mol] 
ΔG 
[kcal/mol] 
 196 1.70 6.23 0.43 -12.0 -3.5 -8.5 
ctDNA 206 4.89 6.69 0.32 -15.8 -6.6 -9.1 
 207 27.50 7.44 0.15 -23.8 -13.7 -10.1 
 196b (59.80) 
0.48 
(7.78) 
5.68 
(0.09) 
0.25 
(-5.4) 
-16.5 
(5.2) 
-8.8 
(-10.6) 
-7.7 
p(dAdT)2 206b 
(5.37) 
2.73 
(6.73) 
6.79 
(0.01) 
0.26 
(279.6) 
-32.5 
(288.7) 
-23.7 
(-9.1) 
-8.8 
 207 32.70 7.51 0.20 -20.9 -10.7 -10.3 
 196 1.32 6.12 0.24 -13.3 -4.9 -8.3 
pdA × pdT 206 3.86 6.59 0.17 -17.5 -8.5 -9.0 
 207 41.0 7.61 0.06 -24.6 -14.3 -10.4 
 196 4.02 6.60 0.36 -10.0 -1.0 -9.0 
p(dGdC)2 206 6.02 6.78 0.28 -15.2 -5.9 -9.3 
 207 23.30 7.37 0.15 -21.4 -11.4 -10.1 
 196 2.54 6.40 0.24 -12.7 -4.0 -8.7 
pdG × pdC 206 14.90 7.17 0.20 -19.9 -10.1 -9.8 
 207 27.70 7.44 0.04 -30.0 -19.9 -10.2 
 196 6.38 6.80 0.39 -9.8 -0.6 -9.3 
pA × pU 206 6.34 6.80 0.34 -13.9 -4.6 -9.3 
 207 23.90 7.38 0.18 -18.7 -8.6 -10.2 
 196 5.14 6.71 0.37 -12.7 -3.5 -9.1 
pG × pC 206 7.93 6.90 0.24 -19.6 -10.2 -9.4 
 207 28.80 7.42 0.12 -27.5 -17.3 -10.2 
a) Calculated for 25° C; b) Two-site model. 
As predicted, the binding constants for the divalent ligands 196 (Phe-Lys-GCP) and 206 
(Lys-Phe-GCP) are in the range of ≥ 106 M-1. For the three-armed 207 (Phe-Lys-GCP) 
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binding constants are even higher by approximately one order of magnitude (> 107 M-1). This 
is in excellent agreement with the denaturation and EB displacement experiments. The two 
divalent receptors do not differ significantly in their binding behavior with the exception of 
p(dAdT)2, which is bound stronger by 206 by a factor of 5 and pdG × pdC, which again is 
bound stronger by 206 by a factor of 6. In all other combinations the difference is rather 
small, although there is a general trend for stronger binding by 206 in comparison to 196 
similar to the observation made during the EB displacement assays. All nucleic acids are 
bound with similar affinity by the divalent ligands. 206 has a slight preference, by a factor of 
2-4 for pdG × pdC, which is bound with K = 1.5 × 107 M-1. All other polynucleotides are 
bound weaker with binding constants in the range between 3.9 × 106 M-1 and 7.9 × 106 M-1. 
196 features similar binding constants ranging from 1.3 × 106 M-1 to 6.4 × 106 M-1 with RNA 
being slightly preferred by a factor of 2-3. As an exception, p(dAdT)2 is bound weaker with a 
binding constant of only 4.8 × 105 M-1. For 207 no preference could be witnessed at all. 
Binding constants closely range around 2-4 × 107 M-1. Obviously the third arm improves the 
binding affinity by a great deal due to the increased number of non-covalent interactions 
between nucleic acid and ligand, e.g. additional charge-charge interactions. 
From an energetic point of view, all complex formations are exothermic with unfavorable 
entropic contributions. Although this general energetic scheme is never changed, the 
complexation of different polynucleotides leads to different contributions of enthalpy and 
entropy to the binding event. For example, the binding of 207 with ctDNA leads to an 
enthalpy ΔH of -23.8 kcal/mol. Binding of pdG × pdC by the same ligand is more exothermic 
(ΔH = -30.0 kcal/mol). This would translate into a binding constant, which is higher by a 
factor of 4 × 104. However, the enthalpic contribution is compensated for by a less favorable 
entropy TΔS (ctDNA: -13.7 → pdG × pdC: -19.9 kcal/mol). As a consequence the binding 
constants towards the two different DNAs are the same within the error of the instrument (K = 
2.8 × 107 M-1). Such pronounced enthalpy-entropy compensation is common for binding to 
macromolecules and a clear indication for the formation of well-defined complexes in 
contrary to unspecific long-range charge-charge interations.228 The difference between the 
two-armed and the trivalent ligand stems solely from a more favorable enthalpy. For instance 
binding to pdA × pdT by 207 generates a ΔH of -24.6 in comparison to -13.3 kcal/mol for its 
two-armed analogue 196, which features identical side chains (Phe-Lys-GCP). This would 
translate into an increase of binding constant by a factor of 3 × 108. However, this effect is by 
large compensated for by a less favorable entropy TΔS (207: -14.3 and 196: -4.9 kcal/mol). 
Once more, this enthalpy-entropy compensation hints at the formation of a well-defined 
complex. The stronger enthalpic interaction of 207 with the nucleic acid leads to the 
formation of a more tightly bound and more rigid complex leading to a significant decrease in 
entropy. The reason for the improved binding of the three armed ligand is probably due to its 
higher charge. From the pKA values of the three ligands (Table 9) it is possible to calculate the 
protonation state at neutral pH. All lysine amine groups are fully protonated at this pH (pKA ≈ 
9.9). The guanidinio groups on the other hand are only partially charged. The two-armed 
ligands feature two and the three-armed one respectively three of these moieties. With the 
help of the rearranged Henderson-Hasselbalch equation (5) the percentaged amount of 
charged species can easily be calculated. 
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Hence, 50 % of the guanidinio groups are protonated for 196 (pKA = 7.00), 61 % for 206 
(pKA = 7.20), and 24 % for 207 (pKA = 6.50). Consequently the three molecules feature an 
average of 3.0 (196), 3.2 (206), and 3.7 (207) positive charges at pH 7. Thus, the additional 
charges might be the explanation, why the three-armed compound binds significantly stronger 
to the nucleic acids and why 206 always binds slightly better than 196. 
With regard to the structure of the nucleic acid-ligand complexes the energetic pattern 
determined by these experiments does not allow for a clear conclusion. In the following it will 
be compared to experimentally determined binding enthalpies and entropies of literature-
known systems. For instance, charge-driven, unspecific backbone binding by e.g. spermidine 
leads to an endothermic process which is driven by entropy.229 Entropy is generated, when the 
monovalent metal counterions are displaced from the phosphate backbone together with their 
water shell and liberated into the solvent. Binding constants of these charge-mediated binding 
events are normally lower than the ones for the three artificial ligands presented herewith. The 
binding constant for the complexation of spermidine with pUC118 plasmid DNA for instance 
is 1.4 × 105 M-1. Since almost all polynucleotide-binding molecules are positively charged, 
the entropic contributions due to liberation of territorially bound cations are general for all 
modes of interaction according to Mannings polyelectrolyte model, be it intercalation, 
unspecific or groove binding.230,231 The degree to which DNA-binders add favorable entropy 
depends on the charge of the ligand and ranges from 1 to 4 kcal/mol.90 Groove binders for 
example normally feature modest endothermal or exothermal contributions of ΔH and their 
complexation is mainly driven by entropy due to the displacement of the highly ordered water 
and counterion molecules, the spine of hydration, from the grooves.232 Intercalation on the 
other hand is mainly driven by enthalpy and often features unfavorable entropic contributions. 
This is due to the partial unwinding of the DNA which leads to lengthening and stiffening of 
the helix. The more rigid nucleic acid looses degrees of motional freedom, which leads to 
unfavorable entropy and thus the favorable contributions to entropy by water/ion 
displacement are overcompensated.233 
The energetic pattern generated by nucleic acid complex formation with 196, 206, and 207 
resembles most the intercalation mode. However, based on the structure of the three ligands 
intercalation is rather unlikely. The aromatic moieties present in the three molecules, namely 
the phenyl and pyrrole rings, are too small for efficient stacking into base pairs. The lack of 
entropic driving force must thus originate from somewhere else. One possible explanation is a 
binding mode which does not liberate many water molecules and counterions, e.g. groove 
binding without deep penetration thereof. This would leave the inner water shells intact and 
only remove the less ordered outer ones. Still, even such a process would liberate enough 
water/counterions to generate a favorable entropic contribution. Hence, the liberation must be 
overcompensated by other processes. Possible reasons for unfavorable entropy may either be 
due to conformational changes of the polynucleotide or stem from the loss of rotational and 
vibrational degrees of freedom of the ligand, especially if the complex is very tight and well-
defined. The pronounced entropy-enthalpy compensation which could also be observed 
speaks in the favor for the latter aspect.  
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Binding events of groove-binding proteins, which bind with little distortion of the DNA, for 
instance feature favorable enthalpic and unfavorable entropic contributions similar to the 
results obtained for 196, 206, and 207.234 In contrast to small molecule groove binders, which 
are regularly rather rigid and pre-shaped to adapt to the groove curvature (cf. DAPI or 
distamycin in chapter 2.3.5), proteins are large molecules. Upon binding to DNA large 
conformational changes can be observed (cf. bZIP in chapter 2.3.5), which may either take 
place at the binding site of the protein or at regions far away from it. By changing their 
conformation their functional nucleic acid recognizing groups are reoriented in order to favor 
hydrogen bonding or electrostatic and hydrophobic contacts, thus optimizing the enthalpic 
gain. On the other hand entropy has to be paid for these conformational changes. Probably 
something similar happens upon binding of 196, 206, and 207. Although these molecules are 
still rather small, and may therefore not be treated as protein-like, they are not typical groove 
binders either, which are already well-shaped for binding. Hence, for the complexation of the 
di- and trivalent ligands a binding mode can be proposed which proceeds with favorable 
enthalpy due to charge-charge and hydrophobic interactions paired with hydrogen bonding 
but leads to a large entropic penalty due to the rigidification and subsequent loss of rotational 
and vibrational degrees of freedom. 
In conclusion, with the help of thermal melting studies, spectroscopic methods and 
isothermal titration calorimetry it could be shown that the synthesized ligands are able to bind 
to nucleic acids with high binding constants. The divalent 196 and 206 bind with binding 
constants ≥ 106 M-1 and the trivalent 207 binds even stronger by one order of magnitude with 
K ≥ 107 M-1. There is no pronounced preference for any type of polynucleotide due to 
enthalpy-entropy compensation. The binding events are characterized by strong exothermal 
but entropically unfavorable contributions. Due to their structure, intercalation is not likely 
and a groove binding mode with severe restraints of degrees of freedom of the ligand upon the 
formation of a tightly bound complex can be proposed. In order to test this hypothesis 
additional experiments were undertaken in order to elucidate the binding mode of the three 
PN-binders. 
DAPI Displacement Assay 
In order to test the hypothesis of groove binding, displacement assays with the minor groove 
binder DAPI and the two nucleic acids p(dAdT)2 and pdA × pdT, which form very well-
defined minor grooves, were carried out similar to the ones conducted with EB in the last 
chapter.235 This way it could be tested whether 196, 206, and 207 are able to compete with 
DAPI for binding in the minor groove. First, a solution of DAPI was prepared in aqueous 
cacodylate buffer (0.01 M) in a fluorescence microcuvette equipped with a stopper (900 µL) 
at a concentration of 0.5 µM (1 eq). Upon irradiation at 358 nm the fluorescence spectrum 
between 420 and 500 nm was recorded at 25° C. Then the polynucleotide was added (2.5 µM, 
5 eq) and after 5 min incubation time the spectrum was measured again – now with increased 
fluorescence intensity upon minor groove binding of DAPI. Stock solutions of 196 (35 µM), 
206, and 207 (each 50 µM) were added to the mixture in aliquots of increasing volume (e.g. 
10 × 1, 2, 4, 8 µL) and the spectrum was measured after 1 min incubation time after each 
addition. Figure 115 depicts a representative titration with pdA × pdT and 207 and the excerpt 
at 460 nm, which was corrected for dilution and DAPI´s own emission before fitting with a 
first order exponential decay function (see appendix C.6, Figure C. 66-Figure C. 70 for all 
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other combinations). All measurements were carried out at least in duplicate. The average 
amounts of artificial ligand which were necessary to displace 50 % of DAPI were calculated 
and are listed as the IC50 values in Table 13. By carrying out additional titrations of the three 
ligands into a solution of DAPI it was ensured that there is no interaction between these 
molecules. Therefore, the displacement of the minor groove binder is only due to the 
attraction between the nucleic acid and 196, 206, or 207. 
  
Figure 115. DAPI displacement experiment with pdA × pdT and 207 (left) and excerpt of the fluorescence 
emission at 460 nm plotted against the ratio of EB/207 plus the corresponding fit (right). 
Table 13. IC50 values and standard deviations as obtained from DAPI displacement assays. 
Polynucleotide 196 206 207 
p(dAdT)2 52.15 (± 16.98) 15.93 (± 3.68) 1.72 (± 0.34) 
pdA × pdT 7.73 (± 2.69) 20.79 (± 5.87) 1.28 (± 0.15) 
 
The results of the displacement assay clearly show that especially trivalent 207 is able to 
efficiently displace DAPI from both nucleic acids. The divalent ligands 196 and 206 do also 
displace the minor groove binder but less efficient by one order of magnitude, which is in 
perfect agreement with the ITC data. Furthermore, 196 is less well able to displace DAPI 
from p(dAdT)2 than 206, which is also in good agreement with the calorimetric data. The 
ability to displace DAPI from pdA × pdT (196 > 206) on the other hand does not correspond 
to the ITC data. There the opposite effect was observed (196 < 206). Still, these measure-
ments demonstrate that all three systems are able to displace DAPI from very well-defined 
minor grooves where this minor groove binder is bound very tightly (pdA × pdT: K = 6.3 × 
107 M-1, and p(dAdT)2: K = 8.4 × 106 M-1).236,237 These observations are in agreement with the 
hypothesis of groove binding. Especially for 207 a minor groove binding mode is probable. 
CD-Spectroscopy 
Circular dichroism spectroscopy is an excellent tool for studying the secondary structure of 
nucleic acids and their interaction with ligands. Depending on the ligand´s mode of inter-
action, especially concerning their relative orientation and distance towards the helical axis, 
different changes in the CD spectra are obtained. Since 196, 206, and 207 are chiral 
molecules, they feature a CD signal on their own. Therefore, the concentration dependent CD 
signature of these three molecules was determined first. Solutions of increasing amount of the 
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ligands were prepared in a fluorescence cuvette equipped with a stopper (2 mL) in cacodylate 
buffer (0.01 M) at neutral pH and the corresponding CD spectra were recorded between 220 
and 350 nm at 25° C. The background-corrected spectra (cuvette + buffer) of 196, 206, and 
207 are depicted in Figure 116. As demonstrated by the excerpts of exemplary absorption 
maxima, the changes of the CD signals are directly proportional to the concentration. 
 
 
Figure 116. Concentration dependent CD signature of the three ligands 196, 206, and 207 revealed linear 
increase/decrease of the CD signals. 
Due to this linear relationship between concentration and CD signal, the CD spectra of 
polynucleotide/ligand mixtures could easily be corrected for the ligand´s own CD signature in 
the following titration experiments. All spectra were furthermore corrected for the 
background CD signal (buffer + cuvette). For better comparability, the wavelengths of the CD 
spectra were plotted against the molar CD absorption coefficient Δε, which takes into account 
the concentration of the nucleic acid and can be calculated from the observable  after 
correction for the ligand´s CD signal with the help of the following equation: 
∆ߝ ൌ  
߆
33,000 · ܿ · ݀
 
Δε = molar CD absorption coefficient 
 = ellipticity 
c  = concentration 
d  = path length = 1 cm 
The factor 33,000 originates from the conversion of the ellipticity unit (mdeg). 
First, the binding properties of 196 towards various double-stranded DNAs and RNAs were 
tested. Solutions of the polynucleotides were prepared in neutral cacodylate buffer (0.01 M) in 
fluorescence cuvettes equipped with stoppers (1.5-2 mL, 8-40 µM) and their CD spectra were 
measured between 220 and 350 nm at 25° C. Aliquots of a 1 mM stock solution of the ligand 
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were added (e.g. 5 × 0.75, 5 × 1.50 µL) and after 1 min incubation time the resulting CD 
spectra were measured again. Figure 117 illustrates the spectrum between 260 and 340 nm 
obtained from titrating 196 into a solution of ctDNA. Upon addition of the ligand a symmetric 
bisignate induced CD (ICD) signal could be observed at the UV/Vis absorption maximum of 
the pyrrole unit (300 nm). This kind of signal is an indication for exciton coupling between 
two pyrrole chromophores. Obviously two pyrrole units come within close proximity upon 
binding to ctDNA. Such a process is plausible when considering that only one of the two GCP 
units is positively charged at this pH while the other one is neutral. Exciton coupling is not 
possible for intercalators due to the nearest neighbor exclusion principle and is therefore an 
indication for groove binding.78 Furthermore, the isoelliptic point which is present from 0.1 eq 
onwards suggests a predominant and well-defined binding mode of the ligand for ratios 
higher than 0.1.  
The excerpt at 284 nm (and also at 319 nm) is of sigmoidal character. At ratios higher than 
0.1 eq the slope is becoming steeper to flatten again at higher ratios until a plateau is reached 
at 0.35 eq. At this ratio the ICD inducing groove binding mode is saturated. This value is in 
good agreement with the stoichiometry n = 0.43 obtained by ITC. In general, the point of 
saturation correlates very well with the ITC-derived stoichiometry for all ligand-nucleic acid 
combinations as shown in Table 14. Hence, the process witnessed by ITC can be linked to 
groove binding. The sigmoidal shape of changes at both, positive and negative ICD bands, 
suggests that for efficient binding some definite concentration of compounds per DNA 
binding site has to be achieved. Above this ligand/DNA basepair ratio pyrroles are forced into 
dimers due to the tight packing of molecules within the DNA minor groove, whereby these 
pyrrole dimers are in one preferred orientation with respect to the DNA helical axis. The high 
saturation ratio r = 0.3-0.4 eq suggests that pyrroles from two different molecules are 
combined into a stacked structure which yields excitonic ICD bands. Otherwise saturation 
should appear at ratios r < 0.2 eq due to the size of molecules. 
 
Figure 117. CD titration experiment with ctDNA and 196. The spectra are corrected for the ligand´s CD signal. 
A similar binding mode is adopted by 196 towards all tested B-type helix nucleic acids. 
Figure 118 shows corresponding CD titration experiments for pdA × pdT, p(dAdT)2, and 
p(dGdC)2 as well as excerpts of their CD maxima around 320 nm. All spectra feature a 
bisignate ICD and the excerpts are of sigmoidal shape. The titration with p(dAdT)2 resembles 
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the one with ctDNA most, which was to be expected due to the similar secondary structure of 
these two nucleic acids.  
 
 
Figure 118. Top: CD titrations of pdA × pdT (left), p(dAdT)2 (middle), or p(dGdC)2 (right) with 196. The 
spectra are corrected for the ligand´s own CD signal. Bottom: Excerpts of the CD maximum around 320 nm. 
The titrations differ from the one for ctDNA in the way that the bidentate ICD signal is not 
symmetric any longer. For all three B-type DNAs different CD signals were obtained. The 
negative band around 320 nm is most pronounced for pdA × pdT, followed by p(dAdT)2 and 
p(dGdC)2. The positive signal at 290 nm behaves the other way round. The titration with this 
nucleic acid also features an isoelliptic point, which starts shifting after saturation (at 0.3 eq). 
The same was observed for the alternating GC polymer: From 0.05 eq ligand to the point of 
saturation (0.35 eq) there is an isoelliptic point which starts shifting upon addition of more 
ligand. p(dAdT)2 behaves similarly, but its isoelliptic point starts shifting before saturation 
takes place (0.05-0.25 eq). Probably additional unspecific binding modes exist, which do 
either not result in ICD signals or as in the last case only give rise to a positive ICD which 
could be an indication for minor groove binding without exciton coupling. 
Table 14. Comparison of the stoichiometry (n) as obtained by ITC measurements with the point of saturation 
observed during CD titrations. 
L PN ctDNA p(dAdT)2 pdA × pdT p(dGdC)2 pdG × pdC pA × pU pG × pC 
196 
Saturation 0.35 0.35 0.25 0.35 0.40 0.30 0.35 
na 0.43 0.25 0.24 0.36 0.24 0.39 0.37 
206 
Saturation 0.50 0.25 0.30 0.30 0.20 0.40 0.30 
na 0.32 0.26 0.17 0.28 0.20 0.34 0.24 
207 
Saturation 0.20 0.20 0.15 0.10 0.10 0.20 0.13 
na 0.15 0.20 0.06 0.15 0.04 0.18 0.12 
a) Obtained from ITC. 
As depicted in Figure 119 a totally different result was observed for the GC containing A-
type helices pdG × pdC (DNA) and pG × pC (RNA). These titrations also feature a bidentate 
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signal, but with opposite sign. The band around 285 nm now is negative instead of positive 
and the one at 310 nm positive instead of negative. The bands are also somewhat shifted to 
lower wavelengths (5-10 nm). Both spectra feature sigmoidal excerpts at 285 nm (also at 
310 nm), and isoelliptic points at the pyrrole´s UV/Vis absorption maximum at ca. 300 nm 
indicating exciton coupling. Lewis reported that the intensity of the positive and negative 
bands of bidentate CD signals caused by exciton coupling for two identical chromophores 
with parallel oriented planes depends on the angle between the transition dipoles  following 
the function sin(2).238,239 Hence, it can be concluded from the existence of the bisignate 
signal that the two pyrrole units are not aligned parallelly (sin 0° = 0) but are rather twisted 
helically. Further, Wagenknecht could show that a mirror imaged CD-signature of such 
excition bands (+/- vs. -/+) can be attributed to left- vs. right-handed helical twisting of two 
chromophores caused by differing features of the site where the two chromophores are 
implemented into the DNA.240 According to that the pyrrole units within the pdG × pdC and 
pG × pC grooves are aligned towards each other with opposite helical chirality in comparison 
to all other polynucleotides under investigation. For the RNA an isoelliptic point is present 
throughout the entire titration and the ICD is pronounced strongest. The analogue DNA only 
features an isoelliptic point starting from 0.15 eq and the ICD is somewhat weaker. 
Obviously, 196 adopts an alternative binding mode for A- and B-type helices featuring 
opposite chirality of the alignment of two stacked pyrroles, but is able to bind to both types as 
already shown by the ITC experiments. Such a differentiation between different secondary 
nucleic acid structures/sequences by non-covalently binding small molecules is very rare. 
Probably the ligand is able to bind to both, the major groove for A-helices and the minor 
groove for B-helices due to its flexibility. To both types it binds via unspecific electrostatic 
interactions paired with a groove binding mode. Additional binding modes which do not give 
rise to ICD signals cannot be excluded, however. 
 
 
Figure 119. Top: CD titrations of pdG × pdC (left), pG × pC (middle), or pA × pU (right) with 196. The spectra 
are corrected for the ligand´s own CD signal. Bottom: Excerpts of the CD maxima around 280 or 320 nm. 
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The A-type RNA pA × pU on the other hand is bound differently. Its CD signature 
resembles more the one observed for B-DNA. A weak, bisignate signal around 300 nm is 
formed and the spectra feature an isoelliptic point between 0.05 and 0.30 eq. The excerpt at 
320 nm does not feature a pronounced sigmoidal shape. Hence, besides the secondary 
structure of the polynucleotide also the base sequence seems to be crucial for the binding 
mode of the ligand. Nevertheless, in all cases at least one well-defined groove binding mode 
could be observed. 
Next, the analogue two-armed ligand 206 with inversed amino acid sequence (Lys-Phe-
GCP) was tested. Figure 120 shows the results of the CD titrations with the three B-DNAs 
pdA × pdT, p(dAdT)2, and ctDNA. Only the first one features a clear bisignate CD signal and 
and isoelliptic point at 300 nm and thus a similar binding mode as for 196. For p(dAdT)2 at 
least two different groove binding modes could be observed. First, a broad positive ICD 
around 280 nm appears, which starts to decrease again when more than 0.25 eq of ligand are 
present to result in a weak bisignate signal around 300 nm. The negative lobe of this signal is 
already saturated at 0.25 eq. For ctDNA a similar behavior was witnessed. First, a positive 
ICD band arises around 280 nm and decreases again with increasing amount of ligand. Unlike 
the alternating AT-polymer, no bisignate signal was observed at higher ratios. Obviously, it is 
more difficult for 206 to bring the two pyrrole moieties within close proximity than it is for 
196. A possible explanation for this is the difference in the amino acid sequence. The 
phenylalanine in 206 is directly attached to the pyrrole moiety, which probably makes it more 
difficult to stack two pyrrole units above each other. Furthermore, the strongest ICD was 
observed for pdA × pdT with its very well-defined minor groove. The less well the minor 
groove is developed (pdA × pdT > p(dAdT)2 > ctDNA > p(dGdC)2), the less likely it is that 
the ligand binds to it. Hence, the observed signals are another strong indication for minor 
groove binding in B-type DNA. 
 
 
Figure 120. Top: CD titrations of pdA × pdT (left), p(dAdT)2 (middle), or ctDNA (right) with 206. The spectra 
are corrected for the ligand´s own CD signal. Bottom: Excerpts of the CD maxima around 280 nm. 
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This observation is backed up by the result of the titration with p(dGdC)2 depicted in Figure 
121. During the titration a kinetic effect could be observed (left). Even after 4 min incubation 
time the equilibrium state was not yet reached. Therefore the experiment was repeated by Dr. 
Lidija-Marija Tumir from the working group of our cooperation partner Dr. Ivo Piantanida at 
the Ruđer Bošković Institute (Zagreb, Croatia). Individual mixtures of varying DNA/ligand 
ratios were prepared and incubating for 24 h (middle). The resulting spectra feature a 
complicated pattern of different binding modes without isoelliptic point. First, two positive 
ICD bands form at 280 and 310 nm with a maximal intensity at 0.3 eq. Then these bands 
decrease again and a new bisignate signal is formed around 320 nm with a negative lobe 
around 305 nm and a positive lobe around 330 nm. When even more ligand is added, this 
signal vanishes again, too. Hence, in agreement with the other CD signatures for B-DNA, 206 
seems to have the greatest trouble in forming a defined complex to p(dGdC)2 with its poorly 
accessible minor groove (shallow, featuring the electropositive guanine NH2). 
 
Figure 121. Uncorrected CD spectrum of p(dGdC)2 and 0.25 eq 206 (left). The CD titration with 24 h 
incubation time (middle) and the excerpt at 309 nm are corrected for the ligand´s CD signal. 
With regard to A-type polynucleotides the experiments gave similar results as for 196. A 
bisignate signal with a clear isoelliptic point at 297 nm could be observed for the 
homopolymeric GC RNA (Figure 122, left). The ICD signals were very strong, especially the 
negative lobe at 285 nm. Also for the corresponding DNA pdG × pdC a bisignate signal with 
an isoelliptic point at 295 nm was observed. This point however started shifting after 
saturation of the groove at 0.25 eq. The most striking feature of this titration was the 
extremely strong ICD signal with ΔΔε values as strong as -34 M-1cm-1. Obviously this nucleic 
acid is suited best for groove binding of 206 and stacking of two pyrrole units within the 
groove. This finding is also backed up by the slight preference (factor 2-4) of this ligand for 
pdG × pdC, which was revealed by the ITC experiments. Hence, for GC-containing A-type 
RNA the divalent ligand most likely binds into the well accessible major groove. For pA × pU 
a related signal could be observed this time. A very weak bisignate signal occurred, which 
was shifted towards higher wavelength compared to the other ones (10 nm). Again, the type 
of base pairs present in the RNA seems to play a decisive role for the binding mode of the 
divalent ligand. Thus, just like 196 (vide supra) the ligand 206 is also able to differentiate 
between the polynucleotides secondary structure and sequence by non-covalently binding to 
the groove and thereby aligning the pyrrole moieties towards each other with opposite helical 
chirality (left- vs. right-handed) and thus generating an excition CD signal of opposite sign. 
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Figure 122. Top: CD titrations of pG × pC (left), pdG × pdC (middle), or pA × pU (right) with 206. The spectra 
are corrected for the ligand´s own CD signal. Bottom: Excerpts of the CD maxima around 280 or 320 nm. 
Finally, the binding properties of the trivalent ligand 207 were characterized. This nucleic 
acid binder has the same amino acid sequence as its divalent analogue 196 (Phe-Lys-GCP). 
Accordingly, the results are quite similar to this ligand as illustrated for the four tested 
B-DNAs in Figure 123. For all combinations a bidentate ICD signal around 300 nm could be 
observed with a positive lobe at 290 nm and a negative one at 320 nm. Again, the intensity of 
the ICD signal correlates with the accessibility of the minor groove. The strongest signal 
occurred for pdA × pdT, followed by ctDNA and p(dAdT)2. For the not very well accessible 
p(dGdC)2 the signal was weakest and multiple binding modes were present. In all cases the 
sigmoidal character of the excerpts of the ICD signals was not very pronounced. Further, 
saturation takes place at lower equivalents, which is in agreement with the results from the 
ITC experiments. Hence, in this experimental setup there were not enough data points in the 
very beginning of the titration to determine the threshold value for groove binding. All 
polynucleotide titrations featured a shifting isoelliptic point at 310 nm, an indication for at 
least two binding modes. The overall signal intensity was lower than for the divalent analogue 
196. A possible explanation for this observation are additional unspecific binding modes 
which do not give rise to an induced CD. These modes might be due to the third arm which 
does not fit into the minor groove together with the other two. An alternative explanation is an 
orientation of the third arm which leads to a counterbalancing ICD signal, e.g. if it shows into 
the opposite direction of the groove as do the other two arms. This way, the electronic 
transition dipole moment would point ca. 180° into the other direction with regard to the 
helical axis. The energetic signature derived from ITC titrations is in agreement with such an 
explanation. The higher binding affinity of the tripodal ligand mainly stems from increased 
enthalpic contributions to the binding constant, which are in part compensated for by 
unfavorable entropic contributions. This signature can be explained by a more tight and rigid 
binding mode which is accompanied by a loss of rotational and vibrational degrees of 
freedom. 
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Figure 123. Left; from top to bottom: CD titrations of pdA × pdT, p(dAdT)2, ctDNA or p(dGdC)2 with 207. The 
spectra are corrected for the ligand´s own CD signal. Right: Excerpts of the CD maxima around 275 or 320 nm. 
Figure 124 illustrates a calculated structure of the B-type Dickerson-Drew dodecamer with 
207.71 The molecular modeling was carried out with Macromodel v9.6 making use of the 
OPLC_2005 force field and GBSA water solvation. First, the X-ray crystal structure-derived 
DNA was minimized without restraints together with the ligand 207 in the desired geometry. 
Then a conformational analysis with frozen DNA and 10,000 steps was conducted until the 
depicted minimum was found multiple times. According to the calculation the ligand adopts a 
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stable geometry with two parallel arms in the minor groove and the third arm directed into the 
opposite direction of the same groove. At neutral pH only one of three GCP units carries a 
positive charge. The calculation illustrates the case where two neutral GCP units are stacked 
above each other. The pyrroles are oriented towards the groove floor, while the lysine 
ammonium groups bind to the ribophosphate backbone and all phenyl rings are outside the 
groove. However, this binding mode is probably not the only one but represents rather one of 
the modes which lead to the observed CD signal. 
 
Figure 124. Molecular modeling of 207 in the minor groove of the Dickerson-Drew dodecamer. Two arms are 
oriented to the same side while the third arm points into the other direction. 
 The titrations with A-type nucleic acids are depicted in Figure 125. Similar to the divalent 
ligands a bidentate signal was observed for GC containing DNA and RNA featuring a clear 
isoelliptic points at ca. 300 nm. The sign of the lobes is inverted in comparison to B-type 
DNA and stronger. Obviously, a well-defined complex can be formed in the major groove of 
this kind of polynucleotides, which is well-formed for ligand accommodation and big enough 
to allow for binding of the large trivalent ligand. For these two nucleic acids the energetic 
signature derived from ITC features the largest enthalpy gain together with the largest 
unfavorable entropy. This signature speaks in favor of a distinct binding mode. On the other 
hand, a totally different signature could once more be observed for the RNA pA × pU. A 
negative ICD was observed at 320 nm and isoelliptic point at 297 nm. By ruling out an 
intercalating binding mode such a signal can only stem from major groove binding without 
stacking of the pyrrole units. At this point it has to be stated, that a well-defined binding mode 
does not necessarily correspond to a higher binding constant. For instance, according to the 
displacement assays and ITC experiments 206 binds slightly better to all nucleic acids than 
196 although the latter one forms more defined complexes according to the CD titrations. 
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Figure 125. Top: CD titrations of pG × pC (left), pdG × pdC (middle), or pA × pU (right) with 207. The spectra 
are corrected for the ligand´s own CD signal. Bottom: Excerpts of the CD maxima around 290 or 320 nm. 
In conclusion, the binding studies revealed that all three ligands are able to strongly interact 
with nucleic acids. The two-armed ligands 196 and 206 bind without clear preference for any 
type of polynucleotide with binding constants K > 106 M-1. The results from the displacement 
assays and the ITC experiments show that 206 binds with slightly higher affinity than 196. 
The trivalent analogue 207 also binds without preference for a specific polynucleotide but 
more efficiently with K > 107 M-1. The energetic profiles of the binding events of all three 
ligands, which were determined via ITC, resemble most the one of groove binding proteins or 
intercalators (exothermal with unfavorable entropy). Due to the chemical structure of the 
ligands with their rather small aromatic moieties intercalation can be ruled out, however. 
Strong enthalpy-entropy compensation and the occurrence of isoelliptic points during the CD 
titrations suggest the formation of well-defined polynucleotide/ligand complexes. The 
exothermal binding event is most likely due to charge-charge and hydrophobic interactions 
paired with hydrogen bonding. Upon formation of the well-defined complex an enthalpic 
penalty has to be paid due to the loss of degrees of freedom within the ligand. According to 
the energetic signature obtained via ITC (more exothermic, less favorable enthalpy) the 
addition of the third arm of 207 allows for additional non-covalent interactions and 
consequently leads to the formation of an even more tighly bound complex. 
However, in most cases two binding modes could be observed. One of these modes was 
attributed to unspecific electrostatic binding while another one could be linked to groove 
binding with the help of ITC experiments and CD spectroscopy. The results from the DAPI 
displacement assays are also in agreement with a groove binding mode. Furthermore, the CD 
spectra of PN/ligand complexes featured in most cases a bisignate signal at the UV/Vis 
absorption maximum of the pyrrole group, which was ascribed to the stacking of two GCP 
units with subsequent exciton coupling. Due to the nearest neighbor principle the existence of 
the exciton signal clearly rules out an intercalating binding mode. According to the saturation 
ratios (r) of the ICD signals derived from groove binding the stacking is most likely 
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intermolecular for the divalent ligands 196 and 206 (r ≈ 0.3-0.4) while it is intramolecular for 
the tripodal analogue 207 (r ≈ 0.1).  
For B-helical DNA the ICD signal intensities correlate well with the accessibility of the 
minor groove. Stacking of the pyrrole units of 196 (Phe-Lys-GCP) is more efficient than for 
206 (Lys-Phe-GCP) due to sterical hindrance within the groove caused by the close proximity 
of the rather bulky phenyl group next to the pyrrole moiety. For the other B-type 
polynucleotides unspecific electrostatic interactions and minor groove binding without 
stacking are preferred. The trivalent ligand 207 also binds to the minor groove, but it adopts a 
conformation in which it forms intramolecularly stacked pyrroles. The additional third arm is 
also bound tightly according to ITC and probably pointed into the opposite direction as 
indicated by the rather low intensity of the observed ICD signals. In general, the results from 
the CD and ITC experiments strongly suggest a minor groove binding mode for B-type 
nucleic acids for all three ligands together with additional unspecific alternative electrostatic 
binding modes. 
For A-type nucleic acids on the other hand a major groove binding mode together with 
unspecific electrostatic binding is preferred. All nucleic acid/ligand complexes feature 
bisignate CD signals similar to B-helical DNA. Especially for GC-containing polynucleotides 
very strong ICD signals could be observed. Most strikingly, the lobes of the exciton signals 
feature inverted signs (-/+ vs. +/-) in comparison to B-type DNA. This inversion is probably 
caused by a helical twist of opposite chirality (M vs. P) of the faces of the two stacked pyrrole 
moieties. Furthermore, for RNA also the type of base pairs seems to be important: pA × pU 
always features a CD signature which is distinct from pG × pC. Thus, although the overall 
binding affinity of the ligands towards different nucleic acids is rather similar, they are able to 
differentiate between GC- and AU-containing RNAs as well as between A- and B-type 
secondary structures by producing distinct CD signatures.  
For a more detailed analysis of the structure of the polynucleotide/ligand complexes the 
exact knowledge of the electronic dipole transition moment of the GCP unit would be 
necessary.241,242 Alternatively, additional experimental methods, like NMR- or X-ray crystal 
structure analyses, would be required for the determination of the exact binding mode of the 
ligands. Nevertheless, as evidenced by CD spectroscopy the three ligands are able to 
differentiate between secondary structure and sequence of polynucleotides by means of 
excition coupling and chiral twisting of two stacked pyrrole units. Such differentiation by 
non-covalently bound small molecules is very rare and might be of interest for the 
development of nucleic acid sensors or for DNA analysis. In the next chapter it will be tested 
whether the strong interaction towards nucleic acids can also be exploited for an application 
in another field: cell biology. 
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4.4.4 Transfection Experiments 
After having shown, that the three artificial nucleic acid ligands are able to strongly bind to 
polynucleotides, their capability to shuttle genetic information into human cells was tested. 
For transfection experiments, three main classes of DNA carriers are utilized nowadays: 
cationic lipids,149 cell penetrating peptides,160 and cationic polymers.138 At the moment, there 
are two gold standards, which are widely being applied for gene shuttling, both in vitro and in 
vivo: the cationic polymer polyethyleneimine (PEI)144 and the cationic lipid lipofectamine.18 
The transfection experiments which will be presented in the following were carried out by 
our cooperation partner, the working group of Prof. Shirley Knauer from the Institute of 
Biology at the University of Duisburg-Essen by Aljona Gutschmidt in the course of her master 
thesis.243 The human embryonic kidney cell line HEK293T was transfected with a plasmid 
encoding for a green fluorescence protein (pF143GFP). The plasmid was derived as reported 
in literature.244 Ca. 104 cells were seeded in 96-well cell culture plates and grown for 24 h. 
Then, a mixture of the plasmid (1, 2, or 4 µg) and varying amounts of the artificial gene 
carriers 196, 206, and 207 (0.12, 0.18, 0.24, 0.30, or 0.36 mM) were incubated in phosphate 
buffered saline (PBS) at pH 7.2 for 10 to 15 min and added to the cells (total volume = 
200 µL). The commercial transfecting agent PEI was used as a control. Successfully 
transfected cells were measured 24 or 48 h after treatment as the expression of GFP with the 
help of an inverted fluorescence microscope. The data were processed and analyzed using 
MetaMorph and Adobe Photoshop. All experiments were carried out at least in triplicate. The 
average values of the percentaged quotient of transfected cells to all plated cells as well as the 
corresponding standard deviations are listed in Table 15.  
Table 15. Transfection efficiency determined 24 or 48 h after treatment of HEK293T cells with varying amounts 
of pF143-GFP plasmid and 196, 206, 207, or polyethyleneimine (PEI). 
pF143-GFP / 
[µg] 
[Ligand] /  
[mM] 
Time 
[h] 
Transfection Efficiency and Standard Deviation / [%] 
196 206 207 PEI 
4 
0.12 24 - - 9.2 (± 1.5) 27.4 (± 6.0)
0.18 24 < 1 - 21.9 (± 4.9) n.d.
0.24 24 < 1 - 32.5 (± 2.3) n.d.
0.30 24 - 3.3 (± 1.3) 12.4 (± 5.7) n.d.
2 
0.12 24 n.d. n.d. n.d. 21.5 (± 6.1)
0.12 48 n.d. n.d. n.d. 50.7 (± 9.4)
0.18 48 - < 1 32.7 (± 10.7) n.d.
0.24 24 n.d. n.d. 26.8 (± 10.6) n.d.
0.24 48 < 1 2.8 (± 0.6) 54.1 (± 12.5) n.d.
0.30 48 < 1 n.d. n.d. 47.3 (± 10.0)
0.36 48 < 1 n.d. n.d. 33.6 (± 8.1)
1 
0.12 24 n.d. n.d. n.d. 10.3 (± 2.9)
0.12 48 n.d. n.d. n.d. 52.7 (± 14.8)
0.24 24 n.d. n.d. 17.3 (± 2.1) n.d.
0.24 48 n.d. n.d. 30.7 (± 5.5) n.d.
 
The first experiments were carried out with 4 µg plasmid DNA and 0.12 mM PEI as 
described by the supplier, as well as with increasing amounts of the three synthetic ligands 
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(0.12-0.30 mM). After 24 h there was no substantial amount of fluorescent cells visible for 
any concentration of the two-armed ligands 196 and 206 (< 1 to 3.3 %). For PEI (27.4 %) and 
trivalent gene carrier 207 at a concentration of 0.24 mM (32.5 %) on the other hand a 
significant amount of cells did express the fluorescent protein. At lower concentrations of the 
three-armed ligand the transfection efficiency dropped (e.g. 21.9 % at 0.18 mM). At higher 
concentrations precipitation of the DNA/ligand complex was observed and consequently the 
efficiency dropped again (12.4 % at 0.30 mM). To test whether the amount of plasmid 
influences the efficiency, additional experiments were conducted with the optimized 
concentration of the artificial ligands (0.24 mM) and 2 µg of pF143-GFP. The resulting 
fluorescence was measured 48 h afterwards. 196 was still not able to efficiently transfect the 
cells, and the ligand with inverse sequence 206 only with very low efficiency (2.8 %). The 
trivalent ligand 207 however now was able to transfect 54.1 % of the cells, thus slightly 
outperforming the transfection gold standard PEI (50.7 %). At an even lower amount of DNA 
(1 µg), the efficiency dropped for 207 (30.7 %), but not for PEI (52.7 %). Thus, it could be 
shown that the transfection efficiency of 207 is optimal at a concentration of 0.24 mM with 
2 µg of plasmid DNA. The plasmid comprises 6,238 bps corresponding to a molecular weight 
of ca. 4,050 kDa (calculated with an average weight of 650 Da per bp). Consequently, 2 µg 
DNA dissolved in 200 µL equals a concentration of DNA phosphates of approx. 30 µM. 
Hence, at the optimized transfection conditions eight equivalents of 196, 206, and 207 or six 
equivalents of PEI were utilized. The results of the cell assays at these conditions are 
illustrated in Figure 126. 
 
Figure 126. Brightfield (a-d) and fluorescence images (e-f) of HEK293T cells 48 h after transfection with 2 µg 
pF143-GFP plasmid and either 0.24 mM 196 (a, e), 206 (b, f), 207 (c, g), or 0.18 mM PEI (d, h); i) transfection 
efficiencies of 196, 206, 207, and PEI: Absolute (left), per charge at pH 7.2 (middle), and per mass (right). The 
latter two are normalized to the efficiency of 207 as 100 %.  
196 206 207 PEI 
a) b) c) d) 
e) f) g) h) 
i) 
196 
206 
207 
PEI 
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Since PEI is a polymer (MW = 25 kDa) and the synthetic gene carriers are rather small in 
comparison (MW (196, 206) = 1.3; MW (207) = 1.7 kDa) also mass-normalized efficiencies 
were calculated. Furthermore, charge-normalized efficiencies were calculated. The average 
number of positive charges at pH 7.2 was calculated with the help of the Henderson-
Hasselbalch equation, the reported pKA value for PEI (pKA = 8.4; per average 580 repetition 
units per polymer),245 and the measured pKA values for 196, 206, and 207 as listed in Table 9 
one molecule of 196 carries on average 2.8, 206 3.0, 207 3.5, and PEI 546 positive charges. 
As illustrated in the chart at the bottom of Figure 126 the trivalent gene carrier 207 is ten 
times as efficient per mass as PEI (normalized efficiency of PEI relative to the mass of 207 = 
9 %) and even 100 times as efficient per charge (normalized efficiency of PEI relative to the 
charge of 207 = 1 %). These findings demonstrate that 207 is a significant better transfecting 
agent than PEI. 
Besides efficient transfection, the second crucial characteristic of a gene carrier is whether it 
is cytotoxicity or not. Therefore Gutschmidt determined the cytotoxicity of the non-viral 
vectors with the help of a trypan blue assay.246 This dye is only able to penetrate cell walls of 
dead cells, and can therefore be used for the monitoring of cell toxicity. Thus, the cell vitality 
48 h after treatment with the gene carriers was determined to 103 ± 3 % for 196, 80 ± 2 % for 
206, 92 ± 4 % for 207, and 81 ± 10 % for PEI (normalized to untreated cells = 100 %). Hence, 
207 does not only feature superior transfection properties, it is also less cytotoxic than PEI.  
The two-armed ligands on the other hand are not able to efficiently transfect cells. This large 
difference is surprising, especially when comparing the two compounds 196 and 207, which 
both feature the same side chains (Phe-Lys-GCP). Transfection experiments with 0.36 mM of 
ligand 196 were carried out. At this molarity the number of functional groups of divalent 196 
is the same as for its trivalent analogue 207 at 0.24 mM. Still, even with the 1.5 times 
increased concentration 196 was not able to transfect cells. It was therefore concluded that the 
difference between two- and three-armed gene carriers does not depend on the absolute 
number of functional groups but must originate from somewhere else. To get some more 
insight into the binding properties towards the plasmid, binding studies with the pF143-GFP 
plasmid were carried out. Illustrations of the EB displacement and ITC experiments can be 
found in appendix C.4 (Figure C. 48-Figure C. 50) and C.5 (Figure C. 62). The results of the 
binding studies for the plasmid are listed in Table 16. For comparison also the results for 
ctDNA are reported. 
Table 16. Binding data for the interaction of 196, 206, and 207 with ctDNA and pF143-GFP plasmid at pH 7.0 
in sodium cacodylate buffer (0.01 M) at 25° C. 
Ligand 
 
log Ka ΔHa TΔSa,b na IC50c 
DNA GFP DNA GFP DNA GFP DNA GFP DNA GFP 
196 6.23 6.30 -12.0 -9.6 -3.5 -3.2 0.43 0.24 4.36 1.85 
206 6.69 6.96 -15.7 -17.5 -6.6 -8.0 0.23 0.21 3.17 2.08 
207 7.44 7.42 -23.8 -22.7 -13.7 -12.7 0.15 0.09 0.79 0.51 
a) Determined via ITC titration of 196, 206 (each 0.6 mM) and 207 (0.3 mM) to DNA solutions (0.09 mM for 
196; 0.1 mM for 206 and 207); b) Calculated for 25° C; c) IC50 equals the amount of 196, 206, or 207, which is 
necessary to displace half of the ethidium bromide from a DNA/EB complex in a fluorescence displacement 
assay, [DNA] = 3.00 µM, [EB] = 0.75 µM. 
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The results for pF143-GFP are similar to those obtained for ctDNA. The binding constant 
for the trivalent carrier 207 (3 × 107 M-1) is higher than for divalent 206 (9 × 106 M-1) and 
respectively 196 (2 × 106 M-1). A possible explanation for these differences is the different 
charge of the ligands. To an extent, the differences in affinity surely affect the transfection 
efficiency (207 > 206 > 196). However, the binding constants alone are not a satisfying 
explanation for the dramatic differences in transfection efficiency between di- and trivalent 
gene carriers (207 >> 206 > 196), especially between three-armed 207 and two-armed 196 
which share the same side chain amino acid sequence. A potential source for this difference is 
dissimilar structural changes of the nucleic acid upon complexation with the ligands. In order 
to elucidate these changes atomic force microscopy (AFM)247 and dynamic light scattering 
(DLS)248 measurements were carried out with 196 and 207 next. Because the binding 
properties of the ligands towards pF143-GFP plasmid and ctDNA are similar, the latter one 
was utilized as model system. 
In order to verify these data and to get additional information of the formed complexes, DLS 
measurements of mixtures of 196 and 207 with ctDNA were conducted. This technique makes 
use of the different Rayleigh light scattering properties of differently sized particles irradiated 
with monochromatic, coherent laser light (e.g. at 633 nm).249 Due to the Brownian motion, 
and resulting interference of the scattered light the signal intensity of the scattered light is not 
constant. The Brownian motion depends on the size of the particles. As a measure for the 
mobility the translational diffusion coefficient D is characteristic for a given particle. It 
depends on the hydrodynamic radius RH of the particle, i.e. the shell of solvent molecules 
moving with the same rate as the molecule itself, and can be calculated with the help of the 
Stokes-Einstein equation (5) assuming spherical particles. 
 ܴு ൌ  
௞்
ଷగఎ஽
 (5) 
k = Boltzmann´s constant 
T  = temperature 
η  = viscosity 
The diffusion is faster for molecules with small hydrodynamic radius and as a consequence 
the fluctuation of the scattered light happens with higher frequency for small molecules. The 
correlation between the signal at a certain time point t with the signals within short intervals 
of time Δt gives a decaying, sigmoidal curve which is a characteristic for the size of a particle 
(rapid decay for small molecules and vice versa). Fitting of the so obtained curve with a single 
exponential decay function gives the mean size of the sample (Z-average diameter) and an 
estimation of the width of the size distribution, the polydispersity index (PDI). The higher the 
PDI (0 < PDI < 1), the less monodisperse is the sample. By fitting the correlation curve with 
multiple exponential decay functions the distribution of particle size for polydisperse samples 
is accessible. Three possibilities exist to calculate the so obtained size distribution: The size of 
the particle can either be plotted against the number or the volume of the differently sized 
particles or against the intensity of the scattered light. The scattering intensity is proportional 
to the particle diameter to the power of six (D6) and thus a plot against intensity weights large 
particles most strongly. Plotting against the volume and respectively the number of particles 
weights smaller particles more and more strongly. Due to the weighting, the calculated 
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diameter will in general decrease in the following order: D(intensity) > D(volume) > 
D(number). For studying the influence of 196 and 207 on the size of DNA upon 
complexation, a solution of ctDNA (50 µM) was prepared in aqueous sodium cacodylate 
buffer (0.01 M) at neutral pH in a fluorescence microcuvette equipped with a stopper (1 mL) 
and a DLS measurement was conducted. Aliquots of a stock solution (1 mM) of 196 or 207 
were then titrated into the DNA solution and after 1 min incubation time the scattering 
experiment was repeated. Figure 127 illustrates the volume- and number-weighted size 
distribution of ligand/ctDNA mixtures at different ratios r. The results are summarized in 
Table 17. All measurements were carried out at least in duplicate. The size was calculated for 
spherical particles and is therefore an approximation. The viscosity of the buffered aqueous 
solution was assumed to be equal to pure water. 
 
 
Figure 127. Top: Volume- (left) and number-weighted (right) size distribution of complexes between ctDNA and 
196 obtained from DLS measurements at pH 7.0 in 0.01 M sodium cacodylate buffer; [ctDNA] = 50 µM; r = 
[compound] / [ctDNA]. Bottom: Analogue results of the measurements conducted with 207. 
Pure ctDNA forms particles with an average diameter (volume-weighted) of 40 nm. The 
addition of 0.1 eq of 207 leads to the formation of larger aggregates of 450 nm diameter 
besides the original ones. At a ratio of 0.3 the larger aggregates are predominant. Finally, at r 
= 0.4 even larger aggregates with diameters above 1 µm are formed. Addition of more ligand 
leads to precipitation under the conditions used for these experiments. The addition of 196 
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leads to a similar concentration dependent aggregation, however higher ratios (r = 1.0) are 
needed to result in the large aggregates (> 1 µm). 
Table 17. Results of AFM and DLS measurements for the complex formation between 196 and 207 with ctDNA. 
Ligand ra AFMb [nm] 
DLS Size 
Distribution by 
Volumec [nm] 
DLS Size 
Distribution by 
Numbersc [nm] 
DLS Z-average 
[nm] / PDI 
196 
0 
Hd = 0.5, 1.0, 1.5 
Wd = 31.0 ± 5.4 
Ld = 460 ± 175 
39.4 (98 %) 22.3 (100 %) 73.4 / 0.608 
0.1 - 31.5 (96 %) 20.00 (100 %) 77.0 / 0.479 
0.5 H = 0.5, 1.0, 1.5 Dd = 150 ± 30 
26.8 (76 %) / 
128.7 (24 %) 
24.2 (100 %) 113.5 / 0.247 
1.0 H = 1.1 ± 0.3 1,529 (98 %) 1,414 (100 %) 2,222 / 0.392 
1.5 - -e -e -e 
3.1 H = 16.2 ± 4.9 D = 90 ± 30 - - - 
207 
0.1 - 50.26 (41 %) / 451.2 (59 %) 
45.9 (99 %) / 
307.4 (1 %) 278.0 / 0.333 
0.3 H = 1.5 ± 0.4 D = 500 ± 100 397.6 (91 %) 211.1 (100 %) 284.0 / 0.303 
0.4 
H1 = 14.3 ± 4.2 
W1 = 700 ± 350; 
H2 = 1.3 ± 0.2 
D2 = 4,000-9,000 
322.2 (2 %) / 
1,465 (98 %) 
269.1 (56 %) / 
1,174 (44 %) 1,243 / 0.293 
0.5 H = 17.5 ± 5.2 D = 350 ± 100 -
e -e -e 
1.5 H = 17.0 ± 6.0 D = 150 ± 25 - - - 
a) r = [compound] / [ctDNA]; b) Distances were measured at half height; c) Hydrodynamic diameter (2 × RH) 
and percentage of total volume/numbers; d) H = height, W = width, L = length, D = diameter; e) Precipitation. 
The results obtained by DLS were verified with the help of atomic force microscopy. AFM 
can be used to study the structure of materials deposited on a surface with resolutions up to 
1000 times above the optical diffraction limit. The surface is scanned with a cantilever 
featuring a sharp tip with a radius of curvature on the order of nanometers, which is oscillated 
near its fundamental resonance frequency with an amplitude of 100-200 nm in tapping 
mode.250 When tapping onto the surface the oscillation is decreased due to repulsion 
according to Hooke´s law. This deflection is measured by laser spot reflection from the top 
surface of the cantilever into the detector (e.g. an array of photodiodes). A feedback 
mechanism constantly adjusts the distance between tip and surface. For studying the structural 
changes upon complexation with 196 and 207, untreated ctDNA (16 µM) was dissolved in 
water containing 263 µM magnesium chloride with different ratios of the gene carriers. The 
MgCl2 facilitates the deposition of the negatively charged DNA onto the negatively charged 
mica surface. Furthermore, this way it can be assured that any observed structural change can 
be attributed to the addition of the ligands and not to changes of the surface potential. The so 
obtained solutions were spin coated onto freshly cleaved mica surface and analyzed in tapping 
mode. The resulting images are depicted in Figure 128 and the results are listed in Table 17. 
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Figure 128. AFM images were recorded in tapping mode. Mixtures of 207 (a-d) and 196 (e-h), ctDNA (16 µM) 
and MgCl2 (263 µM) were spin coated onto freshly cleaved mica surface. a) Pure ctDNA; b) [207] = 5 µM 
(0.3 eq); c) [207] = 6.5 µM (0.4 eq); d) [207] = 25 µM (1.5 eq); e) pure ctDNA; f) [196] = 8 µM (0.5 eq); g) 
[196] = 16 µM (1.0 eq); h) [196] = 50 µM (3.1 eq). Scale bar equates to 1 µm in each picture. 
Pure ctDNA (a, e) forms strand-like, elongated structures with some crosslinking. Heights 
range from 0.5 over 1.0 to 1.5 nm and the average width is 31.0 ± 5.4 nm, indicating a 
mixture of DNA double-strands and aggregates thereof (double-strand height: 0.55 ± 0.15 nm, 
width: 12 ± 3 nm).251 Addition of 0.3 equivalents of 207 led to the formation of circular 
aggregates of similar height (1.5 ± 0.4 nm) but with a diameter of 500 ± 100 nm (b). An 
increase of the ratio to 0.4 led to the formation of even larger aggregates now also with a 
significantly increased height of 14.3 ± 4.2 nm and a width of 700 ± 350 nm (c). Beneath 
these high aggregates a very large layer of up to 9 µm width and a height of 1.5 nm was 
formed. Thus, the large aggregate is probably an assembly of the former circular aggregates. 
When further increasing the ratio to r = 1.5, the aggregates become much more compact (d). 
Very tight, circular aggregates with a diameter of ca. 150 ± 25 nm are formed (height = 17.0 ± 
6.0 nm). For 196 a similar concentration dependent condensation can be observed, although at 
higher ratios. At r = 0.5 the elongated strands are attracted to each other, forming loose 
aggregates of 0.5 to 1.5 nm height and an average diameter of 150 ± 30 nm. The addition of 
another 0.5 eq leads to the formation of large structures of several micrometer lengths and 
varying width. Finally, at a ratio of r = 3.1 compact and tight aggregates of 16.2 ± 4.9 nm and 
a diameter of 90 ± 30 nm are formed. The addition of higher amounts of both 196 and 207 led 
to precipitation under the conditions used for AFM measurements. All results obtained from 
the surface-based atomic force microscopy experiments are in excellent agreement with the 
solution phase DLS measurements. From this finding and from the ligand/DNA ratio of r = 8, 
which has been utilized for the transfection experiments it can be concluded that most likely 
even more compact and denser multimolecular complexes are present under transfection 
conditions resembling the polyplexes which form for example upon complex formation 
between nucleic acids and the cationic polymer PEI. In analogy to polyplexes and with regard 
to the large excess of positively charged gene carriers the net charge of these aggregates 
should now be positive. Hence, the compacted DNA is attracted to the negatively charged 
0.5 eq 196 
0.3 eq 207 a) b) c) d) 
e) f) g) h) 1.0 eq 196 
0.4 eq 207 
3.1 eq 196 
1.5 eq 207 ctDNA 
ctDNA 
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surface of the cell instead of being repulsed as would be the case for pure DNA. Cellular 
uptake of particles of this size most likely takes place via an endocytotic pathway.136 
 
Figure 129. Confocal microscopy images from live cell co-localization experiments for DNA uptake in the 
absence (control) or presence of 196, 207, or PEI as non-viral vector. a-d) Membrane and endosomal structures 
stained with a RFP; e-h) DNA labeled with a green fluorescence dye; i-l) overlay of pictures above. 
In order to study in more detail the uptake mechanism into the cell co-localization studies 
with HeLa cells were carried out by Gutschmidt with the help of confocal fluorescence 
microscopy. First, membranes and endosomes were specifically marked by transfecting the 
cells with Lamp1-RFP plasmid DNA encoding for the lysosome associated membrane protein 
1 (Lamp1) tagged with a red fluorescence protein (RFP). 24 h later, the same cells were 
transfected with fluorescence marked, fragmented DNA (2 µg) with 196, 207, or PEI 
(0.24 mM) and without carrier as control experiment. The DNA was obtained by treating 
pF143-GFP plasmid with a labeling kit as described by the manufacturer (PromoKine) and 
consequent purification. After another 4 h the live cells were monitored with the help of 
confocal microscopy as depicted in Figure 129 (from left to right: control, 196, 207, and PEI). 
Endosomes and cell membranes fluoresce in red (a-d) and the DNA in green (e-h). By 
overlaying the images random pattering can be observed for the control experiment, because 
no DNA is taken up into the cell (i). In the presence of gene carriers the labeled DNA is 
clearly localized inside the cell. All three ligands are able to shuttle ds-DNA into the cell. For 
PEI (l) co-localization mainly takes place in membranes. For 196 (j) and 207 (k) the labeled 
polynucleotide is co-localized within endosomes to a degree, the DNA is however mainly 
localized within continuous, membranous structures within the cytosol, which resemble the 
endoplasmic reticulum-transgolgi network. This structuring is especially pronounced for the 
two armed 196, less for trivalent 207 and not at all for PEI. In conclusion, although all three 
carriers are able to transport the DNA into the cell only 207 and PEI enable transfection, but 
196 207 
a) 
PEI control 
b) c) d) 
e) f) g) h) 
i) j) k) l) 
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not 196. Thus, the difference between 196 and 207 does not arise from their DNA-shuttling 
ability but from differences in liberating the DNA once inside of the cell. 
To investigate in more detail the differences in endosomal release between 196 and 207, 
Gutschmidt carried out co-transfection experiments with chloroquine (219, 25 µM), a 
substance which is well known to facilitate endosomal escape.252 After endocytosis the pH 
inside the endosomal vesicles is constantly reduced from pH 7.2 to 4-5 by accumulation of 
protons by the specific ATPase, which ultimately leads to degradation of the enclosed 
material in the lysosomes.142 Weakly basic substances like chloroquine are protonated in the 
process thus acting as a buffer inside the endosome, counterbalancing the lowering of pH (cf. 
proton sponge effect in chapter 2.4.4). Consequently more protons, accompanying counter-
ions and water are pumped into the vesicle further increasing the osmotic pressure. Ultimately 
the vesicle ruptures and its cargo is released into the cytosol before degradation may occur. 
 
Figure 130. Transfection efficiency of 196, 207, and PEI with and without addition of chloroquine (219). 
As illustrated in Figure 130 transfection efficiencies for 196 and 207 were increased upon 
co-transfection with chloroquine. This is another strong indication for endosomal uptake. PEI 
on the other hand does not profit from chloroquine, because it is an efficient proton sponge on 
its own.144 Most important, the effect of 219 on the two-armed carrier 196 is huge (from < 1 
to 50 %) but only modest for tripodal 207 (from 22 to 42 %). This result suggests an almost 
complete lack of buffering capacity for 196. In contrast, 207 seems to be a capable proton 
sponge. The explanation for this difference most likely originates from the number of weakly 
basic sites in the ligands. The pKA value for the GCP moiety is higher in 196 than in 207 (7.00 
vs. 6.50). As a consequence these groups are only partially protonated at physiological pH. At 
the pH of the transfection experiments (7.2) 196 carries 3 and 207 between 3 and 4 positive 
charges. Inside the endosome full protonation of both gene carriers takes place resulting in 4 
positive charges for 196 and 6 for 207. Hence the three-armed ligand has more than double 
the buffer capacity than its divalent analogue (charge difference: +1.2 vs. +2.5) and is 
therefore able to act as proton sponge and thus allows for an early endosomal escape and 
efficient transfection, while 196 is not.  
Figure 131 summarizes the uptake mechanism mediated by the tripodal gene carrier 207. 
First, the ligand binds to the plasmid DNA with high binding constant (K = 3 × 107 M-1) and 
thereby the DNA is condensed into very tight, positively aggregates which are attracted to the 
negatively charged cell surface and of ideal size for endosomal uptake into the cell. Once 
inside, the GCP units of 207 are protonated and due to the proton sponge effect the cargo is 
219 
207 196 PEI 
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released into the cytosol, transported to the nucleus, integrated into the cell own machinery 
for protein biosynthesis, which ultimately leads to expression of GFP. It could be shown that 
207 is a very efficient, new type of small molecule non-viral vector. It combines the 
advantages of cell penetrating peptides (CPPs)160 like low cytotoxicity and ease of 
accessibility by means of SPPS, but does not suffer from their inconveniences, like 
difficulties with endosomal escape, because it is able to act as proton sponge similar to the 
polymer PEI.138 In comparison to CPPs which normally comprise 10 to 30 amino acids it is 
very small and merely features three to four charges at physiological pH. In contrast to that 
CPPs like oligoarginine need at least six charges for efficient cellular uptake.162 Therefore, 
this first generation of novel chemical vectors offers great potential for the delivery of nucleic 
acids. 
 
Figure 131. The 207-mediated uptake mechanism of plasmid DNA into the cell starts by condensing the DNA 
into tightly packed multimolecular aggregates, attraction to the cell surface via charge-charge interaction, 
uptake via endocytosis and subsequent endosomal escape with the help of the proton sponge effect. Ultimately, 
the plasmid encoded GFP is expressed by the cell after integration into the genome located in the nucleus. 
In conclusion, the two- (196, 206) and three-armed (207) were successfully synthesized by 
means of microwave-assisted SPPS and convergent synthesis in solution. It could be shown 
that these substances are very efficient in binding to nucleic acids. The divalent ligands bind 
with binding constants higher than 106 M-1, and the tripodal analogue binds even stronger by 
one order of magnitude (> 107 M-1). Although there is no pronounced selectivity for a specific 
type of polynucleotide, these molecules form well-defined complexes. For B-type nucleic 
acids minor groove binding and for A-type polynucleotides major groove binding was 
observed. Furthermore, it could be shown that the ligands are able to condense linear and 
circular DNA in a concentration dependent manner to very densely packed aggregates and to 
shuttle these through the membrane of human cells via an endocytotic pathway. Only the 
trivalent carrier is then able to enable escape from the endosome with the help of the proton 
sponge effect leading to efficient transfection even surpassing the commercially available 
gold standard for transfection, PEI, in both the efficiency as well as the compatibility with 
biological systems due to a lower cytotoxicity. Because the arms of the di- and trivalent gene 
carriers are of peptidic nature further improving the properties of these ligands with regard to 
their affinity and ability to transfect cells should easily be possible with the help of 
combinatorial chemistry. In the next chapter such a combinatorial approach will be presented.
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
4.5 COMBINATORIAL DNA-LIGAND LIBRARY 
Peptide-based combinatorial chemistry has until now only rarely been used for the 
development of small molecule DNA binders, which are not derived from proteins. Often, 
known natural products127 or synthetic intercalators126 and groove binders124 were modified, 
but these examples were only moderately successful in finding more advanced ligand systems 
which bind with higher affinity than their parent compounds (cf. combinatorial approaches in 
chapter 2.3.5). For all these systems the reported binding constants range from 106 to 107 M-1. 
These libraries were mainly of large and random nature and only a fraction of their encoded 
information was thus accessible: Only hit structures were characterized during the screening – 
the majority of library members was ignored, which led to the loss of information. This is 
why in the framework of this dissertation a rather small, but focused library based on divalent 
ligands like 196 and 206 was prepared instead, which allowed for the characterization of all 
possible compound-DNA interactions. The parent systems are already able to bind to nucleic 
acids with binding constants > 106 M-1 although their amino acid sequence was chosen for the 
targeting of nucleotides and not for polynucleotide binding (see chapter 4.3). Therefore, it was 
assumed that there is great potential for further optimizing the DNA-binding properties of 
these molecules by varying their amino acid sequence. Figure 132 depicts the design of the 
combinatorial library 220. There are three combinatorial positions within the two symmetric 
arms. For the combinatorial variation aromatic (Phe, Tyr, Trp) and basic (Lys, Arg) amino 
acids were utilized, just like in the original ligands 196 and 206. As a control an acidic amino 
acid (Glu) was also implemented. All library members feature a GCP unit as headgroup of 
each arm. Furthermore, sublibraries with only two, one or respectively no combinatorial 
position were synthesized. This way the influence of the length of the side arms on DNA 
binding could be studied. Furthermore, due to the choice of combinatorial amino acid 
building blocks the sublibrary with two amino acid positions also contained the already 
characterized ligands 196 and 206, which could thus be directly compared. In total the library 
comprised 259 potential nucleic acid ligands (63 + 62 + 6 + 1) of varying length and amino 
acid composition. 
     
Figure 132. The library 220 consists of 259 symmetric, divalent DNA ligands with GCP headgroups in each side 
arm, which contain three, two, one, or no combinatorial positions (Phe, Tyr, Trp, Lys, Arg, and Glu). 
Since the screening of the library was supposed to be carried out on-bead, a test ligand (221, 
Figure 133) with the same sequence as 196 (Phe-Lys-GCP) was synthesized first to establish 
220 
AA   =   Phe, Tyr, Trp,  
 Lys, Arg, Glu  
216  = 6 × 6 × 6 (n = 3) 
36  = 6 × 6  (n = 2) 
6    (n = 1) 
1                                (n = 0)  
259 ligands TentaGel 
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the screening method. In contrary to the polystyrene (PS)-based solid supports already 
described within this work like MBHA, Rink or Wang resin, which were used for the 
synthesis of compounds which were cleaved from the resin, the preparation of the test ligand 
was carried out on TentaGel.253 This resin also consists of a PS core but is modified with 
polyethylene glycol (PEG) chains, which in total comprise 70 % of each bead. The advantage 
of this resin is that it has on the one hand good swelling properties in organic solvents like 
DCM and DMF, where it swells to 3 and respectively 3.2 times its original size. This swelling 
is necessary to ensure accessibility of the reactive sites. On the other hand it also features 
excellent swelling properties in aqueous medium (swelling factor: 2.5), in contrast to PS 
resins, and is thus compatible with binding studies of biological macromolecules in aqueous 
solution. The synthesis was carried out according to standard Fmoc SPPS as described for 196 
in chapter 4.3.2.178 The only difference was that the coupling and deprotection steps were not 
carried out under microwave irradiation but at room temperature. Therefore longer reaction 
times (8-12 h for coupling and 2 × 20 min for deprotection steps) were applied. All coupling 
steps were repeated at least twice to ensure complete conversion, or more often if indicated by 
the Kaiser test.181 The Boc protecting groups were cleaved by treating the beads with 50 % 
TFA in DCM containing TIS and water (each 2.5 %) as nucleophilic scavengers.182 The 
TentaGel linker is not cleavable and therefore 221 remains on the resin under deprotection 
conditions. After thoroughly washing and drying of the beads, the test ligand was then used 
for the optimization of the on-bead binding assay. 
 
Figure 133. Resin-bound analogue (221) of the symmetric divalent DNA ligand 196 . 
Boger reported the screening of a solution-based nucleic acid binder library with the help of 
an ethidium bromide displacement assay.127 As described in chapter 4.4.3, the incubation of 
EB with a nucleic acid increases its inherent fluorescence by a factor of 10-100. Addition of a 
competing ligand partially displaces the intercalator thus reducing the overall fluorescence. 
By incubating the EB/DNA complex with resin-bound ligands, it should be possible to 
compare the individual library members for their ability to displace EB from the DNA. In 
order to optimize the conditions for such experiments and to ensure that there is no unspecific 
interaction between resin and nucleic acid various tests were conducted. Ethidium bromide 
(0.75 µM, 1 eq) was incubated in sodium cacodylate buffered water (0.01 M) at neutral pH 
with ctDNA (3 µM, 4 eq) in a 96-well plate (300 µL) and after 5 min incubation time the 
221 
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fluorescence emission upon irradiation at 520 nm between 560 and 650 nm was recorded. 
Different amounts of resin bound ligand and acetylated TentaGel resin (25, 50, 100 eq based 
on the resin loading of 0.25 mmol/g) were then added with the help of an isopycnic 
solution.254 To obtain such a solution of equal density of the swollen resin and solvent, 5 mg 
beads were dissolved in 400 µL of a 4:1 mixture of 1,2-dichloroethane (DCE) and 
isopropanol (iProp). The advantage of an isopycnic solution is, that small amounts of resin do 
not need to be weighed in, but can be titrated thus minimizing the error. Since the so obtained 
solution was not perfectly isopycnic the suspension was vortexed prior to each addition. The 
solutions were incubated by gently shaking the well plates on a shaker and the fluorescence 
emission was measured again after 44 h. Each experiment was carried out in duplicate. The 
biggest changes in fluorescence intensity were observed for the wells containing 100 
equivalents of resin bound ligand. After 44 h the fluorescence intensity was at 76 % of the 
original one. The acetylated TentaGel on the other hand did hardly influence the EB/DNA 
complex at all tested concentrations. At 100 eq for instance the fluorescence intensity after 
44 h was at 94 %. This was regarded as proof-of-principle for the feasibility of an EB 
displacement-based on-bead screening without the need for labeling of nucleic acid or ligand. 
Similar tests with p(dAdT)2 and the minor groove binder DAPI revealed ideal screening 
conditions for [DAPI] = 0.6 µM (1 eq), [p(dAdT)2] = 3 µM (5 eq) and 100 eq of solid-bound 
ligand. In comparison to the solution-based EB-based binding assays a large excess of DNA 
ligand and long incubation times are necessary for displacing the intercalator from its binding 
sites. This is an effect which can commonly be observed for on-bead screenings and which 
can be attributed to the hyperentropic efficacy: Resin-bound substances have to be regarded as 
highly dilute even at concentrations similar to analogue solution phase conditions.255 
Therefore, higher amounts of resin-bound ligands and longer reaction times are necessary for 
the formation of non-covalent ligand/DNA complexes. Furthermore, ctDNA (> 13,000 kDa) 
and p(dAdT)2 (> 5,000 kDa) are very large macromolecule and it is not very likely that they 
are able to fully penetrate into the resin. Therefore, not all resin-bound ligands are able to 
interact with the nucleic acid. Still, with both the synthesis and a screening method at hand, 
the preparation of the ligand library could now be accomplished. 
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4.5.1 Synthesis of the Library 
The synthesis of the library was carried out on TentaGel S NH2 (loading: 0.32 mmol/g) by 
means of split & mix synthesis.256 During the split-step the beads are divided into parts of 
equal amount according to the number of combinatorial building blocks at a given position of 
the growing peptide chain. In Figure 134 (left) the three building blocks are visualized by 
colored circles. After the reaction, the solid-supports are then combined again (mix-step) and 
divided again during the next split step. When this procedure is repeated for example three 
times with three building blocks in each step, the resulting number of library members is 27 
already. Thus, by synthesizing the building blocks in parallel, the split & mix method allows 
rapid generation of libraries.  
Figure 134. Split & mix synthesis allows rapid preparation of combinatorial libraries (left). The IRORI radio-
frequency technology (top: microchip and MicroKan, bottom: scanning station) helps to plan the synthesis and 
the identify each member of one-bead-one-compound libraries (right) 
Additionally, the synthesis of library 220 was carried out with the help of the IRORITM 
radiofrequency technology.257 Therefore an isopycnic solution of TentaGel (35 mg per 
400 µL hexane/DCM = 1/8) was prepared and approximately 30 mg of the solid-support was 
transferred into MikroKans. These sealable polyethylene compartments contain the resin but 
are penetrable for the solvent and dissolved reactants through their synthetic membranes. To 
each Kan a radiofrequency microchip was added before sealing. Each compartment will 
contain exactly one library member, which can be characterized at each point of the synthesis 
and after preparation of the library with the help of its unique radiofrequency signal (a binary 
eleven-digit code), a scanning station and the corresponding IRORI Accu Tag Synthesis 
software, which also allows planning of the split & mix steps. After having filled the 
MikroKans and having identified each microchip signature at the scanning station, the library 
was prepared according to the scheme in Figure 135. 
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
 
Figure 135. The library 220 was prepared according to standard Fmoc SPPS in three split & mix synthetic steps 
with the six building blocks 227-232 to give a total of 63 +62 + 6 +1 = 259 library members. 
The synthesis was carried out according to standard Fmoc synthesis with PyBOP (3 eq) as 
coupling agent in 3 % NMM/DMF under argon atmosphere.178 In comparison to simple SPPS 
of singular compounds all reaction times were prolongated. The coupling of Fmoc-Gly-OH 
(3 eq) was repeated three times (20 h) to ensure complete conversion of the TentaGel amine 
groups. Fmoc deprotection was achieved by treating the solid-support with 20 % piperidine 
(2 × 1 h). After each coupling and deprotection step the resin was thoroughly washed and two 
MikroKans per compartment were opened and tested for complete conversion by means of a 
Kaiser test.181 All coupling steps were carried out twice and repeated if necessary. The 
aromatic template 193 was reacted accordingly and afterwards the three split & mix steps 
were carried out by dividing the resin into six compartments according to the instructions of 
the IRORI software, which were then individually reacted with 6 eq of PyBOP and Fmoc-
Phe-OH (227), Fmoc-Tyr(tBu)-OH (228), Fmoc-Trp(Boc)-OH (229), Fmoc-Lys(Boc)-OH 
(230), Fmoc-Arg(Pbf)-OH (231), or Fmoc-Glu(OtBu)-OH (232). Especially tryptophan and 
arginine are known to be problematic during SPPS. Arginine is prone to addition of 
electrophiles to its nucleophilic guanidinium group, e.g. acylation during coupling steps 
which subsequently leads to ornithine formation through intramolecular decomposition during 
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deprotection.258 Because simple Boc protecting groups are not sufficiently blocking this 
unwanted side reaction,259 arene sulfonyl-based protecting groups like 2,2,4,6,7-pentamethyl-
dihydrobenzofuran-5-sulfonyl (Pbf) have to be used instead.260 In order to prevent the transfer 
of these groups to Trp during TFA mediated deprotection and to prevent oxidation of the 
labile indole ring,261 the Trp nitrogen must also be protected with a Boc group and 
nucleophilic scavengers have to be used during the acidic deprotection step.262 For the 
preparation of the sublibraries with only two, one or no combinatorial positions, the 
corresponding MicroKans were sorted out according to the IRORI software before the first 
(n = 0), after the first (n = 1) or after the second (n = 2) split & mix step. After completion of 
all split & mix steps, the Kans were reunited and reacted with Boc protected GCP (158). This 
last coupling step was repeated three times. Due to the rather poor solubility of Boc-GCP-OH 
it was heated in 3 % NMM/DMF for 20 min together with PyBOP prior to addition to the 
MikroKans before the last repetition of the coupling thus ensuring the formation of the active 
ester which could be witnessed by the formation of a red solution. The resin was thoroughly 
washed (DCM, MeOH) and dried in high vacuum. The protecting groups were removed by 
treating the resin with 95 % TFA containing 2.5 % TIS and 2.5 % water as nucleophilic 
scavengers (2 × 2 h).182 The resin was washed with organic solvents (DCM, MeOH) to 
remove excess TFA, and then with 0.1 N hydrochloric acid and water to exchange all 
trifluoroacetate counterions for chlorides and again with MeOH and DCM before drying in 
high vacuum for 24 h. The library (220) was now ready for screening with nucleic acids. 
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4.5.2 On-Bead Screening with p(dAdT)2  
The library was then first screened against the nucleic acid p(dAdT)2, which forms a very 
well-defined and narrow minor groove by means of a DAPI displacement assay. All 
measurements were carried out in cacodylate buffer (0.01 M) at neutral pH. First, the 
fluorescence emission of DAPI (0.6 µM, 1 eq) upon irradiation at 358 nm was recorded 
between 455 and 465 nm in 96-well plates (300 µL). Then the polynucleotide was added 
(3 µM, 5 eq) and after shaking the mixture for 30 min, the resulting increased fluorescence 
emission was measured. Finally, isopycnic solutions (DCE/iProp = 4/1, 5 mg resin per 
400 µL) of the individual library members were added (300 µM, 100 eq). The suspensions 
were vortexed prior to each addition. The screening was carried out with three wells per 
library member/DNA combination and three blank samples per plate containing only 
p(dAdT)2 and DAPI without resin for normalization of different plates. The well-plates were 
then incubated on a shaker and the resulting fluorescence emission was measured after 20, 40, 
60, and 80 h. Surprisingly, after 20 h of incubation with the resin, the fluorescence intensity 
was higher instead of lower. This effect can be attributed to insufficient mixing of the nucleic 
acid-DAPI mixture prior to addition of the resin. Obviously shaking the plates is not enough 
to guarantee for homogenous solutions. In future attempts, the solutions should additionally 
be mixed with the help of a pipette. Nevertheless, the blank samples allowed normalization of 
the highest fluorescence emission to 100 % and therefore accurate processing and analysis of 
the library. Figure 136 depicts the normalized, relative fluorescence emissions of all library 
members after correction for DAPI´s own emission. Low intensities signify efficient 
displacement of DAPI and therefore high binding affinities. 
 
Figure 136. Relative, normalized fluorescence emissions as obtained by a DAPI displacement assay from the 
B-DNA p(dAdT)2 with the members of library 221 after 80 h incubation in cacodylate buffer (0.01 M) at pH 7. 
As shown in Figure 136 there is a good distribution of the fluorescence intensities between 
26 and 100 % with a broad middle part and only few very good (left) and very bad (Figure 
136, right) performing library members. Since the two divalent ligands 196 and 206 are also 
part of the library already at this time a preliminary comparison to the results in solution could 
be drawn. 196 (Phe-Lys-GCP) is ranked #194 with 74 % remaining DAPI and 206 (Lys-Phe-
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GCP) ranks #72 with 63 %. This is in excellent agreement with the IC50 values obtained from 
the DAPI displacement in solution with IC50 = 52.2 for 196 and 15.9 for 206 (cf. chapter 
4.4.4). Furthermore, it immediately becomes clear that the two divalent ligands are only 
representatives of the broad middle part of the library although their binding constants are 
already in the range > 106 M-1. Hence, the top ranked members of the library 221 should 
feature even higher binding constants and thus excellent affinity for p(dAdT)2. Table 18 lists 
the Top10 compounds. A complete list can be found in appendix C.7. 
Table 18. Top10 ranked members of library 220 as obtained from a DAPI displacement assay with p(dAdT)2. 
The charges are estimates for pH 7: full protonation of Arg, Lys and 50 % protonation of the GCP group. 
# AA1 AA2 AA3 Charge % 
1 Trp Lys Arg +5 26 
2  Arg Lys +5 31 
3 Arg Arg Lys +7 32 
4 Trp Arg Lys +5 33 
5 Arg Lys Lys +7 34 
6 Arg Arg Arg +7 35 
7 Tyr Arg Arg +5 40 
8 Arg Arg Tyr +5 41 
9 Phe Tyr Lys +3 42 
10  Arg Arg +5 42 
 
The positions of the amino acids are numbered AA1-AA3 from C- to N-terminus with AA3 
always being the amino acid next to the GCP unit. Accordingly, the combinatorial positions 
of ligands which only feature two amino acids are numbered AA2 and AA3. The Top10 
overall best performing DNA binder features the sequence Trp-Lys-Arg-CBS. All sequences 
feature a high amount of positive charges (+3 to +7). The charges were thereby estimated for 
pH 7 by assuming full protonation of amine and guanine groups, complete deprotonation of 
carboxylic acids and 50 % protonation of the GCP group. However, although undoubtedly 
charge plays a decisive role for high affinity to the negatively charged nucleic acid, there 
seem to be additional effects concerning the binding properties of the library members. For 
instance, at position AA1 half of the compounds within the Top10 feature an aromatic amino 
acid, the other half arginine. Lysine on the other hand is not present at this position. In 
general, arginine is the most prominent amino acid in the Top10 with 15 occurrences out of a 
total of 28, followed by lysine (7) and aromatic amino acids (6). As expected, no glutamic 
acid is present, which would be negatively charged at this pH and therefore hampering the 
affinity due to charge-charge repulsion with the ribophosphate DNA backbone. Eight 
compounds feature three amino acids per arm, but there are also two ligands with just two 
amino acids. Both of them comprise two positively charged amino acids within each arm. 
Highly charged ligands with just two amino acids seem to be able to compete with their larger 
and higher charged analogues. 
To get a more general impression of the amino acid distribution, the library was split into 
four compartments according to the results of the screening: Top 25 %, Top 25-50 %, Top 50-
75 %, and Top 75-100 %. Then an analysis of the percentaged occurrence of amino acids 
within each compartment was carried out. The result is illustrated in Figure 137. As expected, 
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the best ligands (Top 25 %) are dominated by the basic amino acids lysine and arginine, 
which in total comprise over 50 % of all amino acids within this compartment. On the runner-
up positions follow the aromatic amino acids and on the last spot there is glutamic acid. In the 
middle part of the library (Top 25-75 %) there is no clear correlation. DNA-binders within 
this region are of mixed sequence. The worst performing ligands (Top 75-100 %), feature an 
amino acid distribution antipodal to the best ones. The negatively charged Glu is most 
present, followed by aromatic amino acids. The positively charged basic amino acids are least 
present within this compartment. These results underline the general trend of higher DNA-
affinity of higher charged compounds.  
 
Figure 137. Amino acid distribution in per cent within each of the four compartments of the library. 
A more detailed insight into the role of the amino acids can be obtained when analyzing the 
three individual combinatorial positions AA1-AA3 within the four compartments. The 
distribution of amino acids in per cent is depicted in Figure 138. At position AA1 
phenylalanine (26 %) and arginine (20 %) are preferred in the best performing quarter of the 
library. As already indicated by the Top10 compounds, the second positively charged building 
block, lysine, is underrepresented at this position with only 12 %, and is closely followed by 
the aromatic amino acids tyrosine (11 %) and tryptophan (9 %). Glutamic acid is present least 
(6 %) within the Top 25 % and does not seem to be tolerated at all in this position as can be 
seen in the huge amount of bad performing ligands (Top 75-100 %) with Glu in position AA1. 
At the second combinatorial position, the situation is different. Here, Arg and Lys (28 and 
35 %) are clearly favored. All other amino acids are not performing well. With respect to the 
other two positions, aromatic amino acids are tolerated worst at AA2. The distribution of 
amino acids in the last position AA3 is similar to AA2, although aromatic amino acids seem to 
be better suited here than at AA2. Hence, the positional analysis of the amino acid distribution 
has offered insight into some general trends. Arginine and lysine are overall preferred in the 
best performing ligands with the exception of sequences of the type Lys-AA2-AA3. 
Furthermore, sequences of the type AA1-aromatic-AA3 are not performing as good as 
comparable sequences with aromatic amino acids at other positions. At AA1 (aromatic-AA2-
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AA3) the implementation of aromatic amino acids even seems to be advantageous. This is in 
excellent agreement with the sequence of the first ranked compound, Trp-Lys-Arg-GCP. 
 
Figure 138. Percentaged amino acid distribution at the three combinatorial positions AA1-AA3 within each of 
the four compartments of the library. 
Next, a closer look at the charge distribution was taken. By assuming pKA values for 
arginine (12.5), lysine (10.5), glutamic acid (4.3), and the GCP unit (7.0),11 the charges of the 
library members at neutral pH can be estimated. All Glu side chains are deprotonated, all Lys 
and Arg side chains protonated as well as half of the GCP groups. Therefore, there is a charge 
distribution in steps of two charges between the two extremes +7 and -5.  
 
Figure 139. Absolute charge distribution within each of the four compartments of the library. 
Figure 139 shows the absolute number of the different charges within the four compartments 
of the library. The highest positively charged compounds (+7, +5) are clustered within the 
Top 25 %. Lower positive charged compounds can be found in the broad middle region of the 
library. The worst performing compounds are those with net charges around zero (1, -1). 
Surprisingly, the higher negatively charged ligands (-3, -5) are not clustered in the low 
performing region. There are even some of them in the Top 25 %. These are all compounds 
with one or more glutamic acids combined with aromatic building blocks. Probably these 
compounds do interact directly with the positively charged DAPI and liberate the minor 
groove binder from the nucleic acid by binding to it rather than displacing it by binding to the 
nucleic acid. The second unexpected result is the presence of some highly charged species 
(+7, +5) within the low performing region (Top 50-100 %). A closer look at these substances 
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revealed common sequences of the type Lys-AA2-AA3 and AA1-aromatic-AA3. This is in 
good agreement with the observations of the position-dependent amino acid distribution, 
which also showed that these type of sequences are less well suited for displacing DAPI from 
p(dAdT)2. Hence, besides the charge-driven interaction with the nucleic acid, the amino acid 
sequence does also seem to play a decisive role in binding to the B-DNA and displacing 
DAPI from the narrow minor groove. While the discrimination of Lys-AA2-AA3 sequences 
remains unclear, a possible explanation for the bad performance of AA1-aromatic-AA3 
sequences might be that the ligands bind to the minor groove of the nucleic acid via a 
predominantly positive charged amino acid at position AA3 and/or additional charge-charge 
or hydrophobic interactions of basic/aromatic amino acids at position AA1. An aromatic 
moiety at position AA2 would then also have to bind into the minor groove, which is difficult 
due to the bulkiness of the aromatic side chains in combination with the narrowness of the 
p(dAdT)2 minor groove.  
Finally, the influence of the length of the ligands on their binding properties towards the 
nucleic acid was analyzed. To compare ligands of increasing length, the percentage value 
obtained from the library screening for each ligand with n amino acids was corrected for the 
corresponding value of the ligand with the same amino acid at position AA3 (or AA2-AA3). 
For example, the value for the ligand of the sequence Arg-Arg was subtracted from the 
percentage obtained for the corresponding DNA-binder Lys-Arg-Arg to get information on 
the effect of the additional amino acid, Lys. Finally, an average value for the addition of each 
amino acid building block was calculated for each sublibrary, e.g. for the step from sublibrary 
n = 1 to sublibrary n = 2. 
The library member which features only two GCP units directly attached to the aromatic 
template without any amino acid building block (n = 0) is ranked #123 with 68 % remaining 
DAPI fluorescence. Addition of any one amino acid to the side chains (n = 1) leads to worse 
results (69-81 %). In contrast to that, addition of a second amino acid improves the 
performance of the ligands in all cases. Especially when adding Arg and Lys, on average 21 
and respectively 16 % more DAPI are replaced in comparison to their corresponding DNA-
binders with just one amino acid per arm. Addition of all other building blocks also led to 
modest improvement of the performance – on average 2 to 4 % more DAPI was displaced. It 
is noteworthy that even the addition of the negatively charged glutamic acid led to an 
improvement of nucleic acid binding. Obviously, two amino acids seem to be the minimum 
for efficient interaction with this kind of polynucleotide. A certain degree of flexibility seems 
to be important for the interaction. When further going from two to three amino acids (n = 3), 
the performance is further improved, although the overall effect is smaller. When adding Arg 
(6 %), Phe (5 %) or Trp (4 %) in position AA1, more DAPI is replaced in comparison to their 
two amino acid analogues. Addition of Lys (0 %) and Tyr (1 %) does neither improve nor 
deteriorate the affinity by large. When adding glutamic acid however, 6 % less DAPI is 
replaced. This findings are again in good agreement with the positional analysis of the amino 
acid distribution, which resulted in the observation, that Glu is tolerated worst at position AA1 
and Lys performs surprisingly bad at this position. 
In conclusion, the on-bead screening of the library for its binding affinity towards the B-type 
DNA p(dAdT)2, which forms a very well-defined, narrow minor groove, could successfully 
be carried out with the help of a DAPI displacement assay. Besides the expected charge-
4. RESULTS AND DISCUSSION   155 
 
driven capability to bind to the nucleic acid, also several sequence-dependent influences on 
the binding affinity could be observed. For instance, sequences of the type Lys-AA2-AA3 and 
AA1-aromatic-AA2 seem to be less well suited for binding. In the latter case this can be 
attributed to the sterically difficult binding of the bulky aromatic side chains into the minor 
groove of p(dAdT)2. An alternative explanation is the positive influence of a positively 
charged amino acid at position AA2, which was revealed by comparing the sublibraries of 
different lengths. Presumably, the sequence AA1-cationic-cationic is suited best to the task of 
binding to the nucleic acid. This would explain the difficulty of incorporating anything but a 
basic amino acid at position AA2 and AA3, the huge beneficial effect when going from n = 1 
to n = 2 building blocks and the lower influence of position AA1 on the binding efficiency as 
well as the compatibility of this position with aromatic amino acids. Furthermore, this also 
explains why DNA-binders with just two positive amino acids are able to compete with the 
best ligands (see Top10). In comparison to the already characterized ligands 196 and 206, 
which are only medium performers, the best sequences, like Trp-Lys-Arg-GCP (#1) should 
bind more strongly to p(dAdT)2 by at least one order of magnitude. In order to verify these 
results in solution, five library members were selected and synthesized.  
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4.5.3 Synthesis of Additional Divalent Ligands 
Based on the results of the screening of the library five ligands were identified for synthesis 
on larger scale and characterization by binding studies in solution as depicted in Figure 140. 
They were chosen from different regions of the library, starting with the best performing 
sequence, Trp-Lys-Arg-GCP (#1, 233), followed by Trp-Arg-Lys-GCP (#4, 234), the highly 
charged Lys-Lys-Arg-GCP (#27, 235), Lys-Trp-Arg (#94, 236) and as a negative control Glu-
Trp-Arg-GCP (#234, 237).  
 
Figure 140. Five selected members of the library (233-237) were synthesized for characterization in solution. 
The synthesis was carried out according to the optimized microwave-assisted procedure 
described in chapter 4.3.2. The first attempt to synthesize the novel DNA-ligands was 
therefore conducted on MBHA resin (1.94 mmol/g). The attachment and coupling steps were 
carried out with the help of PyBOP in 5 % DIPEA/DMF under argon atmosphere and 
irradiation to max. 60° C for 20 min at 20 W. Fmoc deprotection was achieved by treating the 
resin with 20 % piperidine/DMF. The same side-chain protection scheme as applied for the 
synthesis of the library was applied (see chapter 4.5.1). All coupling reactions were carried 
out twice or more often if indicated by the Kaiser test. Due to limitations of the available 
amount of Boc-GCP the coupling steps were conducted with 3 instead of 6 eq. Syntheses 
were carried out for the preparation of 233, 234, and 235. Cleavage from the resin and 
removal of the protecting groups was conducted at room temperature by treating the resin 
with 8 % TFMSA in 80 % TFA containing 8 % TIS and 4 % EDT as nucleophilic scavengers. 
HPLC analysis of the crude product revealed the presence of > 40 compounds. Separation via 
MPLC in fractions containing < 5 compounds and consequent analysis with the help of MS 
revealed that no product was obtained for 233 and 234 and only minor amounts for 235. 
Obviously, the cleavage conditions were too harsh for the more susceptible amino acids 
arginine and especially tryptophan. Therefore, the synthesis was repeated as described above, 
but on Fmoc-Rink-Amide resin (0.94 mmol/g) which allowed to cleave the resin-bound 
ligands under milder conditions with 95 % TFA containing 2.5 % TIS and 2.5 % water as 
nucleophilic scavengers. As summarized in Table 19 all compounds were obtained this way in 
233 234 235 
236 237 
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sufficient amounts with moderate yield and could be isolated after several rounds of 
purification via MPLC (RP18, H2O → MeOH, 0.1 % TFA) with high purity as determined 
with the help of analytical HPLC (see Figure C. 5-Figure C. 9). After anion exchange of the 
trifluoroacetate counterions for chlorides the compounds were ready for solution phase 
binding studies. 
Table 19. Yield and purity of the microwave-assisted SPPS of the five selected library members. 
 233 234 235 236 237 
Yield [%] 6 19 9 15 21 
Purity [%] 93 93 91 95 94 
Sequence Trp-Lys-Arg Trp-Arg-Lys Lys-Lys-Arg Lys-Trp-Arg Glu-Trp-Arg 
Library # 1 4 27 94 234 
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4.5.4 Binding Studies in Solution 
To verify the results obtained from the on-bead screening of the library and to rule out 
potential effects on the binding event caused by the solid support, binding studies were carried 
out in solution with the five novel divalent DNA-ligands 233-237. First, a DAPI displacement 
was conducted in cacodylate buffer (0.01 M) at neutral pH and 25° C as depicted in Figure 
141 and explained in chapter 4.4.4. To a mixture of p(dAdT)2 (2.5 µM, 5 eq) and DAPI 
(0.5 µM, 1 eq), which was prepared in a fluorescence microcuvette equipped with a stopper 
(900 µL), stock solutions of the DNA ligands (50 µM) were titrated in aliquots of increasing 
volume (e.g. 10 × 1, 2, 4 µL) and the resulting fluorescence spectrum upon irradiation at 
358 nm was recorded between 420 and 500 nm. Excerpts of the fluorescence emission at 
460 nm were corrected for dilution and after subtraction of DAPI´s own emission, they were 
plotted against [DAPI] / [Ligand] and fitted with a first order exponential decay function to 
obtain the amount of DNA-ligand, which is necessary to displace half of the DAPI from the 
nucleic acid as IC50 values. All measurements were carried out at least in duplicate and are 
depicted in appendix C.6 (Figure C. 66-Figure C. 70). The so obtained results as well as the 
ones for the divalent ligands 196 and 206 and for comparison the three-armed 207 are listed in 
Table 20. 
 
Figure 141. DAPI displacement experiment with p(dAdT)2 and 233 (left) and excerpt of the fluorescence 
emission at 455 nm plotted against the ratio of DAPI/233 with the corresponding fit (right). 
Table 20. IC50 values for divalent (196, 206, 233-237) and trivalent (207) DNA-binders as obtained by DAPI 
displacement assays in buffered aqueous solution (cacodylate buffer, 0.01 M) at neutral pH and the results of the 
screening on-bead. The binding constants obtained from ITC measurements are listed for comparison. 
 233 234 235 206 236 196 237 207a 
IC50b 
[eq] 
0.77  
± 0.2 
0.61 
± 0.1 
2.23 
± 0.3 
15.9  
± 3.7 
0.52 
± 0.1 
52.2 
± 16.9 
42.3 
± 2.0 
1.72 
± 0.3 
On-beadc 
[%] 
26 33 52 63 65 74 80 - 
Library # 1 4 27 72 94 194 234 - 
Solution # 3 2 4 5 1 7 6 - 
logK2d 9.76 9.09 8.77 6.79 9.04 5.80 6.18 7.51 
Sequence 
Trp-Lys-
Arg-GCP 
Trp-Arg-
Lys-GCP 
Lys-Lys-
Arg-GCP 
Lys-Phe-
GCP 
Lys-Trp-
Arg-GCP 
Phe-Lys-
GCP 
Glu-Trp-
Arg-GCP 
Phe-Lys-
GCP 
a) Trivalent ligand; b) Solution phase DAPI displacement; c) On-bead DAPI displacement; d) ITC.  
In general, there is an excellent agreement between the results in solution with those 
obtained from the on-bead screening thus proofing their validity. Low IC50 values correspond 
to low percentaged values of non-displaced DAPI on-bead. All deviations are within the 
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standard deviation of the obtained data with the exception of ligand 236, which has a very low 
IC50 value despite its mediocre performance during the on-bead screening (possibly due to 
corrupted beads). Together with 233 and 234 this DNA-binder had the highest affinity to 
p(dAdT)2 according to the solution phase DAPI displacement. These three ligands all feature 
the same amino acids, Trp, Arg, and Lys, but in different order. The combination of these 
three amino acids seems to be best fit for displacing DAPI from the minor groove of the 
DNA. The IC50 values of the tested ligands range from 0.52 for the best sequence 236 to 52.2 
equivalents for the original divalent ligand 196 thus spanning two orders of magnitude. 
Comparison with the IC50 value of the trivalent ligand 207 (1.72), which had the highest 
affinity of all synthesized nucleic acid binders until this point, clearly demonstrates the 
tremendous improvement of binding affinity as a result of optimization by means of the 
combinatorial library. Based on these values, binding constants of at least 108 M-1 were 
expected. After this qualitative validation of the results of the screening, ITC measurements 
were conducted in order to obtain quantitative binding data. Therefore, aliquots (20-30 × 
5 µL) of the ligands (0.1 mM) were titrated into solutions of p(dAdT)2 (0.04 mM, 1451 µL) in 
neutral cacodylate buffer (0.01 M) at 25° C. The raw data was corrected for the endothermic 
heat of dilution of the ligands and fitted according to two-site models for 233-236 and to a 
one-site model for 237. In contrast to all other ligands, the latter one also featured an 
exothermal heat of dilution. Other binding models did not give satisfying curve fitting. Two 
exemplary titrations are shown in Figure 142, all others can be found in appendix C.5 (Figure 
C. 63). The results are listed in Table 21 together with those obtained for 196, 206, and 207 
(cf. chapter 4.4.3). From top to bottom the divalent ligands are in order of decreasing affinity. 
 Table 21. Results of ITC measurements obtained by titrating the library-derived DNA binders 233-236 
(0.1 mM) to p(dAdT)2 (0.04 mM, 1451 µL) in cacodylate buffer (0.01 M) at neutral pH and 25° C. 
Ligand Sequence 
K 
[107 M-1] 
log K n ΔH 
[kcal/mol] 
TΔSa 
[kcal/mol] 
ΔG 
[kcal/mol] 
233 Trp-Lys-Arg 
0.4 
578 
6.59 
9.76 
0.09 
0.07 
3.2 
-18.5 
12.2 
-5.2 
-9.0 
-13.3 
234 Trp-Arg-Lys 
0.5 
123 
6.73 
9.09 
0.05 
0.09 
4.8 
-19.5 
14.0 
-7.1 
-9.2 
-12.4 
236 Lys-Trp-Arg 
0.1 
111 
5.99 
9.05 
0.06 
0.07 
9.3 
-21.9 
17.4 
-9.5 
-8.2 
-12.3 
235b Lys-Lys-Arg 0.1 
59 
6.08 
8.77 
0.07 
0.07 
7.8 
-13.4 
16.1 
-1.4 
-8.3 
-12.0 
206 Lys-Phe 0.6 6.79 0.27 -18.7 -9.4 -9.3 
237 Glu-Trp-Arg 0.2 6.18 0.55 -4.2 4.2 -8.4 
196 Phe-Lys 0.1 5.80 0.34 -16.4 -8.5 -7.9 
207d Phe-Lys 3.3 7.51 0.20 -21.0 -10.7 -10.3 
a) Calculated for 25° C; b) [235] = 0.06 mM, [p(dAdT)2] = 0.03 mM; c) [237] = 0.2 mM, [p(dAdT)2] = 
0.04 mM; d) Trivalent ligand. 
The results of the ITC experiments are in excellent agreement with the IC50 values of the 
DAPI displacement and with the on-bead screening results. As predicted in the screening, 233 
features the highest binding constant towards p(dAdT)2 with an excellent 5.8 × 109 M-1. With 
the help of the combinatorial optimization of the divalent ligands their affinity could be 
increased by a factor of 1000 (206: K = 6.2 × 106 M-1). In total, the binding constants of the 
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library members span four orders of magnitude (196: K = 6.3 × 105 M-1) clearly proofing the 
importance of the choice of appropriate amino acids for high affinity binding. The best 
receptors of the library are even more efficient in binding to the nucleic acid than their three 
armed analogue 207 (K = 3.3 × 107 M-1) by two orders of magnitude.  
  
Figure 142. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 233 (c = 0.1 mM), or 237 (c = 0.2 mM) to p(dAdT)2 (0.04 mM). Bottom: the 
titrations were corrected for dilution and fitted with a two-site model for 233 and a one-site model for 237. The 
titration with 233 is corrected for the first; and the one for 237 for the first two data points. 
The binding mode of the ligands with three amino acids per arm is different than for their 
shorter analogues 196 and 206 and the negative control 237. While the binding data could 
only be fitted with a two-site model for the first mentioned, the latter ones had to be fitted 
according to a one-site model. For 233-236 two processes seem to be happening 
simultaneously. The first one is similar for all ligands: It takes place with a binding constant 
in the region 0.1-0.5 × 107 M-1 and is endothermic and driven by entropy. Such an energetic 
pattern is typical for unspecific binding to the ribophosphate backbone, which is driven by the 
entropically favored liberation of counterions and water molecules into the solvent.229 The 
second binding event manifests with varying affinity and has the same energetic pattern 
(exothermal, unfavorable entropy) as the binding of 196 and 206 and was therefore attributed 
to groove binding. Probably the charge-mediated backbone binding can only be resolved by 
an ITC experiment if the interaction is strong. Therefore, only the highly charged compounds 
233-236, but not the lower charged 196 and 206 featured this second binding mode. For the 
latter two, the groove binding event is predominant and overlays the backbone binding, which 
is without doubt taking place to some extent with these systems, too. The negative control 237 
finally features yet another binding mode, which is driven by a combination of enthalpy and 
entropy.  
Furthermore, the preferences found in the positional and charge analysis of the library were 
validated, too. When comparing the two ligands with identical amino acids (Trp, Lys, Arg), 
but in different order 233 (Trp-Lys-Arg-GCP) and 236 (Lys-Trp-Arg-GCP) it becomes clear 
that the receptor of type AA1-charged-charged-GCP is favored over the one which combines 
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the two sequence criterions, which were identified as unfavorable for binding: Lys-AA2-AA3 
and AA1-aromatic-AA3. Although this effect is less pronounced than predicted by the on-bead 
screening, the two compounds still differ in their binding affinity by a factor of 5. The second 
important finding of the library screening was validated as well: The affinity to the nucleic 
acid correlates with the charge of the artificial ligands, but only to some extent. A DNA 
binder with the correct amino acid sequence can outperform an analogue ligand with higher 
charge, e.g. 233 binds stronger to p(dAdT)2 by one order of magnitude, although it features 
two charges less than 235 (Lys-Lys-Arg-GCP). Finally, the last trend of the library, the 
occurance of aromatic amino acids in high performing ligands at the first combinatorial 
position (aromatic-AA2-AA3) was also confirmed. The two best ligands in solution (233 and 
234) featured tryptophan in position AA1. 
In conclusion, with the help of standard Fmoc SPPS and a split & mix strategy, a small but 
focused library for the identification of efficient minor groove binders was synthesized. 
Qualitative information about the affinity towards p(dAdT)2 for all library member/nucleic 
acid combinations was collected by screening the library with a DAPI displacement assay. 
Except for one deviation, the qualitative results and general trends were verified in solution by 
DAPI displacement and ITC experiments revealing an improvement of the affinity by three 
orders of magnitude compared to the original divalent ligands. The highest binding constants 
were found for sequences containing the three amino acids Trp, Lys, and Arg. The overall 
highest binding constant was as high as an excellent 5.8 × 109 M-1. Clearly, with the help of 
this rather small library, it was not only possible to reveal sequence dependent binding 
properties, it was also possible to dramatically increase the potency of the divalent DNA 
binders for the recognition of B-type DNA. 
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4.5.5 Identification of DNA-Ligands for Transfection Experiments 
On-Bead Screening with pF143-GFP plasmid DNA 
After having successfully utilized the combinatorial library 220 for the identification of 
efficient minor groove binders, which bind to p(dAdT)2 with high affinity, the idea was to 
utilize the library to identify efficient binders of plasmid DNA and to test whether improved 
binding affinity does lead to enhanced ability to act as transfecting agent. Therefore an 
ethidium bromide displacement on-bead screening was conducted. Since the secondary 
structure of the generic plasmid DNA is not regular, and therefore does not necessarily feature 
a well-defined minor groove for the accommodation of DAPI, the intercalator EB was utilized 
for the displacement assay instead. First, a solution of EB (0.75 µM, 1 eq) was prepared in 96-
well plates (300 µL) in neutral cacodylate buffer (0.01 M) and its fluorescence emission upon 
irradiation at 520 nm was recorded between 595 and 605 nm. Then, pF143-GFP plasmid 
DNA (3 µM, 4 eq) was added, the solutions thoroughly mixed with the help of a pipette and 
after 30 min incubation time the increased fluorescence emission was determined. Then, 100 
equivalents of the individual library members were added as isopycnic suspensions 
(DCE/iProp = 4/1; 5 mg resin per 400 µL). Three wells per ligand/DNA combination were 
analyzed to obtain average values, and three blank samples per plate (without resin) were 
utilized for normalization of the different plates. The mixtures were incubated on a shaker and 
the resulting fluorescence emission was measured after 16, 40, 68 and 88 h. Figure 143 
depicts the relative fluorescence emissions of all library members after 88 h which is 
normalized to 100 % for the lowest performing ligand and corrected for EB´s own emission. 
Low intensities signify efficient displacement of the intercalator and therefore high binding 
affinities to the plasmid DNA. 
 
Figure 143. Relative, normalized fluorescence emissions as obtained by a EB displacement assay from pF143-
GFP plasmid DNA with the members of library 220 after 88 h incubation in cacodylate buffer (0.01 M) at pH 7. 
There is an excellent distribution of the fluorescence intensities between 9 and 100 % with a 
few low affinity ligands and a steadily improving, already well performing middle part, 
followed by a few very well performing DNA binders. The Top10 ranked library members are 
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listed in Table 22. All other results can be found in appendix C.7. The absolute occurrence of 
amino acids within the Top10 is similar to the one observed during the DAPI screening: 
arginine is present most (13), followed by lysine (6) and aromatic amino acids (total: 9). 
Glutamic acid is again not present in the best performing systems. In general, the ligands 
feature high positive charges (+5), but not the highest possible charge (+7). The charges were 
estimated for pH 7 as described in chapter 4.5.2. Similar to the results from other screening 
high charge seems to be advantageous for DNA binding, but not the only criterion. There is 
even an efficient ligand with just three positive charges and two amino acids in the Top10. 
Similar to the DAPI screening, there are two short ligands present, which seem to be able to 
compete with their longer versions. The distribution of the amino acids on the other hand is 
different. Although the two best ligands feature a tryptophan at position AA1, all others do not 
feature an aromatic amino acid at this position in contrary to the DAPI screening with 50 % 
aromatic amino acids at AA1. At AA2 on the other hand, there are now more aromatic amino 
acids present. All these are indications that other prerequisites are necessary to bind to the 
plasmid instead to the AT-heteropolymer. 
Table 22. Top10 ranked members of library 220 as obtained from an EB displacement assay with pF143-GFP 
plasmid DNA and comparison to their rank as obtained from the DAPI displacement screening with p(dAdT)2. 
The charges are estimates for pH 7: full protonation of Arg, Lys and 50 % protonation of GCPs. 
# plasmid # p(dAdT)2 AA1 AA2 AA3 Charge % 
1 4 Trp Arg Lys 5 9 
2 1 Trp Lys Arg 5 13 
3 131 Lys Phe Arg 5 15 
4 148 Lys Lys Phe 5 16 
5 196  Arg Tyr 3 18 
6 37 Arg Lys Tyr 5 18 
7 79 Arg Tyr Arg 5 19 
8 204 Arg Trp Arg 5 19 
9 31 Arg Phe Arg 5 19 
10 10  Arg Arg 5 19 
 
Comparison with the two divalent ligands 196 and 206, which have already been 
characterized for their binding affinity towards the plasmid (K = 2 and 9 × 106 M-1) reveals 
that these are merely ranked in the middle part of the library (206: #136 with 38 %; 196: #148 
with 39 %). Therefore, the compounds with the highest efficiency in displacing EB from the 
plasmid most likely bind to this ds-DNA with binding constants higher by 2 to 3 orders of 
magnitude than the original ligands. 
Comparison of the Top10 ranked library members with their performance during the DAPI 
displacement assay further suggests that there is no direct correlation between the binding 
properties towards the two different nucleic acids. In Figure 144 the ranking of all library 
members in the EB displacement screening is plotted against the one obtained from the DAPI 
displacement. It now becomes clearly obvious that there is no correlation between the two 
screenings. Efficient p(dAdT)2 binders are not necessarily good plasmid binders and vice 
versa. 
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Figure 144. Correlation between the ranking of the library members during DAPI and EB displacement assays. 
Division of the library into four compartments according to their efficiency and 
determination of the percentaged appearance of the individual building blocks within each 
compartment leads to the illustration in Figure 145. A clear trend can be observed for the best 
performing ligands (Top 25 %). Arginine is implemented most often (31 %), followed by 
lysine, tyrosine (both 20 %) and the other two aromatic amino acids (both 13 %). Almost no 
glutamic acid is present within this region of the library. When going to lower affinity 
ligands, the occurrence of arginine is steadily dwindling. Similarly, lysine peaks in the second 
compartment and is less often implemented in DNA-binders of lower affinity. The aromatic 
amino acids are distributed quite evenly over all four compartments, with slightly rising 
amounts for less efficient ligands. The worse the performance of the library members, the 
more often glutamic acid can be found.  
 
Figure 145. Percentaged amino acid distribution within each of the four compartments of the library. 
A closer look at the amino acid distribution at the three combinatorial positions AA1-AA3 
within the four compartments was carried out next. The results are shown in Figure 146. At 
the first combinatorial position the most beneficial amino acid by far is arginine, followed by 
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tyrosine and lysine. The other two aromatic amino acids, phenylalanine and especially 
tryptophan seem to prevent efficient binding when implemented at this position. Especially 
the latter trend is in strong contrast to the two overall best sequences, which feature Trp at 
position AA1 and therefore seem to be the exception to this rule. A comparison of sequences 
of the type Trp-X-X in the Top 25 % with those in the Top 75-100 % compartment revealed, 
that all good performing ligands with Trp in position AA1 are of the type Trp-cation-X, while 
sequences that only bind weakly do not feature an adjacent cationic amino acid, but another 
aromatic one or glutamic acid. Thus, Trp only seems to be favorable for binding in the first 
combinatorial position if Arg or Lys are present in AA2. Not a single glutamic acid is 
implemented in AA1 within the first compartment.  
 
Figure 146. Percentaged amino acid distribution at the three combinatorial positions AA1-AA3 within each of 
the four compartments of the library. 
At position AA2 it is arginine again, which seems to improve binding the most, followed by 
lysine. Aromatic moieties are evenly spread over all four compartments at this position, 
neither benefiting nor preventing binding. This is in contrast to the results obtained for 
p(dAdT)2, where an implementation of an aromatic amino acid at this position had a negative 
influence on the binding affinity. Although generic plasmid DNA is mainly of the B-type, too, 
it does not feature the very deep and narrow minor groove as is the case for the AT-
heteropolymer. Thus, a bulky aromatic amino acid does not prevent efficient binding, because 
it does not have to adapt to the narrow groove. At position AA3, a slight preference for 
arginine and tyrosine was observed, although this trend was not very pronounced as it was the 
case for the other positions. The exception is again glutamic acid, which is not tolerated at 
AA3 either. 
Finally, the binding affinity of the ligands with respect to their charge was studied. The 
absolute appearance of species with the same charge within the four compartments is depicted 
in Figure 147. As expected, the general trend is that highly charged compounds do interact 
stronger with the plasmid than lower charged or even negatively charged ligands. The latter 
ones are mainly clustered in the region of lowest performance. In comparison with the 
positively charged ligands, these molecules do interact worse with the DNA by large. 
However, the highest charged compounds are not necessarily the most efficient ones. For 
instance, half of the compounds of highest charge (+7) can be found within the Top 25-50 % 
region, and not within the Top 25 %.  
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Figure 147. Absolute charge distribution within each of the four compartments of the library. 
Although the general trends for efficient binding of the plasmid DNA are not as clear as it 
was the case for binding to p(dAdT)2, the combinatorial library helped to identify compounds, 
which bind stronger to the plasmid DNA than the original divalent ligands 196 and 206 by at 
least 1-2 orders of magnitude. 
Binding Studies in Solution 
In order to verify the results from the on-bead screening, EB displacement assays were 
carried out in solution with the five already available novel divalent ligands 233-237 (see 
Figure C. 51-Figure C. 55). These ligands represent very well the different parts of the library. 
A solution of ethidium bromide (0.75 µM, 1 eq) was prepared in sodium cacodylate buffer 
(0.01 M) at neutral pH in a fluorescence microcuvette equipped with a stopper (900 µL). 
Upon irradiation at 520 nm the fluorescence emission between 560 and 650 nm was measured 
at 25° C. Then the plasmid was added to the solution (3 µM, 4 eq) and after 5 min incubation 
time the increased fluorescence emission was recorded. Stock solutions of the ligands 
(50 µM) were added in aliquots of increasing volume (e.g. 3 × 1, 5 × 2, 4 µL) and after 1 min 
incubation time after each addition the resulting fluorescence spectrum was measured. All 
experiments were carried out at least in duplicate. The averaged results of the EB 
displacement assays and those for 196, 206 and 207 (cf. chapter 4.4.5) are listed in Table 23. 
Table 23. IC50 values for divalent (196, 206, 233-237) and trivalent (207) DNA-binders as obtained by EB 
displacement assays with pF143-GFP plasmid DNA in buffered aqueous solution (cacodylate buffer, 0.01 M) at 
neutral pH and on-bead screening results. Binding constants from ITC measurements are listed for comparison. 
 234 233 235 206 236 196 237 
IC50a [eq] 
0.51 ± 
0.03 
0.55 ± 
0.04 
0.64 ± 
0.05 
2.08 ± 
0.18 
0.36 ± 
0.04 
1.85 ± 
0.12 
31.2 ± 
0.7 
On-beadb [%] 9 13 28 38 39 39 41 
Library # 1 2 58 136 139 148 171 
Solution # 2 3 4 6 1 5 7 
logK2c 8.74 8.42 7.51 6.96 9.22 6.30 5.82 
Sequence 
Trp-Arg-
Lys-GCP 
Trp-Lys-
Arg-GCP 
Lys-Lys-
Arg-GCP 
Lys-Phe-
GCP 
Lys-Trp-
Arg-GCP 
Phe-Lys-
GCP 
Glu-Trp-
Arg-GCP 
a) Solution phase EB displacement; b) On-bead EB displacement; c) ITC.  
 
0 10 20 30 40
Top 75-100 %
Top 50-75 %
Top 25-50 %
Top 25 %
Absolute Occurence of Charge
-5
-3
-1
1
3
5
7
4. RESULTS AND DISCUSSION   167 
 
With the exception of 236 there is an excellent agreement between the results from the on-
bead screening with the solution phase measurements. Similar to the observations made for 
p(dAdT)2 236 binds stronger than predicted by the screening. This further underlines the 
hypothesis of corrupted beads for this library member. Probably the synthesis failed in this 
case. However, out of the seven substances tested in solution, this is the only one which does 
not behave as expected, indicating that the overwhelming majority of the library is intact. In 
the screening against the plasmid the ligand 236 seems to be the most potent binder with an 
IC50 value as low as 0.36 equivalents, followed by the two ligands 234 (0.51 eq) and 233 
(0.55 eq).  
Table 24. Results of ITC measurements obtained by titrating the library-derived DNA binders 233-236 (0.1 mM) 
to pF143-GFP plasmid DNA (0.04 mM, 1451 µL) in cacodylate buffer (0.01 M) at neutral pH and 25° C. 
Ligand Sequence 
K 
[106 M-1] 
log K n ΔH 
[kcal/mol] 
TΔSa 
[kcal/mol] 
ΔG 
[kcal/mol] 
236b Lys-Trp-Arg 2.6 
1670 
6.42 
9.22 
0.12 
0.08 
4.6 
-21.5 
13.4 
-8.9 
-8.8 
-12.6 
234c Trp-Arg-Lys 0.55 
553 
5.74 
8.74 
0.12 
0.10 
5.4 
-18.1 
13.2 
-6.2 
-7.8 
-11.9 
233d Trp-Lys-Arg (0.003) 
266 
(3.40) 
8.42 
(0.41) 
0.09 
(113) 
-16.6 
(118) 
-5.1 
(-4.7) 
-11.5 
235e Lys-Lys-Arg 0.25 
32.6 
5.40 
7.51 
0.03 
0.08 
(95) 
-16.6 
(102) 
-6.4 
-7.3 
-10.2 
206 Lys-Phe 9.1 6.96 0.23 -17.5 -8.0 -9.5 
196 Phe-Lys 2.0 6.30 0.24 -9.6 -1.0 -8.6 
237f Glu-Trp-Arg 0.7 5.82 0.55 -5.8 2.1 -7.9 
207g Phe-Lys 26.4 7.42 0.09 -22.7 -12.6 -10.1 
a) Calculated for 25° C; b) [236] = 0.1 mM, [pF143-GFP] = 0.04 mM; c) [234] = 0.1 mM, [pF143-GFP] = 
0.035 mM; d) [233] = 0.125 mM, [pF143-GFP] = 0.05 mM; e) [235] = 0.06 mM, [pF143-GFP] = 0.03 mM; f) 
[237] = 0.2 mM, [pF143-GFP] = 0.03 mM; g) Trivalent Ligand. 
 
In order to determine quantitative data, ITC measurements were conducted next. Therefore 
solutions of the ligands 233-237 (0.06-0.2 mM) were titrated in aliquots (25 × 5 µL) to a 
solution of the plasmid (0.03-0.05 mM, 1451 µL) in cacodylate buffer (0.01 M) at pH 7 and 
25° C. The raw data was corrected for the heat of dilution of the ligands and the data was 
fitted according to two-site models for 233-236, and with the help of a one-site model for 237. 
Other binding models did not result in satisfying fits. The titration experiments are depicted in 
appendix C.5 (Figure C. 64-Figure C. 65) and the results are listed in the order according to 
their binding affinity in Table 24. The observed binding constants were in good agreement 
with the EB displacement and the on-bead screening (except for 236 as denoted above). 236 
featured the highest binding constant to the plasmid with K = 1.7 × 109 M-1, followed by 234 
(5.5 × 108 M-1) and 233 (2.7 × 108 M-1). Thus the binding constants of the best performing 
ligands are two to three orders of magnitude higher than those for the original divalent ligands 
196 and 206. They are even higher than for the trivalent DNA binder 207 by two orders of 
magnitude. Again, the highest charged compound 235 does not feature the highest binding 
constant (3.3 × 107 M-1), suggesting that the correct combination of amino acid building 
blocks plays a decisive role besides mere charge-charge interactions to the nucleic acid. The 
binding mode is similar to the one observed for p(dAdT)2, although in this case the 
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experimental results for the first binding event are not as accurate (and therefore listed in 
brackets in Table 24). It occurs with binding constants around 106 M-1 and is entropy driven 
and endothermic. The other event is exothermic but with unfavorable entropy and takes place 
with different binding constants for different ligands. With these data a binding mode with 
two simultaneous processes, an unspecific attraction to the phosphate backbone together with 
groove binding, can be proposed similar to the recognition event with p(dAdT)2. The glutamic 
acid containing 237 again features a different binding mode, which is exothermal and with 
favorable entropy, but takes place with lower affinity.  
Interestingly, for different nucleic acids different high affinity-compounds could be 
identified. Hence, with the help of combinatorial chemistry, polynucleotide-selective 
identification of efficient DNA-binders could be achieved. With these data at hand the 
correlation between the affinity of the ligands towards the pF143-GFP plasmid DNA to the 
ability to shuttle genetic material into human cells could be studied in the next step. 
Transfection Experiments 
Therefore transfection experiments were conducted with the optimized conditions from 
chapter 4.4.5 by Gutschmidt in the working group of Prof. Knauer. HEK293T cells were 
seeded in 96-well cell culture plates and grown for 24 h. Then a mixture of pF143-GFP 
plasmid DNA (2 µg) and the novel, library-derived gene carriers 233-237 (0.24 mM) were 
incubated in phosphate buffered saline at pH 7.2 for 10 to 15 min and added to the cells (total 
volume = 200 µL). After 48 h the number of GFP expressing cells was counted with the help 
of an inverted fluorescence microscope. All experiments were carried out at least in triplicate. 
The average values of the percentage of fluorescent cells were calculated and are reported 
together with the corresponding standard deviations in Table 25. The results obtained for 196, 
206, and 207 are listed for comparison. 
As depicted in Figure 148 three of the novel DNA binders were able to transfect the cells. 
The highest transfection efficiency was achieved by 236 with 9.6 %, followed by 233 (6.5 %) 
and 234 (6.0 %). These three systems all contain the amino acids Trp, Lys and Arg, but in 
different order. The higher charged 235 is not able to transfect cells. Neither is the negative 
control 237. The overall transfection efficiencies are higher than for the original divalent 
DNA ligands 196 and 206 (< 1 and 2.9 %), but lower by large in comparison to the three-
armed 207 (54.1 %). When carrying out the experiments at higher ligand concentrations (0.30 
and 0.36 mM) the efficiencies dropped.  
Table 25. Transfection efficiency determined 48 h after treatment of HEK293T cells with pF143-GFP plasmid 
(2 µg) and varying amounts (0.24-0.36 mM) of 233-237, 196, 206, or 207. 
[Ligand] /  
[mM] 
Transfection Efficiency and Standard Deviation / [%] 
233 234 235 236 237 196 206 207 
0.24 
6.5 
± 2.3 
6.0 
± 2.1 
< 1 
9.6 
± 2.8 
< 1 < 1 
2.8 
± 0.6 
54.1 
± 12.5 
0.30 
3.1 
± 1.6 
5.0 
± 1.6 
< 1 
1.6 
± 0.9 
< 1 < 1 n.d. n.d. 
0.36 
1.9 
± 0.5 
4.8 
± 2.8 
< 1 
1.8 
± 1.4 
< 1 < 1 n.d. n.d. 
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Figure 148. Brightfield (a-e) and fluorescence images (f-j) of HEK293T cells 48 h after transfection with 2 µg 
pF143-GFP plasmid and 233-237 (0.24 mM); k) comparison of binding constants of 233-237, 196, and 206 with 
their transfection efficiency. 
The explanation for the lower transfection efficiencies is probably due to a lack of buffering 
capacity as could be shown for 196 compared to the tripodal carrier 207 in chapter 4.4.5. It is 
likely that the optimized divalent ligands are extremely efficient in transporting the plasmid 
into the cell, but are prevented from more efficient transfection by their lacking capability to 
escape from the endosome. Still, in comparison to the original two-armed carriers 196 and 
206 the transfection efficiency could be increased. Figure 148 (bottom) illustrates that there is 
a direct correlation between binding constant and transfection efficiency for comparable 
DNA-carriers. Only the three ligands with the highest affinity led to transfection efficiencies 
> 5 %. The carrier with the highest affinity also featured the highest efficacy for cell 
transfection. The premise for such a comparison is of course that there are no additional 
effects, which differentiate the non-viral vectors from each other (cf. 196 vs. 207: proton 
sponge effect). Hence, the optimization of binding affinity with the help of combinatorial 
chemistry is a viable tool for improving the transfecting properties of non-viral vector 
systems. The so optimized side chains can now be further modified chemically, for instance 
by implementing them into trivalent systems like 207 or by attaching lipophilic groups for 
improving their capability for endosomal escape. 
In conclusion, the preparation of a small but focused library containing 259 divalent DNA 
ligands of varying lengths, which were built from aromatic (Trp, Tyr, Phe) and basic (Lys, 
Arg) amino acids (and acidic Glu as control), allowed to improve the binding affinity of their 
parent compounds to two different nucleic acids (p(dAdT)2 and pF143-GFP plasmid) by a 
factor of up to 1000. The additional binding affinity does not only originate from additional 
charge-charge interactions of additional basic amino acids in the ligand arms with the 
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ribophosphate backbone, but there is also a sequence-dependent influence onto the binding 
properties. Sequences containing the three amino acids Trp, Lys, and Arg in varying order 
have proved to be excellent for binding to both types of DNA on bead and in solution. 
Finally, the transfection efficiency of the dipodal ligands could also be improved. Although 
the enhancement is not large due to their lacking ability to escape from endosomal vesicles, 
high affinity ligands could be identified and linked to improved transfection ability. By 
further modifying these sequences with for instance lipophilic groups, which would facilitate 
endosomal escape, their efficiency might be further improved. In the next chapter such 
molecules will be prepared and tested for their transfection efficiency. 
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4.6 AMPHIPHILIC GENE CARRIERS FOR CELL TRANSFECTION 
Amphiphilic molecules are frequently being used for efficient cell transfection, for example 
the commercial LipofectamineTM (cf. chapter 2.4.4).18 These gene carriers feature a cationic 
headgroup which binds to the nucleic acid and contracts it. The lipophilic part of the molecule 
forms lamellar bilayers. Hence, the resulting lipoplexes are positively charged and attracted to 
the negatively charged cell surface. After uptake via endocytosis the cationic lipids interact 
with the anionic lipid vesicle wall which as a consequence is disrupted and releases its cargo 
into the cytosol. With the help of the combinatorial library presented in the last chapter 
cationic headgroups could be identified which are able to efficiently bind to plasmid DNA. By 
attaching C18 chains to this headgroup they become amphiphilic, similar to lipoplexes. In the 
following a synthetic route to this kind of gene carrier will be presented as well as the results 
from the corresponding transfection experiments.  
4.6.1 Combined Solution Phase and Solid Phase Peptide Synthesis 
The synthesis of the amphiphilic DNA carriers was carried out in a converged synthesis. 
First, the fully protected ligand was synthesized via microwave-assisted standard Fmoc SPPS 
on SASRIN resin as illustrated in Figure 149.178  
 
Figure 149. Microwave-assisted SPPS of the fully protected headgroup 240. 
After swelling the resin in DCM/DMF (7/3) the attachment of the first amino acid, Fmoc-
γ-aminobutyric acid-OH (Fmoc-GABA-OH, 2 eq), was achieved with DIC (2 eq), HOBt 
(2 eq), and catalytic DMAP in a mixture of DCM/DMF (7/3) under argon atmosphere. The 
coupling step was repeated four times (8-12 h) to ensure complete conversion of the resin´s 
hydroxy groups. GABA was used instead of Gly in this case in order to introduce a longer 
238 
193 
158 
239 240 
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spacer between the lipophilic and the hydrophilic part of the gene carrier. Afterwards the solid 
support was treated with acetic anhydride to cap eventually still remaining free hydroxy 
groups. The Fmoc group was deprotected with 20 % piperidine/DMF and the aromatic 
template 193 (3 eq) was coupled to the liberated N-terminus with the help of PyBOP (3 eq) 
and microwave irradiation (max. 60° C, 20 min, 20 W) in 5 % DIPEA/DMF under argon 
atmosphere. All coupling steps were carried out twice. Coupling and Fmoc deprotection steps 
were monitored with the help of the Kaiser test and repeated if necessary.181 The next two 
amino acids Fmoc-Phe-OH and Fmoc-Lys(Boc)-OH and the Boc protected GCP unit (155) 
were coupled accordingly, but with six instead of three equivalents of reactants. The resin-
bound product 239 was cleaved from the solid support by treating the resin with 1 % 
TFA/DCM (12 × 15 min) followed by thorough washing steps with DCM and MeOH. The 
crude product was purified with the help of MPLC (RP18, H2O → MeOH) to obtain 240 with 
26 % yield. 
 
Figure 150. Solution phase coupling of dioctadecylamine 241 with the fully protected headgroup 240 and 
consequent Boc deprotection with TFA gives the amphiphilic gene carrier 243. 
In the next step, which is shown in Figure 150, the fully protected headgroup 240 (1 eq) was 
reacted with dioctadecylamine (241, 1 eq), HCTU (1.2 eq) as coupling agent and DMAP 
(3 eq) in chloroform adopted from a known procedure for the reaction of Boc-Gly-OH with 
241.263 The resulting product 242 was directly liberated from its Boc protecting groups by 
treating it with 50 % TFA in DCM containing 5 % TIS as nucleophilic scavenger. The crude 
product was isolated via MPLC (RP8, H2O → MeOH, 0.1 % TFA) with 90 % purity 
according to analytical HPLC (see Figure C. 10). Finally, the trifluoroacetate counterions 
were exchanged for chlorides by treating the product several times with 0.1 N HCl and 
consequent lyophilization to give the amphiphilic gene carrier 243 with 24 % yield over two 
steps. This rather moderate yield is probably due to a low conversion of 240 to C18-
240 
241 
242 243 
4. RESULTS AND DISCUSSION   173 
 
derivatized 242. The amine nucleophile is sterically quite demanding and therefore, the 
reaction probably does not proceed very smoothly.  
To circumvent these difficulties, dioctadecylamine (1 eq) was first reacted with Boc-Gly-
OH (244, 1 eq) with HBTU (1.4 eq) and DMAP (3.7 eq) in chloroform under argon 
atmosphere with 93 % yield as illustrated in Figure 151.263 The Boc protecting group was then 
removed by treating 245 with 38 % TFA in DCM to give 246 with 88 % yield. This 
compound could now be attached to protected headgroups more easily than the 
dioctadecylamine on its own. 
 
Figure 151. Attachment of dioctadecylamine to Boc-Gly-OH and deprotection of the Boc group. 
The fully protected headgroups 247-249 shown in Figure 152 were synthesized via 
microwave-assisted SPPS on SASRIN resin as described above for 243. The attachment of 
the first amino acid Fmoc-Gly-OH was achieved with DIC, HOBt in DCM/DMF (7/3) under 
argon atmosphere and catalytic DMAP and repeated four times. The resin was then treated 
with acetic anhydride in 5 % DIPEA/DMF to cap eventually remaining free hydroxy groups. 
Fmoc deprotections were conducted under microwave irradiation (1 + 5 min, max. 60° C, 
20 W) and controlled by the Kaiser test. The following three amino acids Fmoc-Lys(Boc)-
OH, Fmoc-Trp(Boc)-OH and Fmoc-Arg(Pbf)-OH were coupled in varying order with the help 
of PyBOP in 5 % DIPEA/DMF under argon atmosphere and microwave irradiation (20 min, 
max. 60° C, 20 W) and repeated at least twice or more often if indicated by the Kaiser test. 
Finally, the Boc protected GCP moiety was coupled accordingly and the compounds were 
cleaved from the solid support by treating the resin with a mixture containing 1 % TFA, 2.5 % 
TIS, and 2.5 % H2O (4 × 2 h, 8 h) to obtain the fully protected headgroups with moderate 
yield (249: 12 %, 248: 12 %, and 249: 14 %).  
The amino acid sequence of these three building blocks was chosen according to the results 
of the transfection experiments reported in chapter 4.5.5. They correspond to the three most 
efficient transfection agents 233, 234, and 236 derived from the combinatorial library 220. 
The three headgroups (1 eq) were then coupled with C18-derivatized glycine 246 (1.2 eq) with 
the help of PyBOP (1.4 eq) in 7.5 % DIPEA/DMF under argon atmosphere. The crude 
products were then treated with 95 % TFA, 2.5 % TIS, and 2.5 % H2O to remove all 
protecting groups and purified via MPLC (RP8, H2O → MeOH, 0.1 % TFA). The yield over 
two steps and the purity of the amphiphilic gene carriers 250-252 are listed in Table 26. 
Compared to the previous direct linking of the lipophilic amine to the fully protected head 
244 241 
245 246 
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group, it was possible to improve the yield by a factor of 2-3. The purity was determined via 
analytical HPLC at 300 nm and is also listed in Table 26 (see Figure C. 11-Figure C. 13). 
Excellent purities could thus be achieved. Finally, the trifluoroacetate counterions were 
exchanged for chlorides by dissolving the product several times in 0.1 N hydrochloric acid 
and consequent lyophilization. The so obtained compounds were now ready for further 
characterization and transfection experiments with human cells. 
Table 26. Yield over two steps of gene carriers 243, and 250-252. The purity was determined via analytical 
HPLC according to the absorption at 300 nm. 
Compound 243 250 251 252 
Yield [%] 24 65 43 53 
Purity [%] 90 94 99 99 
 
 
Figure 152. The three fully protected headgroups 247-249 were synthesized via microwave-assisted SPPS. C18-
derivatized glycine (246) was coupled to their free C-termini and all protecting groups were removed to obtain 
the amphiphilic gene carriers 250-252. 
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4.6.2 Critical Micelle Concentration 
The so obtained gene carriers 243, and 250-252 are amphiphilic molecules and should 
therefore form micelles in aqueous medium. The critical micelle concentration (CMC) was 
determined with the help of a fluorescence assay.264 Solutions of 1,6-diphenyl-1,3,5-
hexatriene (DPH, 253) were prepared at a concentration of 1 µM in in cacodylate buffer 
(0.01 M) at neutral pH. To these solutions varying amounts of amphiphile (1 µM - 0.1 mM) 
were added and the solutions incubated while shaking for 12 h. Afterwards the DPH 
fluorescence emission upon irradiation at 360 nm was measured between 380 and 600 nm. 
DPH is not soluble in aqueous medium on its own. Consequently only weak fluorescence 
could be observed in the absence and at low concentrations of the amphiphiles. As soon as the 
concentration is above a critical concentration, micelles are formed and the fluorophore is 
taken up within the hydrophobic core. This leads to an increase of fluorescence signal. A 
fluorescence experiment with 243 and the corresponding excerpt at 429 nm is depicted in 
Figure 153. It is clearly visible, that at a concentration of 1.9 µM the fluorescence intensity 
increases abruptly. This concentration corresponds to the critical micelle concentration. Table 
27 features the CMC values for gene carriers 243, and 250-252. 
 
Figure 153. Fluorescence experiment with DPH (1 µM) and increasing amounts of 243 in sodium cacodylate 
buffer (0.01 M) at pH 7 (left). Excerpt at 429 nm for determination of the critical micelle concentration (right). 
Table 27. Critical micelle concentration in aqueous cacodylate buffer (0.01 M) at neutral pH as determined by a 
fluorescence assay with DPH. 
Compound 243 250 251 252 
CMC [µM] 1.9 > 100 > 100 > 100 
 
For the compounds 250-252 no micelle formation could be observed even at concentrations 
as high as 100 µM. Therefore, only a lower limit could be determined for the CMC of these 
three amphiphiles. In comparison to 243, the higher charged headgroup of 250-252 improves 
their solubility in water and thus increases the critical concentration for micelle formation. 
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4.6.3 Transfection Experiments 
The four amphiphilic DNA ligands were tested for their transfection efficiency by Sarah 
Tillman from the working group of Prof. Knauer. HEK293T cells were seeded in 96-well cell 
culture plates and grown for 24 h. Then a mixture of pF143-GFP plasmid DNA (2 µg) and 
various amounts of the gene carriers 243, 250-252 (0.0075 mM, 0.03 mM, and 0.12 mM) 
were incubated in phosphate buffered saline at pH 7.2 for 10 to 15 min and added to the cells 
(total volume = 200 µL). After 48 h the number of GFP expressing cells was counted with the 
help of an inverted fluorescence microscope. All experiments were carried out at least in 
triplicate. The average values of the percentage of fluorescent cells were calculated and are 
reported together with the standard deviations in Table 28. The transfection efficiencies of the 
corresponding parent compounds 196, 233, 234, and 236 (0.24 mM), which are lacking the 
C18 chains, as well as the one of PEI (0.12 mM) are listed for comparison, too.  
Table 28. Transfection efficiencies determined 48 h after treatment of HEK293T cells with varying amounts of 
pF143-GFP plasmid and 243, 250-252. The results from PEI (0.12 mM) and the divalent ligands without C18 
chains 196, 233, 234, and 236 (0.24 mM) are listed for comparison. For the latter ones the binding constant (K) 
towards the pF143-GFP plasmid is listed as well. 
Ligand 
 
C18 log Ka 
 
Transfection Efficiency and Standard Deviation / [%] 
0.0075 mM 0.03 mM 0.12 mM 0.24 mM 
PEI - - n.d. n.d. 50.7 (± 9.4) n.d. 
196 - 6.30 n.d. n.d. - < 1 
243 + - < 1b < 1b < 1b n.d. 
233 - 8.42 n.d. n.d. n.d. 6.5 (± 2.3) 
250 + - < 1 2.8 (±1.7) 12.3 (± 2.9) n.d. 
234 - 8.74 n.d. n.d. n.d. 6.0 (±2.1) 
251 + - 11.0 (± 4.7) 30.0 (± 3.0) 68.2 (± 11.5) n.d. 
236 - 9.22 n.d. n.d. n.d. 9.6 (± 2.8) 
252 + - 14.3 (± 6.8) 49.0 (± 6.5) 21.7 (± 2.6) n.d. 
a) From ITC experiments; b) after 24 h. 
As depicted in Figure 154 the C18-derivatized transfecting agents (243, 250-252) clearly 
outmatch their parent compounds (196, 233, 234, 236) by up to one order of magnitude. The 
best nonviral vector 251 (68.2 %) even outmatches the gold standard PEI (50.7 %). Hence, the 
amphiphilic character of the novel DNA ligands dramatically improves their properties as 
gene carriers, most probably due to an enhanced capability for endosomal escape (cf. chapter 
2.4.4). Furthermore, the minimal concentration for efficient transfection is reduced by half 
(0.24 mM → 0.12 mM). At even lower concentrations however, the efficiency drops, with the 
exception of 252, which performs best at a concentration of 0.03 mM. At 0.12 mM 
precipitation was observed for the 252/DNA complex, which reduced its efficiency. 
Precipitation is also the cause for an upper concentration limit of 0.12 mM for the amphiphilic 
gene carriers.  
Another striking feature of the results is that the transfection efficiency does indeed correlate 
with the affinity of the headgroup of the amphiphiles towards generic DNA. While the 
compounds derived from high affinity sequences 250-252 (K of parent compounds ca. 
109 M-1) feature modest to excellent transfection efficiencies, the low affinity headgroup-
derived 243 (K of parent compound ca. 106 M-1) only enables transfection of minor amounts 
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of the cells. While the correlation is straightforward for 243 (< 1 %, log K = 6.30), 250 
(12.3 %, log K = 8.42), and 251 (68.2 %, log K = 8.74), the gene carrier with the headgroup of 
highest affinity 252 (21.7 %, log K = 9.22) performs less well than expected at a 
concentration of 0.12 mM. Probably, the extremely tight complexation of the nucleic acid by 
252 is the cause for the precipitation at this concentration, which prevents higher transfection 
efficiency. This problem can probably be solved in future experiments by choosing a 
concentration between 0.03 mM (49.0 %) and 0.12 mM (21.7 %) as a compromise between 
efficiency and solubility. Nevertheless, these results clearly confirm the direct correlation 
between the affinity of the DNA carrier towards its cargo DNA and the resulting transfection 
efficiency, which was already observed during the screening of library 220 (cf. chapter 4.5.5). 
 
 
Figure 154. Brightfield (a-d) and fluorescence images (e-h) of HEK293T cells 24 h (a, e) or 48 h (b-d, f-h) after 
transfection with pF143-GFP plasmid (2 µg) and 243 (0.0075 mM), 250, 251 (each 0.12 mM), or 252 
(0.03 mM); i) Transfection efficiencies with C18 chains (243, 250-252, green) and without (196, 233, 234, 236, 
each 0.30 mM, grey). 
In conclusion, by combining combinatorial chemistry with rational design extraordinarily 
efficient gene carriers could be identified, which are even more efficient than the gold 
standard PEI. By screening a small but focused library of divalent peptide-based DNA 
ligands, sequences with high affinity for the pF143-GFP plasmid were found, which already 
featured moderate inherent gene carrier characteristics. By further derivatizing these 
sequences with hydrophobic alkyl chains extremely well performing amphiphilic transfecting 
agents were obtained and the minimum concentration, which is necessary for efficient 
transfection could be reduced by half. The direct correlation between the affinity of the 
amphiphile´s headgroup and its optimization via combinatorial chemistry is to the best of our 
knowledge unprecedented in literature. 
243 250 251 252 
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196  243 233  250 234  251 236  252     PEI 
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5. SUMMARY 
In the first part of this thesis we carried out Resonance Raman studies together with our 
cooperation partners from the working group of Prof. Schlücker concerning the binding event 
of a small molecular receptor with tetrapeptides. Therefore the receptor 13 and the four 
ligands 161-164 shown in Figure 155 were synthesized with the help of standard Fmoc SPPS 
in good to excellent yield and their binding properties were determined via RR. The data was 
analyzed by means of non-negative matrix factorization. Within the first preliminary studies 
we could thus reproduce the literature-known order of affinity 161 > 162. Although more 
work is still on-going, already at this early stage these measurements can be viewed as proof-
of-principle that we are not only able to qualitatively analyze a given binding event by means 
of RR, but that we are now also capable to quantitatively determine the binding constants of 
the complex formations. 
 
Figure 155. Receptor 13 and substrates 161-164 for Resonance Raman binding studies. 
In the second Raman project which we carried out together with our cooperation partner we 
were able to prepare a novel bifunctional solid-support which combines the advantages of 
solid phase synthesis with rapid characterization of the bound substances via surface 
enhanced Raman spectroscopy. As depicted in Figure 156 gold nanoparticles were coated 
with an ultrathin silica layer and aggregated onto a solid support for SPPS thereby completely 
covering its surface. Derivatization with an amine function enabled the attachment of three 
different amino acids Gly, Phe, and Ser (166-168) as well as the dipeptide Gly-Phe (171) via 
standard Fmoc SPPS. The synthesis involved treatment of the designer beads with organic 
solvents like DMF or DCM as well as basic (20 % piperidine) or acidic conditions (33 % 
TFA). Afterwards it could be shown via microscopy techniques, that the gold NP covered 
bead surface was still intact thus ensuring that the bifunctional solid-support is suitable for 
13 161 
162 163 164 
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application in SPPS. The four compounds were then characterized and could be clearly 
distinguished from each other via SERS experiments very rapidly and reliably. The combined 
SPPS/SERS beads fulfill all necessary prerequisites for a manifold of applications, for 
instance the characterization of reaction intermediates during SPPS or the studying of 
molecular recognition events on-bead. This sophisticated nanoparticles-derivatized resin is an 
excellent addition to the fields of supramolecular chemistry and solid phase synthesis because 
it is one of the very few techniques that allows for direct and label-free analysis of resin-
bound compounds. 
 
 
Figure 156. Design of the bifunctional beads which combine SPPS with SERS: a) Silica-encapsulated, 80 nm 
sized Au NPs on a 130 µm TentaGel bead; b) Zoom onto the surface; c) Amine functionalization of the silica-en-
capsulation with amino silane (image from: Gellner Ph.D.).191 The three amino acids 166-168 and the dipeptide 
171 were synthesized via SPPS and could be characterized and distinguished from each other via on-bead SERS. 
The next major part of the dissertation was concerned with the molecular recognition of 
biologically relevant substrates. Therefore the two non-symmetric (187, 188) and the 
symmetric tweezer receptor 196 shown in Figure 157 were synthesized via microwave-
assisted SPPS. In comparison to previous work conducted during my diploma thesis the 
synthesis of both templates, the orthogonally protected 181 of non-symmetric tweezers and 
193 for symmetric hosts, could be improved. The overall yields over seven (181) and 
respectively six (193) steps could be augmented from 24 to 39 % and respectively from 29 to 
42 %. Furthermore the yield and purity of the SPPS could be dramatically ameliorated for all 
receptors with the help of a single mode microwave. Additionally, at the optimized coupling 
conditions (max. 60° C, 20 min, 20 W) the time for the synthesis of e.g. 187 could be 
tremendously reduced from two weeks to merely two days. Furthermore, this second 
generation of host systems features improved physicochemical properties for binding studies 
in water at physiological pH. Especially the reduction of the acidity of the guanidinio group 
by approximately one order of magnitude in comparison to the first generation ensures a 
higher degree of protonation of the GCP oxoanion binding site at pH 7 and therefore 
improved binding properties towards anionic substrates.  
166 167 168 171 
a) b) c)
resin 
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Figure 157. Orthogonally protected template 181 for the microwave-assisted SPPS of non-symmetric tweezer 
receptors 187 and 188. The scaffold 193 was utilized for the preparation of the symmetric tweezer 196. 
UV/Vis titrations revealed that the non-symmetric tweezer receptors 187 and 188 feature 
binding constants of up to 6 × 103 M-1 in buffered water to the polar peptidic substrate N-Ac-
Lys-D-Ala-D-Ala-OH, which plays a decisive role in the biosynthesis of the cell wall of Gram 
positive bacteria. It could be shown that the binding constants increase at lower pH (7 → 6 → 
5). This finding could be linked to the higher degree of protonation of the GCP groups. The 
binding affinity mainly originates from the interaction between the GCP motif and the 
tripeptide´s carboxylate group. Furthermore it was observed that 187 has a higher affinity 
towards the substrate than 188 caused by the lower pKA value of its GCP group and additional 
interactions of the receptor´s side chains with the tripeptide. 
With the help of UV/Vis and fluorescence spectroscopy it could be shown that the 
symmetric tweezer 196 binds to nucleotides by forming 1:1 complexes in buffered water at 
neutral pH with good binding constants of up to 9 × 104 M-1. Nucleotides are bound stronger 
than phosphate or diphosphate by almost one order of magnitude. Most remarkably, adenine 
monophosphate is preferred over its corresponding di- and triphosphate. This preference is as 
of yet unprecedented in literature and could be explained with the help of NMR spectroscopy 
and molecular modeling. The receptor forms salt-bridges to the highest charged α-phosphate 
of the nucleotide with its GCP units, which are oriented perpendicular to each other to allow 
for simultaneous binding to the tetrahedral phosphate anion. Moreover, the aromatic template 
stacks with the nucleobase thus locking the nucleotides in a well-defined geometry where the 
host is able to wrap around its substrate as a half-closed shell. As illustrated by the solvent 
accessible surfaces of the host-guest system depicted in Figure 158 the longer the phosphate 
hinge of the nucleotide (green), the more it is exposed to the solvent which is then better able 
to compete for binding. Consequently, the binding constants drop in the order AMP > ADP > 
181 
188 187 
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ATP. The specific interactions between the symmetric tweezer receptor 196 and phosphate 
and nucleotide anions is an excellent example for the importance to combine multiple non-
covalent interactions in the correct orientation to allow for the formation of distinct host-guest 
complexes for the selective molecular recognition of the desired substrate. 
 
Figure 158. Representation of the solvent-accessible surfaces of the calculated 1:1 complexes of receptor 196 
(yellow) and the phosphate residue of the nucleotides (green). From left to right: AMP, ADP, and ATP. 
For the next project two more artificial systems were synthesized. As shown in Figure 159 
the two-armed 206 features an inverted amino acid sequence in comparison to the parent 
compound 196. It was prepared accordingly with the help of microwave-assisted SPPS. The 
tripodal 207 features the original amino acid sequence and was prepared by a convergent 
synthesis. First, the arms were prepared by standard Fmoc SPPS with all side chain protecting 
groups intact, coupled to the triamine scaffold and finally deprotected. 
 
Figure 159. Additional divalent ligand with inverted amino acid sequence 206 and trivalent ligand 207. 
These three molecules were then tested for their binding properties towards various 
synthetic and generic nucleic acids with the help of thermal melting experiments, 
displacement assays, ITC and CD spectroscopy. The two-armed polynucleotide-ligands 196 
206 207 
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and 206 form highly stable complexes with binding constants of K > 106 M-1 and the trivalent 
ligand 207 binds even stronger by one order of magnitude (K > 107 M-1). The binding mode 
involves electrostatic binding to the ribophosphate backbone paired with minor groove 
binding for B-type DNA and major groove binding for A-type DNA and RNA. Furthermore 
CD spectroscopy revealed a binding mode with two stacked pyrrole units which allowed 
differentiating between the secondary structure and sequence of different nucleic acids by 
means of the sign of the exciton CD signal. Such selective recognition of polynucleotides by 
non-covalently bound small molecule ligands is very rare and has potential for applications in 
polynucleotide sensing. Furthermore, it could be shown by means of AFM and DLS 
experiments that 196 and 207 are able to condense generic DNA in a concentration dependent 
fashion to very tight and densely packed spherical aggregates. Together with our cooperation 
partner, the working group of Prof. Knauer, we could demonstrate that these multimolecular 
complexes are taken up by human cells via endocytosis. However, only the trivalent ligand is 
able to escape from the endosome and transfect cells with genetic information. As indicated in 
Figure 160 this differentiation is due to 207´s supreme buffering capacity in comparison to its 
two-armed analogue. The guanidinio group is getting protonated within the endosome upon 
specific ATPase-mediated proton influx and acts as proton sponge which ultimately leads to 
rupture of the vesicle caused by osmotic pressure. The three-armed gene carrier 207 is 
extremely efficient in transfecting cells. It outmatches the gold standard for non-viral vectors, 
PEI, in terms of efficiency and is at the same time less toxic. Furthermore, 207 is 
extraordinarily small in comparison to other cell penetrating peptides which normally feature 
10-30 residues. It also carries fewer charges than comparable systems like oligo-Arg, which 
needs at least six positive charges for cellular uptake. Hence, this novel chemical vector offers 
great potential for the application in cell biology. 
 
Figure 160. 207-mediated cellular uptake mechanism. The plasmid DNA is condensed into tight aggregates 
which are taken up via endocytosis. The GCP group acts as proton sponge in the endosome leading to its 
rupture. The genetic information is transported into the nucleus and ultimately the GFP protein is expressed. 
In order to improve the binding properties of the divalent ligands the combinatorial DNA-
ligand library 220 shown in Figure 161 was generated by means of split & mix synthesis. This 
small but focused library comprised three combinatorial positions with six possible amino 
acids per position. The building blocks were of cationic (Lys, Arg) and aromatic character 
(Phe, Trp, Tyr) or anionic (Glu) as a control. Furthermore, the number of amino acids (n) and 
5. SUMMARY   183 
 
thus the length of the arms was varied from 3 to 0. Accordingly, the library contained a total 
of 259 members (63 + 62 + 6 + 1). On-bead displacement assays were developed next for the 
screening of the library with two nucleic acids: the B-DNA p(dAdT)2 with its well-defined, 
narrow minor groove and pF143-GFP plasmid DNA, which was utilized for above mentioned 
transfection experiments. With the help of the IRORI radiofrequency technology quantitative 
data could be obtained for all members of the library and not just for a few hit structures, 
which is regularly the case for large and random libraries.  
     
Figure 161. The library 220 consists of 259 symmetric, divalent DNA ligands with GCP headgroups in each side 
arm, which contain three, two, one, or no combinatorial positions (Phe, Tyr, Trp, Lys, Arg, and Glu). 
The screening of the library revealed high affinity sequences for both nucleic acids which 
clearly outmatched the original two-armed ligands. Additional charge-charge interactions 
were one reason for the improved binding properties, but the amino acid sequence also played 
a decisive role in binding to the nucleic acids. Sequences of the type AA1-cationic-cationic-
GCP were especially successful in binding to p(dAdT)2, while those of the type AA1-
aromatic-AA2-GCP were less well suited, probably due to the difficulty to arrange the bulky 
aromatic side chains in the minor groove of the nucleic acid. Concerning the length of the 
DNA binders a huge beneficial effect could be observed when going from one to two amino 
acids. Obviously a certain degree of flexibility is necessary within these ligands for efficient 
binding.  
 
Figure 162. Five library members were synthesized for characterization in solution. The ligand 233 with the 
amino acid sequence Trp-Lys-Arg-GCP is depicted exemplarily. The four other compounds were of the sequence 
Trp-Arg-Lys-GCP (234), Lys-Lys-Arg-GCP (235), Lys-Trp-Arg-GCP (236), and Glu-Trp-Arg-GCP (237). 
Five DNA-binders (233-237) were selected as cross-section of the library and synthesized in 
order to verify the results obtained from the on-bead screening. The ligand 233 is shown 
exemplarily in Figure 162. Solution-based displacement assays were in excellent agreement 
with the results obtained from solid phase. Furthermore, ITC measurements revealed binding 
220 
AA   =   Phe, Tyr, Trp,  
 Lys, Arg, Glu  
216  = 6 × 6 × 6 (n = 3) 
36  = 6 × 6  (n = 2) 
6    (n = 1) 
1                                (n = 0)  
259 ligands 
233 
TentaGel 
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constants of K > 109 M-1. Hence, with the help of combinatorial chemistry the affinity of the 
divalent ligands could be increased by three orders of magnitude 
The on-bead screening with the plasmid DNA revealed that there is no general correlation 
between efficient binding to p(dAdT)2 and high affinity towards the plasmid. However, 
sequences containing the three amino acids Trp, Lys and Arg were very efficient in binding to 
both types of DNA. The highest observed binding constants were increased by a factor of 
1,000 in comparison to the parent compounds (K > 109 M-1). Hence, with the help of 
combinatorial chemistry it was possible to optimize the binding properties of the divalent 
ligands by large and to fine-tune them for specific nucleic acids. Finally, we could show that 
the increased binding affinity to the plasmid also correlated with higher transfection 
efficiencies. Although the so derived, novel two-armed gene carriers were not as efficient as 
the trivalent ligand 207 with its superior buffering capacity, this finding was of great use at it 
revealed the unexpected dependency of the transfection efficiency from the binding affinity. 
 
Figure 163. Four amphiphilic gene carriers were sythesized for cell transfection. The one with the sequence 
Trp-Lys-Arg-GCP (250) is depicted exemplarily. The three others were of the sequence Trp-Arg-Lys-GCP (251), 
Lys-Trp-Arg-GCP (252), and Phe-Lys-GCP (243). 
In order to further exploit the improved ability to transfect cells, three high affinity 
sequences were derivatized with octadecyl chains to generate the gene carriers 250-252. One 
of them is shown exemplarily in Figure 163. Furthermore, an amphiphilic analogue (243) of 
the less affine parent compound 196 was synthesized for comparison. The amphiphilic 
ligands were prepared in a convergent synthesis: First, the fully side chain protected DNA-
binders were synthesized with the help of microwave-assisted SPPS, coupled with C18-
derivatized glycine at their free C-termini, and finally deprotected to obtain the amphiphilic 
carriers. The following cell transfection experiments confirmed the correlation between the 
affinity of the amphiphile´s headgroup towards the plasmid DNA and the efficiency as gene 
carrier. 251 was identified as extremely efficient transfecting agent, which even outperformes 
the gold standard PEI. Furthermore, the minimum concentration for efficient transfection 
could be reduced by half. 
In conclusion, within the framework of this dissertation new insight into molecular 
recognition events of biologically important targets like peptides, nucleotides and nucleic 
acids could be gathered. These findings do not only help to improve our general 
understanding of the complex processes which take place in biological systems but could also 
be utilized for an application in cell biology by generating a novel approach for the 
development of highly efficient gene carriers. 
250 
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6. OUTLOOK 
After having shown that it is principally possible to calculate binding constants for 
molecular recognition events from Resonance Raman experiments, the as of yet preliminary 
data has to be validated and its reproducibility has to be ensured. Concerning the novel 
SERS/SPPS beads, the next step could be to test if the GCP oxoanion binding motif is SERS 
active when bound to the designer solid support (253). If this is the case it would then be 
possible to determine whether a molecular recognition event, e.g. with simple carboxylate 
anions like acetate (254), can be visualized on-bead as indicated in Figure 164. By recording 
the SERS answers upon binding of different substrates and comparing them with their 
solution-derived binding constants it would be possible to analyze whether this method is 
sensitive for binding affinity. The SPPS/SERS beads could then be used for the development 
and consequent label-free on-bead screening of receptor libraries. Furthermore, the detection 
of more complicated host-guest systems of increasing size, e.g. with one or two additional 
amino acids, or even more complex molecules could be tested to explore the scope and 
limitations of this novel technique.  
 
Figure 164. By attaching the GCP oxoanion binding motif onto the novel bifunctional SPPS/SERS beads (253) 
binding events of small carboxylates like acetate (254) can be directly visualized on-bead via SERS. 
With regard to the combinatorial library 220 a screening for nucleotides could be conducted 
next. Since the parent symmetric tweezer compound 196 is already able to selectively 
recognize nucleotides with good binding constants, even more efficient hosts could thus be 
identified. Furthermore, other types of nucleic acids, for instance siRNAs could be subjected 
to a screening in order to identify high affinity sequences to this completely different class of 
polynucleotides.265 The so identified sequences could then be tested for their efficiency in 
transporting siRNAs into cells and thus trigger the RNAi mechanism. 
In general, the library-derived amino acid sequences, which are optimized for binding ds-
DNA, could be implemented into three-armed ligands of the type 207, which has already 
proven to be an excellent gene carrier for plasmid DNA. The divalent high affinity ligands 
already provided better transfection efficiencies than their parent compounds 196 and 206. 
Thus, by attaching the improved sequences to a trivalent scaffold according to the procedure 
developed during this doctoral work, buffering capacity would be introduced into these 
systems and therefore the generation of extremely efficient transfecting agents is likely. By 
preparing for example the gene carriers 255 and 256 shown in Figure 165 a direct comparison 
253 
254 
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with their already synthesized two-armed analogues 233 and 236 would be possible which 
would allow for validating the general applicability of this approach. 
 
Figure 165. By implementing the library-derived high affinity amino acid sequences into three-armed DNA-
ligands (255, 256) highly efficient gene carriers should be accessible. 
In general, the buffering capacity of the GCP unit seems to be crucial for efficient gene 
transfer. Therefore, the generation of a second generation DNA-ligand library with GCP units 
also present within the combinatorial positions could help to identify even more efficient gene 
carriers. The GCP unit can easily be implemented in the form of the building block 257 
shown in Figure 166. The synthesis of this compound is already known and it has already 
been utilized for the preparation of compounds in standard Fmoc-SPPS syntheses.266  
N
H
O
HN NH
NHBoc
O
NH
NHFmoc
HO
O  
Figure 166. The building block 257 allows for implementation of GCP units into combinatorial positions within 
the side chains of di- or trivalent DNA ligands. Furthermore, oligo-GCP units can thus be synthesized for the 
development of even more efficient gene carriers. 
Furthermore, with the help of this building block the preparation of oligo-GCP units by 
means of standard Fmoc SPPS is possible. Such systems could be very efficient small 
molecule gene carriers combining the propensity to bind to DNA and the capability to escape 
from the endosome. Structure-activity studies could be carried out concerning their minimum 
length and the effect of multivalency by preparing linear DNA-ligands of the type 258 
depicted in Figure 167 and by implementing them into di- (259) or trivalent systems (260) 
similar to those developed during this doctoral work. 
255 256 
257 
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Figure 167. Linear (258), divalent (259) and trivalent (260) oligo-GCP compounds as transfecting agents. 
In conclusion, the work conducted during this doctoral thesis has laid the foundation for the 
development of more efficient gene carriers by developing small molecule DNA-binders and 
elucidating their uptake mechanism into human cells. This knowledge suggests to enable 
further enhancement of the characteristics of non-viral vectors in future research. This will 
help to render gene therapy into a broadly applicable standard method for the treatment of a 
wide range of diseases. 
 
258 259 260 
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7. EXPERIMENTAL SECTION 
7.1 GENERAL EXPERIMENTAL AND ANALYTICAL METHODS 
Solvents and Chemicals 
All solvents were dried according to literature procedures.267 Diethyl ether was distilled 
from sodium with benzophenon as indicator. DCM and CCl4 were distilled from calcium 
hydride. Methanol was distilled. DMF was distilled from calcium hydride in vacuum (the first 
250 mL were discarded). Water was purified with a TKA MicroPure ultrapure water system. 
Unless otherwise stated, all other solvents and chemicals were utilized as supplied from the 
manufacturer. 
Inert Gas 
Reactions under inert gas were carried out with Argon (99.998 %) from Air Liquide which 
was dried with Silica Gel Orange. 
Orbital Shaker for Peptide Synthesis 
The solid phase peptide synthesis was carried out on a Yellowline OS 5 basic orbital shaker 
from Heidolph. 
Magnetic Stirrer 
Reactions were stirred and heated with the help of magnetic stirring bars and a MR 3001 K 
magnetic stirrer from Heidolph. 
Single Mode Microwave 
Mircowave assisted SPPS was carried out with a CEM Discover single mode microwave. 
Equipment for Combinatorial Synthesis 
The synthesis of the DNA-ligand library was performed with the help of the AccuTag-100 
Combinatorial Chemistry System from IRORI. The individual members were synthesized in 
MikroKansTM which were equipped with radiofrequency tags. A scanning station was used to 
sort and identify the library members. 
Thin layer Chromatography (TLC) 
Analytical TLC was carried out in order to monitor reactions on aluminium foils 
ALUGRAM SIL G/UV254 and C18 SiO2 aluminium foils ALUGRAM RP-18W/UV254 from 
Macherey-Nagel. The spots were visualized by means of fluorescence quenching upon 
irradiation with UV light of 254 nm or with the help of a ninhydrin (0.5 g) solution in acidic 
ethanol (EtOH/AcOH/TFA = 90/10/1).  
Column Chromatography 
Flash chromatography was done on columns packed with Silica gel 60M with a spherical 
size of 40-63 µm from Macherey-Nagel. Organic solvents were distilled prior to use. 
7. EXPERIMENTAL SECTION   189 
Preparative MPLC 
Purification of polar substances was conducted with the help of reversed phase preparative 
MPLC on a Liquid Chromatography Flash apparatus from Armen Instrument. Glass columns 
were packed with YMC Gel ODS-A or Gel ODS octyl C8 of 50 µm diameter and 12 nm pore 
size. Distilled or HPLC grade solvents and ultrapure water were used as eluents. Detection of 
the products was achieved with the help of a UV detector. 
Analytical HPLC 
The purity of the compounds was determined with the help of an HPLC apparatus from 
Dionex containing the following components: P680 HPLC-pump, ASI-100 Automated 
Sample Injector and UVD 340U detector. A SupelcosilTM LC-18 column (25 cm × 4.6 mm, 
5 µm) from Supelco or a YMC ODS-A column (15 cm × 3.0 mm, 5 µm) was utilized. 
Ultrapure water and HPLC-grade solvents were used as eluents. Detection was achieved with 
the help of a UV detector. 
Preparative HPLC 
Separation of multimilligram amounts of the products were performed after pre-purification 
via MPLC on a Merck SepTech preparative HPLC apparatus equipped with a Knauer 
Dynamic Mixing Chamber and a Shimadzu SPD-10A UV detector. A YMC ODS-A column 
(15 cm × 3.0 cm, 5 µm) was utilized. The conditions were optimized via analytical HPLC on 
the corresponding YMC column (vide supra) and the amount of substance per injection and 
the elution speed (ml/min) were scaled-up by a factor of 100. 
Lyophilization 
Freeze drying of aqueous solutions was carried out with an Alpha 1-4 LD plus apparaturs 
from Christ. 
Vacuum Pumps 
Vacuum was generated with a Vacuubrand CVC3000 pump. High vacuum was generated 
with a RC6 Vacuubrand chemistry hybrid pump. 
Rotary Evaporator 
Distillation of solvent from the reaction mixture was carried out under reduced pressure with 
a Heidolph Hei-VAP Advantage rotary evaporator at 40° C. 
Melting Point Determination 
Melting points were measured with open end glass capillary tubes without correction with a 
Büchi Melting Point B-540. 
pH Measurement 
The pH was determined with the pH-Meter 766 Calimatic from Knick, which was calibrated 
with commercial available buffer standards (pH = 4.00 and 7.00). 
Nuclear Magnetic Resonance (NMR) 
700, 500, 400, and 300 MHz 1H and respectively 175, 125, 100, and 75 MHz 13C-NMR 
spectra were recorded with an Avance II+ 700, a DRX 500, an AC400 and a DMX300 from 
Bruker at 25° C. Chemical shifts are reported as δ values in ppm. The spectra were calibrated 
with the help of the residual peaks of the deuterated solvents as internal standard: DMSO-d6 
(δ [1H] = 2.50 ppm, δ [13C] = 39.52 ppm), MeOD-d4 (δ [1H] = 3.31 ppm, δ [13C] = 
49.05 ppm), or CDCl3 (δ [1H] = 7.26 ppm, δ [13C] = 77.16 ppm). Coupling constants are 
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reported in Hz. For the signal multiplicity the following abbreviations are utilized: br. = 
broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. All assignments have 
been performed according to literature.268 
Fourier Transform Infrared Spectroscopy (FT-IR) 
Infrared spectra were recorded on a FT-IR 430 from Jasco with the help of a MIRacle ATR 
unit from Pike Technologies or as KBr disks on a FT-IR 1600 from Perkin-Elmer. The bands 
are reported in cm-1 and the following abbreviations have been utilized for the 
characterization of the band intensities: br. = broad, s = strong, m = middle, w = weak.  
UV/Vis Spectroscopy 
UV/Vis spectra were recorded with a Jasco V-660 spectrometer in standard quartz 
microcuvettes of 1 cm width which were equipped with stoppers. All spectra are corrected for 
the background (empty cuvette) unless otherwise stated.  
Fluorescence Spectroscopy 
UV/Vis spectra were recorded with a Varian Carey Eclipse spectrometer in standard quartz 
fluorescence microcuvettes of 1 cm width which were equipped with stoppers or in sterile 
Nunclon Surface 96-well plates from Nunc.  
Isothermal Titration Calorimetry 
ITC measurements were carried out with a VP-ITC Microcalorimeter from MicroCal. The 
reference cell was filled with ultrapure, degassed water. All substances were dissolved in 
degassed, ultrapure buffered water. The data were analyzed with the help of Origin 7 from 
Origin Lab and the corresponding ITC plugin from MicroCal. 
Atomic Force Microscopy 
AFM images were recorded in tapping mode with an Innova NanoDrive AFM controller and 
an Innova Atomic Force Microscope from Veeco with N-doped silica cantilevers (AC 160TS 
OLYMPUS). The solutions were spin coated onto freshly cleaved Mica surface from Plano. 
The data were analyzed with Gwiddion-2.20. 
Dynamic Light Scattering 
DLS measurements were conducted with a Zetasizer Nano-ZS from Malvern Instruments 
GmbH and analyzed with the software provided from the manufacturer. 
Force Field Calculations 
Computational force field calculations were carried out with Macromodel v9.6 from 
Schrödinger. For small host-guest systems a 50,000 step conformational analysis (Monte 
Carlo) was carried out first, making use of the Amber* force field and a generalized 
Born/surface area (GBSA) water solvation, followed by a molecular dynamics simulation at 
300 K for 500 ps. Systems containing nucleic acids were calculated with the help of the 
OPLC_2005 force field an GBSA water solvation by minimizing the structure without 
restraints first, followed by a conformational analysis with frozen DNA and 10,000 steps. 
Liquid Extraction 
Extraction of caffeine was conducted with a PrimaDonna apparatus from De´Longhi. 
Centrifuge 
Precipitates were centrifuged with a Rotofix 32 from Hettich. 
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Mass Spectrometry 
ESI mass spectra were recorded with a Bruker BioTOF III spectrometer. EI MS was 
conducted with a MAT 90 from Finnigan. 
Vortexer 
Isopycnic solutions were vortexed prior to transfer to 96-well plates with a Vortex-Genie 2 
from Scientific Industries. 
CD Spectroscopy 
CD spectra were recorded with a J-815 spectrometer from Jasco in quartz fluorescence 
cuvettes of 1 cm width which were equipped with stoppers. All spectra are corrected for the 
background (cuvette + buffer). 
Oven 
All glass ware was dried in a Function Line oven from Heraeus before usage. 
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7.2 GENERAL PROCEDURES FOR SPPS 
Solid phase peptide synthesis was carried out in Schlenck glass vessels equipped with a frit 
and a stopper. Reactions were conducted under argon atmosphere while shaking the reaction 
mixture on a shaker. After completion of a reaction step, the solvent was removed via 
filtration. The amount of solvent used for the reaction steps was chosen in a way so that the 
concentration of the reactants was between 0.1 and 0.2 M. 
Kaiser test 
Two solutions were prepared: Ninhydrin (1.00 g) and respectively phenol (40 g) were 
dissolved in ethanol (10 mL). A few beads of the analyte were suspended in a mixture of 
0.3 mL of each of the two solutions and heated to 110° C for 1-2 min. Consequently, beads 
with free amine functionalities were coloured deeply blue while resin without free amino 
functions stayed colourless. 
Fmoc Deprotection 
In order to remove Fmoc protecting groups the resin was shaken with 20 % piperidine in 
DMF two times for 20 min and then thoroughly washed six times for 5 min with DMF. 
Attachment 
The attachment of the first compound to the resin differed depending on the reactive groups 
present on the solid support. Resins featuring hydroxy groups (Wang, SASRIN) were first 
swollen in a mixture of DCM/DMF (7/3). The first N-Fmoc protected amino acid (2 eq) was 
then attached to the solid support via its free C-terminus. The resin (1 eq) and the amino acid 
(2 eq) were suspended in DCM/DMF (7/3) and then DIC (2 eq) was slowly added dropwise 
under argon atmosphere, followed by HOBt (2 eq) and DMAP (0.2 eq). The mixture was 
shaken for at least 8 h and washed three times for 5 min with DCM/DMF (7/3). The coupling 
and washing steps were repeated four times in total. After the last repetition of the coupling, 
the washing step was carried out with DMF. The solid support was then treated with Ac2O in 
3-5 % NMM or DIPEA in DMF under argon atmosphere for 1 h. Finally, the resin was 
washed three times with DMF for 5 min. 
Resins featuring amine groups (Fmoc-Rink-Amide, MBHA) were swollen in DMF for 1 h. 
The Rink-Amide´s Fmoc protecting group was removed as described above. The first amino 
acid (3 eq) was attached to the resin with PyBOP (3 eq) in 3-5 % NMM or DIPEA in DMF 
under argon atmosphere while shaking the reaction mixture for at least 8 h. The solid support 
was then washed three times for 5 min with DMF. The coupling and washing steps were 
repeated. The solid support was then treated with Ac2O in 3-5 % NMM or DIPEA in DMF 
under argon atmosphere for 1 h. Finally, the resin was washed three times for 5 min with 
DMF. 
Coupling 
The resin (1 eq) was suspended in 3-5 % NMM or DIPEA in DMF and then amino acid 
(3 eq) and PyBOP (3 eq) were added. The reaction mixture was shaken for at least 8 h under 
argon atmosphere. The solid support was then washed three times for 5 min with DMF. 
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Cleavage 
Before cleaving the raw product from the solid support, the beads were thoroughly washed 
with DCM (3 × 5 min), MeOH (3 × 5 min), and again three times with DCM (3 × 5 min). The 
resin was then dried in vacuum for 1 h. The cleavage was carried out as follows: 
- SASRIN: The resin was treated with 1 % TFA containing 2.5 % TIS and 2.5 % H2O in 
DCM four times for 2 h and once more for 20 h and then washed three times with DCM. 
The filtrates were immediately neutralized with the corresponding amount of NEt3. 
- Wang: The solid support was shaken for 4 h in 50 % TFA in DCM containing 5 % TIS 
under argon atmosphere and washed three times for 5 min with the cleavage cocktail. 
- Fmoc-Rink-Amide: The polymer was treated with 95 % TFA containing 2.5 % TIS and 
2.5 % H2O for 4 h under argon atmosphere and washed three times with the cleavage 
mixture. 
- MBHA: The beads were suspended in 80 % TFA containing 8 % thioanisole and 4 % 
EDT. 8 % TFMSA were slowly added under argon atmosphere, the resin was shaken for 
4 h, and then washed three times with TFA for 5 min. 
The filtrates were combined and the solvent reduced to a few mL by distillation under 
reduced pressure. The raw product was then precipitated according to its polarity by adding 
either 40 mL of water or Et2O, centrifuged and the supernatant solvent decanted. The 
remaining solid was dissolved in little MeOH, water was added and the mixture was freeze 
dried under reduced pressure. The raw product was then purified by reversed phase MPLC. 
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7.3 SYNTHESIS OF SMALL OLIGOPEPTIDE SUBSTRATES 
The SPPS of the tetrapeptides 162-164 was carried out on 250-300 mg Wang resin 
(1.63 mmol/g) as described above. 3 % NMM was utilized as base during the coupling steps. 
The raw products were precipitated with Et2O. Purification was carried out via RP MPLC 
(H2O → acetonitrile, 0.1 % TFA) and RP HPLC (H2O/acetonitrile, 0.05 % TFA). 
N-Ac-D-Ala-L-Ala-D-Glu-D-Glu-OH (162) 
 
C18H28N4O10 460.44 g/mol 
Yield 83 % 
Mp. 102.7° C 
1H-NMR (500 MHz, DMSO-d6): δ = 1.16 (d, 3J = 7.05 Hz, 3H, Ala-CH3), 1.21 (d, 
3J = 7.14 Hz, 3H, Ala-CH3), 1.68-2.00 (m, 7H, Ac-CH3, 2 × CH2), 2.14-
2.32 (m, 4H, 2 × CH2), 4.15-4.21 (m, 3H, 3 × CH), 4.28 (dt, 3J = 8.72 Hz, 
3J = 5.04 Hz, Glu-CH), 7.86 (d, 3J = 8.24 Hz, 1H, NH), 8.07 (d, 
3J = 6.47 Hz, 1H, NH), 8.11 (d, 3J = 7.61 Hz, 1H, NH), 8.22 (d, 
3J = 7.21 Hz, 1H, NH), 12.22 (br. s, CO2H) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 17.54 (CH3), 17.88 (CH3), 22.14 (CH3), 
26.02 (CH2), 27.06 (CH2), 29.91 (CH2), 48.41 (CH), 48.54 (CH), 51.12 
(CH), 51.47 (CH), 169.45 (CO), 171.10 (CO), 171.98 (CO), 172.41 
(CO), 173.00 (CO), 173.67 (CO), 173.90 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 459.1663 [M - H+]- 
 calculated for C18H27N4O10: 459.1733 
FT-IR (ATR): ߥ෤ = 3290 (br. w), 2938 (w), 1716 (m), 1634 (s), 1539 (s), 1447 
(m), 1375 (m), 1168 (s), 787 (m) cm-1. 
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N-Ac-D-Glu-D-Glu-D-Glu-D-Ala-OH (163) 
 
C20H30N4O12 518.47 g/mol 
Yield 53 % 
Mp. 228° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.28 (br. s, 3H, Ala-CH3), 1.66-1.97 (m, 9H, 
Ac-CH3, 3 × CH2), 2.25 (br. s, 6H, 3 × CH2), 4.09-4.34 (m, 4H, 4 × CH), 
7.89-7.99 (m, 2H, 2 × NH), 8.01 (d, 3J = 7.25 Hz, 1H, NH), 8.04 (d, 1H, 
3J = 7.23 Hz, NH), 8.17 (br. s, 1H, NH), 12.15 (br. s, 4H, 4 × CO2H) 
ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 16.92 (Ala-CH3), 22.46 (Ac-CH3), 27.41 
(Glu-CH2), 27.50 (Glu-CH2), 27.59 (Glu-CH2), 30.00 (Glu-CH2), 30.10 
(Glu-CH2), 30.27 (Glu-CH2), 51.63 (Ala-CH), 51.87 (Glu-CH), 51.96 
(Glu-CH), 52.12 (Glu-CH), 169.61 (CO), 170.75 (CO), 170.80 (CO), 
170.91 (CO), 171.02 (CO), 171.43 (CO), 173.50 (CO), 173.92 (CO) ppm. 
HR-MS (neg. ESI-ToF): m/z = 258.0865 [M - 2 H+]2- 
 calculated for C20H28N4O122-: 258.0858 
FT-IR (ATR): ߥ෤ = 3328 (br. w), 3218 (w), 2945 (w), 1731 (s), 1601 (s), 1547 
(s), 1237 (w), 1442 (w), 1408 (m), 1350 (w), 1295 (w), 1275 (m), 1167 
(s), 1063 (w), 1018 (w), 949 (w), 892 (w), 790 (s), 621 (s) cm-1. 
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N-Ac-D-Glu-D-Glu-D-Glu-L-Ala-OH (164) 
 
C20H30N4O12 518.47 g/mol 
Yield 76 % 
Mp. 181.6° C 
1H-NMR (300 MHz, DMSO-d6): δ = 1.25 (d, 3J = 7.24 Hz, 3H, Ala-CH3), 1.63-
1.97 (m, 9H, Ac-CH3, 3 × CH2), 2.13-2.32 (m, 6H, 3 × CH2), 4.13-4.34 
(m, 4H, 4 × CH), 7.91 (d, 3J = 8.01 Hz, 1H, NH), 7.98-8.16 (m, 3H, 3 × 
NH), 12.28 (br. s, 4H, 4 × CO2H) ppm. 
13C-NMR (75 MHz, DMSO-d6): δ = 17.21 (Ala-CH3), 22.37 (Ac-CH3), 26.89 
(Glu-CH2), 27.08 (Glu-CH2), 27.40 (Glu-CH2), 29.94 (Glu-CH2), 30.03 
(Glu-CH2), 30.10 (Glu-CH2), 47.39 (Ala-CH), 51.80 (Glu-CH), 51.87 
(Glu-CH), 52.01 (Glu-CH), 169.55 (CO), 170.60 (CO), 170.79 (CO), 
171.38 (CO), 173.68 (CO), 173.80 (CO), 173.84 (CO), 173.88 (CO) ppm. 
HR-MS (neg. ESI-ToF): m/z = 258.0847 [M - 2 H+]2- 
 calculated for C20H28N4O122-: 258.0858 
FT-IR (ATR): ߥ෤ = 3338 (br. w), 1730 (s), 1601 (s), 1542 (s), 1443 (w), 1409 
(m), 1295 (w), 1273 (m), 1169 (s), 1062 (w), 1016 (w), 949 (w), 893 (w), 
790 (s) cm-1. 
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7.4 DERIVATIZATION OF AU-NANOPARTICLES 
Silica-encapsulated Au nanoparticles were obtained aggregated onto TentaGel S NH2 beads 
(170) from Gellner from the working group of Prof. Schlücker at the Institute for Physics at 
the University of Osnabrück. 
Amino Functionalization (169) 
 
Approximately 100 beads of 170 were suspended ethanol (1 mL). 30 % aqueous ammonia 
(50 µL) and a solution of 0.5 % APTMS (261) in EtOH (50 µL) were added under argon 
atmosphere and the mixture was shaken for 30 min. The solid support was washed three times 
for 5 min with DMF (1 mL) to obtain the functionalized beads 169. 
Attachment of Amino Acids (166-168) 
NH
O
NH2 . TFA
HO
NH
O
NH2 . TFA
Ph
NH2
1. PyBOP, 3 % NMM/DMF,
Fmoc-AA-OH
2. 20 % piperidine/DMF
3. 33 % TFA/DCM
NH
O
NH2 . TFA
 
Approximately 20 beads of 169 were suspended in 3 % NMM/DMF (1 mL). PyBOP 
(16 mg, 0.03 mmol) and one of the three amino acids Fmoc-Ser-OH (12 mg, 0.03 mmol), 
Fmoc-Gly-OH (9 mg, 0.03 mmol), or Fmoc-Phe-OH (12 mg, 0.03 mmol) were added and the 
mixture was shaken for at least 8 h. The resin was washed three times for 5 min with DMF 
and the Fmoc group was deprotected by treating the resin with 20 % piperidine/DMF two 
times for 20 min (1 mL). Afterwards the beads were washed six times for 5 min with DMF 
(1 mL). The coupling, deprotection and washing steps were repeated. Finally, the solid 
support was treated with 33 % TFA/DCM and washed with DCM (3 × 5 min), MeOH (3 × 
5 min), and water (3 × 5 min) to obtain the derivatized beads 166-168. 
166 
167 
168 
169 170 
169 
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Attachment of the Dipeptide Gly-Phe (171) 
NH
O
HN
O
TFA . H2N
NH2
1. PyBOP, 3 % NMM/DMF,
Fmoc-Gly-OH
2. 20 % piperidine/DMF
3. Repetition of 1. + 2. with
Fmoc-Phe-OH
4. 33 % TFA/DCM  
Approximately 20 beads of 169 were suspended in 3 % NMM/DMF (1 mL). PyBOP 
(16 mg, 0.03 mmol) and Fmoc-Gly-OH (9 mg, 0.03 mmol) were added and the mixture was 
shaken for at least 8 h. The resin was washed three times for 5 min with DMF and the Fmoc 
group was deprotected by treating the resin with 20 % piperidine/DMF two times for 20 min 
(1 mL). Afterwards the beads were washed six times for 5 min with DMF (1 mL). The 
coupling, deprotection and washing steps were repeated. The second amino acid, Fmoc-Phe-
OH (12 mg, 0.03 mmol) was coupled accordingly. Finally, the solid support was treated with 
33 % TFA/DCM and washed with DCM (3 × 5 min), MeOH (3 × 5 min), and water (3 × 
5 min) to obtain the dipeptide-derivatized beads 171. 
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7.5 GENERAL PROCEDURES FOR MICROWAVE ASSISTED SPPS 
Microwave-assisted SPPS was carried out in polyethylene tubes equipped with a frit. 
Reactions were conducted while bubbling argon through the solution. After completion of a 
reaction step, the solvent was removed via filtration. The amount of solvent used for the 
reaction steps was chosen in a way so that the concentration of the reactants was between 0.1 
and 0.2 M. 
Fmoc Deprotection 
In order to remove Fmoc protecting groups the resin was treated with 20 % piperidine in 
DMF two times for 1 and respectively 5 min under argonatmophere while irradiating the 
mixture with microwaves (20 W, max. 60° C). The solid support was then thoroughly washed 
six times for 2 min with DMF. 
Attachment 
For hydroxy resins (Wang, SASRIN) the attachment of the first compound to the resin was 
carried out as described in chapter 7.2. Resins featuring amine groups (Fmoc-Rink-Amide, 
MBHA) were swollen in DMF for 1 h. The Rink-Amide´s Fmoc protecting group was then 
removed as described above. The first amino acid (3 eq) was attached to the resin (1 eq) with 
PyBOP (3 eq) in 3-5 % NMM or DIPEA in DMF under argon atmosphere while irradiating 
the mixture with microwaves for 20 min (20 W, max. 60° C). The solid support was then 
washed three times for 2 min with DMF. The coupling and washing steps were repeated. The 
solid support was subsequently treated with Ac2O in 3-5 % NMM or DIPEA in DMF under 
argon atmosphere while irradiating the mixture with microwaves for 20 min (20 W, max. 
60° C). Finally, the resin was washed three times for 2 min with DMF. 
Coupling 
The resin (1 eq) was suspended in 3-5 % NMM or DIPEA in DMF and then amino acid 
(3 eq) and PyBOP (3 eq) were added. The reaction mixture was irradiated with microwaves 
for 20 min (20 W, max. 60° C) under argon atmosphere. The solid support was then washed 
three times for 2 min with DMF. 
Cleavage 
Cleavage of the raw product from the solid support was carried out without microwave 
irradiation. Therefore the beads were transferred into Schlenck glass vessels equipped with a 
frit and a stopper and treated according to the cleavage procedure described in chapter 7.2.
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7.6 PREPARATION OF NON-SYMMETRIC TWEEZER RECEPTORS 
Synthesis of the Orthogonally Protected Template 181 
The preparation of 181 has already been described.195 Therefore only the optimized reaction 
steps will be reported in the following.  
Methyl-3,5-bis(bromomethyl)benzoate (174) 
 
 
To a refluxing solution (55° C oil bath temperature) of 173 (5.00 g, 30.45 mmol, 1 eq) in 
DCM (125 mL) NBS (11.92 g, 66.99 mmol, 2.2 eq) and a catalytic amount of AIBN were 
added and the reaction mixture was stirred for 48 h. After cooling down to room temperature 
the solution was washed three times with water (75 mL) and dried with sodium sulfate. The 
solvent was removed via distillation under reduced pressure and the raw product was purified 
by flash chromatography (SiO2, CyHex/EA = 19/1) to obtain 174 as white solid (7.49 g, 
23.26 mmol, 76 %). 
 
C10H10Br2O2 321.99 g/mol 
Yield 76 % 
Mp. 99° C 
Rf 0.67 (SiO2, hexane/EA = 1/9) 
1H-NMR (400 MHz, CDCl3): δ = 3.93 (s, 3H, CH3), 4.50 (s, 4H, 2 × CH2), 7.61 
(dd, 4J1 = 4J2 = 1.7 Hz, 1H, CHar), 7.99 (d, 4J = 1.7 Hz, 2H, 2 × CHar) 
ppm. 
13C-NMR (100 MHz, CDCl3): δ = 31.8 (CH2), 52.4 (CH3), 130.0 (CHar), 131.4 
(Cq), 133.8 (CHar), 138.9 (Cq), 165.9 (CO2Me) ppm. 
MS (pos. EI): m/z = 319.9 [M – e-]+˙ 
 calculated for C10H10Br2O2+˙: 319.9 
FT-IR (KBr disk): ߥ෤ = 2117 (w), 1723 (s), 1435 (m), 1315 (m), 1212 (s), 994 
(m), 898 (w), 771 (m), 697 (s) cm-1. 
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Methyl-3-aminomethyl-5-azidomethylbenzoate, TFA-salt (176) 
 
 
To a solution of 175 (4.00 g, 16.24 mmol, 1 eq) in diethyl ether (120 mL) cyclohexane 
(40 mL) and 5 % aqueous hydrochloric acid (160 mL) were added. The mixture was cooled 
to 0° C and triphenylphosphane (4.26 g, 16.24 mmol, 1 eq) was added. The reaction mixture 
was stirred for 8 h at 0° C and for another 40 h at room temperature. After phase separation 
the organic layer was extracted with 5 % aqueous hydrochloric acid (80 mL) once. The 
aqueous phases were combined and lyophilized under reduced pressure. The raw product 
was purified via MPLC (RP18, 20 % water/methanol → 40 % water/methanol, 0.1 % TFA) 
to give 176 as white solid (4.43 g, 13.26 mmol, 86 %). 
 
C12H13F3N4O4 334.25 g/mol 
Yield 86 % 
Mp. 138° C 
Rf 0.66 (RP18, water/methanol = 1/1, 0.1 % TFA) 
1H-NMR (400 MHz, DMSO-d6): δ = 3.89 (s, 3 H, OCH3), 4.15 (s, 2 H, CH2), 4.61 
(s, 2 H, CH2), 7.73 (dd, 4J1 = 4J2 = 1.6 Hz, 1 H, CHar), 7.97 (d, 4J = 
1.6 Hz, 1 H, CHar), 8.26 (dd, 4J = 1.6 Hz, 1 H, CHar), 8.39 (br. s, 3 H, 
NH3+) ppm. 
13C-NMR (100 MHz, DMSO-d6): δ = 41.6 (CH2), 52.2 (CH3), 52.6 (CH2), 128.7 
(CHar), 129.3 (CHar), 130.2 (Cq), 133.5 (CHar), 135.2 (Cq), 137.0 (Cq), 
165.5 (CO2) ppm. 
HR-MS (pos. ESI-ToF): m/z = 221.1033 [M + H+ – TFA]+ 
 calculated for C10H13N4O2+: 221.1033 
FT-IR (KBr disk): ߥ෤ = 2969 (br. w), 2098 (w), 1710 (m), 1671 (s), 1423 (w), 
1313 (w), 1237 (m), 1176 (s), 889 (w), 836 (w), 779 (m), 722 (m) cm-1. 
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Microwave Assisted SPPS of the Non-Symmetric Tweezer 187 
 
The synthesis of the non-symmetric tweezer was carried out on 100 mg MBHA resin 
(1.52 mmol/g) according to the standard microwave-assisted SPPS procedure described in 
chapter 7.5. During the coupling steps 5 % DIPEA was used as base and PyBOP (229 mg, 
0.46 mmol, 3 eq) as coupling agent. After attaching Fmoc-Gly-OH (226 mg, 0.76 mmol, 
5 eq), the resin was treated with Ac2O (71 µL, 0.76 mmol, 5 eq). After the coupling step the 
Fmoc groop was removed with 20 % piperidine/DMF. Then the template 181 (285 mg, 
0.46 mmol, 3 eq), Fmoc-Ser(Bn)-OH (190 mg, 0.46 mmol, 3 eq), Fmoc-Tyr(Bn)-OH 
(225 mg, 0.46 mmol, 3 eq), and Ac-Gly-OH (53 mg, 0.46 mmol, 3 eq) were coupled and the 
Fmoc-protecting groups were respectively removed after each coupling step. The following 
Boc deprotection was conducted without microwave irradiation by treating the solid support 
with 50 % TFA/DCM two times for 15 min. The resin was then washed three times for 5 min 
with DCM and another three times for 5 min with 5 % DIPEA/DMF. The following coupling 
steps of Fmoc-Asp(OtBu)-OH (188 mg, 0.46 mmol, 3 eq), Fmoc-Phe-OH (177 mg, 
0.46 mmol, 3 eq), and Boc-GCP-OH (158, 181 mg, 0.46 mmol, 3 eq) as well as the 
corresponding Fmoc deprotection steps were again achieved via the standard microwave-
assisted procedure with the exception of the Fmoc deprotection following the attachment of 
asparagine which was achieved by treating the polymeric support with 0.1 M HOBt in 5 % 
181 
158 
187 
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piperazine/DMF instead of 20 % piperidine/DMF. The cleavage of the product from the solid 
support was achieved without microwave irradiation according to the standard procedure for 
MBHA resin described in chapter 7.2. Then the crude product was hydrogenated with H2 and 
10 % Pd/C in acetone for 3 h. The suspension was filtrated over celite and the solvent was 
removed via distillation under reduced pressure. The raw product was purified via MPLC 
(RP18, methanol/water, 0.1 % TFA) and the trifluoroacetate counterions were exchanged by 
dissolving the product two times in 0.1 M aqueous HCl and one time in water followed by 
freeze drying under reduced pressure to obtain 187 as voluminous white solid (21 mg, 
0.02 mmol, 13 %). 
 
C47H56ClN13O14 1062.48 g/mol 
Yield 13 % 
Mp. 162° C (decomposition) 
1H-NMR (700 MHz, MeOD-d4, TFA-salt): δ = 1.96 (s, 3H, CH3), 2.66 (s, 1H, 
CH), 2.79 (br. s, 1H, CH2), 2.86 (dd, 3J1 = 8.83 Hz, 3J2 = 14.19 Hz, 1H, 
CH2), 2.90 (s, 1H, CH), 2.99-3.08 (m, 3H, 2 × CH2), 3.14 (dd, 3J1 = 
5.25 Hz, 3J2 = 17.29 Hz, 1H, CH2), 3.77 (dd, 3J1 = 3J2 = 16.62 Hz, 2H, 
CH2), 3.98 (d, 3J = 16.69 Hz, 1H, CH2), 4.05-4.60 (m, 5H, 2 × CH, CH2, 
CH2-OH), 6.71 (d, 3J = 8.57 Hz, 2H, CHar), 6.76 (s, 1H, CHar), 6.89-6.96 
(m, 2H, 2 × NH), 6.99 (d, 3J = 8.28, 2H, CHar), 7.01-7.09 (m, 1H, NH), 
7.09-7.31 (m, 7H, 7 × CHar), 7.32-7.39 (m, 1H, NH), 7.44-7.52 (m, 1H, 
NH), 7.54 (s, 1H, NH), 7.62-7.76 (m, 1H, NH), 8.03 (s, 1H, NH), 8.88 
(br. s, 1H, NH) ppm. 
13C-NMR (175 MHz, MeOD-d4, TFA-salt): δ = 9.22 (CH3), 18.70, 19.74, 21.85, 
23.45, 25.96, 26.92, 28.12, 30.45 (CH2), 31.69 (CH2), 33.06 (CH2), 36.54 
(CH2), 40.47 (CH2), 41.41 (CH2), 43.61 (CH2), 47.96 (CH), 50.86 (CH), 
53.67 (CH), 57.50 (CH), 60.62 (CH), 114.15 (CHar), 125.52 (CHar), 
125.95 (CHar), 127.79 (CHar), 129.68 (CHar), 130.27 (CHar), 130.60 (Cq), 
130.99 (Cq), 135.00 (Cq), 138.73 (Cq), 140.51 (Cq), 140. 72 (Cq), 169.61 
(CO), 173.50 (CO), 173.59 (CO), 173.88 (CO), 174.73 (CO), 174.87 
(CO), 175.75 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1026.4103 [M – Cl-]+ 
 calculated for C47H56N13O14-: 1026.4064 
FT-IR (ATR): ߥ෤ = 3308 (br. m), 2372 (w), 1669 (s), 1542 (m), 1436 (m), 1280 
(m), 1200 (s), 1134 (s), 839 (m), 800 (m), 762 (w), 722 (m) cm-1. 
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Microwave Assisted SPPS of the Non-Symmetric Tweezer 188 
 
The second non-symmetric tweezer receptor 188 was synthesized accordingly on 80 mg 
MBHA resin (1.30 mmol/g) following the above described microwave-assisted SPPS 
procedure. During coupling steps 3 % DIPEA was used as base and PyBOP as coupling agent 
(162 mg, 0.31 mmol, 3 eq). After attaching Fmoc-Gly-OH (93 mg, 0.31 mmol, 3 eq) and the 
template (160 mg, 0.31 mmol, 3 eq), the amino acids Fmoc-Leu-OH (110 mg, 0.31 mmol, 
3 eq), Fmoc-Val-OH (106 mg, 0.31 mmol, 3 eq) and Ac-Ala-OH (41 mg, 0.31 mmol, 3 eq) 
were coupled to the first arm and Fmoc-Phe-OH (121 mg, 0.31 mmol, 3 eq), Fmoc-Lys(Boc)-
OH (146 mg, 0.31 mmol, 3 eq) and Boc-GCP-OH (124 mg, 0.31 mmol, 3 eq) in the second 
arm. The product was obtained as voluminous white solid (42 mg, 0.04 mmol, 37 %).  
 
C49H72Cl2N14O10 1088.09 g/mol 
Yield 37 % 
Mp. 221° C (decomposition) 
1H-NMR (700 MHz, MeOD-d4, TFA-salt): δ = 0.89-0.94 (m, 6H, 2 × Val-CH3), 
0.96 (d, 3J = 6.28 Hz, 3H, Ala-CH3), 1.26-1.36 (m, 13H, 2 × Val-CH3, 2 
× Lys-CH2, Ac-CH3), 1.54-1.61 (m, 2H, Lys-CH2), 1.67-1.73 (m, 2H, 
Lys-CH2), 2.00-2.06 (m, 2H, CH2), 2.07-2.13 (m, 1H, CH), 2.19 (t, 3J = 
7.53 Hz, 1H, CH), 2.77 (t, 3J = 7.69 Hz, Lys-CH), 3.21 (dd, 3J 1= 7.33 
Hz, 3J2 = 14.64 Hz, 1H, CH), 3.42 (tdd, 3J1 = 1.53 Hz, 3J2 = 3.12 Hz, 2J  
= 28.69 Hz, 2H, Leu-CH2), 4.10 (d, 3J = 4.28 Hz, 1H, CH), 4.13 (d, 3J = 
6.90 Hz, 1H, CH), 4.19 (d, 3J = 16.21, 1H, Gly-CH2), 4.25-4.35 (m, 2H, 
CH2), 4.36-4.44 (m, 2H, CH2), 4.58 (s, 2H, NH2), 4.63 (d, 3J = 15.93 Hz, 
1H, Gly-CH2), 5.35 (t, 3J = 4.61 Hz, Phe-CH), 6.81 (d, 3J = 4.08 Hz, 1H, 
Pyr-CHar), 6.87 (d, 3J = 3.90 Hz, 1H, Pyr-CHar), 7.15-7.20 (m, 1H, Phe-
CHar), 7.23 (d, 3J = 4.34 Hz, 4H, 4 × Phe-CHar), 7.26-7.30 (m, 1H, NH), 
7.32 (s, 1H, CHar), 7.35-7.40 (m, 1H, NH), 7.41-7.48 (m, 1H, NH), 7.56 
188 
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(s, 1H, CHar), 7.64 (s, 1H, CHar), 7.66-7.71 (m, 1H, NH), 7.80 (br. s, 1H, 
NH), 7.90 (s, 1H, NH) ppm. 
13C-NMR (175 MHz, MeOD-d4, TFA-salt): δ = 22.47 (CH3), 35.80 (CH2), 36.86 
(CH2), 37.83 (CH2), 40.39 (CH), 43.26 (CH2), 43.52 (CH2), 44.05 (CH2), 
45.47 (CH), 53.50 (CH), 55.66 (CH), 63.74 (CH-OH), 114.06 (CHar), 
116.36 (CHar), 117.38 (Cq), 119.05 (Cq), 120.73 (Cq), 124.53 (CHar), 
125.14 (CHar), 128.37 (CHar), 129.69 (CHar), 130.22 (CHar), 130.44 
(CHar), 131.28 (CHar), 134.55 (Cq), 137.86 (Cq), 139.71 (Cq), 140.64 
(Cq), 157.54 (CO), 161.34 (CO), 162.97 (CO), 163.15 (CO), 166.95 
(CO), 169.02 (CO), 171.94 (CO), 172.16 (CO), 172.82 (CO), 174.14 
(CO), 175.07 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1015.5537 [M – HCl – Cl-]+ 
 calculated for C49H71N14O10+: 1015.5472 
FT-IR (ATR): ߥ෤ = 3268 (br. m), 2364 (w), 1638 (s), 1542 (s), 1469 (m), 1278 
(m), 1202 (s), 1136 (m), 839 (w), 722 (w), 704 (w) cm-1. 
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7.7 SYNTHESIS OF SYMMETRIC TWEEZERS 
Synthesis of the Template 193 
The preparation of 193 has already been described elsewhere.195 Therefore only the 
optimized reaction steps will be reported in the following.  
Methyl-3,5-bis(N-Fmoc-aminomethyl)benzoate (192) 
 
 
A solution of 190 (4.37 g 10.35 mmol, 1 eq) and sodium hydrogencarbonate (3.91 g, 
46.54 mmol, 4.5 eq) in water (80 mL) was stirred for 10 min. Then dioxane (160 mL) was 
added, the mixture cooled to 0° C and a solution of Fmoc-Cl (5.90 g, 22.8 mmol, 2.2 eq) in 
dioxane (80 mL) was added dropwise during 15 min. The reaction mixture was stirred for 
20 h while warming up to room temperature. The dioxane was removed via distillation under 
reduced pressure and 500 mL of water were added. The raw product was extracted with EA 
(4 × 750 mL). The organic phases were combined and the solvent was removed via 
distillation under reduced pressure. The resulting solid was purified by means of flash 
chromatography (SiO2, first EA/CyHex = 1/2 until elution of the first substance, then 
MeOH/EA = 1/9) to obtain 192 as white solid (4.70 g, 7.46 mmol, 71 %). 
C40H34N2O6 638.71 g/mol 
Yield 71 % 
Mp. 205° C 
Rf 0.53 (SiO2, CyHex/EA = 1/1) 
1H-NMR (300 MHz, DMSO-d6): δ = 3.83 (s, 3H, CH3), 4.10-4.36 (m, 10H, 2 × 
CH2, 2 × Fmoc-CH2, 2 × Fmoc-CH), 7.27-7.46 (m, 9H, CHar, 8 × Fmoc-
CHar), 7.63-7.63-7.72 (m, 4H, 4 × Fmoc-CHar), 7.78 (s, 2H, 2 × CHar), 
7.87 (t, 3J = 7.86 Hz, 4H, 4 × Fmoc-CHar), 7.98 (t, 3J = 6.06 Hz, 2H, 2 × 
NH) ppm. 
13C-NMR (75 MHz, DMSO-d6): δ = 43.48 (CH2), 46.69 (Fmoc-CH), 52.13 (CH3), 
65.54 (Fmoc-CH2), 120.11 (Fmoc-CHar), 125.12 (CHar), 126.32 (CHar), 
127.03 (CHar), 127.60 (CHar), 129.79 (Cq), 140.71 (Cq), 143.82 (Cq), 
145.19 (Cq), 156.32 (Fmoc-CO), 166.16 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 661.2340 [M + Na+]+ 
 calculated for C40H35N2O6+: 661.2309 
FT-IR (ATR): ߥ෤ = 3303 (br. m), 3064 (w), 3015 (w), 2951 (w), 2891 (w), 1719 
(m), 1691 (s), 1542 (s), 1446 (m), 1254 (s), 1217 (s), 1146 (s), 1046 (m), 
995 (m), 737 (s), 667 (m) cm-1. 
190 192 
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3,5-bis(N-Fmoc-aminomethyl)benzoic acid (193) 
 
 
A suspension of 192 (2.35 g, 3.68 mmol) in dioxane/water (2/1, 150 mL) was cooled to 0° C 
and concentrated, aqueous HCl (10 mL) was added slowly. The reaction mixture was heated 
(100° C oil bath temperature) and stirred for 26 h. The resulting solution was cooled to room 
temperature and 400 mL of water were added. The precipitate was filtrated, washed with 
water and dried in an dissicator over phosphorous pentoxide to give 193 (2.08 g, 3.33 mmol, 
90 %) as white solid. 
 
C39H32N2O6 624.68 g/mol 
Yield 90 % 
Mp. 212° C (decomposition) 
Rf 0.30 (SiO2, EA) 
1H-NMR (400 MHz, CDCl3): δ = 4.18-4.33 (m, 10H, 2 × CH2, 2 × Fmoc- CH2, 2 
× Fmoc-CH), 7.28 (m, 5H, 4 × Fmoc-CHar, CHar), 7.40 (dd, 3J1 = 3J2 = 
7.4 Hz, 4H, 4 × Fmoc-CHar), 7.69 (d, 3J = 7.3 Hz, 4H, 4 × Fmoc-CHar), 
7.77 (s, 2H, 2 × CHar), 7.88 (d, 3J = 7.5 Hz, 4H, 4 × Fmoc-CHar), 7.95 
(dd, 3J1 = 3J2 = 6.1 Hz, 2H, 2 × NH) ppm. 
13C-NMR (100 MHz, CDCl3): δ = 43.5 (CH2), 46.6 (Fmoc-CH), 65.4 (Fmoc- 
CH2), 120.0 (Fmoc-CHar), 125.1 (CHar), 126.4 (CHar), 126.9 (CHar), 
127.4 (CHar), 139.9 (Cq), 140.6 (Cq), 143.7 (Cq), 156.2 (Fmoc-CO) ppm. 
HR-MS (neg. ESI-ToF): m/z = 623.2160 [M – H+]- 
 calculated for C39H31N2O6-: 623.2188 
FT-IR (KBr disk): ߥ෤ = 3343 (m), 2921 (m), 2847 (w), 2093 (m), 1713 (s), 1691 
(s), 1522 (s), 1452 (m), 1364 (w), 1254 (s), 1222 (s), 1156 (s), 1044 (w), 
862 (w), 773 (w), 738 (m) cm-1. 
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Microwave Assisted SPPS of the Tweezer 196 (Phe-Lys-GCP) 
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1. 20 % piperidine/DMF
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The synthesis of 196 was carried out on 68 mg MBHA resin (1.30 mmol/g) according to the 
standard microwave-assisted procedure described in chapter 7.5. During coupling steps 5 % 
DIPEA was used as base. After attaching Fmoc-Gly-OH (93 mg, 0.27 mmol, 3 eq) with 
PyBOP (157 mg, 0.27 mmol, 3 eq), the resin was treated with Ac2O (48 µL, 0.44 mmol, 5 eq). 
After the coupling step the Fmoc groop was removed with 20 % piperidine/DMF. Then the 
template 193 (195 mg, 0.27 mmol, 3 eq) was coupled with 3 eq of PyBOP. Afterwards Fmoc-
Phe-OH (242 mg, 0.54 mmol, 6 eq), Fmoc-Lys(Boc)-OH (292 mg, 0.54 mmol, 6 eq), and 
Boc-GCP-OH (248 mg, 0.54 mmol, 6 eq) were coupled with 6 eq of PyBOP (314 mg, 
0.54 mmol). The cleavage of the product from the solid support was achieved without 
microwave irradiation according to the standard procedure for MBHA resin described in 
chapter 7.2. The raw product was purified via MPLC (RP18, methanol/water, 0.1 % TFA) and 
the trifluoroacetate counterions were exchanged by dissolving the product two times in 0.1 M 
aqueous HCl and one time in water followed by freeze drying under reduced pressure to 
obtain 187 as voluminous white solid (42 mg, 0.03 mmol, 37 %). 
 
C55H74Cl4N18O10 1289.10 g/mol 
Yield 37 % 
Mp. 230° C (decomposition) 
1H-NMR (500 MHz, MeOD-d4, TFA-salt): δ = 1.19-1.35 (m, 4H, 2 × Lys-CH2), 
1.52-1.62 (m, 4H, 2 × Lys-CH2), 1.64-1.75 (m, 4H, 2 × Lys-CH2), 2.80 
(t, 3J = 7.40 Hz, 4H, 2 × Lys-CH2), 4.07 (d, 3J = 15.49 Hz, 2H, CH2), 
4.25-4.39 (m, 4H, 2 × CH2), 4.55 (dd, 3J1 = 9.49 Hz, 3J2 = 5.20 Hz, 2H, 2 
193 
158 
196 
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× CH), 4.62 (d, 3J = 15.58 Hz, 2H, 2 × CH), 6.89 (d, 3J = 3.82 Hz, 2H, 2 
× Pyr-CH), 7.06 (d, 3J = 3.87 Hz, 2H, 2 × Pyr-CH), 7.12 (s, 1H, CHar), 
7.15-7.19 (m, 2H, 2 × Phe-CHar), 7.21-7.27 (m, 8H, 8 × Phe-CHar), 7.45 
(s, 2H, 2 × CHar) ppm. 
13C-NMR (125 MHz, MeOD-d4, TFA-salt): δ = 23.08 (Lys-CH2), 28.16 (Lys-
CH2), 31.48 (Lys-CH2), 37.27 (Phe-CH2), 40.47 (Lys-CH2), 43.35 (Gly-
CH2), 43.49 (CH2), 55.97 (CH), 56.87 (CH), 114.16 (CHar), 116.25 
(CHar), 125.26 (CHar), 127.10 (Cq), 127.77 (CHar), 129.55 (CHar), 130.31 
(CHar), 132.86 (Cq), 134.32 (Cq), 139.01 (Cq), 140.49 (), 157.18 (Cq), 
161.50 (Cq), 162.61 (Cq), 168.99 (Cq), 173.50 (Cq), 175.04 (Cq), 175.18 
(Cq) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1143.5690 [M – 3 HCl – Cl-]+ 
 calculated for C55H71N18O10+: 1143.5595 
FT-IR  (ATR): ߥ෤ = 3307 (br m), 2362 (w), 1665 (s), 1541 (s), 1280 (m), 1198 
(s), 1132 (s), 839 (m), 800 (m), 721 (w), 655 (m) cm-1. 
 
 
  
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
Microwave Assisted SPPS of the Tweezer 206 (Lys-Phe-GCP) 
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The tweezer 206 was synthesized accordingly on 200 mg MBHA resin (1.52 mmol/g) 
following the above described microwave-assisted SPPS procedure. During coupling steps 
5 % DIPEA was used as base and PyBOP as coupling agent. After attaching Fmoc-Gly-OH 
(272 mg, 0.92 mmol, 3 eq) capping with Ac2O (145 µL, 1.52 mmol, 5 eq), Fmoc deprotection 
and coupling of the template (379 mg, 0.92 mmol, 3 eq), the amino acids Fmoc-Lys(Boc)-OH 
(855 mg, 1.79 mmol, 6 eq), Fmoc-Phe-OH (707 mg, 1.79 mmol, 6 eq) and the binding motif 
Boc-GCP-OH (725 mg, 1.79 mmol, 6 eq) were coupled. The product was obtained as 
voluminous white solid (82 mg, 0.06 mmol, 21 %).  
 
C55H74Cl4N18O10 1289.10 g/mol 
Yield 21 % 
Mp. > 250° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.28-1.39 (m, 4H, 2 × Lys-CH2), 1.50-1.57 
(m, 4H, 2 × Lys-CH2), 1.59-1.67 (m, 2H, Lys-CH2), 1.69-1.78 (m, 2H, 
Lys-CH2), 2.70-2.78 (m, 4H, 2 × Lys-CH2), 2.90 (dd, 3J1 = 10.77 Hz, 3J2 
= 13.77 Hz, 2H, Phe-CH2), 2.90 (dd, 3J1 = 3.82 Hz, 3J2 = 13.75 Hz, 2H, 
Phe-CH2), 3.83 (ddd, 3J1 = 5.87 Hz, 3J2 = 3J3 = 13.75 Hz, 2H, Gly-CH2), 
4.24-4.37 (m, 6H, 2 × CH, 2 × CH2), 4.55 (ddd, 3J1 = 4.34 Hz, 
3J2 = 8.31 Hz, 3J3 = 10.83 Hz, 2H, 2 × CH), 6.85 (dd, 3J = 2.42 Hz, 4J = 
4.01 Hz, 2H, 2 × Pyr-CH), 7.14 (dd, 3J1 = 6.27 Hz, 3J2 = 13.56 Hz, 2H, 2 
× Phe-CHar), 7.23 (t, 3J = 7.58 Hz, 4H, 4 × Phe-CHar), 7.29 (s, 1H, CHar), 
7.33 (d, 3J = 7.26 Hz, 4H, 4 × Phe-CHar), 7.46 (dd, 3J = 2.35 Hz, 4J = 
4.03 Hz, 2H, 2 × Pyr-CH), 7.49 (s, 2H, NH2), 7.66 (s, 2H, 2 × CHar), 7.79 
(br. s, 6H, 2 × Lys-NH3+), 8.36-8.66 (m, 13H, 2 × GCP-NH4+, 5 × NH), 
206 
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8.75 (d, 3J = 8.05 Hz, 2H, 2 × NH), 11.95 (s, 2H, 2 × GCP-NH), 12.41 (s, 
2H, 2 × Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 22.21 (Lys-CH2), 26.46 (Lys-CH2), 31.19 
(Lys-CH2), 37.10 (Phe-CH2), 41.81 (Lys-CH2), 42.30 (Gly-CH2), 52.69 
(CH), 54.22 (CH), 113.21 (Pyr-CHar), 115.68 (Pyr-CHar), 124.39 (CHar), 
125.54 (Cq), 126.20 (CHar), 127.99 (CHar), 129.02 (CHar), 132.02 (Cq), 
134.09 (Cq), 137.84 (Cq), 139.35 (Cq), 155.28 (CO), 158.79 (CO), 159.57 
(CO), 166.17 (CO), 171.18 (CO), 171.31 (CO), 171.35 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1143.5649 [M + H+]+ 
 calculated for C55H71N18O10+: 1143.5595 
FT-IR (ATR): ߥ෤ = 3091 (br. m), 2948 (w), 2908 (w), 2840 (w), 1683 (s), 1650 
(s), 1558 (s), 1540 (s), 1508 (s), 1216 (s), 1116 (m), 1007 (w), 1268 (s), 
998 (s), 871 (s), 763 (m) cm-1. 
 
  
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
Microwave Assisted SPPS of the Tweezer 233 (Trp-Lys-Arg-GCP) 
 
The divalent DNA-ligand 233 was synthesized accordingly on 200 mg Fmoc-Rink-Amide 
resin (0.94 mmol/g) following the above described microwave-assisted SPPS procedure. 
During coupling steps 5 % DIPEA was used as base and PyBOP as coupling agent. After 
attaching Fmoc-Gly-OH (335 mg, 1.13 mmol, 6 eq) capping with Ac2O (176 µL, 1.188 mmol, 
10 eq), Fmoc deprotection and coupling of the template (352 mg, 0.56 mmol, 3 eq), the amino 
acids Fmoc-Trp(Boc)-OH (594 mg, 1.13 mmol, 6 eq), Fmoc-Lys(Boc)-OH (529 mg, 
1.13 mmol, 6 eq), Fmoc-Arg(Pbf)-OH (732 mg, 1.13 mmol, 6 eq), and the binding motif Boc-
GCP-OH (448 mg, 1.13 mmol, 6 eq) were coupled. The cleavage of the raw product was 
carried out without microwave irradiation according to the procedure described in chapter 7.2. 
After purification via MPLC (RP8, MeOH/water, 0.1 % TFA) and exchange of the counter 
ion from trifluoroacetate to chloride the product was obtained as voluminous white solid 
(20 mg, 0.06 mmol, 6 %).  
 
C71H102Cl6N28O12 1752.47 g/mol 
Yield 6 % 
Mp. > 250° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.23-1.29 (m, 4H, 2 × Lys-CH2), 1.42-1.57 
(m, 12H, 2 × Lys-CH2, 4 × Arg-CH2), 1.59-1.69 (m, 4H, 2 × Lys-CH2), 
2.65-2.72 (m, 4H, 2 × Lys-CH2), 2.99-3.13 (m, 8H, 2 × Trp-CH2, 2 × 
Arg-CH2), 3.80-3.93 (m, 2H, Gly-CH2), 4.18-4.33 (m, 6H, 2 × Arg-CH, 
2 × CH2,), 4.44-4.51 (m, 2H, 2 × CH), 4.55 (dd, 3J1 = 7.05 Hz, 3J2 = 
14.16 Hz, 2H, 2 × CH), 6.90 (s, 2H, 2 × Pyr-CHar), 6.94-7.00 (m, 2H, 2 
× Trp-CHar), 7.06 (br. s, 8H, 2 × Arg-NH4+), 7.08-7.16 (m, 6H, NH2, 2 
× Pyr-CHar, 2 × Trp-CHar), 7.32 (d, 3J = 8.18 Hz, 2H, 2 × Trp-CHar), 
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7.51 (s, 1H, CHar), 7.54-7.61 (m, 4H, 2 × NH, 2 × Trp-CHar), 7.62-7.74 
(m, 8H, 2 × Lys-NH3+, 2 × CHar), 8.05 (d, 3J = 7.56 Hz, 2H, 2 × NH), 
8.17 (d, 3J = 5.84 Hz, 2H, 2 × NH), 8.31-8.66 (m, 13H, 5 × NH, 2 × 
GCP-NH4+), 10.79 (s, 2H, Trp-NH), 11.38 (s, 2H, GCP-NH), 12.57 (s, 
2H, Pyr-NH) ppm. 
13C-NMR (175 MHz, DMSO-d6): δ = 22.09 (CH2), 25.15 (CH2), 26.56 (CH2), 
27.93 (CH2), 29.10 (CH2), 31.22 (CH2), 38.65 (CH2), 40.43 (CH2), 
42.03 (CH2), 42.41 (CH2), 48.52 (CH), 52.33 (CH), 53.64 (CH), 109.73 
(CHar), 111.33 (CHar), 113.77 (CHar), 114.95 (Cq), 116.50 (Cq), 118.24 
(CHar), 118.43 (CHar), 120.87 (CHar), 123.69 (CHar), 124.54 (CHar), 
125.70 (Cq), 127.31 (CHar), 129.01 (Cq), 129.57 (Cq), 134.08 (Cq), 
136.01 (Cq), 139.21 (Cq), 155.10 (CO), 156.64 (CO), 158.02 (CO), 
158.20 (CO), 158.36 (CO), 166.38 (CO), 171.36 (CO), 171.41 (CO), 
171.44 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 767.4103 [M – 4 HCl – 2 Cl-]2+ 
 calculated for C71H98N28O122+: 767.3954 
FT-IR (ATR): ߥ෤ = 3292 (br. w), 1699 (br. s), 1541 (br. S), 1418 (br. m), 1232 
(br. s), 1166 (br. s) cm-1. 
  
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
Microwave Assisted SPPS of the Tweezer 234 (Trp-Arg-Lys-GCP) 
 
The divalent DNA-ligand 234 was synthesized accordingly on 200 mg Fmoc-Rink-Amide 
resin (0.94 mmol/g) following the above described microwave-assisted SPPS procedure. 
During coupling steps 5 % DIPEA was used as base and PyBOP as coupling agent. After 
attaching Fmoc-Gly-OH (335 mg, 1.13 mmol, 6 eq), capping with Ac2O (176 µL, 
1.188 mmol, 10 eq), Fmoc deprotection and coupling of the template (352 mg, 0.56 mmol, 
3 eq), the amino acids Fmoc-Trp(Boc)-OH (594 mg, 1.13 mmol, 6 eq), Fmoc-Arg(Pbf)-OH 
(732 mg, 1.13 mmol, 6 eq), Fmoc-Lys(Boc)-OH (529 mg, 1.13 mmol, 6 eq), and the binding 
motif Boc-GCP-OH (448 mg, 1.13 mmol, 6 eq) were coupled. The cleavage of the raw 
product was carried out without microwave irradiation according to the procedure described 
in chapter 7.2. After purification via MPLC (RP8, MeOH/water, 0.1 % TFA) and exchange of 
the counter ion from trifluoroacetate to chloride the product was obtained as voluminous 
white solid (63 mg, 0.06 mmol, 19 %).  
 
C71H102Cl6N28O12 1752.47 g/mol 
Yield 19 % 
Mp. > 250° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.30-1.72 (m, 20H, 6 × Lys-CH2, 4 × Arg-
CH2), 2.71-2.81 (m, 4H, 2 × Lys-CH2), 2.98-3.09 (m, 6H, Trp-CH2, 2 × 
Arg-CH2), 3.14 (dd, 3J1 = 5.46 Hz, 3J2 = 14.41 Hz, 2H, Trp-CH2), 3.81-
3.91 (m, 2H, Gly-CH2), 4.16-4.34 (m, 6H, 2 × CH2, 2 × CH), 4.46 (dd, 
3J1 = 8.65 Hz, 3J2 = 13.16 Hz, 2H, 2 × CH), 4.61 (dd, 3J1 = 7.08 Hz, 3J2 
= 13.96 Hz, 2H, 2 × CH), 6.90 (dd, 4J = 2.33 Hz, 3J = 3.85 Hz, 2H, 2 × 
Pyr-CHar), 6.96 (t, 3J = 7.37 Hz, 2H, 2 × Trp-CHar), 7.05 (t, 3J = 
7.48 Hz, 2H, Trp-CHar), 7.09-7.15 (m, 4H, 2 × Pyr-CHar, 2 × Trp-CHar), 
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7.17 (s, 2H, NH2), 7.24 (br. s, 8H, 2 × Arg-NH4+), 7.32 (d, 3J = 8.11 Hz, 
2H, 2 × Trp-CHar), 7.52 (s, 1H, CHar), 7.56-7.56 (m, 4H, 2 × NH, 2 × 
Trp-CHar), 7.64 (s, 2H, 2 × CHar), 7.74 (s, 6H, 2 × Lys-NH3+), 8.00 (d, 
3J = 7.44 Hz, 2H, 2 × NH), 8.25 (d, 3J = 7.48 Hz, 2H, 2 × NH), 8.43-
8.79 (m, 13H, 5 × NH, 2 × GCP-NH4+), 10.79 (s, 2H, Trp-NH), 11.51 
(s, 2H, GCP-NH), 12.52 (s, 2H, Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 22.50 (CH2), 24.91 (CH2), 26.56 (CH2), 
27.93 (CH2), 28.89 (CH2), 31.20 (CH2), 38.65 (CH2), 40.32 (CH2), 
41.96 (CH2), 42.31 (CH2), 52.19 (CH), 52.53 (CH), 53.55 (CH), 109.54 
(CHar), 111.22 (Cq), 113.57 (CHar), 114.90 (CHar), 118.16 (CHar), 
118.32 (CHar), 120.83 (CHar), 123.55 (CHar), 124.56 (CHar), 125.58 
(Cq), 127.21 (CHar), 128.96 (Cq), 132.10 (Cq), 134.03 (Cq), 135.95 (Cq), 
139.17 (Cq), 155.13 (CO), 156.63 (CO), 158.22 (CO), 158.47 (CO), 
158.73 (CO), 158.93 (CO), 166.41 (CO), 171.15 (CO), 171.21 (CO), 
171.63 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 767.4194 [M – 4 HCl – 2 Cl-]2+ 
 calculated for C71H98N28O122+: 767.3954 
FT-IR (ATR): ߥ෤ = 3280 (br. w), 1698 (m), 1636 (br. s), 1540 (br. s), 1456 (br. 
m), 1252 (br. s), 1264 (br. s), 746 (s), 615 (br. s) cm-1. 
  
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
Microwave Assisted SPPS of the Tweezer 235 (Lys-Lys-Arg-GCP) 
 
The divalent DNA-ligand 235 was synthesized accordingly on 125 mg Fmoc-Rink-Amide 
resin (0.94 mmol/g) following the above described microwave-assisted SPPS procedure. 
During coupling steps 5 % DIPEA was used as base and PyBOP as coupling agent. After 
attaching Fmoc-Gly-OH (210 mg, 0.71 mmol, 6 eq), capping with Ac2O (110 µL, 1.18 mmol, 
10 eq), Fmoc deprotection and coupling of the template (440 mg, 0.71 mmol, 6 eq), the amino 
acids Fmoc-Lys(Boc)-OH (330 mg, 0.71 mmol, 6 eq), Fmoc-Lys(Boc)-OH (330 mg, 
0.71 mmol, 6 eq), Fmoc-Arg(Pbf)-OH (457 mg, 0.71 mmol, 6 eq), and the binding motif Boc-
GCP-OH (280 mg, 0.71 mmol, 6 eq) were coupled. The cleavage of the raw product was 
carried out without microwave irradiation according to the procedure described in chapter 7.2. 
After purification via MPLC (RP8, MeOH/water, 0.1 % TFA) and exchange of the counter 
ion from trifluoroacetate to chloride the product was obtained as voluminous white solid 
(18 mg, 0.01 mmol, 9 %).  
 
C61H108Cl8N28O12 1709.31 g/mol 
Yield 9 % 
Mp. > 250° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.22-1.39 (m, 8H, 4 × Lys-CH2), 1.42-1.84 
(m, 24H, 4 × Arg-CH2, 8 × Lys-CH2), 2.69-2.78 (m, 8H, 4 × Lys-CH2), 
3.12 (td, 4H, 3J1 = 6.87 Hz, 3J2 = 13.80 Hz, 2 × Arg-CH2), 3.78-3.92 
(ddd, 3J1 = 3J2 = 16.65 Hz, 3J3 = 6.56 Hz, Gly-CH2), 4.09-4.31 (m, 6H, 
2 × CH, 2 × CH2), 4.36 (dd, 3J1 = 15.41 Hz, 3J2 = 5.01 Hz, 2H, 2 × CH), 
4.47 (dd, 3J1 = 14.11 Hz, 3J2 = 6.50 Hz, 2H, 2 × CH), 6.91 (d, 3J = 
3.59 Hz, 2H, 2 × Pyr-CHar), 7.12 (d, 3J = 4.37 Hz, 2H, 2 × Pyr-
CHar),7.14 (br. s, 8H, 2 × Arg-NH4+), 7.17 (s, 2H, NH2), 7.28 (s, 2H, 2 
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× NH), 7.51 (s, 1H, CHar), 7.64 (s, 2H, 2 × CHar), 7.75 (br. s, 12H, 4 × 
Lys-NH3+), 8.04 (d, 3J = 6.42 Hz, 2H, 2 × NH), 8.17 (d, 3J = 7.10 Hz, 
2H, 2 × NH), 8.20-8.79 (m, 13H, 5 × NH, 2 × GCP-NH4+), 11.51 (s, 
2H, 2 × GCP-NH), 12.52 (s, 2H, 2 × Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 22.24 (CH2), 25.18 (CH2), 26.44 (CH2), 
26.52 (CH2), 28.83 (CH2), 30.87 (CH2), 31.27 (CH2), 38.54 (CH2), 
38.57 (CH2), 40.34 (CH2), 41.88 (CH2), 42.41 (CH2), 44.00 (CH), 52.51 
(CH), 52.68 (CH), 113.67 (CHar), 115.65 (CHar), 124.37 (CHar), 125.79 
(Cq), 128.89 (CHar), 134.15 (Cq), 139.42 (Cq), 156.85 (Cq), 159.11 (Cq), 
166.35 (Cq), 171.31 (Cq), 171.47 (Cq), 171.57 (Cq),171.60 (Cq) ppm. 
HR-MS (pos. ESI-ToF): m/z = 709.4035 [M – 4 HCl – 2 Cl-]2+ 
 calculated for C61H102N28O1222+: 709.4111 
FT-IR (ATR): ߥ෤ = 3273 (br. w), 1636 (br. s), 1541 (br. s), 1457 (w), 1280 (br. 
m), 1195 (br. m) cm-1. 
 
  
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
Microwave Assisted SPPS of the Tweezer 236 (Lys-Trp-Arg-GCP) 
 
The divalent DNA-ligand 236 was synthesized accordingly on 200 mg Fmoc-Rink-Amide 
resin (0.94 mmol/g) following the above described microwave-assisted SPPS procedure. 
During coupling steps 5 % DIPEA was used as base and PyBOP as coupling agent. After 
attaching Fmoc-Gly-OH (335 mg, 1.13 mmol, 6 eq), capping with Ac2O (176 µL, 1.88 mmol, 
10 eq), Fmoc deprotection and coupling of the template (352 mg, 0.56 mmol, 3 eq), the amino 
acids Fmoc-Lys(Boc)-OH (529 mg, 1.13 mmol, 6 eq), Fmoc-Trp(Boc)-OH (594 mg, 
1.13 mmol, 6 eq), Fmoc-Arg(Pbf)-OH (732 mg, 1.13 mmol, 6 eq), and the binding motif Boc-
GCP-OH (224 mg, 0.56 mmol, 3 eq) were coupled. The cleavage of the raw product was 
carried out without microwave irradiation according to the procedure described in chapter 7.2. 
After purification via MPLC (RP8, MeOH/water, 0.1 % TFA) and exchange of the counter 
ion from trifluoroacetate to chloride the product was obtained as voluminous white solid 
(49 mg, 0.03 mmol, 15 %).  
 
C71H102Cl6N28O12 1752.47 g/mol 
Yield 15 % 
Mp. > 250° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.22-1.32 (m, 4H, 2 × Lys-CH2), 1.39-1.61 
(m, 12H, 2 × Lys-CH2, 4 × Arg-CH2), 1.64-1.75 (m, 4H, 2 × Lys-CH2), 
2.68-2.79 (m, 4H, 2 × Lys-CH2), 2.99 (dd, 3J1 = 8.19 Hz, 3J2 = 
14.63 Hz, 2H, Trp-CH2), 3.07 (td, 3J1 = 6.61 Hz, 3J2 = 12.77 Hz, 4H, 2 
× Arg-CH2), 3.16 (dd, 3J1 = 4.04 Hz, 3J2 = 14.44 Hz, 2H, Trp-CH2), 
3.86 (ddd, 3J1 = 5.79 Hz, 3J2 = 16.30 Hz, 3J3 = 16.66 Hz, 2H, 2 × Gly-
CH2), 4.20-4.30 (m, 4H, 2 × CH2), 4.34 (dd, 3J1 = 5.55 Hz, 3J2 = 
15.57 Hz, 2H, 2 × CH), 4.46 (dd, 3J1 = 7.60 Hz, 3J2 = 13.72 Hz, 2H, 2 × 
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CH), 4.61 (dd, 3J1 = 7.82 Hz, 3J2 = 13.17 Hz, 2H, 2 × CH), 6.88-6.95 
(m, 4H, 2 × Trp-CHar, 2 × Pyr-CHar), 7.01 (t, 3J = 7.63 Hz, 2H, 2 × Trp-
CHar), 7.07 (br. s, 8H, 2 × Arg-NH4+), 7.08-7.11 (m, 6H, 2 × Pyr-CHar, 
2 × Trp-CHar, NH2), 7.29 (d, 3J = 8.16 Hz, 2H, 2 × Trp-CHar), 7.49 (s, 
1H, CHar), 7.54 (d, 3J = 7.86 Hz, 2H, 2 × Trp-CHar), 7.61 (t, 3J = 5.42, 
2H, 2 × NH), 7.65 (s, 2H, 2 × CHar), 7.73 (s, 6H, 2 × Lys-NH3+), 8.13 
(t, 3J = 8.18 Hz, 4H, 4 × NH), 8.36 (t, 3J = 5.43 Hz, 2H, 2 × NH), 8.47 
(br. s, 8H, 2 × GCP-NH4+), 8.54-8.62 m, 3H, 3 × NH), 10.78 (s, 2H, 
Trp-NH), 11.44 (s, 2H, GCP-NH), 12.52 (s, 2H, Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 22.15 (CH2), 25.01 (CH2), 26.61 (CH2), 
27.25 (CH2), 28.91 (CH2), 31.29 (CH2), 38.60 (CH2), 40.28 (CH2), 
41.81 (CH2), 42.32 (CH2), 52.48 (CH), 52.68 (CH), 53.26 (CH), 109.63 
(CHar), 111.13 (Cq), 113.60 (CHar), 114.89 (CHar), 118.10 (CHar), 
118.30 (CHar), 120.74 (CHar), 123.53 (CHar), 124.29 (CHar), 125.58 
(Cq), 127.20 (CHar), 132.01 (Cq), 134.07 (Cq), 135.88 (Cq), 139.35 (Cq), 
155.04 (CO), 156.61 (CO), 158.28 (CO), 158.53 (CO), 158.95 (CO), 
166.28 (CO), 171.17 (CO), 171.32 (CO), 171.36 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 767.4194 [M – 4 HCl – 2 Cl-]2+ 
 calculated for C71H98N28O122+: 767.3954 
FT-IR (ATR): ߥ෤ = 3176 (br. s), 11646 (br. s), 1541 (br. s), 1473 (br. m), 1254 
(br. s), 1194 (m), 814 (w), 747 (s) cm-1. 
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Microwave Assisted SPPS of the Tweezer 237 (Glu-Trp-Arg-GCP) 
 
The divalent DNA-ligand 237 was synthesized accordingly on 200 mg Fmoc-Rink-Amide 
resin (0.94 mmol/g) following the above described microwave-assisted SPPS procedure. 
During coupling steps 5 % DIPEA was used as base and PyBOP as coupling agent. After 
attaching Fmoc-Gly-OH (168 mg, 0.56 mmol, 3 eq), capping with Ac2O (176 µL, 1.88 mmol, 
10 eq), Fmoc deprotection and coupling of the template (352 mg, 0.56 mmol, 3 eq), the amino 
acids Fmoc-Glu(OtBu)-OH (480 mg, 1.13 mmol, 6 eq), Fmoc-Trp(Boc)-OH (594 mg, 
1.13 mmol, 6 eq), Fmoc-Arg(Pbf)-OH (732 mg, 1.13 mmol, 6 eq), and the binding motif Boc-
GCP-OH (224 mg, 0.56 mmol, 3 eq) were coupled. The cleavage of the raw product was 
carried out without microwave irradiation according to the procedure described in chapter 7.2. 
After purification via MPLC (RP8, MeOH/water, 0.1 % TFA) and exchange of the counter 
ion from trifluoroacetate to chloride the product was obtained as voluminous white solid 
(66 mg, 0.04 mmol, 21 %).  
 
C69H90Cl4N26O16 1681.43 g/mol 
Yield 21 % 
Mp. > 250° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.41-1.52 (m, 4H, 2 × CH2), 1.52-1.54 (m, 
2H, CH2), 1.67-1.76 (m, 2H, CH2), 1.77-1.95 (m, 2H, CH2), 1.92-1.99 
(m, 2H, CH2), 2.16-2.29 (m, 4H, 2 × Glu-CH2), 2.98 (dd, 3J1 = 8.11 Hz, 
3J2 = 14.24 Hz, 2H, Trp-CH2), 3.07 (td, 3J1 = 6.22 Hz, 3J2 = 12.49 Hz, 
4H, 2 × Arg-CH2), 3.16 (dd, 3J1 = 4.35 Hz, 3J2 = 14.55 Hz, 2H, Trp-
CH2), 3.86 (ddd, 3J1 = 5.79 Hz, 3J2 = 16.30 Hz, 3J3 = 16.66 Hz, 2H, 
Gly-CH2), 4.22-4.35 (m, 6H, 2 × CH, 2 × CH2), 4.45-4.53 (m, 2H, 2 × 
CH), 4.60 (dd, 3J1 = 7.85 Hz, 3J2 = 13.36 Hz, 2H, 2 × CH), 6.88-6.93 
237 
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(m, 4H, 2 × Trp-CHar, 2 × Pyr-CHar), 7.01 (t, 3J = 7.75 Hz, 2H, 2 × Trp-
CHar), 7.07-7.16 (m, 6H, NH2, 2 × Pyr-CHar, 2 × Trp-CHar), 7.17 (br. s, 
8H, 2 × Arg-NH4+), 7.28 (d, 3J = 8.14 Hz, 2H, 2 × Trp-CHar), 7.44 (s, 
1H, CHar), 7.48 (t, 3J = 5.46 Hz, 2H, 2 × NH), 7.55 (d, 3J = 7.97 Hz, 
2H, 2 × Trp-CHar), 7.66 (s, 2H, 2 × CHar), 8.16 (d, 3J = 7.07 Hz, 2H, 2 × 
NH), 8.22 (d, 3J = 7.43 Hz, 2H, 2 × NH), 8.27 (t, 3J = 5.86 Hz, 2H, 2 × 
NH), 8.85 (br. s, 8H, 2 × GCP-NH4+), 8.54-8.61 (m, 3H, 3 × NH), 10.77 
(s, 2H, Trp-NH), 11.29 (s, 2H, GCP-NH), 12.13 (br. s, 2H, CO2H), 
12.54 (s, 2H, Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 24.96 (CH2), 27.17 (CH2), 26.56 (CH2), 
27.25 (CH2), 29.10 (CH2), 30.06 (CH2), 40.31 (CH2), 41.89 (CH2), 
42.38 (CH2), 52.26 (CH), 53.30 (CH), 53.34 (CH), 109.69 (CHar), 
111.39 (CHar), 111.83 (Cq), 113.62 (CHar), 114.90 (CHar), 115.03 (Cq), 
118.11 (CHar), 118.32 (CHar), 120.74 (CHar), 123.50 (CHar), 124.48 
(CHar), 127.16 (Cq), 135.88 (Cq), 139.29 (Cq), 156.53 (CO), 158.09 
(CO), 158.32 (CO), 170.95 (CO), 171.10 (CO), 171.21 (CO), 171.47 
(CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 768.3458 
 calculated for C69H88N26O162+: 768.3431 
FT-IR (ATR): ߥ෤ = 3275 (br. w), 1636 (br. s), 1540 (br. s), 1436 (br. m), 1271 
(br. m), 1197 (br. s), 1134 (br. s), 800 (m), 721 (s) cm-1. 
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7.8 PREPARATION OF A TRIVALENT POLYNUCLEOTIDE LIGAND 
1,3,5-Tris(bromomethyl)benzene (212) 
 
Mesitylene (211, 2 mL, 14.3 mmol, 1 eq), NBS (9.83 g, 55.2 mmol, 3.8 eq) and AIBN 
(catalytic) were dissolved in CCl4 (60 mL) and refluxed (70° C oil bath temperature) for 40 h. 
After cooling down to room temperature, the resulting solid was filtrated and washed with 
CCl4. The solvent was removed via distillation in vacuum and the resulting brown oil was 
purified by means of flash chromatography (SiO2, CyHex/EA = 15/1) to obtain 212 as white 
solid (1.19 g, 3.35 mmol, 23 %. 
 
C9H9Br3 356.59 g/mol 
Yield 23 % 
Mp. 89-92° C 
Rf 0.56 (SiO2, CyHex/EA = 15/1) 
1H-NMR (300 MHz, CDCl3): δ = 4.46 (s, 6H, CH2), 7.35 (s, 3H, CHar.) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 32.2 (CH2), 129.9 (CHar.), 139.2 (Car.q) ppm. 
MS (pos. GC-EI) m/z = 356 [M – e-]+˙ 
FT-IR (ATR): ߥ෤ = 3027 (w), 2998 (w), 2965 (w), 2923 (w), 1209 (s) 1145 (s), 
979 (s), 701 (s) cm-1. 
 
  
211 212 
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1,3,5-Tris(N-phtalimidomethyl)benzene (213) 
 
Potassium phthalimide (411 mg, 2.22 mmol, 3.0 eq) and 212 (261 mg, 0.73 mmol, 1 eq) 
were dissolved in DMSO (40 mL) and refluxed (90° C oil bath temperature) for 6 h. After 
cooling down to room temperature water was added (200 mL) and the suspension was 
extracted with DCM (5 × 100 mL). The organic phases were combined and dried with 
Na2SO4. The solvent was then removed via distillation under reduced pressure and the 
resulting solid purified by flash chromatography (SiO2, DCM/acetone = 20/1) to obtain 213 as 
white solid (285 mg, 0.51 mmol, 84 %). 
 
C33H21N3O6 555.47 g/mol 
Yield 84 % 
Mp. 267° C 
Rf  0.55 (SiO2, DCM/acetone = 20/1) 
1H-NMR (500 MHz, CDCl3): δ = 4.78 (s, 6H, CH2), 7.35 (s, 3H, CHar), 7.68-7.83 
(m, 12H, CHar) ppm. 
13C-NMR (125 MHz, CDCl3): δ = 41.6 (CH2), 123.6 (CHar), 127.9 (CHar), 132.2 
(Cq), 134.1 (CHar), 137.5 (Cq), 168.2 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 578.1343 [M + Na+]+ 
 calculated for C33H21N3O6Na+: 578.1323 
FT-IR (ATR): ߥ෤ = 3027 (w), 2998 (w), 2965 (w), 2923 (w), 1209 (s) 1145 (s), 
979 (s), 701 (s) cm-1. 
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1,3,5-Triaminomethylbenzene (210) 
 
213 (39 mg, 0.07 mmol, 1 eq) was dissolved in EtOH/toluene (2/1, 30 mL) and heated to 
90° C. Hydrazine monohydrate (105 µL, 2.12 mmol, 30 eq) were added and the mixture 
refluxed for 72 h. After cooling down to room temperature the resulting solid was filtrated 
and washed with EtOH/toluene (2/1). The solvent was then removed via distillation under 
reduced pressure and the raw product resuspended in EA (30 mL). After addition of cold 
40 % KOH solution and phase separation the aqueous phase was was extracted with EA (4 × 
30 mL). The organic phases were combined and dried with Na2SO4. Afterwards the solvent 
was removed via distillation under reduced pressure to give 210 (11 mg, 0.07 mmol, 93 %) as 
white solid. 
 
C9H15N3 165.24 g/mol 
Yield 93 % 
Mp. 109-110° C 
1H-NMR (300 MHz, MeOD-d4): δ = 4.78 (s, 6H, CH2), 7.35 (s, 3H, CHar) ppm. 
13C-NMR (75 MHz, MeOD-d4): δ = 41.6 (CH2), 127.9 (CHar), 132.2 (Cq) ppm. 
HR-MS (pos. ESI-ToF): m/z = 166.1353 [M + H+]+ 
 calculated for C9H16N3+: 166.1339 
FT-IR (ATR): ߥ෤ = 3196 (br. s), 3019  (w), 2955  (w), 1631 (m), 1539 (m), 997 
(m), 882 (m), 764 (s), 628 (m), 619 (s) cm-1. 
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Microwave Assisted SPPS of the Fully Protected Side Chain 216 (Phe-Lys-GCP) 
 
The synthesis of fully protected 216 was carried out on 300 mg SASRIN resin (1.3 mmol/g) 
according to standard Fmoc SPPS as described in chapter 7.2. The attachment of the first 
amino acid Fmoc-Phe-OH (471 mg, 1.17 mmol, 3 eq) was carried out with DIC (182 µl, 
1.17 mmol, 3 eq), HOBt (179 mg, 1.17 mmol, 3 eq) and DMAP (catalytic) in DCM/DMF 
(7/3). Afterwards the resin was treated with Ac2O (110 µl, 1.17 mmol, 3 eq) in 3 % 
NMM/DMF (10 ml) and the Fmoc group was removed with 20 % piperidine/DMF. The next 
amino acid Fmoc-Lys(Boc)-OH (547 mg, 1.17 mmol, 3 eq) and the binding motif Boc-GCP-
OH (347 mg, 1.17 mmol, 3 eq) were coupled with PyBOP. The cleavage of the raw product 
was carried out without microwave irradiation according to the procedure described in chapter 
7.2. The product was precipitated by adding water, purified via MPLC (RP18, MeOH/water) 
to obtain the product 216 as voluminous white solid (74 mg, 0.04 mmol, 28 %).  
 
C32H45N7O9 671.74 g/mol 
Yield 28 % 
Mp. 177° C (decomposition) 
1H-NMR (500 MHz, CDCl3): δ = 1.36 (s, 9H, Boc-CH3), 1.38-1.47 (m, 8H, Lys-
CH2), 1.59 (s, 9H, Boc-CH3), 1.68-1.93 (m, 2H, Lys-CH2), 2.95-3.08 (m, 
2H, Lys-CH2), 3.12-3.30 (m, 2H Phe-CH2), 4.75 (s, 1H, NH); 4.89-5.01 
(m, 1H, Phe-CH), 5.69-5.80 (m, 1H, Lys-CH), 6.56-6.65 (m, 2H, Phe-
CHar, Pyr-CHar), 6.80-6.88 (m, 2H, Phe-CHar), 7.01-7.13 (m, 4H, NH, 2 
× Phe-CHar, Pyr-CHar), 8.35-8.44 (m, 1H, NH), 9.73 (br. s, 1H, Gua-NH), 
10.41 (br. s, 1H, Gua-NH), 11.65 (s, 1H, Pyr-NH), 11.82 (s, 1H, CO2H), 
12.01 (s, 1H, Gua-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 22.8 (Lys-CH2), 28.0 (Boc-CH3), 28.5 (Boc-
CH3), 29.9 (Lys-CH2), 35.0 (Lys-CH2), 39.0 (Phe-CH2), 40.5 (Lys-CH2), 
52.0 (Lys-CH), 55.0 (Phe-CH), 78.9 (Boc-Cq), 84.9 (Boc-Cq), 109.8 
(Pyr-CH), 119.6 (Pyr-CH), 126.5 (Phe-CHar), 127.2 (Phe-CHar), 129.2 
(Phe-CHar), 131.63 (Pyr-Cq), 136.6 (Phe-Cq), 155.3 (Cq), 156.0 (Cq), 
157.7 (Cq), 159.1 (Cq), 161.7 (Cq), 171.1 (Cq), 178.8 (Cq) ppm. 
HR-MS (neg. ESI-ToF): m/z = 670.3342 [M – H+]- 
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 calculated for C32H44N7O9-: 670.3206 
FT-IR (ATR): ߥ෤ = 3145 (br. w), 2948 (s), 1683 (s), 1623 (s), 1521 (s), 1247 (s), 
1199 (s), 1143 (s), 971 (s), 833 (s), 771 (s) cm-1. 
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Synthesis of the Trivalent DNA-Ligand 207 (Phe-Lys-GCP) 
 
 
To a solution of 216 (71 mg, 0.11 mmol, 3 eq) and HATU (41 mg, 0.11 mmol, 3 eq) in 
DMF (5 ml) 150 µl of DIPEA were added and the mixture was stirred for 1 h under argon 
atmosphere. After addition of the aromatic triamine scaffold 210 (6 mg 0.04 mmol, 1 eq) the 
solution was stirred for another 36 h under argon atmosphere. 210 was obtained as described 
in literature.216,217 Water (10 ml) was added and the resulting suspension extracted with ethyl 
acetate (3 × 25 ml). The combined organic phases were dried with Na2SO4 and the solvent 
was removed in vacuum. The resulting solid was purified by MPLC on normal phase silica 
gel (cyclohexane to ethyl acetate within 30 min), dissolved in 50 % TFA/DCM (10 ml) and 
stirred for 16 h under argon atmosphere. After removal of the solvent in vacuum the crude 
product was purified by MPLC (RP18, water to methanol within 30 min, 0.1 % TFA), re-
dissolved in 1 M aqueous HCl and freeze dried. The last step was repeated twice and after an 
additional lyophilization in pure water 207 was obtained as a white, voluminous 
hydrochloride salt (16 mg, 0.01 mmol, 26 %). 
C75H96N24O12 1744.48 g/mol 
Yield 26 % 
Mp. > 250° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 0.94-1.10 (m, 6H, 3 × Lys-CH2), 1.17-1.62 
(m, 12H, 63 × Lys-CH2), 2.63-3.11 (m, 12 H, 3 × Lys-CH2, 3 × Phe-
CH2); 4.07-4.60 (m, 12H, 3 × Lys-CH, 3 × CH2, 3 × Phe-CH), 6.83-6.91 
(m, 3H, 3 × Pyr-CHar), 6.97 (s, 3H, 3 × CHar), 7.01 (s, 3H, 3 × CHar), 
7.06-7.27 (m, 18H, 3 × Pyr-CH, 15 × Phe-CHar), 7.70 (br, s, 9H, 3 × Lys-
NH3), 8.30-8.67 (m, 12H, 3 × NH, 3 × Pyr-NH, 6 × Gua-NH), 11.38 (s, 
3H, 3 × Pyr-NH), 12.48 (s, 3H, 3 × Gua-NH) ppm. 
216 
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13C-NMR (125 MHz, DMSO-d6): δ = 22.2 (Lys-CH2), 26.6 (Lys-CH2), 31.4 (Lys-
CH2), 37.8 (Phe-CH2), 38.7 (Lys-CH2), 42.2 (CH2), 52.6 (Lys-CH), 53.9 
(Phe-CH), 113.7 (Pyr-CH), 115.0 (Pyr-CH), 125.0 (CHar), 126.3 (Phe-
CHar), 127.9 (Phe-CHar), 129.4 (CHar), 137.9 (Phe-Cq), 139.3 (Cq), 139.5 
(Cq), 158.4 (Cq), 158.7 (Cq), 158.9 (Cq), 171.0 (Cq), 171.4 (Cq) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1525.7583 [M – 5 HCl – Cl-]+ 
 calculated for C75H97N24O12+: 1525.7712 
FT-IR (ATR): ߥ෤ = 3152 (br. m), 2905 (w), 2362 (s), 2336 (s), 1701 (s), 1685 
(s), 1657 (s), 1541 (s), 1517 (s), 1289 (m), 828 (w), 685 (m) cm-1. 
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7.9 SPPS OF THE DNA-BINDER LIBRARY 
 
The synthesis of the library was carried out by means of standard Fmoc SPPS (chapter 7.2), 
which was altered slightly due to the IRORI MikroKan setting. First an isopycnic solution of 
Tentagel S NH2 (9.10 g, 0.32 mmol/g) was prepared in a mixture of hexane/DCM (1/8, 
104 mL) and 400 µL thereof were filled into each of the 259 MikroKans which were then 
equipped with a radiofrequency chip. After scanning of the MikroKans with the IRORI 
scanning station the resin was randomly split into three equal parts and swollen in DMF 
(80 mL) for 20 h in three Schlenck glass reaction vessels equipped with a frit. Then the 
attachment of the first amino acid Fmoc-Gly-OH (1.44 g per reaction vessel, 4.83 mmol, 5 eq) 
was conducted with PyBOP (2.54 g per reaction vessel, 4.83 mmol, 5 eq) in 3 % NMM/DMF 
(80 mL) by shaking the mixture for 20 h under argon atmosphere. After washing the beads 
three times for 10 min with DMF (80 mL) the coupling and washing steps were repeated 
another two times. 12 randomly chosen MicroKans were opened and a negative Kaiser test 
revealed complete conversion. This test was carried out after each coupling and deprotection 
step and in all cases led to the expected result. Fmoc deprotection was achieved by treating 
the solid support with 20 % piperidine/DMF (80 mL) two times for 1 h. The MikroKans were 
then thoroughly washed three times with DMF (80 mL), three times with DCM (80 mL), and 
another three times with DMF (80 mL) each time for 10 min. Afterwards the template 193 
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(1.81 g per reaction vessel, 2.90 mmol, 3 eq) was coupled similarly with PyBOP (1.51 g per 
reaction vessel, 2.90 mmol, 3 eq). This and all following coupling steps were repeated twice. 
Before carrying out the combinatorial steps the MikroKan containing the compound without 
amino acids in its side arms was identified and removed after the Fmoc deprotection step. The 
remaining MikroKans were split into six parts according to the IRORI software and each 
compartment was reacted with either Fmoc-Phe-OH (227, 1.87 g, 4.83 mmol, 10 eq), Fmoc-
Tyr(tBu)-OH (228, 2.21 g, 4.83 mmol, 10 eq), Fmoc-Trp(Boc)-OH (229, 2.54 g, 4.83 mmol, 
10 eq), Fmoc-Lys(Boc)-OH (230, 2.26 g, 4.83 mmol, 10 eq), Fmoc-Arg(Pbf)-OH (231, 
3.12 g, 4.83 mmol, 10 eq), or Fmoc-Glu(OtBu)-OH (232, 2.05 g, 4.83 mmol, 10 eq) with 
PyBOP (2.51 g, 4.83 mmol, 10 eq) in 3 % NMM/DMF (50 mL) under argon atmosphere for 
20 h. After the following Fmoc deprotection the sublibrary with just one amino acid per side 
chain was removed and the remaining MikroKans were again split into six parts and reacted 
as described above. After the next Fmoc deprotection step the next sublibrary containing 
members with two amino acids per arm was removed and another combinatorial step was 
carried out. After Fmoc deprotection all MikroKans were combined (containing the 
sublibraries) and randomly split into three parts. Finally, the binding motif Boc-GCP-OH 
(158, 2.39 g per reaction vessel, 5.80 mmol, 6 eq) was coupled with the help of PyBOP 
(3.02 g per reaction vessel, 5.80 mmol, 6 eq) in 3 % NMM/DMF (80 mL). The last coupling 
step was repeated three times in total. Before the last repetition Boc-GCP-OH was heated for 
20 min to 50° C together with PyBOP in 3 % NMM/DMF whereupon it dissolved with red 
colour and then added to the resin. The MikroKans were then washed three times for 10 min 
with DMF (80 mL), three times with DCM (80 mL), three times with MeOH (80 mL), 
another three times with (80 mL) and then dried under reduced pressure for 4 h. Afterwards 
the beads were treated with 95 % TFA containing 2.5 % water and 2.5 % TIS two times for 
2 h and washed two times for 10 min with DCM (80 mL), two times with MeOH (80 mL), 
three times with 0.1 N aqueous HCl (80 mL), two times with water (80 mL), two times with 
MeOH (80 mL), and two times with DCM (80 mL). Finally, the library 221 was dried under 
reduced pressure for 24 h. 
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7.10 SYNTHESIS OF AMPHIPHILIC GENE CARRIERS 
SPPS of the Fully Protected Headgroup 240 (Phe-Lys-GCP) 
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The synthesis of fully protected 240 was carried out on 150 mg SASRIN resin (1.3 mmol/g) 
according to the microwave-assisted Fmoc SPPS procedure described in chapter 7.5. After 
swelling of the resin in DCM/DMF (7/3, 5 mL), the attachment of the first amino acid Fmoc-
GABA-OH (190 mg, 0.59 mmol, 3 eq) was carried out without microwave irradiation with 
DIC (91 µl, 0.59 mmol, 3 eq), HOBt (79 mg, 0.59 mmol, 3 eq) and DMAP (catalytic) in 
DCM/DMF (7/3, 5 mL). The coupling step was repeated four times in total. Afterwards the 
resin was treated with Ac2O (55 µl, 0.59 mmol, 3 eq) in 5 % DIPEA/DMF (5 ml). The 
following removal of the Fmoc group and the coupling of the template 193 (365 mg, 
0.59 mmol, 3 eq) with PyBOP (304 mg, 0.59 mmol, 3 eq) as well as the couplings of the 
following amino acids Fmoc-Phe-OH (453 mg, 1.17 mmol, 6 eq), Fmoc-Lys(Boc)-OH 
(548 mg, 1.17 mmol, 6 eq) and the binding motif Boc-GCP-OH (158, 465 mg, 1.17 mmol, 
6 eq) were all carried out under argon atmosphere and microwave irradiation with PyBOP 
(609 mg, 1.17 mmol, 6 eq) in 5 % DIPEA/DMF (5 mL). All coupling steps were repeated 
twice. The cleavage of the raw product was carried out without microwave irradiation by 
treating the resin with 1 % TFA/DCM twelve times for 15 min followed by washing three 
times with DCM, three times with MeOH, and three times with DCM. The organic phases 
were combined and reduced via distillation in vacuum. The product was precipitated by 
adding water, purified via MPLC (RP8, H2O → MeOH) to obtain the product 240 as 
voluminous white solid (79 mg, 0.05 mmol, 26 %).  
 
  
193 
158 
240 
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS  
C77H105N17O19 1572.76 g/mol 
Yield 26 % 
Mp. 218° C 
1H-NMR (500 MHz, DMSO-d6): δ = 1.07-1.20 (m, 4H, 2 × Lys-CH2), 1.30-1.38 
(m, 22H, 2 × Boc-tBu, 2 × Lys-CH2), 1.46 (s, 18H, 2 × Boc-tBu), 1.50-
1.65 (m, 4H, 2 × Lys-CH2), 1.70-1.77 (m, 2H, CH2), 2.24 (t, 3J = 7.47 
Hz, 2H, CH2), 2.81-2.89 (m, 6H, 2 × Lys-CH2, CH2), 3.05 (dd, 3J1 = 4.75 
Hz, 3J2 = 13.67 Hz, 2H, Phe-CH2), 3.22-3.30 (m, 2H, Phe-CH2), 4.22-
4.35 (m, 6H, 2 × CH2, 2 × Lys-CH), 4.53 (dd, 3J1 = 8.60 Hz, 3J2 = 13.76 
Hz, 2H, 2 × Phe-CH), 6.73 (t, 3J = 5.52 Hz, 2H, 2 × Lys-NHBoc), 6.78-
6.82 (m, 2H, 2 × Pyr-CHar), 6.83-6.86 (m, 2H, 2 × Pyr-CHar), 7.10-7.21 
(m, 11H, 10 × Phe-CHar, CHar), 7.61 (s, 2H, 2 × CHar), 8.08 (d, 3J = 7.87 
Hz, 2H, 2 × NH), 8.36-8.47 (m, 5H, 5 × NH), 8.57 (s, 2H, NH), 9.34 (s, 
2H, NH), 11.37 (br. s, 2H, NH), 11.63 (s, 2H, Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 22.81 (CH2), 24.49 (CH2), 27.55 (Boc-CH3), 
27.68 (Boc-CH3), 29.19 (CH2), 31.04 (CH2), 37.29 (CH2), 38.50 (CH2), 
39.54 (CH2), 42.04 (CH2), 53.12 (CH), 53.93 (CH), 77.22 (Boc-Cq), 
80.76 (Boc-Cq), 112.36 (CHar), 112.93 (CHar), 113.58 (CHar), 124.70 
(CHar), 126.09 (CHar), 127.85 (CHar), 129.04 (CHar), 129.11 (CHar), 
134.65 (Cq), 137.58 (Cq), 139.08 (Cq), 155.42 (CO), 159 .63 (CO), 
166.02 (CO), 170.72 (CO), 171.65 (CO), 174.11 (CO) ppm. 
HR-MS (neg. ESI-ToF): m/z = 1570.7765 [M – H+]- 
 calculated for C77H104N17O19-: 1570.7700 
FT-IR (ATR): ߥ෤ = 3291 (br. w), 2930 (w), 1635 (br. s), 1523 (br. s), 1456 (m), 
1394 (m), 1367 (m), 1240 (br. s), 1147 (br. s), 1047 (m), 841 (m), 755 
(s), 700 (s) cm-1. 
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SPPS of the Fully Protected Headgroup 247 (Trp-Lys-Arg-GCP) 
O
H
N
OH
O
H
N
H
NO O
HN NH
OO
NHO
HN
O
HN O
NH
O
NH HN
NH
O
NHBoc
HN
HN
O
BocHN
NH
NHBoc
BocHN
NHBoc
HN NH
BocHN
NH
PbfHN
NH
NHPbf
 
The synthesis of fully protected 247 was synthesized accordingly on 150 mg SASRIN resin 
(1.3 mmol/g). After swelling of the resin in DCM/DMF (7/3, 5 mL), the attachment of the 
first amino acid Fmoc-Gly-OH (174 mg, 0.59 mmol, 3 eq) was carried out without microwave 
irradiation with DIC (91 µl, 0.59 mmol, 3 eq), HOBt (79 mg, 0.59 mmol, 3 eq) and DMAP 
(catalytic) in DCM/DMF (7/3, 5 mL). The coupling step was repeated four times in total. 
Afterwards the resin was treated with Ac2O (55 µl, 0.59 mmol, 3 eq) in 5 % DIPEA/DMF 
(5 ml). The following removal of the Fmoc group and the coupling of the template 193 
(365 mg, 0.59 mmol, 3 eq) with PyBOP (304 mg, 0.59 mmol, 3 eq) as well as the couplings 
of the following amino acids Fmoc-Trp(Boc)-OH (616 mg, 1.17 mmol, 6 eq), Fmoc-
Lys(Boc)-OH (548 mg, 1.17 mmol, 6 eq), and Fmoc-Arg(Pbf)-OH (759 mg, 1.17 mmol, 6 eq) 
were all carried out under argon atmosphere and microwave irradiation with PyBOP (609 mg, 
1.17 mmol, 6 eq) in 5 % DIPEA/DMF (5 mL). The binding motif Boc-GCP-OH (158, 
233 mg, 0.59 mmol, 3 eq) was coupled similarly with PyBOP (304 mg, 0.59 mmol, 3 eq). All 
coupling steps were repeated twice. The cleavage of the raw product was carried out without 
microwave irradiation by treating the resin with 1 % TFA/DCM containing 2.5 % water and 
2.5 % TIS four times for 2 h and another time for 20 h followed by washing three times with 
DCM, three times with MeOH, and three times with DCM. The organic phases were 
combined and reduced via distillation in vacuum. The product was precipitated by adding 
water, purified via MPLC (RP8, H2O → MeOH) to obtain the product 247 as voluminous 
white solid (62 mg, 0.02 mmol, 12 %).  
 
  
247 
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C127H175N27O31S2 2640.04 g/mol 
Yield 12 % 
Mp. 225-230° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.20-1.30 (m, 8H, 4 × CH2), 1.33 (s, 18H, 2 
× Boc-tBu), 1.35-1.40 (m, 12H, 4 × Pbf-CH3), 1.41-1.44 (m, 4H, 2 × 
CH2), 1.45 (s, 18H, 2 × Boc-tBu), 1.50-1.54 (m, 4H, 2 × CH2), 1.58 (s, 
18H, 2 × Boc-tBu), 1.61-1.78 (m, 4H, 2 × CH2), 1.95 (s, 6H, 2 × Pbf-
CH3), 2.38 (s, 6H, 2 × Pbf-CH3), 2.45 (s, 6H, 2 × Pbf-CH3), 2.78 (dd, 
3J1 = 6.22 Hz, 3J2 = 11.91 Hz, 4H, 2 × Lys-CH2), 2.89 (s, 4H, 2 × Pbf-
CH2), 2.96-3.11 (m, 8H, 2 × Arg-CH2, 2 × Trp-CH2), 3.87-3.95 (m, 2H, 
Gly-CH2), 4.20 (dd, 3J1 = 7.34 Hz, 3J2 = 13.16 Hz, 4H, 2 × CH2), 4.40 
(s, 2H, 2 × CH), 4.29-4.36 (m, 2H, 2 × CH), 4.59 (dd, 3J1 = 6.73 Hz, 3J2 
= 13.83 Hz, 2H, 2 × CH), 6.57 (s, 2H, 2 × NH), 6.67 (t, 3J = 5.34 Hz, 
2H, 2 × Trp-CHar), 6.81 (s, 4H, 4 × Pyr-CHar), 6.95 (s, 1H, CHar), 7.11 
(s, 2H, 2 × NH), 7.20 (t, 3J = 7.49 Hz, 2H, 2 × Trp-CHar), 7.25 (t, 3J = 
7.53 Hz, 2H, 2 × Trp-CHar), 7.49 (s, 2H, 2 × CHar), 7.62-7.69 (m, 4H, 4 
× Trp-CHar), 8.00 (d, 3J = 8.47 Hz, 2H, 2 × NH), 8.14 (s, 4H, 4 × NH), 
8.31 (s, 3H, 3 × NH), 8.55-8.68 (m, 6H, 6 × NH), 9.32 (s, 2H, NH), 
11.75 (s, 2H, Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 9.05 (CH3), 12.12 (CH3), 17.48 (CH3), 
18.82 (CH3), 22.51 (CH2), 25.41 (CH2), 27.13 (CH2), 27.58 (CH3), 
27.67 (CH3), 27.95 (CH3), 27.99 (CH2), 28.15 (CH2), 28.86 (CH2), 
29.07 (CH2), 31.62 (CH3), 40.08 (CH2), 40.25 (CH2), 42.32 (CH2), 
45.61 (CH2), 52.41 (CH), 52.55 (CH), 52.65 (CH), 77.18 (Cq), 83.35 
(Cq), 86.13 (Cq), 112.93 (CHar), 113.52 (CHar), 114.36 (CHar), 114.48 
(Cq), 116.09 (Cq), 116.29 (Cq), 119.26 (CHar), 122.27 (CHar), 123.69 
(CHar), 124.16 (CHar), 130.12 (Cq), 131.33 (Cq), 133.68 (Cq), 134.08 
(Cq), 134.45 (Cq), 137.14 (Cq), 139.08 (Cq), 148.91 (CO), 155.36 (CO), 
156.08 (CO), 157.28 (CO), 158.30 (CO), 159.53 (CO), 170.94 (CO), 
171.46 (CO), 171.64 (CO), 174.40 (CO) ppm. 
MS (neg. and pos. ESI-ToF): not found 
FT-IR (ATR): ߥ෤ = 3290 (br. m), 2924 (m), 2853 (m), 2161 (w), 2035 (w), 1654 
(s), 1542 (s), 1445 (m), 1275 (m), 1200 (s), 1132 (s), 838 (m), 800 (m), 
722 (m) cm-1. 
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SPPS of the Fully Protected Headgroup 248 (Trp-Arg-Lys-GCP) 
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The synthesis of fully protected 248 was synthesized accordingly on 150 mg SASRIN resin 
(1.3 mmol/g). After swelling of the resin in DCM/DMF (7/3, 5 mL), the attachment of the 
first amino acid Fmoc-Gly-OH (174 mg, 0.59 mmol, 3 eq) was carried out without microwave 
irradiation with DIC (91 µl, 0.59 mmol, 3 eq), HOBt (79 mg, 0.59 mmol, 3 eq) and DMAP 
(catalytic) in DCM/DMF (7/3, 5 mL). The coupling step was repeated four times in total. 
Afterwards the resin was treated with Ac2O (55 µl, 0.59 mmol, 3 eq) in 5 % DIPEA/DMF 
(5 ml). The following removal of the Fmoc group and the coupling of the template 193 
(365 mg, 0.59 mmol, 3 eq) with PyBOP (304 mg, 0.59 mmol, 3 eq) as well as the couplings 
of the following amino acids Fmoc-Trp(Boc)-OH (616 mg, 1.17 mmol, 6 eq), Fmoc-
Arg(Pbf)-OH (759 mg, 1.17 mmol, 6 eq), and Fmoc-Lys(Boc)-OH (548 mg, 1.17 mmol, 6 eq) 
were all carried out under argon atmosphere and microwave irradiation with PyBOP (609 mg, 
1.17 mmol, 6 eq) in 5 % DIPEA/DMF (5 mL). The binding motif Boc-GCP-OH (158, 
233 mg, 0.59 mmol, 3 eq) was coupled similarly with PyBOP (304 mg, 0.59 mmol, 3 eq). All 
coupling steps were repeated twice. The cleavage of the raw product was carried out without 
microwave irradiation by treating the resin with 1 % TFA/DCM containing 2.5 % water and 
2.5 % TIS four times for 2 h and another time for 20 h followed by washing three times with 
DCM, three times with MeOH, and three times with DCM. The organic phases were 
combined and reduced via distillation in vacuum. The product was precipitated by adding 
water, purified via MPLC (RP8, H2O → MeOH) to obtain the product 248 as voluminous 
white solid (62 mg, 0.02 mmol, 12 %).  
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C127H175N27O31S2 2640.04 g/mol 
Yield 12 % 
Mp. 225-230° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.19-1.29 (m, 12H, 6 × Lys-CH2), 1.32 (s, 
18H, 2 × Boc-tBu), 1.38 (s, 12H, 4 × Pbf-CH3), 1.46 (s, 18H, 2 × Boc-
tBu), 1.47-1.53 (m, 4H, 2 × CH2), 1.56 (s, 18H, 2 × Boc-tBu), 1.59-1.67 
(m, 4H, 2 × CH2), 1.97 (s, 6H, 2 × Pbf-CH3), 2.39 (s, 6H, 2 × Pbf-CH3), 
2.45 (s, 6H, 2 × Pbf-CH3), 2.81-2.89 (m 4H, 2 × Lys-CH2), 2.92 (s, 4H, 
2 × Pbf-CH2), 2.93-3.04 (m, 8H, 2 × Arg-CH2, 2 × Trp-CH2), 3.84-3.94 
(m, 2H, Gly-CH2), 4.18-4.30 (m, 6H, 2 × CH, 2 × CH2), 4.40 (s, 2H, 2 
× CH), 4.34 (s, 2H, 2 × CH), 4.60 (dd, 3J1 = 7.12 Hz, 3J2 = 13.49 Hz, 
2H, 2 × CH), 6.44 (s, 4H, 4 × NH), 6.71 (t, 3J = 5.49 Hz, 2H, 2 × Trp-
CHar), 6.78-6.84 (m, 4H, 4 × Pyr-CHar), 7.14 (s, 1H, CHar), 7.19 (t, 3J = 
7.41 Hz, 2H, 2 × Trp-CHar), 7.27 (t, 3J = 7.73 Hz, 2H, 2 × CHar), 7.62-
7.67 (m, 4H, 4 × Trp-CHar), 7.99 (d, 3J = 8.13 Hz, 2H, 2 × NH), 8.05 (d, 
3J = 5.82 Hz, 2H, 2 × NH), 8.07-8.15 (s, 3H, 3 × NH), 8.44 (s, 2H, 2 × 
NH), 8.57 (s, 6H, 6 × NH), 9.32 (s, 2H, 2 × NH), 11.67 (s, 2H, Pyr-NH) 
ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 8.63 (CH3), 12.15 (CH3), 17.48 (CH3), 
18.83 (CH3), 22.95 (CH2), 25.24 (CH2), 27.36 (CH2), 27.57 (CH3), 
27.67 (CH3), 27.94 (CH2), 28.14 (CH3), 28.18 (CH3), 29.00 (CH2), 
29.15 (CH3), 31.25 (CH2), 39.93 (CH2), 40.02 (CH2), 42.00 (CH2), 
42.34 (CH2), 45.65 (CH2), 52.33 (CH), 52.55 (CH), 53.00 (CH), 77.19 
(Cq), 83.33 (Cq), 83.49 (Cq), 86.16 (Cq), 112.90 (CHar), 113.62 (CHar), 
114.47 (CHar), 116.13 (Cq), 116.26 (Cq), 122.97 (CHar), 123.73 (CHar), 
124.20 (CHar), 124.50 (CHar), 131.35 (Cq), 133.09 (Cq), 134.46 (Cq), 
134.94 (Cq), 137.18 (Cq), 139.12 (Cq), 148.92 (CO), 155.42 (CO), 
155.96 (CO), 157.33 (CO), 157.74 (CO), 158.36 (CO), 159.65 (CO), 
170.86 (CO), 171.45 (CO), 172.09 (CO) ppm. 
MS (neg. and pos. ESI-ToF): not found 
FT-IR (ATR): ߥ෤ = 3311 (br. m), 2977 (m), 2931 (m), 2159 (w), 1634 (s), 1541 
(s), 1453 (m), 1368 (m), 1242 (s), 1148 (s), 1087 (s), 834 (w), 750 (m) 
cm-1. 
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SPPS of the Fully Protected Headgroup 249 (Lys-Trp-Arg-GCP) 
 
The synthesis of fully protected 248 was synthesized accordingly on 150 mg SASRIN resin 
(1.3 mmol/g). After swelling of the resin in DCM/DMF (7/3, 5 mL), the attachment of the 
first amino acid Fmoc-Gly-OH (174 mg, 0.59 mmol, 3 eq) was carried out without microwave 
irradiation with DIC (91 µl, 0.59 mmol, 3 eq), HOBt (79 mg, 0.59 mmol, 3 eq) and DMAP 
(catalytic) in DCM/DMF (7/3, 5 mL). The coupling step was repeated four times in total. 
Afterwards the resin was treated with Ac2O (55 µl, 0.59 mmol, 3 eq) in 5 % DIPEA/DMF 
(5 ml). The following removal of the Fmoc group and the coupling of the template 193 
(365 mg, 0.59 mmol, 3 eq) with PyBOP (304 mg, 0.59 mmol, 3 eq) as well as the couplings 
of the following amino acids Fmoc-Lys(Boc)-OH (548 mg, 1.17 mmol, 6 eq), Fmoc-
Trp(Boc)-OH (616 mg, 1.17 mmol, 6 eq), and Fmoc-Arg(Pbf)-OH (759 mg, 1.17 mmol, 6 eq) 
were all carried out under argon atmosphere and microwave irradiation with PyBOP (609 mg, 
1.17 mmol, 6 eq) in 5 % DIPEA/DMF (5 mL). The binding motif Boc-GCP-OH (158, 
233 mg, 0.59 mmol, 3 eq) was coupled similarly with PyBOP (304 mg, 0.59 mmol, 3 eq). All 
coupling steps were repeated twice. The cleavage of the raw product was carried out without 
microwave irradiation by treating the resin with 1 % TFA/DCM containing 2.5 % water and 
2.5 % TIS four times for 2 h and another time for 20 h followed by washing three times with 
DCM, three times with MeOH, and three times with DCM. The organic phases were 
combined and reduced via distillation in vacuum. The product was precipitated by adding 
water, purified via MPLC (RP8, H2O → MeOH) to obtain the product 248 as voluminous 
white solid (72 mg, 0.02 mmol, 14 %).  
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C127H175N27O31S2 2640.04 g/mol 
Yield 14 % 
Mp. 225-230° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.21-1.27 (m, 4H, 2 × Lys-CH2), 1.28-1.32 
(m, 4H, 2 × Lys-CH2), 1.34 (s, 18H, 2 × Boc-tBu), 1.37 (s, 12H, 4 × 
Pbf-CH3), 1.38 (s, 18H, 2 × Boc-tBu), 1.48-1.51 (m, 4H, 2 × Lys-CH2), 
1.54 (s, 18H, 2 × Boc-tBu), 1.69-1.71 (m, 4H, 2 × Lys-CH2), 1.95 (s, 
6H, 2 × Pbf-CH3), 2.38 (s, 6H, 2 × Pbf-CH3), 2.44 (s, 6H, 2 × Pbf-CH3), 
2.84 (dd, 3J1 = 6.98 Hz, 3J2 = 12.72 Hz, 4H, 2 × Lys-CH2), 2.89 (s, 4H, 
2 × Pbf-CH2), 2.93-3.05 (m, 8H, 2 × Arg-CH2, 2 × Trp-CH2), 3.91 (d, 3J 
= 5.07 Hz, 2H, Gly-CH2), 4.21-4.33 (m, 6H, 2 × CH, 2 × CH2), 4.40 (s, 
2H, 2 × CH), 4.67 (dd, 3J1 = 7.58 Hz, 3J2 = 13.64 Hz, 2H, 2 × CH), 6.35 
(s, 2H, 2 × NH), 6.73 (t, 3J = 5.14 Hz, 2H, 2 × Lys-NHBoc), 6.79 (s, 
2H, 2 × Pyr-CHar), 6.84 (s, 2H, 2 × Pyr-CHar), 7.16 (t, 3J = 7.42 Hz, 2H, 
2 × Trp-CHar), 7.25 (t, 3J = 7.48 Hz, 2H, 2 × Trp-CHar), 7.29 (s, 1H, 
CHar), 7.48 (s, 2H, 2 × CHar), 7.61-7.68 (m, 4H, 4 × Trp-CHar), 7.98 (d, 
3J = 7.85 Hz, 2H, 2 × NH), 8.06 (d, 3J = 6.54 Hz, 2H, 2 × NH), 8.22 (d, 
3J = 7.41 Hz, 2H, 2 × NH), 8.41 (d, 3J = 5.95 Hz, 4H, 4 × NH), 8.59 (s, 
2H, 2 × NH), 8.69 (t, 3J = 5.73 Hz, 1H, Gly-NH), 9.02 (s, 4H, 4 × NH), 
9.36 (s, 2H, NH), 11.64 (s, 2H, Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 8.54 (CH3), 12.13 (CH3), 17.48 (CH3), 
18.82 (CH3), 22.60 (CH2), 25.49 (CH2), 26.92 (CH2), 27.53 (CH3), 
27.68 (CH3), 28.17 (CH3), 29.16 (CH2), 29.24 (CH2), 30.61 (CH3), 
31.69 (CH2), 41.63 (CH2), 41.87 (CH2), 42.34 (CH2), 45.67 (CH2), 
52.18 (CH), 52.40 (CH), 52.87 (CH), 77.25 (Cq), 83.25 (Cq), 86.18 (Cq), 
113.00 (CHar), 113.60 (CHar), 114.30 (CHar), 116.12 (Cq), 116.34 (Cq), 
119.28 (CHar), 122.27 (CHar), 123.71 (CHar), 124.11 (CHar), 124.19 
(Cq), 124.39 (CHar), 128.92 (CHar), 129.39 (Cq), 130.22 (Cq), 131.37 
(Cq), 133.89 (Cq), 134.02 (Cq), 134.50 (Cq), 137.17 (Cq), 139.43 (Cq), 
148.92 (CO), 155.44 (CO), 155.93 (CO), 157.33 (CO), 157.60 (CO), 
157.85 (CO), 158.08 (CO), 158.22 (CO), 159.37 (CO), 166.23 (CO), 
170.83 (CO), 171.19 (CO), 171.37 (CO), 171.60 (CO) ppm. 
MS (neg. and pos. ESI-ToF): not found 
FT-IR (ATR): ߥ෤ = 3318 (br. m), 2981 (m), 2506 (w), 1670 (s), 1541 (s), 1454 
(m), 1369 (m), 1248 (m), 1128 (s), 1034 (m), 829 (m), 799 (m), 719 (m) 
cm-1. 
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Synthesis of the Amphiphile 243 (Phe-Lys-GCP) 
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The protected headgroup 240 (65 mg, 0.04 mmol, 1 eq) and dioctadecylamine (241, 22 mg, 
0.04 mmol, 1 eq) were suspended in CHCl3. Under argon atmosphere HCTU (21 mg, 
0.05 mmol, 1.2 eq) and DMAP (15 mg, 0.11 mmol, 3 eq) were added and the suspension was 
stirred for 20 h at room temperature. Then 10 mL DMF were added and the mixture was 
stirred for 4 h at 40° C (oil bath temperature). The chloroform was removed via distillation 
under reduced pressure and water (40 mL) was added. The resulting solid was filtrated, 
purified by MPLC (RP8, water/MeOH) and treated with 50 % TFA/DCM containing 5 % TIS 
for 9 h under argon atmosphere. The solvent was removed via distillation under reduced 
pressure, water was added and the solution was lyophilized. The raw product was then 
purified by MPLC (RP8, H2O → MeOH, 0.01 % TFA) and dissolved two times in 0.1 N 
aqueous HCl and another time in water followed by lyophilization to obtain 243 (18 mg, 
0.01 mmol, 24 %) as voluminous white solid. 
 
C93H150Cl4N18O10 1822.11 g/mol 
Yield 24 % 
Mp. > 275° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 0.75-1.86 (m, 82H, 32 × C18-CH2, 6 × Lys-
CH2, 2 × C18-CH3), 1.93-2.07 (m, 2H, CH2), 2.29 (t, 3J = 7.21 Hz, 2H, 
CH2), 2.35-2.47 (m, 2H, C18-NCH2), 2.56-2.65 (m, 2H, C18-NCH2), 
2.67-2.80 (m, 4H, 2 × Lys-CH2), 2.85 (dd, 3J 1 = 9.46 Hz, 3J 2 = 13.27 
Hz, 2H, CH2), 3.00-3.10 (m, 2H, Phe-CH2), 3.14-3.19 (m, 2H, Phe-
CH2), 4.20-4.41 (m, 6H, 2 × CH2, 2 × Lys-CH), 4.51-4.60 (m, 2H, 2 × 
Phe-CH), 6.84 (br. s, 2H, 2 × Pyr-CHar), 7.03-7.40 (m, 13H, 10 × Phe-
240 241 
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CHar, CHar, 2 × Pyr-CHar), 7.41-8.82 (m, 15H, 8 × GCP-NH4+, 7 × NH), 
11.31 (br. s, 2H, 2 × NH), 11.94 (br. s, 2H, 2 × Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 14.00 (CH3), 22.19 (CH2), 22.45 (CH2), 
25.11 (CH2), 26.16 (CH2), 26.41 (CH2), 26.70 (CH2), 27.32 (CH2), 
28.59 (CH2), 28.65 (CH2), 28.74 (CH2), 28.79 (CH2), 28.88 (CH2), 
28.94 (CH2), 28.96 (CH2), 28.99 (CH2), 31.04 (CH2), 31.36 (CH2), 
37.59 (CH2), 38.83 (CH2), 38.86 (CH2), 42.20 (CH2), 45.28 (CH2), 
47.33 (CH2), 49.37 (CH2), 52.96 (CH), 54.11 (CH), 113.71 (CHar), 
124.82 (CHar), 126.32 (CHar), 128.04 (CHar), 129.25 (CHar), 137.65 
(Cq), 139.22 (Cq), 158.25 (CO), 158.48 (CO), 158.75 (CO), 166.24 
(CO), 170.97 (CO), 171.27 (CO), 171.51 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1677.1617 [M – 3 HCl – Cl-]+ 
 calculated for C93H147N18O10+: 1677.1572 
FT-IR (ATR): ߥ෤ = 3264 (br. w), 2921 (w), 2852 (w), 1698 (m), 1636 (s), 1541 
(s), 1457 (m), 1277 (m), 1200 (m), 749 (s), 700 (s), 626 (s) cm-1. 
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Synthesis of the Amphiphile 250 (Trp-Lys-Arg-GCP) 
 
Fully protected 247 (20.0 mg, 7.6 µmol, 1 eq), Boc-Gly-dioctadecylamide 246 (6.5 mg, 
9.3 mmol, 1.2 eq) and PyBOP (5.4 mg, 11.4 mmol, 1.4 eq) were dissolved in 7.5 % 
DIPEA/DMF (13 mL) under argon atmosphere and stirred for 16 h. 246 was prepared as 
described in literature.263 Water (100 mL) was added, the pH was adjusted to 7 by adding 1 N 
aqueous HCl and the mixture was extracted four times with EA (100 mL). The organic phases 
were combined and the solvent was removed via distillation under reduced pressure. The 
yellowish, viscous residue was treated with TFA containing 2.5 % water and 2.5 % TIS under 
argon atmosphere for 4 h. The solvent was removed via distillation in vacuum and the crude 
product was purified by MPLC (RP8, H2O → MeOH, 0.1 % TFA). The resulting product was 
dissolved two times in 0.1 N aqueous HCl and another time in water followed by 
lyophilization to obtain 250 (11.3 mg, 4.9 µmol, 65 %) as hydrochloride salt. 
 
C109H177Cl6N29O13 2314.48 g/mol 
Yield 65 % 
Mp. > 180° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 1.20-1.30 (m, 8H, 4 × CH2), 1.33 (s, 18H, 2 
× Boc-tBu), 1.35-1.40 (m, 12H, 4 × Pbf-CH3), 1.41-1.44 (m, 4H, 2 × 
CH2), 1.45 (s, 18H, 2 × Boc-tBu), 1.50-1.54 (m, 4H, 2 × CH2), 1.58 (s, 
18H, 2 × Boc-tBu), 1.61-1.78 (m, 4H, 2 × CH2), 1.95 (s, 6H, 2 × Pbf-
CH3), 2.38 (s, 6H, 2 × Pbf-CH3), 2.45 (s, 6H, 2 × Pbf-CH3), 2.78 (dd, 
3J1 = 6.22 Hz, 3J2 = 11.91 Hz, 4H, 2 × Lys-CH2), 2.89 (s, 4H, 2 × Pbf-
CH2), 2.96-3.11 (m, 8H, 2 × Arg-CH2, 2 × Trp-CH2), 3.87-3.95 (m, 2H, 
Gly-CH2), 4.20 (dd, 3J1 = 7.34 Hz, 3J2 = 13.16 Hz, 4H, 2 × CH2), 4.40 
(s, 2H, 2 × CH), 4.29-4.36 (m, 2H, 2 × CH), 4.59 (dd, 3J1 = 6.73 Hz, 3J2 
= 13.83 Hz, 2H, 2 × CH), 6.57 (s, 2H, 2 × NH), 6.67 (t, 3J = 5.34 Hz, 
2H, 2 × Trp-CHar), 6.81 (s, 4H, 4 × Pyr-CHar), 6.95 (s, 1H, CHar), 7.11 
(s, 2H, 2 × NH), 7.20 (t, 3J = 7.49 Hz, 2H, 2 × Trp-CHar), 7.25 (t, 3J = 
7.53 Hz, 2H, 2 × Trp-CHar), 7.49 (s, 2H, 2 × CHar), 7.62-7.69 (m, 4H, 4 
× Trp-CHar), 8.00 (d, 3J = 8.47 Hz, 2H, 2 × NH), 8.14 (s, 4H, 4 × NH), 
8.31 (s, 3H, 3 × NH), 8.55-8.68 (m, 6H, 6 × NH), 9.32 (s, 2H, NH), 
11.75 (s, 2H, Pyr-NH) ppm. 
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13C-NMR (125 MHz, DMSO-d6): δ = 9.05 (CH3), 12.12 (CH3), 17.48 (CH3), 
18.82 (CH3), 22.51 (CH2), 25.41 (CH2), 27.13 (CH2), 27.58 (CH3), 
27.67 (CH3), 27.95 (CH3), 27.99 (CH2), 28.15 (CH2), 28.86 (CH2), 
29.07 (CH2), 31.62 (CH3), 40.08 (CH2), 40.25 (CH2), 42.32 (CH2), 
45.61 (CH2), 52.41 (CH), 52.55 (CH), 52.65 (CH), 77.18 (Cq), 83.35 
(Cq), 86.13 (Cq), 112.93 (CHar), 113.52 (CHar), 114.36 (CHar), 114.48 
(Cq), 116.09 (Cq), 116.29 (Cq), 119.26 (CHar), 122.27 (CHar), 123.69 
(CHar), 124.16 (CHar), 130.12 (Cq), 131.33 (Cq), 133.68 (Cq), 134.08 
(Cq), 134.45 (Cq), 137.14 (Cq), 139.08 (Cq), 148.91 (CO), 155.36 (CO), 
156.08 (CO), 157.28 (CO), 158.30 (CO), 159.53 (CO), 170.94 (CO), 
171.46 (CO), 171.64 (CO), 174.40 (CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1048.6949 [M – 2 HCl – 2 Cl-]2+ 
 calculated for C109H173N29O132+: 1048.6893 
FT-IR (ATR): ߥ෤ = 2924 (m), 2853 (m), 2358 (w), 1663 (s), 1549 (m), 1433 
(m), 1278 (m), 1179 (s), 1129 (s), 836 (m), 800 (m), 720 (s) cm-1. 
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Synthesis of the Amphiphile 251 (Trp-Arg-Lys-GCP) 
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Fully protected 248 (30.1 mg, 11.4 µmol, 1 eq), Boc-Gly-dioctadecylamide 246 (10.4 mg, 
15.0 mmol, 1.3 eq) and PyBOP (8.9 mg, 17.1 mmol, 1.5 eq) were dissolved in 7.5 % 
DIPEA/DMF (15 mL) under argon atmosphere and stirred for 16 h. 246 was prepared as 
described in literature.263 Water (100 mL) was added, the pH was adjusted to 7 by adding 1 N 
aqueous HCl and the mixture was extracted four times with EA (100 mL). The organic phases 
were combined and the solvent was removed via distillation under reduced pressure. The 
yellowish, viscous residue was treated with TFA containing 2.5 % water and 2.5 % TIS under 
argon atmosphere for 4 h. The solvent was removed via distillation in vacuum and the crude 
product was purified by MPLC (RP8, H2O → MeOH, 0.1 % TFA). The resulting product was 
dissolved two times in 0.1 N aqueous HCl and another time in water followed by 
lyophilization to obtain 251 (11.4 mg, 4.9 µmol, 43 %) as hydrochloride salt. 
 
C109H177Cl6N29O13 2314.48 g/mol 
Yield 43 % 
Mp. > 180° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 0.84 (t, 3J = 6.75 Hz, 6H, 2 × CH3), 1.13-
1.29 (m, 64H, 16 × C18-CH2), 1.31-1.73 (m, 20H, 6 × Lys-CH2, 4 × 
Arg-CH2), 2.75 (s, 4H, 2 × Lys-CH2), 2.98-3.22 (m, 12H, 2 × C18-CH2, 
2 × Trp-CH2, 2 × Arg-CH2), 3.89-4.05 (m, 4H, 2 × Gly-CH2), 4.19 (dd, 
3J1 = 4.83 Hz, 3J2 = 15.70 Hz, 2H, 2 × CH), 4.25-4.35 (m, 4H, 2 × 
CH2), 4.45 (dd, 3J1 = 8.54 Hz, 3J2 = 12.33 Hz, 2H, 2 × CH), 4.56 (dd, 
3J1 = 6.88 Hz, 3J2 = 13.63 Hz, 2H, 2 × CH), 6.90 (s, 2H, 2 × Pyr-CHar), 
6.96 (t, 3J = 7.41 Hz, 2H, 2 × Trp-CHar), 7.04 (t, 3J = 7.20 Hz, 2H, 2 × 
Trp-CHar), 7.08-7.15 (m, 3H, CHar, 2 × Trp-CHar), 7.16-7.20 (m, 4H, 2 
× NH, 2 × Pyr-CHar), 7.25 (br. s, 8H, 2 × Arg-NH4+), 7.31 (d, 3J = 
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8.12 Hz, 2H, 2 × Trp-CHar), 7.53-7.61 (m, 4H, 2 × NH, 2 × Trp-CHar), 
7.66 (s, 2H, 2 × CHar), 7.71 (br. s, 6H, 2 × Lys-NH3+), 8.01 (d, 3J = 
6.91 Hz, 2H, 2 × NH), 8.08 (t, 3J = 4.82 Hz, 1H, Gly-NH), 8.24 (d, 3J = 
7.05 Hz, 2H, 2 × NH), 8.43-8.63 (m, 10H, 2 × NH, 2 × GCP-NH4+), 
8.71 (t, 3J = 5.47 Hz, 1H, Gly-NH), 10.77 (s, 2H, Trp-NH), 11.52 (s, 
2H, GCP-NH), 12.52 (s, 2H, Pyr-NH) ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 13.85 (CH3), 22.00 (CH2), 22.48 (CH2), 
24.89 (CH2), 26.02 (CH2), 26.22 (CH2), 26.55 (CH2), 27.09 (CH2), 
28.13 (CH2), 28.53 (CH2), 28.61 (CH2), 28.78 (CH2), 28.80 (CH2), 
28.83 (CH2), 28.88 (CH2), 28.91 (CH2), 28.93(CH2), 31.20 (CH2), 34.27 
(CH2), 38.65 (CH2), 40.24 (CH2), 40.31 (CH2), 41.73 (CH2), 41.98 
(CH2), 42.44 (CH2), 44.08 (CH2), 46.26 (CH2), 52.18 (CH), 52.53 (CH), 
53.49 (CH), 109.53 (CHar), 111.21 (Cq), 113.51 (CHar), 115.89 (CHar), 
118.14 (Cq), 118.27 (CHar), 118.32 (CHar), 120.75 (CHar), 123.57 
(CHar), 124.58 (Cq), 124.72 (Cq), 127.20 (CHar), 133.86 (Cq), 135.95 
(Cq), 139.22 (Cq), 156.59 (CO), 157.91 (CO), 158.16 (CO), 158.40 
(CO), 158.65 (CO), 167.28 (CO), 169.19 (CO), 171.18 (CO), 171.62 
(CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1048.6911 [M – 2 HCl – 2 Cl-]2+ 
 calculated for C109H173N29O132+: 1048.6893 
FT-IR (ATR): ߥ෤ = 2924 (m), 2539 (m), 1639 (s), 1663 (s), 1549 (m), 1276 
(m), 1200 (s), 1179 (s), 1132 (s), 837 (m), 800 (m), 721 (s) cm-1. 
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Synthesis of the Amphiphile 252 (Lys-Trp-Arg-GCP) 
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Fully protected 248 (30.9 mg, 11.5 µmol, 1 eq), Boc-Gly-dioctadecylamide 246 (9.9 mg, 
14.3 mmol, 1.2 eq) and PyBOP (7.2 mg, 13.8 mmol, 1.2 eq) were dissolved in 7.5 % 
DIPEA/DMF (15 mL) under argon atmosphere and stirred for 16 h. 246 was prepared as 
described in literature.263 Water (100 mL) was added, the pH was adjusted to 7 by adding 1 N 
aqueous HCl and the mixture was extracted four times with EA (100 mL). The organic phases 
were combined and the solvent was removed via distillation under reduced pressure. The 
yellowish, viscous residue was treated with TFA containing 2.5 % water and 2.5 % TIS under 
argon atmosphere for 4 h. The solvent was removed via distillation in vacuum and the crude 
product was purified by MPLC (RP8, H2O → MeOH, 0.1 % TFA). The resulting product was 
dissolved two times in 0.1 N aqueous HCl and another time in water followed by 
lyophilization to obtain 251 (14.2 mg, 6.1 µmol, 53 %) as hydrochloride salt. 
 
C109H177Cl6N29O13 2314.48 g/mol 
Yield 53 % 
Mp. > 180° C (decomposition) 
1H-NMR (500 MHz, DMSO-d6): δ = 0.85 (t, 3J = 6.87 Hz, 6H, 2 × CH3), 1.17-
1.27 (m, 64H, 16 × C18-CH2), 1.35-1.62 (m, 16H, 3 × Lys-CH2, 4 × 
Arg-CH2), 1.63-1.76 (m, 4H, 2 × Lys-CH2), 2.70-2.76 (m, 4H, 2 × Lys-
CH2), 2.96-3.20 (m, 12H, 2 × C18-CH2, 2 × Trp-CH2, 2 × Arg-CH2), 
3.88-4.05 (m, 4H, 2 × Gly-CH2), 4.20-4.29 (m, 4H, 2 × CH2), 4.34 (dd, 
3J1 = 5.25 Hz, 3J2 = 15.81 Hz, 2H, 2 × CH), 4.44 (s, 2H, 2 × CH), 4.60 
(dd, 3J1 = 7.35 Hz, 3J2 = 12.77 Hz, 2H, 2 × CH), 6.85-6.93 (m, 4H, 2 × 
Pyr-CHar, 2 × Trp-CHar), 7.00 (t, 3J = 7.51 Hz, 2H, 2 × Trp-CHar), 7.08-
7.24 (m, 7H, CHar, 2 × Trp-CHar, 2 × NH, 2 × Pyr-CHar), 7.26 (br. s, 
8H, 2 × Arg-NH4+), 7.28 (d, 3J = 7.95 Hz, 2H, 2 × Trp-CHar), 7.54 (d, 3J 
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= 7.91 Hz, 2 × Trp-CHar), 7.61 (s, 2H, 2 × NH,), 7.67 (s, 2H, 2 × CHar), 
7.73 (br. s, 6H, 2 × Lys-NH3+), 8.04 (d, 3J = 4.85 Hz, 1H, Gly-NH), 
8.14 (t, 3J = 6.80 Hz, 2H, 2 × NH), 8.35 (s, 2H, 2 × NH), 8.41-8.70 (m, 
10H, 2 × NH, 2 × GCP-NH4+), 8.74 (t, 3J = 5.64 Hz, 1H, Gly-NH), 
10.77 (s, 2H, Trp-NH), 11.49 (s, 2H, GCP-NH), 12.52 (s, 2H, Pyr-NH) 
ppm. 
13C-NMR (125 MHz, DMSO-d6): δ = 13.95 (CH3), 22.09 (CH2), 22.26 (CH2), 
25.09 (CH2), 26.12 (CH2), 26.32 (CH2), 26.70 (CH2), 27.16 (CH2), 
28.21 (CH2), 28.64 (CH2), 28.70 (CH2), 28.89 (CH2), 28.94 (CH2), 
28.97 (CH2), 29.00 (CH2), 29.03 (CH2), 31.29 (CH2), 38.72 (CH2), 
40.34 (CH2), 40.38 (CH2), 41.89 (CH2), 42.40 (CH2), 42.61 (CH2), 
44.18 (CH), 52.38 (CH), 52.39 (CH), 109.74 (CHar), 111.21 (Cq), 
113.67 (CHar), 116.02 (CHar), 118.17 (Cq), 118.40 (CHar), 120.81 
(CHar), 123.62 (CHar), 135.98 (Cq), 139.51 (Cq), 156.70 (CO), 158.20 
(CO), 158.44 (CO), 166.37 (CO), 167.47 (CO), 171.48 (CO), 171.53 
(CO) ppm. 
HR-MS (pos. ESI-ToF): m/z = 1048.6923 [M – 2 HCl – 2 Cl-]2+ 
 calculated for C109H173N29O132+: 1048.6893 
FT-IR (ATR): ߥ෤ = 3273 (br. m), 2923 (m), 2852 (m), 2359 (w), 1638 (s), 1541 
(s), 1434 (m), 1275 (m), 1200 (s), 1132 (s), 837 (m), 800 (m), 721 (s) 
cm-1. 
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7.11 BIOLOGICAL TESTS 
Preparation of Polynucleotides 
p(dAdT)2, p(dGdC)2, pdA × pdT, pdG × pdC, pA × pU, and pG × pC were dissolved in 
sodium cacodylate buffer (pH 7, 0.05 M) as obtained from the supplier Aldrich (10 UN in 
250 µL or 5 mg in 350 µL), cooled to 4° C for 20 h, transferred into a glass vial rinsing the 
original vessel with 25 or 35 µL buffer. ctDNA (10 mg) was transferred to a falcon, dissolved 
in sodium cacodylate buffer (1.5 ml, pH 7, 0.05 M), cooled to 4° C for 20 h, and sonicated 
eight times for 4 sec. Then it was filtrated through a 0.45 µm PTFE filter, which was washed 
with 0.5 ml of buffer. The concentration of the compounds was determined as the 
concentration of phosphates with the help of the epsilon value at the absorption maxima listed 
in Table 29. by titrating five times 1 µL into sodium cacodylate buffer (pH 7, 0.05 M) and 
measuring the resulting UV/Vis absorption. The mammalian expression plasmid pF143 
encoding for GFP under the control of a CMV-promoter was obtained as described in 
literature.244 
Table 29. Molar extinction coefficients ε at the maximum of UV absorption (λmax) of various nucleic acids.  
Nucleic acid pdA × pdT p(dAdT)2 pdG × pdC p(dGdC)2 pA × pU pG × pC ctDNA 
ε [L/mol · cm] 6000 6600 7400 8400 6000 7400 6600 
λmax [nm] 260 262 253 254 260 253 260 
 
Cell lines 
The human embryonic kidney cell line HEK293T (ATCC-No. CRL-1573) was obtained 
from the American Type Culture Collection and maintained as recommended in complete 
Dulbecco`s Modified Eagle Medium supplemented with 10 % fetal bovine serum, 1 % 
Glutamine and 1 % Antibiotic-Antimycotic (Invitrogen) at 37° C in a humidified atmosphere 
of 5 % CO2.  
Transfection and Microscopy 
Per well, 1 × 104 cells were seeded in 96 well cell culture plates (Greiner bio-one) in a total 
medium volume of 200 µl 24 h before transfection. The cationic transfection reagent 
polyethylenimine (PEI, pH 6.8, Sigma-Aldrich) was used at concentration of 0.12 mM in 
phosphate buffered saline (PBS) (Invitrogen) with 2 µg of plasmid DNA per well. 
Transfection with 196, 206, 207, 233-237 was carried out at concentrations ranging from 0.12 
to 0.36 mM with 1, 2, or 4 µg plasmid DNA in a total volume of 30 µl in PBS buffer. 
Transfection efficiency was analyzed 24 and 48 h after transfection with an inverted 
fluorescence microscope (Axiovert 200M, Carl Zeiss) with a 10X air objective. Images were 
processed and analyzed using MetaMorph 6.3r6 (Molecular Devices) and Adobe Photoshop 
CS2 (Adobe Systems). 
Endosomal Escape Assay 
To facilitate endosomal escape, cells were incubated with complete medium containing 
25 µM chloroquine 30 min before transfection. Transfection was carried out with 0.24 mM 
transfecting agent and 2 µg plasmid DNA. 
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Trypan Blue Cell Viability Assay 
Cytotoxity of the transfection reagents was evaluated using the negatively charged azo-dye 
trypan blue (Applichem) which only penetrates cells with membrane damage. HEK293T cells 
were grown and transfected as described above. Equal amounts of the cell solution were 
mixed with trypan blue (0.2 % in 0.9 % NaCl), incubated for 5 min at RT. Cells were counted 
under a light microscope in counting cambers (MEGUMED). 
Plasmid DNA Labeling and Co-localization Experiments 
Plasmid DNA was labeled with the PromoFluor-500 Nick Translation Labeling Kit 
(PromoKine) according to the manufacturer’s instructions. Briefly, following nick translation 
of the pF143-GFP vector with PromorFluor-500-dUTPs for 2 h at 15° C, cleanup of the 
mixture was performed using a DNA purification Kit (Macharey-Nagel) as advised. For 
transfection, HeLa cells were seeded in 8-well plates, grown for 24 h and transfected with 
2 µg of Lamp1-RFP Plasmid-DNA mixed with 1 mM PEI. After an additional incubation of 
24 h, cells were transfected again with 0.2 µg of labeled DNA mixed with 0.24 mM 
transfecting agent or with the labeled DNA alone and examined under a confocal fluorescence 
microscope (Leica) 2 and 4 h after transfection. 
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APPENDICES  
A: ZUSAMMENFASSUNG UND AUSBLICK 
Zusammenfassung 
Im ersten Teil der Doktorarbeit wurden zusammen mit unseren Kooperationspartnern, der 
Arbeitsgruppe von Prof. Schlücker, Resonanz-Raman (RR) Bindungsstudien bezüglich des 
Erkennungsvorganges zwischen einem kleinen molekularem Rezeptor und tetrapeptidischen 
Substraten durchgeführt. Dafür wurden der in Abbildung 1 abgebildete Rezeptor 13 und die 
vier Liganden 161-164 mittels Fmoc-Festphasensynthese in guten bis exzellenten Ausbeuten 
hergestellt. Mittels RR und der mathematischen Methode der nicht-negativen 
Matrixfaktorisierung konnten die Bindungseigenschaften aller vier Kombinationen erfolgreich 
untersucht werden. So wurde die in der Literatur bereits bekannte Reihenfolge der Affinität 
des Rezeptors gegenüber den Substraten 161 > 162 korrekt abgebildet. Auch wenn diese 
Ergebnisse in den momentan durchgeführten weiterführenden Arbeiten bestätigt werden 
müssen, können diese ersten Resultate bereits als Beweis für die allgemeine Tauglichkeit 
dieser Resonanz-Raman-basierten Methode zur Analyse von supramolekularen 
Komplexbildungen angesehen werden. Es ist nunmehr nicht nur möglich, einen derartigen 
Bindungsvorgang rein qualitativ zu beschreiben, vielmehr konnte gezeigt werden, dass mit 
Hilfe dieser Methodik ebenfalls eine quantitative Beschreibung supramolekularer Vorgänge 
mittels der Bestimmung der Bindungskonstanten möglich ist. 
 
Abbildung 1. Rezeptor 13 und vier tetrapeptidische Substrate (161-164) für Resonanz-Raman Bindungsstudien. 
Im zweiten Raman Projekt, das ebenfalls zusammen mit unseren Kooperationspartnern 
bearbeitet wurde, konnten wir erfolgreich neuartige, bifunktionelle polymere Träger 
herstellen, die die Vorteile der Festphasensynthese mit der Möglichkeit der schnellen 
Charakterisierung von festphasengebundenen Substanzen mittels oberflächenverstärkter 
13 161 
162 163 164 
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Raman Spektroskopie verbinden. Dafür wurden, wie in Abbildung 2 gezeigt, Gold-Nano-
partikel mit einer extrem dünnen Glasschicht versehen und auf einen polymeren Träger 
derartig aufgebracht, dass dessen Oberfläche vollständig mit den Nanopartikeln bedeckt war. 
Die oberflächengebundenen Partikel wurden dann mit einer Aminfunktion derivatisiert und 
somit für die Peptidsynthese mittels standard Fmoc-Strategie zugänglich gemacht. Somit 
konnten die drei Aminosäuren Gly, Phe, und Ser (166-168) sowie das Dipeptid Gly-Phe (171) 
auf den Träger angebracht werden. Mittels mikroskopischer Techniken konnte gezeigt 
werden, dass die bifunktionellen Einheiten auch nach der Synthese und somit trotz der 
Behandlung mit Base (20 % Piperidin), Säure (33 % TFA) und organischen Lösemitteln 
(DMF, DCM) vollkommen intakt waren, und aus diesem Grund hervorragend für eine 
Anwendung in der Festphasensynthese geeignet sind. Die vier festphasengebundenen 
Substanzen konnten dann mittels Raman Experimenten schnell und zuverlässig zweifelsfrei 
voneinander unterschieden werden. Somit erfüllen die kombinierten Festphasen/Raman 
Einheiten alle notwendigen Voraussetzungen für eine Vielzahl von Anwendungen, z.B. für 
die Charakterisierung von Zwischenprodukten einer Festphasensynthese oder der 
Untersuchung von molekularen Erkennungsvorgängen. Zusammenfassend stellt dieses 
neuartige mit Nanopartikeln versehene bifunktionelle Harz also eine exzellente Erweiterung 
der Felder der supramolekularen Chemie und der Festphasensynthese dar, die eine direkte und 
markerfreie Analyse von festphasengebundenen Substanzen ermöglicht.  
 
 
Abbildung 2. Design von bifunktionellen Einheiten zur Kombination von Festphasensynthese mit oberflächen-
verstärkter Raman Spektroskopie. a) Glasverkapselte, 80 nm große Goldnanopartikel auf einem 130 µm großen 
TentaGel Kügelchen; b) Zoom auf die Oberfläche; c) Aminfunktionalisierung der Glasverkapselung mittels eines 
Aminosilans (Bild aus: Doktorarbeit Gellner).191 Die drei Aminosäuren 166-168 und das Dipeptid 171 wurden 
mittels Festphasensynthese hergestellt und konnten mit Hilfe von verstärkter Raman Spektren direkt am Harz 
charakterisiert und voneinander unterschieden werden. 
Ein weiteres großes Arbeitsfeld der Dissertation befasste sich mit der molekularen 
Erkennung von biologisch relevanten Substraten. Dazu wurden zunächst zwei 
unsymmetrische (187, 188) und ein symmetrischer Tweezer Rezeptor (196, Abbildung 3) 
166 167 168 171 
a) b) c) 
resin 
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mittels mikrowellengestützter Festphasensynthese hergestellt. Im Vergleich zu früheren 
Arbeiten im Rahmen meiner Diplomarbeit konnte die Synthese für beide dafür benötigte 
Template, dem orthogonal geschützten Derivat der Benzoesäure 181 für die Darstellung von 
unsymmetrischen Rezeptoren, sowie dem analogen 193 für die Synthese von symmetrischen 
Tweezern, verbessert werden. So konnte die Gesamtausbeute über sieben (181) bzw. sechs 
(193) Reaktionsschritte von 24 auf 39 % und respektive von 29 auf 42 % erhöht werden. Des 
Weiteren konnten sowohl die Ausbeute als auch die Reinheit der Rezeptoren durch die 
Verwendung einer Mikrowelle signifikant erhöht werden. Mit den eigens für die Synthese 
optimierten Mikrowellenbedingungen (max. 60° C, 20 min, 20 W) war es außerdem möglich 
z.B. den unsymmetrischen Rezeptor 187 innerhalb von nur zwei Tagen anstatt von zwei 
Wochen, die für die konventionelle Synthese notwendig waren, herzustellen. Die so 
synthetisierte zweite Generation von zweiarmigen Rezeptoren verfügte im Vergleich zu 
ähnlichen während der Diplomarbeit synthetisierten Systemen über verbesserte physiko-
chemische Eigenschaften für die Komplexierung von Substraten in Wasser bei physio-
logischem pH. Vor allem die Verringerung der Azidität der Guanidiniogruppe um ca. eine 
Größenordnung garantiert einen höheren Protonierungsgrad der GCP Oxoanionen 
Bindungsstelle bei pH 7, was zu stark verbesserten Bindungseigenschaften hinsichtlich der 
Interaktion mit anionischen Substraten führte. 
 
Abbildung 3. Orthogonal geschütztes Templat 181 für die mikrowellengestützte Festphasensynthese der 
unsymmetrischen Tweezer Rezeptoren 187 und 188. Das entsprechende symmetrische Gegenstück 193 wurde für 
die Darstellung des divalenten Rezeptors 196 mit zwei gleichartigen Seitenketten verwendet.  
Nach der erfolgreichen Synthese konnte mittels UV/Vis-Titrationen ermittelt werden, dass 
die beiden unsymmetrischen Tweezer Rezeptoren 187 und 188 Bindungskonstanten von bis 
zu 6 × 103 M-1 in gepuffertem Wasser für das polare, peptidische Substrat N-Ac-Lys-D-Ala-D-
Ala-OH, welches eine entscheidende Rolle in der Biosynthese der Zellwand von Gram 
181 
188 187 
193 196 
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positiven Bakterien spielt, aufweisen. Es konnte demonstriert werden, dass die Bindungs-
konstante mit sinkendem pH (7 → 6 → 5) steigt, und dass dieser Zusammenhang auf den 
Protonierungsgrad der GCP Gruppen zurückzuführen ist. Die Bindungsaffinität beruht 
hauptsächlich auf der Wechselwirkung zwischen dem GCP Bindungsmotiv des Rezeptors mit 
der Carboxylatgruppe des Tripeptids. Außerdem konnte gezeigt werden, dass 187 aufgrund 
des geringeren pKA-Wertes seiner GCP Gruppe gepaart mit zusätzlichen Wechselwirkungen 
der Seitenketten des Rezeptors mit dem Substrat eine höhere Affinität zu dem getesteten 
Tripeptid aufweist als der analoge Tweezer 188.  
Bezüglich des symmetrischen Rezeptors 196 konnte mittels übereinstimmender UV/Vis- 
und fluoreszenzspektroskopischer Methoden gezeigt werden, dass dieser Tweezer in 
gepuffertem Wasser bei neutralem pH stabile 1:1 Komplexe mit Nukleotiden bildet, die mit 
guten Bindungskonstanten von bis zu 9 × 104 M-1 gebunden werden. Nukleotide werden dabei 
um annähernd eine Größenordnung stärker gebunden als Phosphate oder Diphosphate. Die 
bemerkenswerteste Eigenschaft des Rezeptors liegt jedoch darin, dass er Adenosin-
monophosphat über das entsprechende Diphosphat und dieses wiederum über das Triphosphat 
präferiert. Eine derartige Bevorzugung ist bisher beisspiellos in der Literatur und konnte mit 
Hilfe von NMR Spektroskopie und Kraftfeldrechnungen erklärt werden. Der Rezeptor bildet 
mit seinen beiden GCP Einheiten eine doppelte Salzbrücke zu dem am höchsten geladenen 
α-Phosphat des jeweiligen Nukleotids aus, indem sich die beiden Pyrrole perpendikulär 
zueinander ausrichten und gleichzeitig das tetraedrische Phosphatanion binden. Gleichzeitig 
findet eine π-π-Wechselwirkung zwischen dem aromatischen Templat des Rezeptors und der 
Nukleobase statt, wodurch das Nukleotid in einer hochgeordneten Geometrie komplexiert 
wird. 196 umschließt dabei das Substrat als eine halbgeschlossene Schale. Die in Abbildung 4 
illustrierte lösemittelzugängliche Oberfläche dieses Wirt-Gast-Systems verdeutlicht, dass der 
Nukleotid-Phosphatrest (grün) mit größer werdender Länge immer mehr aus der Halbschale 
des Rezeptors (gelb) in das umgebende Lösemittel herausragt und somit für kompetitive 
Einflüsse desselben exponiert wird, wodurch dieses immer mehr um die Komplexierung des 
Substrates konkurriert. Die Konsequenz davon ist, dass die Bindungskonstante in der 
Reihenfolge AMP > ADP > ATP sinkt.  
 
Abbildung 4. Darstellung der lösemittelzugänglichen Oberfläche von berechneten 1:1 Komplexen des Rezeptors 
196 (gelb) und der Phosphatreste der Nukleotidsubstrate (grün). Von links nach rechts: AMP, ADP und ATP. 
Mit Hilfe dieser Experimente konnte eindrucksvoll gezeigt werden, dass die spezifische 
Interaktion zwischen dem symmetrischen Tweezer Rezeptor 196 mit dem Phosphat- und 
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Nukleotidanionen ein exzellentes Beispiel für die Notwendigkeit dafür ist, mehrere 
nichtkovalente Wechselwirkungen in einer geeigneten Orientierung miteinander zu 
kombinieren, um die Ausbildung von spezifischen Wirt-Gast-Komplexen und somit eine 
selektive molekulare Erkennung eines Substrates zu ermöglichen. 
Für das nächste bearbeitete Projekt wurden zwei weitere artifizielle Systeme synthetisiert. 
Wie in Abbildung 5 gezeigt, weist der ebenfalls mittels mikrowellengestützer Festphasen-
synthese dargestellte symmetrische Tweezer 206 im Vergleich mit dem ursprünglichen 
Analogon 196 (Phe-Lys-GCP) eine invertierte Aminosäuresequenz auf (Lys-Phe-GCP). Das 
mittels einer konvergenten Synthese hergestellte trivalente Analogon 207 verfügt wiederum 
über die ursprüngliche Aminosäuresequenz (Phe-Lys-GCP). Zu dessen Darstellung wurde 
zunächst die Seitenkette mittels Fmoc-Festphasensynthese derart synthetisiert, dass alle 
Schutzgruppen der Aminosäuren intakt waren um die Arme dann in Lösung über den freien C-
Terminus an das Triamintemplat zu kuppeln und anschließend zu entschützen. 
 
Abbildung 5. Divalenter Ligand 206 mit invertierter Aminosäuresequenz Lys-Phe-GCP und trivalenter Ligand 
207 mit ursprünglicher Sequenz Phe-Lys-GCP. 
Die drei Moleküle 196, 206 und 207 wurden dann mittels thermaler Denaturierungs-
experimente, Verdrängungsassays, ITC und CD Spektroskopie bezüglich ihrer Bindungs-
eigenschaften gegenüber verschiedenen synthetischen und generischen Nukleinsäuren 
getestet. Die zweiarmigen Polynukleotid-Liganden 196 und 206 bilden äußerst stabile 
Komplexe mit Bindungskonstanten von K > 106 M-1. Der trivalente Ligand 207 ist sogar in 
der Lage um eine weitere Größenordnung stärker (K > 107 M-1) an die Biomoleküle zu 
binden. Der Bindungsmodus setzt sich bei diesen Vorgängen aus elektrostatischer 
Wechselwirkung mit dem negativ geladenen Ribophosphat Rückgrade der Nukleinsäuren mit 
einer Komplexierung in der kleinen Furche für B-Typ DNA bzw. in der großen Furche für 
A-Typ DNA und RNA zusammen. Mit Hilfe von CD-Spektroskopie konnte gezeigt werden, 
dass die drei Nukleinsäureliganden mittels zweier gestapelter Pyrroleinheiten binden und dass 
sie so in der Lage sind zwischen verschiedenen Sekundärstrukturen und Sequenzen von 
Polynukleotiden zu unterscheiden und Exzitonen CD-Signal mit unterschiedlichem 
206 207 
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Vorzeichen hervorrufen. Eine derartige selektive Erkennung von Polynucleotiden durch nicht-
kovalent gebundene kleine Moleküle ist bisher nur sehr selten in der Literatur beschrieben 
und ermöglicht eine potentielle Anwendung dieser Systeme als DNA/RNA-Sensoren. 
Des Weiteren konnte mittels AFM und DLS Experimenten gezeigt werden, dass 196 und 
207 in der Lage sind generische DNA in einer konzentrationsabhängigen Art und Weise zu 
dicht gepackten, sphärischen Aggregaten zu komprimieren. Zusammen mit unseren 
Kooperationspartnern, der Arbeitsgruppe von Prof. Knauer, konnten wir zeigen, dass diese 
multimolekularen Komplexe endozytotisch von humanen Zellen aufgenommen werden. 
Jedoch war nur der trivalente Ligand in der Lage aus den endosomalen Vesikeln zu 
entkommen und somit Zellen mit genetischem Material zu transfizieren. Wie in Abbildung 6 
schematisch gezeigt, beruht diese Differenzierung auf der überlegenen Pufferkapazität von 
207, die in etwa doppelt so hoch ist wie beim analogen zweiarmigen Äquivalent 196. Die 
Guanidino-Gruppe wird aufgrund der Einströmung von Protonen mittels der spezifischen 
ATPase in das Endosom sukzessive protoniert und agiert somit als „Protonenschwamm“, was 
letztendlich zum Bruch der endosomalen Vesikelwand aufgrund des erhöhten osmotischen 
Drucks führt. In vergleichenden Experimenten konnte bewiesen werden, dass der dreiarmige 
Ligand 207 effizienter als der standardmäßig eingesetzte nichtvirale Vektor PEI bei 
gleichzeitig verringerter Zytotoxizität ist. Im Vergleich zu anderen zellpenetrierenden 
Peptiden, die normalerweise von DNA-bindenden Peptiden abgeleitet und aus 10-30 
Aminosäuren aufgebaut sind, ist 207 außerordentlich klein und weist weniger Ladungen auf 
und verfügt somit über großes Potential für die Anwendung in der Zellbiologie. 
 
Abbildung 6. 207-vermittelter zellulärer Aufnahmemechanismus. Plasmid DNA wird zu dichten Aggregaten 
kondensiert, welche mittels Endozytose in die Zelle aufgenommen werden. Die GCP Gruppe fungiert dabei als 
Protonenschwamm, was zum Bruch des endosomalen Vesikels führt. Die genetische Information wird dann in 
den Zellkern transportiert um letztendlich eine Expression des GFP Proteins auszulösen. 
Um die Bindungseigenschaften der divalenten Liganden zu verbessern wurde im nächsten 
Schritte die kombinatorische DNA-Liganden Bibliothek 220, die in Abbildung 7 schematisch 
dargestellt ist, mittels Split & Mix Synthese hergestellt. Die Mitglieder dieser relativ kleinen, 
jedoch hochgradig fokussierten Bibliothek verfügen über drei kombinatorische Positionen, die 
jeweils mit sechs unterschiedlichen Aminosäuren bestückt wurden. Als Bausteine wurden 
dabei kationissche (Lys, Arg), aromatische (Phe, Trp, Tyr) oder als negative Kontrolle 
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anionische (Glu) Aminosäuren verwendet. Zusätzlich wurde die Länge der beiden Arme der 
Liganden variabel gestaltet, indem die Anzahl der eingebauten Aminosäuren zwischen 0 und 
3 variiert wurde. Dementsprechend enthielt die Substanzbibliothek insgesamt 259 Mitglieder 
(63 + 62 + 6 + 1). Um die Bibliothek direkt am Harz zu screenen wurde zunächst ein Assay 
entwickelt, welcher die Bestimmung der Affinitäten der Liganden zu den zwei getesteten 
Nukleinsäuren ermöglichte. Dabei wurde zum Einen die synthetische B-DNA p(dAdT)2 mit 
ihrer sehr ausgeprägten, gut definierten kleinen Furche und zum Anderen die pF143-GFP 
Plasmid DNA, welche für die oben erwähnten Transfektionsexperimente genutzt wurde, 
verwendet. Im Gegensatz zu großen, randomisierten Bibliotheken, bei denen lediglich Hit-
Strukturen ermittelt werden können, konnten mit Hilfe der IRORI Radiofrequenztechnologie 
quantitative Daten für alle Bibliotheksmitglieder ermittelt werden. 
     
Abbildung 7. Die Bibliothek 220 besteht aus 259 symmetrischen, divalenten DNA Liganden, die über jeweils 
eine GCP Kopfgruppe in den beiden Seitenketten verfügen. Diese bestehen aus entweder drei, zwei, einer oder 
keiner kombinatorischen Position (Phe, Tyr, Trp, Lys, Arg und Glu). 
Mit Hilfe des neu entwickelten Screenings konnten für p(dAdT)2 hochaffine Sequenzen 
identifiziert werden, die die ursprünglichen zweiarmigen Liganden klar übertreffen. Wie 
erwartet führten zusätzliche Ladungswechselwirkungen von höher positiv geladenen 
Liganden mit der negativ geladenen DNA zu verbesserten Bindungseigenschaften. 
Wesentlich aufschlussreicher war jedoch, dass auch die Aminosäuresequenz eine entschei-
dende Rolle dabei spielte. So waren Sequenzen des Typs AA1-kationisch-kationisch-GCP 
besonders effizient das alternierende Heteropolymer p(dAdT)2 zu binden, wohingegen solche 
des Typs AA1-aromatisch-AA2-GCP weniger geeignet waren. Dies ist wohl darauf zurückzu-
führen, dass sperrige aromatische Seitenketten relativ schlecht in die schmale kleine Furche 
dieser DNA eingefügt werden können. Bezüglich der Rolle der Länge der zwei Arme der 
Liganden konnte ein immens positiver Effekt für den Übergang von einer zu zwei 
Aminosäuren pro Arm beobachtet werden. Offensichtlich ist ein gewisser Grad an Flexibilität 
notwendig um eine hohe Affinität der Liganden zu den getesteten Nukleinsäuren zu 
gewährleisten. 
Um die Resultate des Screenings an fester Phase mittels Experimente in Lösung zu 
verifizieren wurden die fünf DNA-Liganden 233-237 synthetisiert, die einen Querschnitt über 
alle Affinitätsbereiche der Bibliothek repräsentieren. Der Ligand 233 ist exemplarisch in 
Abbildung 8 gezeigt. Die Wiederholung des Assays in Lösung mit diesen Substanzen lieferte 
Ergebnisse, die in exzellenter Übereinstimmung mit denen der festen Phase waren. Außerdem 
konnte mittels ITC Messungen gezeigt werden, dass extrem hohe Bindungskonstanten von bis 
220 
AA   =   Phe, Tyr, Trp,  
 Lys, Arg, Glu  
216  = 6 × 6 × 6 (n = 3) 
36  = 6 × 6  (n = 2) 
6    (n = 1) 
1                                (n = 0)  
259 Liganden 
TentaGel 
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zu K > 109 M-1 erzielt werden können. Die Affinität der zweiarmigen Liganden konnte somit 
mit Hilfe der kombinatorischen Bibliothek um hervorragende drei Größenordnungen 
gesteigert werden. 
 
Abbildung 8. Fünf Bibliotheksmitglieder wurden für eine Charakterisierung in Lösung synthetisiert. Neben dem 
abgebildeten Ligand 233 der Sequenz Trp-Lys-Arg-GCP weisen die vier weiteren Moleküle die Sequenzen Trp-
Arg-Lys-GCP (234), Lys-Lys-Arg-GCP (235), Lys-Trp-Arg-GCP (236) und Glu-Trp-Arg-GCP (237) auf. 
Ein analoges Festphasenscreening für die Plasmid DNA sowie dessen Verifizierung in 
Lösung konnte aufzeigen, dass im Allgemeinen keine Korrelation zwischen effizienter 
Komplexierung von p(dAdT)2 und hoher Affinität zum Plasmid besteht. Es konnte jedoch 
gezeigt werden, dass Liganden, die die drei Aminosäuren Trp, Lys und Arg enthalten sehr 
effizient darin sind beide DNA Typen zu binden. Die höchsten so erzielten Bindungs-
konstanten bezüglich des Plasmids waren um einen Faktor 1000 höher als diejenige der 
urprünglichen divalenten Liganden (K > 109 M-1). Somit konnte mittels der kombinatorischen 
Bibliothek 220 nicht nur die Affinität der divalenten Liganden optimiert werden, sondern die 
Bibliothek ermöglichte außerdem die Identifizierung von Polynukleotid-spezifischen 
Liganden. In Zusammenarbeit mit unseren Kooperationspartnern konnte schließlich eine 
direkte Korrelation zwischen erhöhten Bindungskonstanten zum Plasmid mit einer erhöhten 
Transfektionseffizienz ermittelt werden. Auch wenn die so abgeleiteten neuen zweiarmigen 
Gentransportmoleküle aufgrund fehlender Pufferkapazität nicht die Effizienz des dreiarmigen 
Analogons 207 erreichten, ist dieser unerwartete Zusammenhang von hohem Nutzen für die 
Entwicklung zukünftiger nichtviraler Vektoren. 
Um die verbesserten Transfektionseigenschaften der neu entwickelten Tweezer weiter 
auszuschöpfen, wurden drei der hochaffinen Sequenzen mit Oktadecylketten derivatisiert um 
so die Substanzen 250-252 zu erhalten. 250 ist als Vertreter dieser amphiphilen 
Gentransporter in Abbildung 9 exemplarisch aufgeführt. Des Weiteren wurde zu 
Vergleichszwecken ein amphiphiles Analogon (243) des ursprünglichen Tweezers 196 
synthetisiert. Die Darstellung dieser vier Substanzen erfolgte mittels einer konvergenten 
Syntheseroute: Zunächst wurden die vollständig geschützten DNA-Liganden mittels 
mikrowellengestützter Festphasensynthese hergestellt um sie dann über ihre freien C-Termini 
mit C18-derivatisiertem Glycin zu kuppeln und anschließend zu entschützen. Die folgenden 
Zelltransfektionsexperimente bestätigten den Zusammenhang zwischen einer zum Plasmid 
hochaffinen Kopfgruppe am Amphiphil mit der einhergehenden Effizienz als Gentransporter. 
251 konnte als äußerst effizienter Transfektionsvektor identifiziert werden, der sogar den 
233 
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Goldstandard PEI übertrifft. Zudem konnte so die für eine effiziente Transfektion minimal 
benötigte Vektorkonzentration um die Hälfte reduziert werden. 
 
Abbildung 9. Vier amphiphile Gentransporter wurden für die Zelltransfektion synthetisiert. Exemplarisch ist 
derjenige mit der Sequenz Trp-Lys-Arg-GCP (250) abgebildet. Die drei weiteren Systeme verfügen über die 
Sequenzen Trp-Arg-Lys-GCP (251), Lys-Trp-Arg-GCP (252) und Phe-Lys-GCP (243). 
Zusammenfassend konnten im Rahmen dieser Dissertation neue Erkenntnisse über 
molekulare Erkennungsvorgänge von biologisch relevanten Substraten wie Peptide, 
Nukleotide und Nukleinsäuren gewonnen werden. Diese Resultate tragen nicht nur dazu bei 
unser generelles Verständnis über die komplexen Prozesse, die in biologischen Systemen 
stattfinden, zu verbessern, sie konnten auch direkt für eine Anwendung in der Zellbiologie 
mittels der Entwicklung eines neuen Ansatzes für die Identifizierung und Darstellung 
neuartiger, hocheffizienter nichtviraler Vektoren verwendet werden. 
Ausblick 
Nachdem gezeigt werden konnte, dass es prinzipiell möglich ist, Bindungskonstanten von 
molekularen Erkennungsereignissen mittels Resonanz-Raman Experimenten zu bestimmen, 
müssen diese bisher vorläufigen Ergebnisse verifiziert werden und auf ihre Reproduzier-
barkeit hin getestet werden. Bezüglich der bifunktionellen Festphasensynthese/Raman-
Partikel könnte der nächste Schritt sein zu testen ob das GCP Oxoanionen Bindungsmotif 
durch oberflächenverstärkte Raman Spektroskopie abgebildet werden kann, wenn es wie in 
Abbildung 10 gezeigt auf dem modifiziertem Harz gebunden ist. Wenn dem so ist, kann im 
Folgenden bestimmt werden, ob es möglich ist, ein molekulares Erkennungsereignis wie z.B. 
die Komplexierung von Acetat (254) direkt an der festen Phase zu visualisieren. Durch den 
Vergleich der Raman-Spekren nach der Zugabe von unterschiedlichen Substraten mit den 
dazugehörigen experimentell bestimmten Bindungskonstanten, kann des Weiteren getestet 
werden ob diese Methode dafür geeignet ist unterschiedliche Bindungsaffinitäten abzubilden 
und somit ein rasches Substratscreening zu ermöglichen. Somit könnten die modifizierten 
festen Trägerpartikel für die Darstellung und das markerfreie Screening von Rezeptor- oder 
Substratbibliotheken verwendet werden. Schließlich könnten in zukünftigen Experimenten 
auch komplexere Wirt-Gast-Systeme mit z.B. ein oder zwei zusätzlichen Aminosäuren 
untersucht werden um die Grenzen und den potentiellen Anwendungsbereich dieser neuen 
Technik auszuloten. 
250 
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Abbildung 10. Indem das GCP Oxoanionen Bindungsmotif auf die bifunktionellen Harzkügelchen angebracht 
wird (253) könnten Bindungsvorgänge von kleinen Carboxylaten wie z.B. Acetat (254) direkt an der festen Phase 
mittels oberflächenverstärkter Raman-Spektroskopie sichtbar gemacht werden. 
Hinsichtlich der kombinatorischen Bibliothek 220 könnte als nächstes ein Screening mit 
Nukleotiden durchgeführt werden. Da der entsprechende ursprüngliche Tweezer 196 schon in 
der Lage dazu war selektiv Nukleotide mit guten Bindungskonstanten zu erkennen, sollte es 
möglich sein noch effizientere Rezeptoren mit Hilfe der Bibliothek zu ermitteln. Alternativ 
könnten weitere Arten von Nukleinsäuren wie z.B. siRNAs einem Screening unterzogen 
werden, um hochaffine Sequenzen für diesen vollkommen andersartigen Typ von 
Oligonukleotiden zu identifizieren. Die so ermittelten Sequenzen könnten dann auf ihre 
Effizienz hin getestet werden, siRNAs in Zellen zu schleusen und somit den RNAi 
Mechanismus auszulösen.265 
Die bereits identifizierten hochaffinen Aminosäuresequenzen, die für die Komplexierung 
von Plasmid DNA optimiert sind, könnten des Weiteren in dreiarmige Liganden des Typs 207 
eingebaut werden, der schon mit einer weniger potenten Sequenz ein exzellenter 
Gentransporter ist. Da hochaffine Sequenzen bereits bei divalenten Liganden zu einer 
Verbesserung der Transfektionseffizienz führten, sollte eine Implementierung in ein 
dreiarmiges Gerüst zu einer weiteren Steigerung der bereits sehr guten Eigenschaften 
derartiger nichtviraler Vektoren führen, da somit auch die für den Ausbruch aus den 
endosomalen Vesikeln notwendige Pufferkapazität in den Transporter implementiert würde. 
Die Darstellung der Gentransportern 255 und 256 (Abbildung 11) würde einen direkten 
Vergleich mit den bereits vorhandenen zweiarmigen Analoga 233 und 236 ermöglichen und 
somit die allgemeine Anwendbarkeit dieser Methodik verifizieren. 
 
Abbildung 11. Der Einbau von durch das Bibliotheksscreening identifizierten zu DNA hochaffinen Aminosäure-
sequenzen in dreiarmige Systeme wie 255 und 256 sollte hocheffiziente Gentransporter zugänglich machen. 
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Im Allgemeinen scheint die Pufferkapazität der GCP Einheit ein entscheidendes Kriterium 
für die Effizienz der in dieser Arbeit entwickelten DNA-Transporter zu sein. Somit wäre die 
Darstellung einer zweiten Generation der Polynukleotid-Ligand-Bibliothek mit GCP 
Einheiten nicht nur als Kopfgruppe, sondern auch in den kombinatorischen Positionen 
zielführend um neue effektive Systeme zu identifizieren. Der Einbau kann sehr einfach mittels 
des Bausteins 257 (siehe Abbildung 12), dessen Synthese und Verwendung in der 
Festphasensynthese von Peptiden bereits beschrieben ist, erfolgen.266 
 
Abbildung 12. Der Baustein 257 ermöglicht den Einbbau von GCP Einheiten in die kombinatorischen 
Positionen innerhalb der Seitenketten von di- oder trivalenten DNA-Liganden. Des Weiteren können damit 
oligo-GCP-basierte Systeme synthetisiert werden um noch effizientere Gentransporter zu entwickeln. 
Außerdem ermöglicht dieser Baustein auch die Herstellung von oligo-GCP Einheiten mittels 
Fmoc-Festphasensynthese. Derartige Systeme könnten aufgrund ihrer Befähigung einerseits 
DNA zu binden und andererseits aufgrund ihrer Pufferkapazität den Ausbruch aus dem 
Endosom zu ermöglichen sehr effiziente, kleine molekulare Gentransporter darstellen. 
Struktur-Wirkungs-Studien bezüglich der minimalen Länge oder des Einflusses der Valenz 
könnten durch die Synthese von linearen Nukleinsäure-Liganden des Typs 258 (siehe 
Abbildung 13) oder durch den Einbau in analoge di- (259) oder trivalente Systeme (260) 
durchgeführt werden. Die notwendigen Synthesestrategien dazu wurden bereits innerhalb 
dieser Dissertation entwickelt, was eine rasche Umsetzung ermöglichen sollte. 
 
Abbildung 13. Lineare (258), divalente (259) und trivalente (260) oligo-GCP Einheiten für die Transfektion.  
Zusammenfassend wurde mit der Arbeit, die im Rahmen dieser Dissertation durchgeführt 
wurde, der Grundstein für die Entwicklung von effizienten Gentransportern gelegt, indem 
kleine molekulare DNA-Liganden entwickelt wurden und deren Bindungseigenschaften zu 
verschiedenen Polynukleotiden sowie der zelluläre Aufnahmemechanismus von Plasmid/ 
Ligand-Komplexen in humane Zellen untersucht und erklärt werden konnte. Dieses Wissen 
ermöglicht es, die Charakteristika von Gentransportern in zukünftigen Forschungsprojekten 
weiter zu verbessern und somit dazu beizutragen, Gentherapie als eine allgemein und breit 
einsetzbare Methode für die Behandlung einer Vielzahl von Krankheiten zu verwirklichen. 
257 
258 259 260 
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B: LIST OF ABBREVIATIONS 
° degree 
µ micro 
13C carbon isotope 13 
1H proton isotope 1 
A alanine / adenine / absorption 
Å Ångstrom 
AA amino acid 
abs absolute 
Abu aminobutyric acid 
Ac acetyl 
Acc acceptor 
ADP adenosine diphosphate 
AFM atomic force microscopy 
Aib 2-amino-2-methylpropionic acid 
AIBN azobisisobutyronitrile 
AMP adenosine monophosphate 
analyt. analytical 
APTMS 3-amino-N-propyltrimethoxysilane 
aq. aqueous 
Arg arginine 
Asn asparagine 
Atc 4-thiazolidinecarboxylic acid 
ATP adenosine triphosphate 
Benz benzene 
bis-tris 2,2-bis(hydroxymethyl)-2,2´,2´´-
nitrilotriethanol 
Bn benzyl 
Boc tert-butoxycarbonyl 
bp base pair 
br. broad 
bZIP basic-leucine zipper protein 
c centi 
c concentration 
C cytidine / Celsius 
C ITC optimization factor 
cat. catalytic 
Cbz carbobenzyloxy 
CD circular dichroism 
CDP cytidine diphosphate 
cf. compare 
Chg cyclohexyl glycine 
CIS complexation-induced chemical shift 
CMC critical micelle concentration  
CMP cytidine monophosphate 
ctDNA calf thymus DNA 
CTP cytidine triphosphate 
CyD cyclodextrine 
Cys cysteine 
d doublet / desoxy / path length 
D translational diffusion coefficient / 
diameter 
Da Dalton 
Dapa 2,3-diaminopropionic acid 
DCE 1,2-dichloroethane 
DCM dichloromethane 
deg degree 
DIBAL-H diisobutylaluminium hydride 
DIPEA diisopropylethyl amine 
Disc 1,3-dihydro-2H-isoindole carboxylic 
acid 
DLS dynamic light scattering 
DMABA dimethylaminobutyric acid  
DMF dimethyl formamide 
DMSO dimethylsulfoxide 
DNA desoxyribonucleic acid 
Do donor 
DOGS dioctadecylamido-glycylspermine 
DOSPA 2,3-dioleyloxy-N-[2-(spermine-
carboxamido)ethyl]-N,N-dimethyl-1-
propaneaminium trfluoroacetate 
DOTAP 1,2-dioleoyl-3-trimethylammonium-
propane 
DOTMA N-[1-(2,3-dioleyloxy)propyl]-N,N,N-
trimethyl-ammonium chloride 
DPH 1,3-diphenyl-1,3,5-hexatriene 
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dpppe 1,5-bis(diphenylphosphino)pentane 
ds double stranded 
e- electron 
E glutamic acid 
EI electron ionization 
e.g. for example 
EA ethyl acetate 
EB ethidium bromide 
EDT 1,2-ethanedithiol 
eq equivalent 
ESI electrospray ionization 
et al. et alii 
Et ethyl 
Fmoc fluorenylmethyloxycarbonyl 
FT-IR fourier-transform infrared 
g gramm 
G guanine 
GABA γ-aminobutyric acid 
GC gas chromatography 
GCP guanidiniocarbonyl pyrrole 
GDP guanosine diphosphate 
GFP green fluorescence protein 
GMP guanosine monophosphate 
GSABA generalized Born/surface area 
GTP guanosine triphosphate 
H height 
H proton 
HBTU 2-(1H-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophos-
phate 
HCTU 1-(bis-dimethylamino-methylene)-5-
chloro-3-oxy-1H-benzotriazol-1-ium 
hexafluorophosphate 
HEK293T human embryonic kidney cell line 
HeLa human cancer cell line 
His histidine 
HOBt 1-hydroxybenzotriazole 
Hp hydroxypyrrole 
HPLC high pressure liquid chromatography 
HR high resolution 
Hz Hertz 
i.e. that is 
IC50 equivalents necessary to displace half 
of the bound polynucleotide-ligand 
ICD induced CD 
Ile isoleucine 
Im imidazole 
IR infrared 
ITC isothermal titration calorimetry 
k kilo / Boltzmann´s constant 
K lysine 
L length 
L liter / ligand 
Lamp1 lysosome associated membrane 
protein 
LCP left-circular polarized light 
Leu leucine 
Lys lysine 
M mega / mol/l 
m meta 
m milli / medium / multiplett / meter / 
methyl 
m/z mass per charge 
max. maximal 
MBHA 4-methylbenzhydrylamine 
MD molecular dynamics 
Me methyl 
Met methionine 
min  minute(s) 
MM molecular modeling 
Mp. melting point 
MPLC medium performance liquid chroma-
tography 
mRNA messenger RNA 
MS mass spectrometry 
n nano 
n stoichiometry 
n.d. not determined 
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NBS N-bromosuccinimide 
NMM N-methylmorpholine 
NMP N-methylpyrrolidone 
NMR nuclear magnetic resonance 
NP nanoparticles / normal phase 
ORF open reading frame 
p para 
P phosphate 
p poly 
Pbf 2,2,4,6,7-pentamethyldihydrobenzo-
furan-5-sulfonyl 
PBS phosphate buffered saline 
iProp isopropanol 
Pbf 2,2,4,6,7-pentamethyldihydrobenzo-
furan-5-sulfonyl 
PBS phosphate buffered saline 
Pd/C palladium on charcoal 
PDI polydispersity index 
PEG polyethylene glycol 
PEI polyethylenimine 
PEM photoelastic modulator 
pF143-GFP plasmid encoding for a green fluo-
rescence protein 
Ph phenyl 
pH pondus hydrogenii 
Phe phenylalanine 
Pip piperidine 
PLL poly(l-lysine) 
PN polynucleotide 
Ppa piperazin 
PPi diphospahte 
ppm  parts per million 
pre premature 
Pro proline 
PS polystyrene 
Py pyrrole 
PyBOP benzotriazol-1-yloxytripyrrolidino-
phoshonium hexafluorophosphate 
q quadruplet 
r equivalents of ligand with respect to 
the nucleic acid´s phosphate groups 
Ra Raman 
RCP right-circular polarized light 
Rf retention factor 
RFP red fluorescence protein 
RH hydrodynamic radius 
RNA ribonucleic acid 
RP reversed phase 
RR Resonance Raman 
s strong / singulett / second 
Sar sarcosine 
sec second 
SEM surface electron microscopy 
Ser serine 
SERS surface enhanced Raman spectros-
copy 
SPPS solid phase peptide synthesis 
ss single stranded 
t tert / time 
T thymidine 
t triplet 
TEM transmission electron microscopy 
TFA trifluoroacetic acid 
Thr threonine 
Tic 1,2,3,4-tetrahydroisoquinoline-3-
carboxylic acid 
TLC thin layer chromatography 
Tm melting point 
TMEDA N,N,N´,N´-tetramethylethylenedi-
amine 
TMP thymidine monophosphate 
ToF time of flight 
Trp tryptophan 
TTP thymidine triphosphate 
Tyr tyrosine 
U uracil 
UDP uridine diphosphate 
UMP uridine monophosphate 
UTP uridine triphosphate 
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UTR untranslated region 
UV ultraviolet 
Val valine 
Vis visible 
vs. versus 
W Watt 
w weak 
W width 
δ chemical shift / standard deviation 
η viscosity 
λ wavelength 
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C: SUPPLEMENTARY EXPERIMENTAL DATA 
C.1 HPLC Data 
  
Figure C. 1. The purity of the non-symmetric tweezer receptor 187 was determined to 99 % via analytical HPLC 
on a SupelcosilTM LC-18 column (25 cm × 4.6 mm, 5 µm), solvent: 45 to 55 % methanol/water in 33 min (0.05 % 
TFA), flow rate 0.75 mL/min, retention time tR = 13.6 min; the peak integration is based on detection at 300 nm. 
  
Figure C. 2. The purity of the non-symmetric tweezer receptor 188 was determined to 90 % via analytical HPLC 
on a SupelcosilTM LC-18 column (25 cm × 4.6 mm, 5 µm), solvent: 45 to 65 % methanol/water in 32 min (0.05 % 
TFA), flow rate 0.75 mL/min, retention time tR = 6.2 min; the peak integration is based on detection at 300 nm. 
 
Figure C. 3. The purity of the symmetric tweezer receptor 196 was determined to 94 % via analytical HPLC on 
a YMC ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 40 to 50 % methanol/water in 30 min (0.05 % TFA), 
flow rate 0.43 mL/min, retention time tR = 22.1 min; the peak integration is based on detection at 300 nm. 
Reprinted with permission from Kuchelmeister, H. Y.; Schmuck, C. Chem. Eur. J. 2011, 17, 5311-5318. 
Copyright 2011 John Wiley and Sons.206 
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Figure C. 4. The purity of the symmetric tweezer receptor 206 was determined to 94 % via analytical HPLC on 
a YMC ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 35 to 55 % methanol/water in 20 min (0.05 % TFA), 
flow rate 0.43 mL/min, retention time tR = 16.3 min; the peak integration is based on detection at 300 nm. 
 
Figure C. 5. The purity of the symmetric divalent ligand 233 was determined to 93 % via analytical HPLC on a 
YMC ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 25 to 35 % methanol/water in 20 min (0.05 % TFA), flow 
rate 0.43 mL/min, retention time tR = 15.6 min; the peak integration is based on detection at 300 nm. 
 
Figure C. 6. The purity of the symmetric divalent ligand 234 was determined to 93 % via analytical HPLC on a 
YMC ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 25 to 35 % methanol/water in 20 min (0.05 % TFA), flow 
rate 0.43 mL/min, retention time tR = 14.1 min; the peak integration is based on detection at 300 nm. 
 
Figure C. 7. The purity of the symmetric divalent ligand 235 was determined to 91 % via analytical HPLC on a 
YMC ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 10 to 10 % methanol/water in 20 min (0.05 % TFA), flow 
rate 0.43 mL/min, retention time tR = 17.6 min; the peak integration is based on detection at 300 nm. 
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Figure C. 8. The purity of the symmetric divalent ligand 236 was determined to 95 % via analytical HPLC on a 
YMC ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 20 to 50 % methanol/water in 20 min (0.05 % TFA), flow 
rate 0.43 mL/min, retention time tR = 13.9 min; the peak integration is based on detection at 300 nm. 
  
Figure C. 9. The purity of the symmetric divalent ligand 237 was determined to 94 % via analytical HPLC on a 
YMC ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 20 to 50 % methanol/water in 20 min (0.05 % TFA), flow 
rate 0.43 mL/min, retention time tR = 17.3 min; the peak integration is based on detection at 300 nm. 
 
Figure C. 10. The purity of the amphiphilic ligand 243 was determined to 90 % via analytical HPLC on a YMC 
ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 10 to 100 % methanol/water in 20 min (0.05 % TFA), flow rate 
0.43 mL/min, retention time tR = 7.4 min; the peak integration is based on detection at 300 nm. 
 
Figure C. 11. The purity of amphiphilic ligand 250 was determined to 94 % via analytical HPLC on a YMC 
ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 50 to 1000 % methanol/water in 20 min (0.05 % TFA), flow 
rate 0.43 mL/min, retention time tR = 20.7 min; the peak integration is based on detection at 300 nm. 
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Figure C. 12. The purity of the amphiphilic ligand 251 was determined to 99 % via analytical HPLC on a YMC 
ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 30 to 100 % methanol/water in 20 min (0.05 % TFA), flow rate 
0.43 mL/min, retention time tR = 22.0 min; the peak integration is based on detection at 300 nm. 
 
Figure C. 13. The purity of the amphiphilic ligand 252 was determined to 99 % via analytical HPLC on a YMC 
ODS-A column (15 cm × 3.0 mm, 5 µm), solvent: 30 to 100 % methanol/water in 20 min (0.05 % TFA), flow rate 
0.43 mL/min, retention time tR = 22.0 min; the peak integration is based on detection at 300 nm. 
 
 
 
 
 
 
  
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS   
C.2 UV/Vis and Fluorescence Titrations 
UV/Vis Titrations 
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Figure C. 14. UV Titration with ADP and excerpt at 300 nm of global fit according to SpecFit. 
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Figure C. 15. UV Titration with ATP and excerpt at 300 nm of global fit according to SpecFit. 
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Figure C. 16. UV Titration with cAMP and excerpt at 300 nm of global fit according to SpecFit. 
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Figure C. 17. UV Titration with CMP and excerpt at 300 nm of global fit according to SpecFit. 
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Figure C. 18. UV Titration with PPi and excerpt at 300 nm of global fit according to SpecFit. 
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Figure C. 19. UV Titration with P and excerpt at 300 nm of global fit according to SpecFit. 
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Figure C. 20. UV Titration with UMP and excerpt at 300 nm of global fit according to SpecFit. 
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Figure C. 21. UV Titration with GMP and excerpt at 300 nm of global fit according to SpecFit. 
MOLECULAR RECOGNITION OF BIOLOGICALLY RELEVANT TARGETS   
Fluorescence Titrations 
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Figure C. 22. Fluorescence Titration with ADP and excerpt at 355 nm of global fit according to SpecFit. 
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Figure C. 23. Fluorescence Titration with ATP and excerpt at 355 nm of global fit according to SpecFit. 
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Figure C. 24. Fluorescence Titration with GMP and excerpt at 355 nm of global fit according to SpecFit. 
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Figure C. 25. Fluorescence Titration with CMP and excerpt at 355 nm of global fit according to SpecFit. 
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Figure C. 26. Fluorescence Titration with cAMP and excerpt at 355 nm of global fit according to SpecFit. 
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Figure C. 27. Fluorescence Titration with PPi and excerpt at 355 nm of global fit according to SpecFit. 
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Figure C. 28. Fluorescence Titration with P and excerpt at 355 nm of global fit according to SpecFit. 
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C.3 Thermal Melting Experiments 
 
Figure C. 29. Thermal melting experiment of ctDNA with 206 (left) and 207 (right). 
 
 Figure C. 30. Thermal melting experiment of p(dAdT)2 with 196 (left) and 206 (right).  
 
Figure C. 31. Thermal melting experiment of p(dAdT)2 with 207 (left) and of pdA × pdT with 196 (right). 
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Figure C. 32. Thermal melting experiment of pdA × pdT with 206 (left) and of pA × pU with 196 (right). 
 
Figure C. 33. Thermal melting experiment of pA × pU with 207.  
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C.4 EB Displacement Assays 
 
Figure C. 34. EB displacement experiment with ctDNA and 196 (left) and excerpt of the fluorescence emission at 
600 nm plotted against the ratio of EB/196 with the corresponding fit (right). 
 
Figure C. 35. EB displacement experiment with ctDNA and 206 (left) and excerpt of the fluorescence emission at 
600 nm plotted against the ratio of EB/206 with the corresponding fit (right). 
 
Figure C. 36. EB displacement experiment with p(dAdT)2 and 196 (left) and excerpt of the fluorescence emission 
at 600 nm plotted against the ratio of EB/196 with the corresponding fit (right). 
 
Figure C. 37. EB displacement experiment with p(dAdT)2 and 206 (left) and excerpt of the fluorescence emission 
at 600 nm plotted against the ratio of EB/206 with the corresponding fit (right). 
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Figure C. 38. EB displacement experiment with p(dAdT)2 and 207 (left) and excerpt of the fluorescence emission 
at 600 nm plotted against the ratio of EB/207 with the corresponding fit (right). 
 
Figure C. 39. EB displacement experiment with pdA × pdT and 196 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/196 with the corresponding fit (right). 
 
Figure C. 40. EB displacement experiment with pdA × pdT and 206 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/206 with the corresponding fit (right). 
 
Figure C. 41. EB displacement experiment with pdA × pdT and 207 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/207 with the corresponding fit (right). 
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Figure C. 42. EB displacement experiment with p(dGdC)2 and 196 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/196 with the corresponding fit (right). 
 
Figure C. 43. EB displacement experiment with p(dGdC)2 and 206 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/206 with the corresponding fit (right). 
 
Figure C. 44. EB displacement experiment with p(dGdC)2 and 207 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/207 with the corresponding fit (right). 
 
Figure C. 45. EB displacement experiment with pA × pU and 196 (left) and excerpt of the fluorescence emission 
at 600 nm plotted against the ratio of EB/196 with the corresponding fit (right). 
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Figure C. 46. EB displacement experiment with pA × pU and 206 (left) and excerpt of the fluorescence emission 
at 600 nm plotted against the ratio of EB/206 with the corresponding fit (right). 
 
Figure C. 47. EB displacement experiment with pA × pU and 207 (left) and excerpt of the fluorescence emission 
at 600 nm plotted against the ratio of EB/207 with the corresponding fit (right). 
 
 
Figure C. 47. EB displacement experiment with pF143-GFP and 196 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/196 with the corresponding fit (right). 
 
Figure C. 47. EB displacement experiment with pF143-GFP and 206 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/206 with the corresponding fit (right). 
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Figure C. 47. EB displacement experiment with pF143-GFP and 207 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/207 with the corresponding fit (right). 
 
Figure C. 51. EB displacement experiment with pF143-GFP and 233 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/233 with the corresponding fit (right). 
 
Figure C. 52. EB displacement experiment with pF143-GFP and 234 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/234 with the corresponding fit (right). 
 
Figure C. 53. EB displacement experiment with pF143-GFP and 235 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/235 with the corresponding fit (right). 
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Figure C. 54. EB displacement experiment with pF143-GFP and 236 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/236 with the corresponding fit (right). 
 
Figure C. 55. EB displacement experiment with pF143-GFP and 237 (left) and excerpt of the fluorescence 
emission at 600 nm plotted against the ratio of EB/237 with the corresponding fit (right). 
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C.5 ITC Experiments 
 
Figure C. 56. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196, 206 (c = 0.6 mM), or 207 (c = 0.3 mM) to pdA × pdT (c = 0.1 mM). Bottom: 
the titrations were corrected for dilution and fitted with a one-site model. The titrations with 196 and 206 are 
corrected for the first, and the one for 207 for the first two data points. 
 
Figure C. 57. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196, 206 (c = 0.6 mM), or 207 (c = 0.3 mM) to p(dGdC)2 (c = 0.1 mM). Bottom: the 
titrations were corrected for dilution and fitted with a one-site model. The titration with 196 is corrected for the 
first five, and the ones for 206 and 207 for the first data point. 
207 196 206 
207 196 206 
APPENDICES   281 
 
 
Figure C. 58. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196, 206 (c = 0.6 mM), or 207 (c = 0.3 mM) to pdG × pdC (c = 0.1 mM). Bottom: 
the titrations were corrected for dilution and fitted with a one-site model. The titrations with 196, 206, and 207 
are corrected for the first data point. 
 
Figure C. 59. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196, 206 (c = 0.6 mM), or 207 (c = 0.3 mM) to pA × pU (c = 0.1 mM). Bottom: the 
titrations were corrected for dilution and fitted with a one-site model. The titrations with 196 and 206 are 
corrected for the first, and the one for 207 for the first two data points. 
206 207 196 
207 196 206 
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Figure C. 60. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196, 206 (c = 0.6 mM), or 207 (c = 0.3 mM) to pG × pC (c = 0.1 mM). Bottom: the 
titrations were corrected for dilution and fitted with a one-site model. The titration with 196 is corrected for the 
first five, and the ones for 206 and 207 for the first data point. 
 
Figure C. 61. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196, 206 (c = 0.6 mM), or 207 (c = 0.3 mM) to p(dAdT)2 (c = 0.1 mM). Bottom: the 
titrations were corrected for dilution and fitted with a one-site model. The titrations with 196 and 206 are 
corrected for the first six, and the one for 207 for the first data point. 
 
 
207 196 206 
207 
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Figure C. 62. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 196, 206 (c = 0.6 mM), or 207 (c = 0.3 mM) to pF143-GFP (196: 0.09 mM; 206, 
207: 0.1 mM). Bottom: the titrations were corrected for dilution and fitted with a one-site model. The titration 
with 196 is corrected for the first, third, and seventh; the one for 206 for the first, fifth, sixth, and seventh; and 
the one for 207 for the first data point. 
 
Figure C. 63. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 234, 235 (c = 0.1 mM), or 237 (c = 0.2 mM) to p(dAdT)2 ( 0.04 mM). Bottom: the 
titrations were corrected for dilution and fitted with a two-site model for 234, 235 and a one-site model for 237. 
The titration with 234 is corrected for the first three; and the one for 237 for the first two data points. 
207 196 206 
237 234 235 
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Figure C. 64. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 233 (c = 0.125 mM), 234 (c = 0.1 mM), or 235 (c = 0.06 mM) to pF143-GFP (233: 
0.05 mM; 234: 0.035 mM; 235: 0.03 mM). Bottom: the titrations were corrected for dilution and fitted with a 
two-site model. The titrations are corrected for the first data point. 
 
Figure C. 65. Top: ITC experiments were carried out in sodium cacodylate buffer (0.01 M) at neutral pH by 
titrating aliquots of 5 µL of 236(c = 0.1 mM) or 237 (c = 0.2 mM) to pF143-GFP (236: 0.04 mM; 237: 
0.03 mM). Bottom: the titrations were corrected for dilution and fitted with a two-site model for 236 and a one-
site model for 237. The titration of 236 is corrected for the first, 13th, 20th, 21st, 23rd, 24th, 25th data points. 
   
  
235 233 234 
237 236 
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C.6 DAPI Displacement Assays 
  
Figure C. 66. DAPI displacement experiment with pdA × pdT and 196 (left) and excerpt of the fluorescence 
emission at 460 nm plotted against the ratio of DAPI /196 with the corresponding fit (right). 
  
Figure C. 67. DAPI displacement experiment with pdA × pdT and 206 (left) and excerpt of the fluorescence 
emission at 460 nm plotted against the ratio of DAPI /206 with the corresponding fit (right). 
  
 Figure C. 68. DAPI displacement experiment with p(dAdT)2 and 196 (left) and excerpt of the fluorescence 
emission at 460 nm plotted against the ratio of DAPI /196 with the corresponding fit (right). 
  
Figure C. 69. DAPI displacement experiment with p(dAdT)2 and 206 (left) and excerpt of the fluorescence 
emission at 460 nm plotted against the ratio of DAPI /206 with the corresponding fit (right). 
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Figure C. 70. DAPI displacement experiment with p(dAdT)2 and 207 (left) and excerpt of the fluorescence 
emission at 455 nm plotted against the ratio of DAPI /207 with the corresponding fit (right). 
 
Figure C. 71. DAPI displacement experiment with p(dAdT)2 and 234 (left) and excerpt of the fluorescence 
emission at 455 nm plotted against the ratio of DAPI /234 with the corresponding fit (right). 
 
Figure C. 72. DAPI displacement experiment with p(dAdT)2 and 235 (left) and excerpt of the fluorescence 
emission at 455 nm plotted against the ratio of DAPI /235 with the corresponding fit (right). 
 
Figure C. 73. DAPI displacement experiment with p(dAdT)2 and 236 (left) and excerpt of the fluorescence 
emission at 455 nm plotted against the ratio of DAPI /236 with the corresponding fit (right). 
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Figure C. 74. DAPI displacement experiment with p(dAdT)2 and 237 (left) and excerpt of the fluorescence 
emission at 455 nm plotted against the ratio of DAPI /237 with the corresponding fit (right). 
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C.7 On-Bead Screening of the Library 
Screening Results for p(dAdT)2 
Table C. 1. Screening results of the combinatorial library 220 normalized to 100 %. The DNA ligands are listed 
in descending order of their ability to displace DAPI from p(dAdT)2. 
# AA1 AA2 AA3 
Remaining DAPI 
[%] Archive 
1 Trp Lys Arg 26 2-E07 
2 Arg Lys 31 3-C02 
3 Arg Arg Lys 32 1-A02 
4 Trp Arg Lys 33 2-E02 
5 Arg Lys Lys 34 1-A08 
6 Arg Arg Arg 35 1-A01 
7 Tyr Arg Arg 40 2-B01 
8 Arg Arg Tyr 41 1-A04 
9 Phe Tyr Lys 42 1-H08 
10 Arg Arg 42 3-C01 
11 Arg Arg Trp 43 1-A05 
12 Lys Arg Trp 44 1-D05 
13 Phe Tyr Arg 44 1-H07 
14 Trp Lys Lys 44 2-E08 
15 Phe Phe Lys 45 1-H02 
16 Lys Lys Lys 45 1-D08 
17 Phe Lys Arg 46 1-G07 
18 Arg Lys Phe 47 1-A09 
19 Arg Trp Lys 47 1-C02 
20 Glu Lys Lys 48 2-H08 
21 Tyr Arg Lys 50 2-B02 
22 Tyr Lys Lys 51 2-B08 
23 Tyr Tyr Phe 51 2-C09 
24 Lys Arg Phe 51 1-D03 
25 Phe Arg 51 3-D01 
26 Glu Arg Lys 52 2-H02 
27 Lys Lys Arg 52 1-D07 
28 Lys Tyr Arg 53 1-E07 
29 Tyr Lys Tyr 53 2-B10 
30 Arg Lys Arg 53 1-A07 
31 Arg Phe Arg 54 1-B01 
32 Lys Lys 54 3-C08 
33 Phe Phe Trp 54 1-H05 
34 Phe Phe Glu 54 1-H06 
35 Phe Tyr Phe 54 1-H09 
36 Lys Arg 55 3-C07 
37 Arg Lys Tyr 55 1-A10 
38 Tyr Tyr Arg 56 2-C07 
39 Arg Trp 57 3-C05 
40 Phe Glu Tyr 58 2-A10 
41 Glu Glu Trp 58 3-B11 
42 Arg Glu Lys 58 1-C08 
43 Lys Arg Arg 58 1-D01 
44 Phe Phe Arg 58 1-H01 
45 Arg Phe 58 3-C03 
46 Arg Glu Arg 58 1-C07 
47 Glu Arg Tyr 59 2-H04 
48 Trp Arg 59 3-E01 
49 Phe Glu Phe 59 2-A09 
50 Lys Trp 59 3-C11 
51 Trp Lys Glu 60 2-E12 
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52 Arg Lys Trp 60 1-A11 
53 Phe Lys Trp 60 1-G11 
54 Phe Lys Lys 60 1-G08 
55 Lys Arg Glu 61 1-D06 
56 Phe Lys Tyr 61 1-G10 
57 Lys Tyr Glu 61 1-E12 
58 Trp Glu Trp 61 2-G11 
59 Phe Glu Lys 61 2-A08 
60 Trp Lys Phe 61 2-E09 
61 Phe Lys Phe 61 1-G09 
62 Tyr Tyr Glu 61 2-C12 
63 Phe Tyr Trp 61 1-H11 
64 Lys Tyr 61 3-C10 
65 Phe Arg Glu 62 1-G06 
66 Glu Arg Glu 62 2-H06 
67 Arg Glu Tyr 62 1-C10 
68 Tyr Phe Glu 62 2-C06 
69 Trp Glu Lys 62 2-G08 
70 Trp Glu Tyr 62 2-G10 
71 Trp Tyr Glu 62 2-F12 
72 Lys Phe 63 3-C09 
73 Lys Trp Lys 63 1-F02 
74 Glu Glu Glu 63 3-B12 
75 Trp Phe Arg 63 2-F01 
76 Tyr Trp Lys 63 2-D02 
77 Glu Lys Arg 63 2-H07 
78 Glu Lys Phe 63 2-H09 
79 Arg Tyr Arg 64 1-B07 
80 Arg Tyr Lys 64 1-B08 
81 Arg Arg Phe 64 1-A03 
82 Trp Trp Glu 64 2-G06 
83 Trp Glu Phe 64 2-G09 
84 Glu Glu Phe 64 3-B09 
85 Trp Arg Tyr 64 2-E04 
86 Tyr Trp Phe 64 2-D03 
87 Glu Trp Phe 65 3-B03 
88 Phe Tyr Glu 65 1-H12 
89 Trp Trp Phe 65 2-G03 
90 Trp Phe Phe 65 2-F03 
91 Trp Arg Trp 65 2-E05 
92 Trp Lys Trp 65 2-E11 
93 Glu Arg Arg 65 2-H01 
94 Lys Trp Arg 65 1-F01 
95 Glu Trp Glu 65 3-B06 
96 Trp Phe Lys 65 2-F02 
97 Trp Tyr Arg 65 2-F07 
98 Trp Lys Tyr 65 2-E10 
99 Phe Phe Tyr 66 1-H04 
100 Tyr Arg Tyr 66 2-B04 
101 Lys Lys Trp 66 1-D11 
102 Trp Arg Arg 66 2-E01 
103 Lys Lys Glu 66 1-D12 
104 Tyr Phe Trp 66 2-C05 
105 Arg Tyr Trp 66 1-B11 
106 Arg Lys Glu 67 1-A12 
107 Phe Arg Tyr 67 1-G04 
108 Phe Tyr Tyr 67 1-H10 
109 Lys Arg Tyr 67 1-D04 
110 Tyr Tyr Lys 67 2-C08 
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111 Lys Phe Tyr 67 1-E04 
112 Phe Trp Trp 67 2-A05 
113 Tyr Tyr Trp 67 2-C11 
114 Arg Phe Glu 68 1-B06 
115 Tyr Glu Tyr 68 2-D10 
116 Phe Trp Arg 68 2-A01 
117 Glu Arg Trp 68 2-H05 
118 Arg Trp Trp 68 1-C05 
119 Phe Glu Arg 68 2-A07 
120 Lys Trp Phe 68 1-F03 
121 Phe Arg Arg 68 1-G01 
122 Tyr Phe Lys 68 2-C02 
123 68 3-F07 
124 Trp Glu Arg 68 2-G07 
125 Lys Phe Lys 68 1-E02 
126 Glu Tyr Glu 68 3-A12 
127 Arg Trp Tyr 69 1-C04 
128 Trp Phe Trp 69 2-F05 
129 Trp Trp Trp 69 2-G05 
130 Tyr Arg 69 3-D07 
131 Lys Phe Arg 69 1-E01 
132 Phe Arg Lys 69 1-G02 
133 Trp Arg Glu 69 2-E06 
134 Glu 69 3-F06 
135 Phe Trp Glu 69 2-A06 
136 Arg Trp Glu 69 1-C06 
137 Tyr Lys 69 3-D08 
138 Tyr Tyr 69 3-D10 
139 Trp Tyr Tyr 69 2-F10 
140 Tyr Arg Glu 70 2-B06 
141 Trp Trp Arg 70 2-G01 
142 Trp Glu Glu 70 2-G12 
143 Lys Arg Lys 70 1-D02 
144 Phe Lys Glu 70 1-G12 
145 Glu Lys 70 3-E08 
146 Trp Glu 70 3-E06 
147 Tyr Tyr Tyr 70 2-C10 
148 Lys Lys Phe 70 1-D09 
149 Glu Arg 71 3-E07 
150 Arg Phe Tyr 71 1-B04 
151 Trp Tyr Trp 71 2-F11 
152 Lys Glu 71 3-C12 
153 Phe Trp 71 3-D05 
154 Phe Phe Phe 71 1-H03 
155 Arg Tyr Phe 71 1-B09 
156 Tyr Glu Lys 71 2-D08 
157 Arg Tyr Glu 71 1-B12 
158 Glu Phe 71 3-E09 
159 Phe Trp Lys 71 2-A02 
160 Tyr Glu Trp 71 2-D11 
161 Trp Tyr Lys 71 2-F08 
162 Phe Arg Trp 72 1-G05 
163 Arg Glu 72 3-C06 
164 Lys Tyr Tyr 72 1-E10 
165 Tyr Phe Phe 72 2-C03 
166 Tyr Glu Phe 72 2-D09 
167 Arg Phe Trp 72 1-B05 
168 Tyr Lys Phe 72 2-B09 
169 Arg Glu Phe 72 1-C09 
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170 Lys Glu Glu 72 1-F12 
171 Glu Trp 72 3-E11 
172 Tyr Trp Trp 72 2-D05 
173 Tyr Glu Arg 72 2-D07 
174 Lys Trp Tyr 73 1-F04 
175 Trp Lys 73 3-E02 
176 Glu Arg Phe 73 2-H03 
177 Glu Lys Glu 73 2-H12 
178 Tyr Trp Tyr 73 2-D04 
179 Arg Trp Phe 73 1-C03 
180 Phe Glu Glu 73 2-A12 
181 Trp Arg Phe 73 2-E03 
182 Tyr Arg Phe 73 2-B03 
183 Trp Phe Glu 73 2-F06 
184 Lys Glu Phe 73 1-F09 
185 Tyr Lys Trp 74 2-B11 
186 Arg Tyr Tyr 74 1-B10 
187 Phe Arg Phe 74 1-G03 
188 Trp Phe Tyr 74 2-F04 
189 Glu Phe Trp 74 3-A05 
190 Glu Glu Lys 74 3-B08 
191 Tyr Trp Glu 74 2-D06 
192 Lys Tyr Phe 74 1-E09 
193 Lys Lys Tyr 74 1-D10 
194 Phe Lys 74 3-D02 
195 Phe Glu Trp 74 2-A11 
196 Arg Tyr 74 3-C04 
197 Tyr Phe Tyr 74 2-C04 
198 Tyr Lys Glu 75 2-B12 
199 Glu Phe Phe 75 3-A03 
200 Tyr Trp Arg 75 2-D01 
201 Arg 75 3-F05 
202 Glu Lys Trp 75 2-H11 
203 Tyr Glu Glu 75 2-D12 
204 Arg Trp Arg 75 1-C01 
205 Trp Tyr Phe 75 2-F09 
206 Glu Tyr Tyr 75 3-A10 
207 Lys Tyr Lys 75 1-E08 
208 Lys 76 3-F04 
209 Trp Tyr 76 3-E04 
210 Tyr Phe Arg 76 2-C01 
211 Arg Glu Glu 76 1-C12 
212 Glu Phe Lys 76 3-A02 
213 Lys Glu Lys 76 1-F08 
214 Glu Glu 76 3-E12 
215 Tyr Glu 76 3-D12 
216 Lys Glu Tyr 76 1-F10 
217 Tyr Phe 76 3-D09 
218 Trp Trp Lys 77 2-G02 
219 Arg Phe Phe 77 1-B03 
220 Lys Trp Glu 77 1-F06 
221 Lys Trp Trp 77 1-F05 
222 Arg Phe Lys 77 1-B02 
223 Tyr Trp 78 3-D11 
224 Trp Phe 78 3-E03 
225 Phe Phe 78 3-D03 
226 Lys Phe Glu 78 1-E06 
227 Lys Phe Phe 79 1-E03 
228 Tyr Arg Trp 79 2-B05 
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229 Phe Trp Phe 79 2-A03 
230 Trp Trp Tyr 79 2-G04 
231 Lys Phe Trp 80 1-E05 
232 Phe 80 3-F03 
233 Glu Lys Tyr 80 2-H10 
234 Glu Trp Arg 80 3-B01 
235 Trp 81 3-F01 
236 Tyr 81 3-F02 
237 Glu Glu Tyr 82 3-B10 
238 Lys Glu Trp 82 1-F11 
239 Arg Glu Trp 82 1-C11 
240 Glu Tyr 82 3-E10 
241 Glu Tyr Lys 83 3-A08 
242 Glu Tyr Arg 83 3-A07 
243 Lys Tyr Trp 83 1-E11 
244 Glu Trp Trp 84 3-B05 
245 Phe Glu 86 3-D06 
246 Glu Glu Arg 86 3-B07 
247 Tyr Lys Arg 87 2-B07 
248 Glu Phe Arg 87 3-A01 
249 Phe Trp Tyr 88 2-A04 
250 Arg Arg Glu 89 1-A06 
251 Trp Trp 89 3-E05 
252 Glu Tyr Phe 89 3-A09 
253 Lys Glu Arg 89 1-F07 
254 Phe Tyr 91 3-D04 
255 Glu Phe Glu 93 3-A06 
256 Glu Tyr Trp 93 3-A11 
257 Glu Phe Tyr 94 3-A04 
258 Glu Trp Lys 98 3-B02 
259 Glu Trp Tyr 100 3-B04 
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Screening Results for pF143-GFP plasmid DNA 
Table C. 2. Screening results of the combinatorial library 220 normalized to 100 %. The DNA ligands are listed 
in descending order of their ability to displace EB from pF143-GFP plasmid DNA. 
# AA1 AA2 AA3 Remaining EB [%] Archive 
1 Trp Arg Lys   9 2-E02 
2 Trp Lys Arg 13 2-E07 
3 Lys Phe Arg 15 1-E01 
4 Lys Lys Phe 16 1-D09 
5  Arg Tyr 18 3-C04 
6 Arg Lys Tyr 18 1-A10 
7 Arg Tyr Arg 19 1-B07 
8 Arg Trp Arg 19 1-C01 
9 Arg Phe Arg 19 1-B01 
10  Arg Arg 19 3-C01 
11 Arg Lys Trp 20 1-A11 
12  Arg Lys 20 3-C02 
13 Lys Arg Tyr 20 1-D04 
14 Arg Phe Tyr 21 1-B04 
15 Arg Lys Lys 21 1-A08 
16 Trp Lys Lys 21 2-E08 
17 Trp Arg Tyr 21 2-E04 
18 Lys Arg Phe 22 1-D03 
19 Arg Phe Lys 22 1-B02 
20 Trp Arg Phe 22 2-E03 
21 Tyr Tyr Trp 23 2-C11 
22  Lys Tyr 24 3-D10 
23 Lys Lys Tyr 24 1-D10 
24 Phe Trp Lys 24 2-A02 
25 Trp Arg Arg 24 2-B01 
26 Lys Tyr Arg 24 1-E07 
27 Lys Lys Glu 24 1-D12 
28 Lys Arg Lys 25 1-D02 
29 Arg Arg Lys 25 1-A02 
30 Arg Tyr Trp 25 1-B11 
31 Phe Lys Arg 26 1-G07 
32 Tyr Phe Lys 26 2-C02 
33 Tyr Lys Phe 26 2-B09 
34 Arg Tyr Glu 26 1-B12 
35 Tyr Arg Arg 26 2-B01 
36 Arg Arg Phe 26 1-A03 
37 Tyr Lys Arg 27 2-B07 
38 Lys Lys Trp 27 1-D11 
39 Arg Trp Tyr 27 1-C04 
40 Arg Tyr Tyr 27 1-B10 
41 Arg Trp Glu 27 1-C06 
42 Phe Phe Arg 27 1-H01 
43 Arg Arg Tyr 27 1-A04 
44 Tyr Arg Phe 27 2-B03 
45 Arg Phe Trp 27 1-B05 
46 Lys Arg Glu 27 1-D06 
47 Phe Trp Arg 28 2-A01 
48 Tyr Phe Arg 28 2-C01 
49 Arg Glu Glu 28 1-C12 
50 Tyr Arg Trp 28 2-B05 
51 Arg Tyr Lys 28 1-B08 
52 Tyr Phe Tyr 28 2-C04 
53 Tyr Phe Trp 28 2-C05 
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54 Tyr Tyr Lys 28 2-C08 
55 Trp Arg Trp 28 2-E05 
56 Phe Trp Tyr 28 2-A04 
57 Arg Phe Phe 28 1-B03 
58 Lys Lys Arg 28 1-D07 
59 Arg Glu Phe 29 1-C09 
60 Tyr Arg Tyr 29 2-B04 
61 Tyr Tyr Tyr 29 2-C10 
62 Phe Trp Phe 29 2-A03 
63 Arg Arg Glu 29 1-A06 
64  Arg Trp 29 3-C05 
65 Tyr Lys Trp 29 2-B11 
66 Arg Glu Trp 29 1-C11 
67 Glu Arg Lys 29 2-H02 
68 Arg Trp Trp 29 1-C05 
69 Lys Lys Lys 30 1-D08 
70 Phe Tyr Tyr 30 1-H10 
71 Tyr Lys Glu 31 2-B12 
72   Arg 31 3-F05 
73 Phe Tyr Arg 31 1-H07 
74 Tyr Phe Phe 32 2-C03 
75 Tyr Arg Glu 32 2-B06 
76 Glu Lys Lys 32 2-H08 
77 Phe Tyr Glu 32 1-H12 
78 Phe Trp Trp 32 2-A05 
79  Lys Lys 33 3-C08 
80 Trp Lys Tyr 33 2-E10 
81 Lys Phe Lys 33 1-E02 
82  Tyr Arg 33 3-D07 
83 Tyr Lys Tyr 33 2-B10 
84 Phe Lys Lys 33 1-G08 
85 Lys Tyr Phe 33 1-E09 
86  Lys Arg 33 3-C07 
87   Lys 34 3-F04 
88 Arg Arg Trp 34 1-A05 
89 Lys Trp Lys 34 1-F02 
90 Arg Glu Arg 34 1-C07 
91 Phe Glu Glu 34 2-A12 
92 Phe Phe Tyr 34 1-H04 
93 Tyr Trp Lys 34 2-D02 
94 Arg Lys Phe 34 1-A09 
95 Phe Arg Tyr 35 1-G04 
96 Arg Glu Lys 35 1-C08 
97 Phe Lys Glu 35 1-G12 
98 Lys Arg Arg 35 1-D01 
99 Trp Trp Arg 35 2-G01 
100 Phe Tyr Lys 35 1-H08 
101 Glu Lys Arg 35 2-H07 
102 Phe Lys Tyr 35 1-G10 
103 Phe Lys Phe 35 1-G09 
104 Tyr Arg Lys 35 2-B02 
105  Tyr Lys 36 3-D08 
106  Phe Trp 36 3-D05 
107 Phe Lys Trp 36 1-G11 
108 Arg Lys Arg 36 1-A07 
109 Arg Trp Lys 36 1-C02 
110 Lys Tyr Glu 36 1-E12 
111 Phe Glu Arg 36 2-A07 
112 Trp Arg Glu 37 2-E06 
APPENDICES   295 
 
113 Phe Phe Trp 37 1-H05 
114 Arg Arg Arg 37 1-A01 
115 Lys Arg Trp 37 1-D05 
116 Lys Glu Trp 37 1-F11 
117 Glu Arg Arg 37 2-H01 
118 Glu Phe Arg 37 3-A01 
119 Phe Phe Lys 37 1-H02 
120 Glu Trp Lys 37 3-B02 
121 Lys Glu Arg 37 1-F07 
122 Tyr Tyr Arg 37 2-C07 
123 Glu Tyr Arg 37 3-A07 
124 Trp Trp Tyr 38 2-G04 
125 Lys Phe Tyr 38 1-E04 
126 Lys Phe Phe 38 1-E03 
127 Lys Phe Glu 38 1-E06 
128 Glu Phe Lys 38 3-A02 
129  Tyr Trp 38 3-D11 
130  Phe Arg 38 3-D01 
131 Glu Lys Phe 38 2-H09 
132 Lys Glu Phe 38 1-F09 
133 Tyr Tyr Phe 38 2-C09 
134  Lys Glu 38 3-C12 
135 Trp Lys Trp 38 2-E11 
136  Lys Phe 38 3-C09 
137 Tyr Lys Lys 39 2-B08 
138  Trp Arg 39 3-E01 
139 Lys Trp Arg 39 1-F01 
140 Trp Glu Arg 39 2-G07 
141 Glu Lys Trp 39 2-H11 
142 Glu Arg Tyr 39 2-H04 
143 Glu Arg Phe 39 2-H03 
144 Lys Trp Tyr 39 1-F04 
145 Phe Arg Glu 39 1-G06 
146 Glu Arg Trp 39 2-H05 
147 Phe Arg Trp 39 1-G05 
148  Phe Lys 39 3-D02 
149   Phe 39 3-F03 
150  Arg Glu 39 3-C06 
151 Lys Glu Tyr 40 1-F10 
152 Phe Phe Phe 40 1-H03 
153 Phe Tyr Trp 40 1-H11 
154 Glu Lys Tyr 40 2-H10 
155  Lys Trp 40 3-C11 
156 Lys Tyr Lys 40 1-E08 
157 Glu Glu Glu 40 3-B12 
158 Lys Tyr Tyr 40 1-E10 
159  Trp Tyr 40 3-E04 
160 Trp Lys Glu 40 2-E12 
161 Lys Phe Trp 40 1-E05 
162 Glu Phe Glu 40 3-A06 
163 Lys Glu Glu 40 1-F12 
164  Phe Phe 40 3-D03 
165 Lys Glu Lys 40 1-F08 
166 Trp Trp Phe 40 2-G03 
167 Phe Arg Phe 40 1-G03 
168  Arg Phe 41 3-C03 
169 Tyr Phe Glu 41 2-C06 
170 Lys Trp Trp 41 1-F05 
171 Glu Trp Arg 41 3-B01 
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172 Trp Trp Lys 41 2-G02 
173 Glu Tyr Lys 41 3-A08 
174 Lys Tyr Trp 41 1-E11 
175 Trp Lys Phe 41 2-E09 
176   CBS 41 3-F07 
177  Phe Tyr 42 3-D04 
178  Tyr Phe 42 3-D09 
179 Glu Glu Arg 42 3-B07 
180 Phe Tyr Phe 42 1-H09 
181 Lys Trp Phe 42 1-F03 
182 Trp Phe Tyr 42 2-F04 
183  Trp Lys 42 3-E02 
184  Glu Arg 42 3-E07 
185 Phe Glu Lys 43 2-A08 
186 Trp Trp Trp 43 2-G05 
187 Tyr Glu Arg 43 2-D07 
188 Arg Tyr Phe 43 1-B09 
189 Lys Trp Glu 43 1-F06 
190 Tyr Trp Arg 43 2-D01 
191  Glu Lys 44 3-E08 
192 Trp Phe Arg 44 2-F01 
193 Tyr Glu Lys 44 2-D08 
194   Tyr 44 3-F02 
195  Trp Phe 44 3-E03 
196 Arg Lys Glu 45 1-A12 
197  Trp Trp 45 3-E05 
198   Trp 45 3-F01 
199 Glu Lys Glu 46 2-H12 
200  Glu Glu 46 3-E12 
201 Phe Arg Lys 46 1-G02 
202 Phe Trp Glu 48 2-A06 
203   Glu 48 3-F06 
204 Tyr Trp Trp 48 2-D05 
205 Glu Glu Lys 48 3-B08 
206 Tyr Trp Tyr 48 2-D04 
207 Phe Glu Phe 49 2-A09 
208 Arg Phe Glu 49 1-B06 
209 Trp Glu Glu 49 2-G12 
210 Trp Tyr Arg 49 2-F07 
211 Trp Tyr Phe 50 2-F09 
212 Tyr Tyr Glu 50 2-C12 
213 Glu Arg Glu 50 2-H06 
214  Tyr Tyr 50 3-D10 
215 Phe Glu Tyr 50 2-A10 
216 Glu Tyr Glu 51 3-A12 
217 Arg Trp Phe 51 1-C03 
218 Tyr Trp Phe 51 2-D03 
219 Phe Arg Arg 52 1G01 
220 Glu Glu Trp 52 3-B11 
221  Glu Phe 53 3-E09 
222 Phe Glu Trp 53 2-A11 
223 Trp Phe Phe 54 2-F03 
224 Glu Phe Phe 55 3-A03 
225 Arg Glu Tyr 56 1-C10 
226 Glu Trp Glu 56 3-B06 
227 Glu Glu Tyr 56 3-B10 
228 Glu Trp Tyr 60 3-B04 
229 Trp Phe Lys 61 2-F02 
230 Trp Tyr Glu 61 2-F12 
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231 Trp Tyr Tyr 61 2-F10 
232 Glu Glu Phe 62 3-B09 
233 Trp Phe Trp 62 2-F05 
234 Trp Tyr Lys 62 2-F08 
235 Glu Tyr Tyr 64 3-A10 
236  Glu Trp 65 3-E11 
237 Trp Tyr Trp 65 2-F11 
238 Tyr Glu Phe 65 2-D09 
239  Phe Glu 65 3-D06 
240 Tyr Glu Glu 65 2-D12 
241  Trp Glu 68 3-E06 
242 Phe Phe Glu 69 1-H06 
243  Tyr Glu 69 3-D12 
244 Glu Trp Phe 70 3-B03 
245 Glu Tyr Phe 71 3-A09 
246 Trp Glu Lys 72 2-G08 
247 Trp Glu Tyr 73 2-G10 
248 Trp Trp Glu 74 2-G06 
249 Trp Glu Trp 78 2-G11 
250 Glu Trp Trp 79 3-B05 
251 Glu Phe Tyr 81 3-A04 
252 Tyr Glu Trp 83 2-D11 
253  Glu Tyr 84 3-E10 
254 Glu Phe Trp 85 3-A05 
255 Glu Tyr Trp 86 3-A11 
256 Trp Glu Phe 87 2-G09 
257 Tyr Glu Tyr 88 2-D10 
258 Trp Phe Glu 99 2-F06 
259 Tyr Trp Glu 100 2-D06 
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